OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	anomaly_curious_finding

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC3432839	8/2012	S24-PMC3432839	['HOWEVER, they MAY BE an INDICATOR of increased risk of arthritis in Adulthood, SINCE it HAS BEEN SHOWN that children with Limb pains are more LIKELY to have parents and/or grandparents with a history of arthritis COMPARED TO the general population.1among SMALL STUDIES of selected groups of children, recurrent Limb pains HAVE BEEN REPORTED to be PARTICULARLY PREVALENT in obese children,4and in those with some Vitamin D deficiency,5THOUGH this WAS NOT FOUND in a SMALL STUDY in new mexico.6other POSSIBILITIES HAVE BEEN summarised by evans and scutter.7\nAdult arthritis HAS long BEEN CONSIDERED to be a condition that COULD BE ameliorated or prevented by dietary manipulation, with SUGGESTIONS of different components of the diet being IMPORTANT—particularly Ω-3 Fatty Acids.8TO OUR KNOWLEDGE the ONLY specific dietary factor that has BEEN CONSIDERED in regard to childhood Limb pain concerns a study of 532 greek children aged 4–12.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 322), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 347), ('IMPORTANT_CONSIDERATION', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 433), ('INCOMPLETE_EVIDENCE', 446), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 454), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 572), ('INCOMPLETE_EVIDENCE', 586), ('INCOMPLETE_EVIDENCE', 620), ('INCOMPLETE_EVIDENCE', 684), ('IMPORTANT_CONSIDERATION', 738), ('PROBABLE_UNDERSTANDING', 777), ('INCOMPLETE_EVIDENCE', 799), ('ANOMALY_CURIOUS_FINDING', 837), ('INCOMPLETE_EVIDENCE', 842)]	27	[('UBERON_0000113', 'post-juvenile adult stage', 68, 'adulthood'), ('UBERON_0002101', 'limb', 122, 'limb'), ('UBERON_0002101', 'limb', 311, 'limb'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin D'), ('UBERON_0007023', 'adult organism', 556, 'Adult'), ('CHEBI_18320', '1,4-dithiothreitol', 761, 'ω-3'), ('CHEBI_35366', 'fatty acid', 765, 'fatty acids'), ('UBERON_0002101', 'limb', 876, 'limb')]
PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
PMC3427192	4/2012	S28-PMC3427192	['studies of Vitamin D exposure in early Life and Respiratory outcomesauthoryearcountrystudy designsample sizeage of children at assessmentdetermination of Vitamin D statusassociation between Vitamin D and Respiratory outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth to 1 ymaternal Food-frequency questionnaire and Cord Blood 25(Oh)Dlower 25(Oh)D concentrations ASSOCIATED with an increased risk of Respiratory syncytial Virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal Food-frequency questionnairehighest quartile of Vitamin D intake during Pregnancy ASSOCIATED with a lower risk of recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth to 5 ycord Blood 25(Oh)Dhigher 25(Oh)D ASSOCIATED with a decreased risk of Respiratory infection and wheezing BUT NO associations with childhood asthma NOTEDCARROLL602011CANADACROSS-sectional340 mother-infant dyads5–29 weeksmaternal whole Blood 25(Oh)Dincreasing maternal 25(Oh)D ASSOCIATED with decreased odds of asthma in mothers BUT no associations with infantile wheezing noteddevereux612007scotlandprospective cohort2000 Pregnant women, 1212 children5 ymaternal Food-frequency questionnairehighest and lowest maternal Vitamin D intakes ASSOCIATED with lower risk of wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with lower risk of asthma and allergic rhinitisgale632008ukprospective cohort466 mothers and 178 children9 mo and 9 ymaternal Serum 25(Oh)Dmaternal Vitamin D levels > 75 nmol/l ASSOCIATED with increased risk of atopic dermatitis and asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with a decreased risk of wheeze and atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(Oh)Dincreased maternal 25(Oh)D ASSOCIATED with a decreased risk of lower Respiratory infections BUT NOT wheezing or asthmarothers662011united statesprospective cohort219 childrenbirth to 5 ycord Blood 25(Oh)Dboth low and high Cord Blood 25(Oh)D ASSOCIATED with increased Aeroallergen sensitization BUT NOT with allergic rhinitis or asthma\nin other Birth cohort studies where 25(Oh)D concentrations were measured in the Plasma and whole Blood of Pregnant women, median 25(Oh)D concentrations ranged from APPROXIMATELY 20 to 29.5 ng/ml.60,63,65a 50% decrease in the odds of maternal asthma was FURTHER OBSERVED with every 35 nmol/l increase in 25(Oh)D levels, SUGGESTING a POSSIBLE LINK between Vitamin D status and asthma during Pregnancy.60HOWEVER, similar to the studies of maternal Vitamin D intake, NO CONSISTENT RELATIONSHIPS between 25(Oh)D concentrations and Respiratory symptoms during childhood HAVE BEEN observed.']	[('SUPERFICIAL_RELATIONSHIP', 381), ('SUPERFICIAL_RELATIONSHIP', 616), ('SUPERFICIAL_RELATIONSHIP', 765), ('ANOMALY_CURIOUS_FINDING', 836), ('ANOMALY_CURIOUS_FINDING', 878), ('SUPERFICIAL_RELATIONSHIP', 1006), ('ANOMALY_CURIOUS_FINDING', 1058), ('SUPERFICIAL_RELATIONSHIP', 1267), ('SUPERFICIAL_RELATIONSHIP', 1439), ('SUPERFICIAL_RELATIONSHIP', 1627), ('SUPERFICIAL_RELATIONSHIP', 1824), ('SUPERFICIAL_RELATIONSHIP', 1999), ('ANOMALY_CURIOUS_FINDING', 2064), ('SUPERFICIAL_RELATIONSHIP', 2213), ('ANOMALY_CURIOUS_FINDING', 2266), ('INCOMPLETE_EVIDENCE', 2471), ('INCOMPLETE_EVIDENCE', 2560), ('INCOMPLETE_EVIDENCE', 2568), ('INCOMPLETE_EVIDENCE', 2626), ('INCOMPLETE_EVIDENCE', 2639), ('SUPERFICIAL_RELATIONSHIP', 2648), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2706), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2770), ('SUPERFICIAL_RELATIONSHIP', 2784), ('INCOMPLETE_EVIDENCE', 2871)]	25	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 39, 'life'), ('UBERON_0001004', 'respiratory system', 48, 'respiratory'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 204, 'respiratory'), ('CHEBI_33290', 'food', 301, 'food'), ('UBERON_0002240', 'spinal cord', 334, 'cord'), ('UBERON_0000178', 'blood', 339, 'blood'), ('CHEBI_78858', '(R)-2-methylpyrrolidine', 345, '25(OH)DLower'), ('CHEBI_71657', 'versiconol acetate', 358, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 418, 'respiratory'), ('NCBITaxon_1', 'root', 440, 'virus'), ('CHEBI_33290', 'food', 534, 'food'), ('CHEBI_27300', 'vitamin D', 582, 'vitamin D'), ('GO_0007565', 'female pregnancy', 606, 'pregnancy'), ('UBERON_0000178', 'blood', 737, 'blood'), ('CHEBI_72842', '9-oxo-ODE', 743, '25(OH)DHigher'), ('CHEBI_71657', 'versiconol acetate', 757, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 801, 'respiratory'), ('UBERON_0000178', 'blood', 965, 'blood'), ('CHEBI_74350', 'N-diazoacetylnorleucine methyl ester', 971, '25(OH)DIncreasing'), ('PR_000011614', 'opioid growth factor receptor', 974, 'OH'), ('PR_000006449', 'diacylglycerol kinase kappa', 977, 'DIncreasing'), ('CHEBI_71657', 'versiconol acetate', 998, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 998, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 1152, 'pregnant'), ('CHEBI_33290', 'food', 1193, 'food'), ('CHEBI_27300', 'vitamin D', 1249, 'vitamin D'), ('CHEBI_33290', 'food', 1378, 'food'), ('CHEBI_27300', 'vitamin D', 1422, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1576, 'serum'), ('CHEBI_51469', 'butyllithium', 1582, '25(OH)DMaternal'), ('CHEBI_27300', 'vitamin D', 1598, 'vitamin D'), ('CHEBI_33290', 'food', 1763, 'food'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('CHEBI_86378', '(25R)-3beta-hydroxycholest-5-en-26-oic acid', 1965, '25(OH)DIncreased'), ('PR_000011040', 'nuclear receptor coactivator 1', 1967, '(OH'), ('CHEBI_71657', 'versiconol acetate', 1991, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1991, '25(OH ... D'), ('UBERON_0001004', 'respiratory system', 2041, 'respiratory'), ('UBERON_0000178', 'blood', 2163, 'blood'), ('CHEBI_73803', 'Ala-Asp', 2169, '25(OH)DBoth'), ('UBERON_0002240', 'spinal cord', 2194, 'cord'), ('UBERON_0000178', 'blood', 2199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 2205, '25(OH)D'), ('CHEBI_2500', 'Aescin', 2239, 'aeroallergen'), ('GO_0007567', 'parturition', 2316, 'birth'), ('CHEBI_71657', 'versiconol acetate', 2343, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 2387, 'plasma'), ('UBERON_0000178', 'blood', 2404, 'blood'), ('GO_0007565', 'female pregnancy', 2413, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2436, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 2610, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 2616, 'D'), ('CHEBI_27300', 'vitamin D', 2661, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2696, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2752, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2806, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 2833, 'respiratory')]
PMC3717170	5/2013	S141-PMC3717170	['the results from SMALL clinical trials and post hoc analyses of larger trials on the EFFECT of Vitamin D supplementation on diabetes-related parameters HAVE BEEN INCONCLUSIVE, although Vitamin D APPEARS to have beneficial EFFECTS in Persons AT RISK for diabetes.36–39HOWEVER, no firm conclusions can be drawn from the available intervention studies BECAUSE of several LIMITATIONS: (1) NEARLY ALL studies were UNDERPOWERED; (2) the MINORITY of studies were designed specifically for Glycemic outcomes; (3) MOST STUDIES DID NOT REPORT use of diabetes medications at baseline or during the study; (4) SOME TRIALS used large infrequent doses of Vitamin D, which MAY BE Metabolized DIFFERENTLY compared to daily doses and MAY provide EITHER no benefit OR result in an UNFAVORABLE benefit/risk ratio.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('ANOMALY_CURIOUS_FINDING', 195), ('SUPERFICIAL_RELATIONSHIP', 222), ('IMPORTANT_CONSIDERATION', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('PROBLEM_COMPLICATION', 349), ('INCOMPLETE_EVIDENCE', 368), ('PROBLEM_COMPLICATION', 368), ('PROBABLE_UNDERSTANDING', 385), ('PROBLEM_COMPLICATION', 409), ('INCOMPLETE_EVIDENCE', 431), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 658), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 677), ('INCOMPLETE_EVIDENCE', 717), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 729), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 747), ('IMPORTANT_CONSIDERATION', 763)]	23	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'persons'), ('GO_0006096', 'glycolytic process', 482, 'glycemic'), ('CHEBI_27300', 'vitamin D', 641, 'vitamin D'), ('GO_0008152', 'metabolic process', 665, 'metabolized')]
PMC4448820	5/2015	S537-PMC4448820	['caption (table-wrap): table 6\n\neffects of Micronutrient supplementation on Immune function and vaccine responses (Human studies)1type of malnutrition and type of Immune functioneffects of supplementation on Immune System (reference)vitamin a\u2003Epithelial barrier function● high-dose vas above 6 mo of age decreases risk of death from infections such as measles and diarrheal diseases (290)● vas in the context of hiv infection or Lower Respiratory Tract infections HAS BEEN ASSOCIATED with adverse outcomes (105,263,290–292)● improved barrier function (105)● abnormal dual-Sugar (Lactulose, Mannitol) Intestinal permeability inversely CORRELATED with Serum Retinol (293) and PARTIALLY normalized by supplementation in va-deficient Individuals in SOME STUDIES (294) BUT NOT OTHERS (295,296)● increased symptomatology after high-dose vas during acute Lower Respiratory Tract infections REPORTED in SOME STUDIES (105) MAY INDICATE restored Mucus Production\u2003innate physiologic barriers● vas did not affect crp, saa, and/or agp concentrations among children with subclinical or clinical vad (297–299)● crp and agp did not change in men with low va stores given va (300)\u2003Macrophage function● increased Monocyte numbers (301)● decreased Tnf-Α concentrations in children (301) BUT the OPPOSITE in men (106)● decreased Ifn-Γ concentrations in children (302) but not in Pregnant women (303)● increased Il-10 concentrations in children (105,301) BUT no or an opposite effect in Adults (106,303,304)\u2003Neutrophil function● Neutrophil Phagocytosis of latex beads increased in va-deficient children given a single dose of Va (305)● Neutrophil Phagocytosis of E. Coli did not change in men with low Va stores given Va (300)\u2003Nk Cell function● an increase in Nk Cells in hiv-infected children supplemented with Va (105)● Nk Cell numbers did not change in men with low Va given supplemental Va; HOWEVER, there was a positive CORRELATION between Va stores and Peripheral Blood Nk Cells (300)\u2003T Cell function● increased Lymphocyte counts, particularly cd4 counts (105)● Cd4:Cd8 ratios were increased or unchanged by supplementation (306)● increase in Naive cd4 T Cells after supplementation; higher Memory Cd8, Cd45Ro (307)● higher Mitogen-induced Il-2, Il-4, and Tnf in response to supplementation (106)\u2003B Cell function● supplementation had no overall effect on Measles vaccine response (308) and a negative response in Individuals with baseline high titers (103)● no overall effect on oral polio vaccination● supplemented children increased Igg1 responses to dtp, minor igg3 response, no change in igg2 and igg4 (309)● no overall effect on bcg vaccine in Va-supplemented children, lower response in va-supplemented boys at 2 mo (310)● increased Antibody responses to some vaccines (Measles vaccine by 9 mo of age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response to ppd in boys (103) and hospitalized children (105)Zinc\u2003Epithelial barrier function● zn supplementation in children LED TO an improvement in the lactulose:Mannitol Excretion ratio in SOME (311) BUT NOT OTHER (312,313) STUDIES; ratio MAY improve in infected children without zn deficiency given supplemental zn (314)\u2003innate physiologic barriers ● zn-supplemented children had higher Serum Complement C3 (315)\u2003Nk Cell function● children with diarrhea supplemented with zn supplementation do not exhibit an increase in Nk Cells (316)● increased Nk Cell activity in the elderly (317)\u2003T Cell function● increased cd4+ cell count in aids patients (318)● increased Thymocyte count in Thymus (319)● increased thymulin activity (320)● no CONSISTENT effect of zn supplementation on dth to tb Antigen [reviewed in (103)]\u2003B Cell function● no effect of zn supplementation of mothers on Bcg response in children (321)\nagp, α1-acid Glycoprotein; bcg, bacille calmette-guérin; cd, cluster of differentiation; Cd45Ro , Cluster Of Differentiation Antigen 45 Ro; Crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, Serum Amyloid a; tb, tuberculosis; va, Vitamin A; vad, Vitamin A deficiency; vas, Vitamin A supplementation.']	[('INCOMPLETE_EVIDENCE', 463), ('SUPERFICIAL_RELATIONSHIP', 472), ('SUPERFICIAL_RELATIONSHIP', 633), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 763), ('INCOMPLETE_EVIDENCE', 882), ('INCOMPLETE_EVIDENCE', 894), ('INCOMPLETE_EVIDENCE', 913), ('INCOMPLETE_EVIDENCE', 917), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1267), ('ANOMALY_CURIOUS_FINDING', 1267), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1433), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1873), ('SUPERFICIAL_RELATIONSHIP', 1903), ('SUPERFICIAL_RELATIONSHIP', 3021), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3088), ('INCOMPLETE_EVIDENCE', 3088), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3099), ('INCOMPLETE_EVIDENCE', 3123), ('INCOMPLETE_EVIDENCE', 3138), ('INCOMPLETE_EVIDENCE', 3633)]	23	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 42, 'micronutrient'), ('UBERON_0002405', 'immune system', 75, 'immune'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('UBERON_0002405', 'immune system', 162, 'immune'), ('UBERON_0002405', 'immune system', 207, 'immune system'), ('UBERON_0000483', 'epithelium', 242, 'Epithelial'), ('UBERON_0004905', 'articulation', 428, 'lower respiratory tract'), ('CHEBI_24870', 'ion', 571, 'sugar'), ('CHEBI_25098', 'lyxoside', 578, 'lactulose'), ('CHEBI_25169', 'mannoside', 589, 'mannitol'), ('UBERON_0000160', 'intestine', 599, 'intestinal'), ('UBERON_0001977', 'blood serum', 649, 'serum'), ('CHEBI_26536', 'retinoic acid', 655, 'retinol'), ('NCBITaxon_1', 'root', 729, 'individuals'), ('UBERON_0004905', 'articulation', 847, 'lower respiratory tract'), ('GO_0007498', 'mesoderm development', 935, 'mucus production'), ('UBERON_0000912', 'mucus', 935, 'mucus'), ('CL_0000235', 'macrophage', 1163, 'Macrophage'), ('CL_0000576', 'monocyte', 1194, 'monocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 1228, 'TNF-α'), ('PR_000008920', 'interferon alpha-7', 1308, 'IFN-γ'), ('GO_0007565', 'female pregnancy', 1358, 'pregnant'), ('PR_000001470', 'interleukin-28B', 1390, 'IL-10'), ('UBERON_0007023', 'adult organism', 1465, 'adults'), ('CL_0000775', 'neutrophil', 1486, 'Neutrophil'), ('CL_0000775', 'neutrophil', 1507, 'Neutrophil'), ('GO_0007608', 'sensory perception of smell', 1507, 'Neutrophil'), ('GO_0006909', 'phagocytosis', 1518, 'phagocytosis'), ('CHEBI_37958', 'dye', 1604, 'VA'), ('CL_0000775', 'neutrophil', 1614, 'Neutrophil'), ('GO_0070231', 'T cell apoptotic process', 1614, 'Neutrophil phagocytosis'), ('NCBITaxon_10088', 'Mus <genus>', 1641, 'E. coli'), ('CHEBI_37958', 'dye', 1680, 'VA'), ('CHEBI_37958', 'dye', 1696, 'VA'), ('CL_0000623', 'natural killer cell', 1705, 'NK cell'), ('GO_0005634', 'nucleus', 1705, 'NK'), ('CL_0000623', 'natural killer cell', 1738, 'NK cells'), ('GO_0005634', 'nucleus', 1738, 'NK'), ('CHEBI_37958', 'dye', 1790, 'VA'), ('CL_0000623', 'natural killer cell', 1800, 'NK cell'), ('GO_0005634', 'nucleus', 1800, 'NK'), ('CHEBI_37958', 'dye', 1847, 'VA'), ('CHEBI_37958', 'dye', 1869, 'VA'), ('CHEBI_37958', 'dye', 1923, 'VA'), ('UBERON_0012101', 'perinatal stage', 1937, 'peripheral blood'), ('CL_0000623', 'natural killer cell', 1954, 'NK cells'), ('GO_0005634', 'nucleus', 1954, 'NK'), ('CL_0000084', 'T cell', 1969, 'T cell'), ('CL_0000542', 'lymphocyte', 1996, 'lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 2046, 'CD4'), ('PR_000005170', 'CD37 molecule', 2050, 'CD8'), ('CL_0000898', 'naive T cell', 2127, 'naive ... T cells'), ('GO_0007613', 'memory', 2175, 'memory'), ('PR_000005170', 'CD37 molecule', 2182, 'CD8'), ('PR_000005170', 'CD37 molecule', 2187, 'CD45RO'), ('CHEBI_52290', 'mitogen', 2208, 'mitogen'), ('PR_000001470', 'interleukin-28B', 2224, 'IL-2'), ('PR_000001470', 'interleukin-28B', 2230, 'IL-4'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 2240, 'TNF'), ('CL_0000236', 'B cell', 2281, 'B cell'), ('NCBITaxon_33208', 'Metazoa', 2339, 'measles'), ('NCBITaxon_1', 'root', 2397, 'individuals'), ('GO_0071735', 'IgG immunoglobulin complex', 2519, 'IgG1'), ('CHEBI_37958', 'dye', 2633, 'VA'), ('GO_0042571', 'immunoglobulin complex, circulating', 2723, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 2760, 'measles'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 2956, 'Zinc'), ('UBERON_0000483', 'epithelium', 2961, 'Epithelial'), ('CHEBI_25169', 'mannoside', 3060, 'mannitol'), ('GO_0007588', 'excretion', 3069, 'excretion'), ('UBERON_0001977', 'blood serum', 3287, 'serum'), ('PR_000004908', 'complement component C8 alpha chain', 3293, 'complement C3'), ('CL_0000623', 'natural killer cell', 3313, 'NK cell'), ('GO_0005634', 'nucleus', 3313, 'NK'), ('CL_0000623', 'natural killer cell', 3421, 'NK cells'), ('CL_0000623', 'natural killer cell', 3447, 'NK cell'), ('CL_0000084', 'T cell', 3485, 'T cell'), ('CL_0000893', 'thymocyte', 3562, 'thymocyte'), ('UBERON_0002370', 'thymus', 3581, 'thymus'), ('CHEBI_59132', 'antigen', 3686, 'antigen'), ('CL_0000236', 'B cell', 3714, 'B cell'), ('CHEBI_33250', 'atom', 3777, 'BCG'), ('CHEBI_17089', 'glycoprotein', 3821, 'glycoprotein'), ('PR_000005170', 'CD37 molecule', 3897, 'CD45RO'), ('PR_000011040', 'nuclear receptor coactivator 1', 3906, 'cluster of differentiation antigen 45 RO'), ('CHEBI_59132', 'antigen', 3933, 'antigen'), ('PR_000005890', 'crooked neck-like protein 1', 3948, 'CRP'), ('UBERON_0001977', 'blood serum', 4083, 'serum'), ('CHEBI_60425', 'amyloid fibril', 4089, 'amyloid'), ('CHEBI_27300', 'vitamin D', 4122, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4138, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4165, 'vitamin A')]
PMC4910734	6/2015	S135-PMC4910734	['MANY of the Micronutrients STUDIES HAVE BEEN BASED ON Plasma and Urinary clinical results, which SUGGEST the elevation of Lipid Peroxide-generated Aldehydes (Hne, mda)84–86as well as deficiencies in antioxidants, such as Vitamin E, Sulfur-containing Compounds, such as cysteine, methionine, and Gsh,119carnitine,120biotin,121and ( n -3) pufas.122given the depressed levels of Sulfur-containing Compounds in asd Individuals, it is NOT SURPRISING that these children are more sensitive than neurotypicals to the exposure of mercury and other heavy metals.78the antioxidant supplements, which SHOW symptom improvements include, but are not limited to Ubiquinol,123nac,124carnosine, and Vitamin C.125other Micronutrients, including b1,126B6-Mg2+,127Folate, Vitamin E, Retinol, and Zn2+, HAVE BEEN selected for a variety of reasons RELATING to the INVOLVEMENT in abnormal Metabolic pathways IMPLICATED in asd,1even THOUGH the clinical assays do not always show a deficiency in asd Individuals compared to neurotypical controls.119with all of the single Micronutrient STUDIES, there are CONFLICTING results regarding efficacy.119there are a FEW STUDIES, which utilize broad-spectrum Micronutrient supplementation and report improvements in clinical BIOMARKERS and/or various autism-rating scales.76,121,128the broad-spectrum Micronutrient STUDIES are very PROMISING BECAUSE all DEMONSTRATE a significant CORRELATION between nutritional deficiencies and severity of autistic symptoms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 430), ('ANOMALY_CURIOUS_FINDING', 434), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 783), ('SUPERFICIAL_RELATIONSHIP', 827), ('SUPERFICIAL_RELATIONSHIP', 843), ('SUPERFICIAL_RELATIONSHIP', 886), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 910), ('ANOMALY_CURIOUS_FINDING', 910), ('INCOMPLETE_EVIDENCE', 1062), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('INCOMPLETE_EVIDENCE', 1135), ('SUPERFICIAL_RELATIONSHIP', 1243), ('INCOMPLETE_EVIDENCE', 1333), ('PROBABLE_UNDERSTANDING', 1350), ('PROBABLE_UNDERSTANDING', 1360), ('INCOMPLETE_EVIDENCE', 1372), ('SUPERFICIAL_RELATIONSHIP', 1398)]	23	[('CHEBI_33839', 'macromolecule', 12, 'micronutrients'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('UBERON_0001088', 'urine', 65, 'urinary'), ('CHEBI_48107', 'nitric acid', 122, 'lipid peroxide'), ('CHEBI_17478', 'aldehyde', 147, 'aldehydes'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 158, 'HNE'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin E'), ('CHEBI_36933', 'oxygen-19 atom', 232, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 250, 'compounds'), ('CHEBI_16856', 'glutathione', 295, 'GSH'), ('CHEBI_36933', 'oxygen-19 atom', 376, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 394, 'compounds'), ('NCBITaxon_1', 'root', 411, 'individuals'), ('CHEBI_17976', 'ubiquinol', 648, 'ubiquinol'), ('CHEBI_27300', 'vitamin D', 683, 'vitamin C'), ('CHEBI_33839', 'macromolecule', 702, 'micronutrients'), ('CHEBI_73173', '2,4-DB', 731, '126B6'), ('CHEBI_6636', 'magnesium dichloride', 737, 'Mg2+,'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 742, '127folate'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin E'), ('CHEBI_26536', 'retinoic acid', 764, 'retinol'), ('CHEBI_29105', 'zinc(2+)', 777, 'Zn2+,'), ('GO_0008152', 'metabolic process', 867, 'metabolic'), ('NCBITaxon_1', 'root', 976, 'individuals'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1048, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1177, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1319, 'micronutrient')]
PMC5706533	11/2017	S176-PMC5706533	['in the meantime, we ENDORSE the NOTION that WHENEVER feasible, investigators SHOULD report all clinically IMPORTANT outcomes, EVEN in SMALL trials that are individually UNDERPOWERED to detect EFFECTS on such outcomes.45\njohn ioannidis RECENTLY REMARKED that “systematic reviews MAY SOMETIMES be most helpful IF, INSTEAD of focusing on the summary of the evidence, HIGHLIGHT the BIASES that are INVOLVED and what NEEDS to be done to remedy the state-of-the-EVIDENCE in the given field.”46we conclude that there is currently INSUFFICIENT EVIDENCE to guide RECOMMENDATIONS for Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 77), ('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 134), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 235), ('ANOMALY_CURIOUS_FINDING', 244), ('ANOMALY_CURIOUS_FINDING', 244), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 282), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312), ('INCOMPLETE_EVIDENCE', 364), ('PROBLEM_COMPLICATION', 378), ('SUPERFICIAL_RELATIONSHIP', 394), ('FUTURE_WORK', 412), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 523), ('FUTURE_WORK', 554)]	23	[('GO_0007565', 'female pregnancy', 574, 'prenatal'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D')]
PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4990268	8/2016	S1116-PMC4990268	['intable 6below, we have offered very brief comments on such implementation CONSIDERATIONS.10.1371/journal.pone.0160562.t006\n\ncaption (table-wrap): table 6\n“best buy” ratings for interventions reviewed.interventionpopulation impactease of Deliverycommentsbreastfeeding—early initiation ✓ ☺large magnitude EFFECT on newborn mortalityiron/ anemia ✓✓✓ ☺LIKELY a significant mortality EFFECT, BUT EVIDENCE is WEAK; clear benefit however for iugr multi-Micronutrient supplementation✓ ☺ ALTHOUGH iugr is reduced , in many low income settings there MAY BE no net benefit; under SOME conditions there MAY BE net harm Calcium ✓✓✓😐 large magnitude EFFECTS but significant logistical barriers at currently recommended dose antenatal Vitamin A ☺ no effects on our outcomes of interest Postnatal Vitamin A ✓ ☺EVIDENCE for IMPACT on early infant deaths in Vitamin-A deficient populationsiodine ✓ ☺major benefit in ↓’d burden of Cognitive disabilitybalanced protein-energy supplementation ✓✓✓😐 significant benefits, but cost & logistical challenges limit scalability deworming ☺ no effects on our outcomes of interest iptp/itns ✓✓✓✓ ☺large magnitude EFFECTS in malarious areastetanus Toxoid ✓ ☺in most settings, coverage is now relatively high; this NEEDS to be sustainedchlorhexidine advance distribution ✓ ☺large magnitude EFFECT on newborn mortality in high nmr populationssyphilis screening & treatment ✓✓✓ ☺relatively inexpensive and straightforward diagnostics and treatmentpmtct ✓😐 high population effective coverage REQUIRES robust services and systemsmisoprostol advance distribution ✓ ☺to ensure SAFETY, Delivery strategy NEEDS to reliably ensure counseling on correct timing of use (i.e.']	[('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 349), ('SUPERFICIAL_RELATIONSHIP', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('INCOMPLETE_EVIDENCE', 392), ('INCOMPLETE_EVIDENCE', 404), ('ANOMALY_CURIOUS_FINDING', 480), ('INCOMPLETE_EVIDENCE', 541), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 592), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 795), ('SUPERFICIAL_RELATIONSHIP', 808), ('SUPERFICIAL_RELATIONSHIP', 1134), ('FUTURE_WORK', 1234), ('SUPERFICIAL_RELATIONSHIP', 1309), ('IMPORTANT_CONSIDERATION', 1508), ('IMPORTANT_CONSIDERATION', 1590), ('FUTURE_WORK', 1616), ('IMPORTANT_CONSIDERATION', 1616)]	21	[('GO_0031078', 'histone deacetylase activity (H3-K14 specific)', 238, 'DeliveryCommentsBreastfeeding'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 447, 'micronutrient'), ('CHEBI_31341', 'calcium dihydroxide', 608, 'Calcium'), ('CHEBI_77082', 'O-adipoylcarnitine(1-)', 616, '✓✓✓😐'), ('CHEBI_33233', 'fundamental particle', 721, 'vitamin A ☺'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 721, 'vitamin A ☺'), ('GO_0007567', 'parturition', 772, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 782, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 841, 'vitamin'), ('PR_000027594', 'histone H3', 841, 'vitamin-A'), ('GO_0050890', 'cognition', 913, 'cognitive'), ('CHEBI_29238', 'tritium atom', 1168, 'toxoid'), ('GO_0007567', 'parturition', 1598, 'delivery')]
PMC5706533	11/2017	S157-PMC5706533	['one of the most ROBUST FINDINGS in our systematic review—which has been PREVIOUSLY REPORTED32—was the beneficial EFFECT of Prenatal Vitamin D on RISK of persistent/recurrent wheeze (or asthma) in offspring, BASED ON data from two large well conducted trials in which wheeze/asthma was the primary outcome.3334this is broadly CONSISTENT with the POSSIBLY positive EFFECT of Vitamin D on severity of illness in Adults with asthma.5before Prenatal Vitamin D CAN be RECOMMENDED as a routine preventive measure against childhood asthma, HOWEVER, FURTHER WORK IS REQUIRED to CLARIFY the minimum effective dose and longer term follow-up to determine IF OBSERVED early EFFECTS on symptoms TRANSLATE into reductions in the incidence of asthma and improvements in Pulmonary function.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 145), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 213), ('INCOMPLETE_EVIDENCE', 325), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 363), ('INCOMPLETE_EVIDENCE', 455), ('FUTURE_WORK', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 532), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 557), ('FUTURE_WORK', 569), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('INCOMPLETE_EVIDENCE', 646), ('SUPERFICIAL_RELATIONSHIP', 661), ('SUPERFICIAL_RELATIONSHIP', 681)]	21	[('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('UBERON_0007023', 'adult organism', 409, 'adults'), ('GO_0007565', 'female pregnancy', 436, 'prenatal'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('UBERON_0002048', 'lung', 754, 'pulmonary')]
PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC3702245	6/2013	S30-PMC3702245	['maternal 25(Oh)D concentrations during Pregnancy was SHOWN in ONE uk STUDY48TO AFFECT childhood bone mass at nine years of age, but this WAS NOT confirmed in a larger more RECENT STUDY from the uk.61in populations where Vitamin D deficiency is very SEVERE, maternal Vitamin D deficiency during Pregnancy HAS BEEN ASSOCIATED with neonatal craniotabes62and congenital rickets.63–65taken TOGETHER, the results from OBSERVATIONAL studies SUGGEST a POSSIBLE EFFECT of low maternal 25(Oh)D during Pregnancy on Fetal Bone Development, BUT the ASSOCIATION with lower childhood bone mass is UNPROVEN.']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 172), ('IMPORTANT_CONSIDERATION', 249), ('INCOMPLETE_EVIDENCE', 304), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 385), ('INCOMPLETE_EVIDENCE', 412), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 444), ('SUPERFICIAL_RELATIONSHIP', 453), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 528), ('ANOMALY_CURIOUS_FINDING', 528), ('SUPERFICIAL_RELATIONSHIP', 536), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582)]	19	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 9, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 476, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 479, 'OH ... D'), ('GO_0007565', 'female pregnancy', 491, 'pregnancy'), ('GO_0007631', 'feeding behavior', 504, 'fetal'), ('GO_0048539', 'bone marrow development', 510, 'bone development')]
PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]
PMC3809191	1/2013	S55-PMC3809191	['in ONE cross-sectional STUDY, Serum 25(Oh) D levels during 24-28 weeks of Gestation were lower in gdm women than in nondiabetic Pregnant women.9in ANOTHER STUDY, maternal Serum 25 (Oh) D concentrations measured at the time of gdm screening test were significantly and inversely ASSOCIATED with fasting glucose, ALTHOUGH the ASSOCIATION of Vitamin D with gdm risk was not statistically significant.8our FINDINGS are also CONSISTENT with a study in an indian population, SHOWING no significant ASSOCIATION between 25 (Oh) D concentrations (at 30 weeks of Gestation) and gdm risk.6\ndeficiency of Vitamin D was shown to be ASSOCIATED with fetal and Brain growth deficiency and type 1 diabetes in children.13significantly reduced risk of type 1 Diabetes Mellitus Development was FOUND when high doses of Vitamin D supplementation (up to 2000 iu/d) were given during infancy in a Birth-cohort study.14\nVitamin D deficiency was also ASSOCIATED with INCREASED risk for Pregnancy complications and SERIOUS health PROBLEMS in the offspring.5,15-17higher risks of Preeclampsia and cesarean section ratios were shown in Pregnants with low levels of Vitamin D.16,17moreover supplementation of Vitamin D HAS BEEN DEMONSTRATED to decrease the RISK of Preeclampsia by 27% in a STUDY.18\n\ncaption (fig): fig.1\n\nthe correlation between Serum Vitamin D and pth levels\n\ncaption (fig): fig.2\n\nSerum Vitamin D levels in veiled and nonveiled Pregnant\n\ncaption (fig): fig.3\n\nVitamin D levels and the frequency of muscle cramps (x²=3.57, p=0.05).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 278), ('ANOMALY_CURIOUS_FINDING', 311), ('SUPERFICIAL_RELATIONSHIP', 324), ('INCOMPLETE_EVIDENCE', 402), ('INCOMPLETE_EVIDENCE', 420), ('INCOMPLETE_EVIDENCE', 469), ('SUPERFICIAL_RELATIONSHIP', 492), ('SUPERFICIAL_RELATIONSHIP', 619), ('INCOMPLETE_EVIDENCE', 774), ('SUPERFICIAL_RELATIONSHIP', 926), ('IMPORTANT_CONSIDERATION', 942), ('IMPORTANT_CONSIDERATION', 989), ('IMPORTANT_CONSIDERATION', 1004), ('INCOMPLETE_EVIDENCE', 1190), ('IMPORTANT_CONSIDERATION', 1228), ('INCOMPLETE_EVIDENCE', 1261)]	19	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH) D'), ('PR_000008838', 'serine protease HTRA1', 36, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0007565', 'female pregnancy', 128, 'pregnant'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_71657', 'versiconol acetate', 177, '25 (OH) D'), ('PR_000009880', 'Lon protease, mitochondrial', 177, '25 ... OH ... D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 339, 'Vitamin'), ('CHEBI_71657', 'versiconol acetate', 512, '25 (OH) D'), ('GO_0007565', 'female pregnancy', 553, 'gestation'), ('CHEBI_27300', 'vitamin D', 593, 'vitamin D'), ('UBERON_0000955', 'brain', 645, 'brain'), ('GO_1903709', 'uterine gland development', 740, 'diabetes mellitus development'), ('CHEBI_27300', 'vitamin D', 799, 'vitamin D'), ('GO_0007567', 'parturition', 874, 'birth'), ('CHEBI_28384', 'vitamin K', 896, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 961, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 1053, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 1108, 'pregnants'), ('CHEBI_28384', 'vitamin K', 1137, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 1180, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 1236, 'preeclampsia'), ('UBERON_0001977', 'blood serum', 1317, 'serum'), ('CHEBI_28384', 'vitamin K', 1323, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1323, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 1371, 'Serum'), ('CHEBI_28384', 'vitamin K', 1377, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1377, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1418, 'pregnant'), ('CHEBI_28384', 'vitamin K', 1450, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1450, 'Vitamin D')]
PMC3888066	12/2012	S14-PMC3888066	['methodologies used in this study HAVE BEEN CRITICIZED, including aggregating Heart defects as Neural Crest defects, ESTIMATING missing information on Retinol supplementation and DEMONSTRATING the Vitamin A threshold of >10,000 iu/day.9SUBSEQUENT STUDIES have DISPUTED the 10,000 iu/day THRESHOLD BASED ON Non-Human Primate STUDIES and SMALL clinical trials in Humans.10\n\nEVIDENCE to SUPPORT the NOTION that a Toxin is responsible for SOME Neurodevelopmental disorders\na Toxin that MAY cause Neurodevelopmental disorders MUST BE able to cross NOT ONLY the Placenta, BUT ALSO the Blood Brain Barrier (bbb).']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 259), ('PROBABLE_UNDERSTANDING', 286), ('INCOMPLETE_EVIDENCE', 296), ('PROBABLE_UNDERSTANDING', 296), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 371), ('INCOMPLETE_EVIDENCE', 383), ('INCOMPLETE_EVIDENCE', 395), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 481), ('IMPORTANT_CONSIDERATION', 520), ('ANOMALY_CURIOUS_FINDING', 542)]	19	[('UBERON_0000948', 'heart', 77, 'heart'), ('UBERON_0002342', 'neural crest', 94, 'neural crest'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 305, 'non'), ('NCBITaxon_9606', 'Homo sapiens', 309, 'human'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 315, 'primate'), ('NCBITaxon_9606', 'Homo sapiens', 360, 'humans'), ('CHEBI_27026', 'toxin', 409, 'toxin'), ('GO_0007399', 'nervous system development', 439, 'neurodevelopmental'), ('CHEBI_27026', 'toxin', 470, 'toxin'), ('GO_0007399', 'nervous system development', 491, 'neurodevelopmental'), ('UBERON_0001987', 'placenta', 555, 'placenta'), ('UBERON_0000120', 'blood brain barrier', 578, 'blood brain barrier')]
BMJ_2010_Apr_29_340_c1640	4/2010	S96-BMJ_2010_Apr_29_340_c1640	['by the time of Delivery, maternal and infant Cord Serum 25-Hydroxyvitamin d3concentrations are highly CORRELATED.37UNFORTUNATELY, much REMAINS UNKNOWN, leading to large international variations in maternal Vitamin D monitoring and supplementation during Pregnancy.353839\na maternal EFFECT operating Antenatally would also be CONSISTENT with the stronger maternal than paternal “parent of origin” EFFECT in familial multiple sclerosis.1340it HAS BEEN PREVIOUSLY PROPOSED14THAT maternal Vitamin D deficiency, a PROBLEM for SOME dark skinned women migrating to regions with low ambient ultraviolet radiation, such as the uk, MIGHT EXPLAIN the increase in incidence of disease SEEN among second generation migrants in such locations.41our FINDINGS are CONSISTENT with this EXPLANATION.']	[('SUPERFICIAL_RELATIONSHIP', 102), ('ANOMALY_CURIOUS_FINDING', 113), ('ANOMALY_CURIOUS_FINDING', 113), ('FULL_UNKNOWN', 135), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 325), ('SUPERFICIAL_RELATIONSHIP', 396), ('INCOMPLETE_EVIDENCE', 441), ('INCOMPLETE_EVIDENCE', 450), ('INCOMPLETE_EVIDENCE', 461), ('IMPORTANT_CONSIDERATION', 509), ('INCOMPLETE_EVIDENCE', 521), ('INCOMPLETE_EVIDENCE', 622), ('PROBABLE_UNDERSTANDING', 628), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 735), ('INCOMPLETE_EVIDENCE', 748), ('PROBABLE_UNDERSTANDING', 769)]	18	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 56, '25-hydroxyvitamin'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy'), ('GO_0007288', 'sperm axoneme assembly', 299, 'antenatally'), ('CHEBI_27300', 'vitamin D', 485, 'vitamin D')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
PMC5028238	10/2016	S201-PMC5028238	["COMMENT on Vitamin D3's in-direct inhibition of Dhcr7\nOF NOTE, Vitamin D (Cholecalciferol) decreases the Dhcr7 activity through an indirect mechanism.54there HAS BEEN SOME SPECULATION on the POSSIBILITY of Teratogenic AFFECTS resulting from high doses of Vitamin D when taken as a Prenatal supplement.89HOWEVER, a RECENT REVIEW of Vitamin D supplementation among Pregnant women FOUND that Vitamin D supplementation MAY reduce the RISK of pre-eclampsia, low Birth weight, Preterm Birth90,91and adverse Kidney outcomes in offspring.92BECAUSE the mechanism of Vitamin D3's inhibition of Dhcr7 is indirect (UNLIKE our studied Pharmacological Dhcr7 Inhibitors) it is LIKELY to be MEDIATED through a COMPLEX pathway with many INTERACTING feedback loops."]	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 54), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 191), ('SUPERFICIAL_RELATIONSHIP', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 378), ('INCOMPLETE_EVIDENCE', 415), ('IMPORTANT_CONSIDERATION', 430), ('PROBABLE_UNDERSTANDING', 530), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 603), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 675), ('DIFFICULT_TASK', 694), ('SUPERFICIAL_RELATIONSHIP', 720)]	18	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 48, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 74, 'cholecalciferol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 105, 'DHCR7'), ('CHEBI_50905', 'teratogenic agent', 206, 'teratogenic'), ('GO_0031649', 'heat generation', 206, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('GO_0007565', 'female pregnancy', 281, 'prenatal'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D'), ('GO_0007565', 'female pregnancy', 363, 'pregnant'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007565', 'female pregnancy', 471, 'preterm'), ('GO_0042633', 'hair cycle', 479, 'birth90'), ('UBERON_0002113', 'kidney', 501, 'kidney'), ('CHEBI_33279', 'vitamin D5', 557, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 557, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 584, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 622, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 638, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 644, 'inhibitors')]
PMC5129897	10/2016	S16-PMC5129897	['NEITHER ASSUMPTION holds for Vitamin D. robert heaney OUTLINED the GUIDELINES for Nutrient studies including Vitamin D. the most RELEVANT features are that one SHOULD start with an understanding of the 25(Oh)D concentration–health outcome RELATION, 25(Oh)D concentrations SHOULD BE measured in prospective participants, ONLY those with low concentrations SHOULD BE enrolled, sufficient Vitamin D SHOULD BE given to raise 25(Oh)D concentrations to where a significant beneficial EFFECT is expected, and achieved 25(Oh)D concentrations SHOULD BE measured.2until those steps are followed routinely, FEW Vitamin D clinical TRIALS will report beneficial EFFECTS.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 67), ('PROBABLE_UNDERSTANDING', 67), ('IMPORTANT_CONSIDERATION', 129), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 239), ('FUTURE_WORK', 272), ('INCOMPLETE_EVIDENCE', 320), ('FUTURE_WORK', 355), ('FUTURE_WORK', 396), ('SUPERFICIAL_RELATIONSHIP', 478), ('FUTURE_WORK', 534), ('INCOMPLETE_EVIDENCE', 596), ('FUTURE_WORK', 619), ('SUPERFICIAL_RELATIONSHIP', 649)]	17	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 421, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 427, 'D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 517, 'D'), ('CHEBI_27300', 'vitamin D', 600, 'vitamin D')]
PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
PMC3717170	5/2013	S142-PMC3717170	['pittas CONCLUDED that ALTHOUGH the OBSERVATION studies STRONGLY SUGGEST an IMPORTANT ROLE for Vitamin D in type 2 diabetes, and such a ROLE is biologically PLAUSIBLE, there is LACK OF EVIDENCE from intervention studies to SUPPORT the CONTENTION that type 2 diabetes CAN be improved or PREVENTED by raising 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 285)]	16	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 306, '25(OH)D3concentration'), ('PR_000005058', 'extracellular calcium-sensing receptor', 306, '25(OH ... D3concentration')]
PMC3888066	12/2012	S12-PMC3888066	['this NOTION is BASED ON the KNOWN Teratogenic EFFECTS of Retinoic Acids on the Central Nervous System,1–3the CALCULATED dose of Retinol and Beta Carotene Ingested by the mother during early Pregnancy, and STRONG EVIDENCE that the fetus Metabolizes Beta Carotene to Retinoids and has LIMITED ability to store Beta Carotene in Fat Cells.4–7\nin 1995, rothman et al DEMONSTRATED that high maternal dietary intake of Vitamin A in the form of Retinol, ie, >10,000 iu/day, particularly in the first Trimester, MAY BE ASSOCIATED with Cranial-Neural-Crest Birth defects.8using a smooth regression curve, THIS study of 22,748 Pregnant women and their offspring IDENTIFIED 1 infant in 57 with malformations that COULD BE ATTRIBUTED to the intake of supplements of Preformed Vitamin A at a dose >10,000 iu/day.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 15), ('ANOMALY_CURIOUS_FINDING', 21), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 283), ('INCOMPLETE_EVIDENCE', 362), ('INCOMPLETE_EVIDENCE', 503), ('SUPERFICIAL_RELATIONSHIP', 510), ('QUESTION_ANSWERED_BY_THIS_WORK', 595), ('INCOMPLETE_EVIDENCE', 651), ('INCOMPLETE_EVIDENCE', 701), ('SUPERFICIAL_RELATIONSHIP', 710)]	16	[('CHEBI_50905', 'teratogenic agent', 34, 'teratogenic'), ('CHEBI_26536', 'retinoic acid', 57, 'retinoic acids'), ('UBERON_0001017', 'central nervous system', 79, 'central nervous system'), ('CHEBI_26536', 'retinoic acid', 128, 'retinol'), ('CHEBI_51438', 'D-isoascorbic acid', 140, 'beta carotene'), ('GO_0007631', 'feeding behavior', 154, 'ingested'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0008152', 'metabolic process', 236, 'metabolizes'), ('CHEBI_51438', 'D-isoascorbic acid', 248, 'beta carotene'), ('CHEBI_26537', 'retinoid', 265, 'retinoids'), ('CHEBI_51438', 'D-isoascorbic acid', 308, 'beta carotene'), ('CL_0000136', 'fat cell', 325, 'fat cells'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 437, 'retinol'), ('GO_0009294', 'DNA mediated transformation', 492, 'trimester'), ('UBERON_0001456', 'face', 526, 'cranial'), ('UBERON_0002342', 'neural crest', 534, 'neural-crest'), ('GO_0007567', 'parturition', 547, 'birth'), ('GO_0007565', 'female pregnancy', 616, 'pregnant'), ('GO_0007565', 'female pregnancy', 753, 'preformed'), ('CHEBI_27300', 'vitamin D', 763, 'vitamin A')]
PMC4340999	3/2015	S93-PMC4340999	['INCONSISTENT findings and MIXED explanations of underlying mechanism HAVE BEEN REPORTED, including SPECULATION that early temperature exposure is ASSOCIATED with physiological Regulation Of Birth Weight or that extremely low ambient temperature INFLUENCES the Conceived Embryo or the selection of the Sperm that fuses with the Ovum.19–21HOWEVER, the findings from the current study APPEARED to more strongly SUGGEST the POSSIBLE etiological ROLE of Prenatal maternal exposure to ultraviolet b radiation (uvb) and Vitamin D status in Adult chronic diseases.29–31\nsun exposure provides one of the MAJOR ways to meet Vitamin D REQUIREMENTS during Pregnancy, ESPECIALLY for those of older generations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 334), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 335), ('ANOMALY_CURIOUS_FINDING', 382), ('INCOMPLETE_EVIDENCE', 408), ('INCOMPLETE_EVIDENCE', 420), ('SUPERFICIAL_RELATIONSHIP', 441), ('IMPORTANT_CONSIDERATION', 595), ('IMPORTANT_CONSIDERATION', 624), ('IMPORTANT_CONSIDERATION', 655)]	16	[('GO_0009937', 'regulation of gibberellic acid mediated signaling pathway', 176, 'regulation of birth weight'), ('GO_0070268', 'cornification', 260, 'conceived'), ('UBERON_0000922', 'embryo', 270, 'embryo'), ('CL_0000019', 'sperm', 301, 'sperm'), ('UBERON_0000978', 'leg', 327, 'ovum'), ('GO_0007565', 'female pregnancy', 449, 'prenatal'), ('CHEBI_27300', 'vitamin D', 513, 'vitamin D'), ('UBERON_0007023', 'adult organism', 533, 'adult'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('GO_0007565', 'female pregnancy', 644, 'pregnancy')]
PMC4490503	6/2015	S137-PMC4490503	['gdm develops when beta cell dysfunction coexists, and MAY BE characterised by further abnormalities in adipokine and cytokine profiles, increased Free Fatty Acids (ffa), Triglycerides (tg), low Vitamin D and Endothelial dysfunction.ijms-16-13442-t001_table 1\n\ncaption (table-wrap): table 1\n\nlongitudinal studies of inflammatory markers in prediction of gdm.inflammatory markerfirst author (year)study designgdm statusgdm diagnostic criteriagestational age at testing (weeks)EFFECT in gdmmatching or adjustment for confounderstnf-αkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weekstnf-Α ↑ 34–36 weeks in gdm inversely CORRELATED with Insulin sensitivityfat massgao (2008) [65]nested case-control22 gdm 10 igt 20 ngtunknown12–20 weeks 24–32 weekstnf-Α ↑ in gdm positively CORRELATED with bmi 14–20 weeksn/ageorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmisaucedo (2011) [67]prospective60 gdm 60 ngt24–28 weeks ada criteria 2010 [68]30 weeks 6 weeks 6 months Postpartumtnf-Α ↑ in both groups at 6 weeks Tnf-Α ↑ 6months Postpartum in gdmage weightlopez-tinoco (2012) [69]case-control63 gdm 63 ngt24–28 weeks nddg criteria [70]mean ~29 weekstnf-Α ↑ in gdmbmiguillemette (2014) [71]prospective61 gdm 695 ngt24–28 weeks iadpsg criteria [44]5–16 weeks 24–28 weekstnf-Α ↑ in both groups and ASSOCIATED with Insulin resistanceage bmi tg adiponectin.il-6morrisett (2011) [72]case-control20 gdm 27 ngt26.1 ± 3.7 weeks cda criteria [73]26.1 ± 3.7 weeks 8 weeks post-partumil-6 ↑ in gdm and post-Partum, CORRELATED with Insulin sensitivity and bmibmihassiakos (2015) [74]case-control40 gdm 94 ngt24–28 weeks iadpsg criteria [44]11–14 weekil-6 ↑ in gdm and inversely RELATED to Birth weightmaternal weightleptinkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weeksleptin ↑ across Pregnancy inverse CORRELATION with Insulin sensitivity, BUT non-significant when adjusted for fat massfat massgeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmiqiu (2004) [75]prospective47 gdm 776 ngt26–28 weeks carpenter and coustan criteria [64]13 weeks10-ng/ml ↑ in leptin ASSOCIATED with 20% ↑ gdmparity bmi family history of non-Insulin dependent diabetesadiponectingeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksage ethnicity gravidity parity bmimcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weekadiponectin ↓ gdm and offspringage maternal weightwilliams (2004) [77]nested case-control41 gdm 70 ngt26–28 weeks carpenter and coustan criteria [64]13 week4.6-fold ↑ risk of gdm if adiponectin < 6.4 mcg/ml, overweight women 11-fold ↑ risk of gdmbmilain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksadiponectin < 25th 11-fold ↑ risk gdmbmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or random Glucose ≥ 8.9 mmol/l24–32 weeks↓ adiponectin ASSOCIATED with ↑ Glucose and bmibmi c-peptide Gestation genderlacroix (2013) [79]prospective38 gdm 407 ngt24–28 weeks iadpsg criteria [44]6–13 week↓ adiponectin ASSOCIATED with ↑ risk gdm (or1.12 per 1 µg/ml ↓ of adiponectin) and ASSOCIATED with Insulin sensitivitybmi hba1cianniello (2013) [39]prospective16 gdm 32 ngt24–28 weeks carpenter and coustan criteria [64]all trimesters↓ adiponectin PREDICTIVE of gdm in overweight/obesen/aweerakiet (2006) [80]prospective60 gdm 299 ngt24–28 weeks carpenter and coustan criteria [64]21–27 weekadiponectin 10 µg/ml has sensitivity of 91% and specificity of 31% for gdmbmirbp-4krzyzanovska (2008) [81]nested case-control20 gdm 22 ngt24–28 weeks carpenter and coustan criteria [64]30 weekrbp-4 ↓ in gdmn/ananda (2013) [82]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/aabetew (2013) [84]nested case-control173 gdm 187 ngt24–28 weeks carpenter and coustan criteria [64]16 weeksrbp-4 ↑ in gdm BUT NOT significant after adjustmentmaternal age ethnicityresistinlain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksno differencebmigeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or Random Glucose ≥ 8.9 mmol/l24–32 weeksnot ASSOCIATED with Glucose or Birth weightbmi c-peptide Gestation gendernanda (2012) [85]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/amcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weeksresistin ↓ in gdm and offspringage maternal weightvisfatinkrzyzanovska (2006) [86]nested case-control64 gdm 30 ngt24–28 weeks carpenter and coustan criteria [64]28–30 weeks 38–40 weeks 2 weeks post-Partumvisfatin ↑ in gdmbmiferreira (2011) [87]case-control100 gdm 300 ngt24–28 weeks who criteria 2006 [83]11–13 weekvisfatin ↑ in gdmn/a\nngt = normal Glucose tolerance; igt = impaired Glucose tolerance; fpg = fasting plasma Glucose; homa-ir = homeostasis model assessment for Insulin resistance; matsuda index = measure of Insulin sensitivity; bmi = body mass index; tg = Triglycerides; n/a = not available; ↓ = decreased levels; ↑ = increased levels; adips = australasian diabetes in Pregnancy society; ada = american diabetes association; nddg = national diabetes data group; iadpsg = international association of diabetes and Pregnancy study group; cda = canadian diabetes association; who = world health organisation.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 474), ('SUPERFICIAL_RELATIONSHIP', 689), ('SUPERFICIAL_RELATIONSHIP', 842), ('SUPERFICIAL_RELATIONSHIP', 1457), ('SUPERFICIAL_RELATIONSHIP', 1665), ('SUPERFICIAL_RELATIONSHIP', 1827), ('SUPERFICIAL_RELATIONSHIP', 2027), ('ANOMALY_CURIOUS_FINDING', 2065), ('SUPERFICIAL_RELATIONSHIP', 2387), ('SUPERFICIAL_RELATIONSHIP', 3275), ('SUPERFICIAL_RELATIONSHIP', 3437), ('SUPERFICIAL_RELATIONSHIP', 3506), ('SUPERFICIAL_RELATIONSHIP', 3670), ('ANOMALY_CURIOUS_FINDING', 4255), ('SUPERFICIAL_RELATIONSHIP', 4764)]	16	[('CHEBI_37958', 'dye', 146, 'free'), ('CHEBI_35366', 'fatty acid', 151, 'fatty acids'), ('CHEBI_17855', 'triglyceride', 170, 'triglycerides'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0001986', 'endothelium', 208, 'endothelial'), ('PR_000000034', 'BMP', 655, '-α'), ('PR_000045358', 'insulin family protein', 705, 'insulin'), ('PR_000000034', 'BMP', 819, '-α'), ('GO_0030254', 'protein secretion by the type III secretion system', 1131, 'postpartumTNF'), ('PR_000000034', 'BMP', 1144, '-α'), ('PR_000000134', 'tumor necrosis factor alpha', 1175, 'TNF-α'), ('GO_0007565', 'female pregnancy', 1191, 'postpartum'), ('PR_000000034', 'BMP', 1314, '-α'), ('PR_000000034', 'BMP', 1433, '-α'), ('PR_000045358', 'insulin family protein', 1473, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1636, '-6'), ('GO_0007567', 'parturition', 1657, 'partum'), ('PR_000045358', 'insulin family protein', 1681, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1801, '-6'), ('GO_0007567', 'parturition', 1838, 'birth'), ('GO_0007565', 'female pregnancy', 2009, 'pregnancy'), ('PR_000045358', 'insulin family protein', 2044, 'insulin'), ('PR_000045358', 'insulin family protein', 2445, 'insulin'), ('GO_0007565', 'female pregnancy', 3132, 'pregnant'), ('CHEBI_17234', 'glucose', 3230, 'glucose'), ('CHEBI_17234', 'glucose', 3293, 'glucose'), ('GO_0007565', 'female pregnancy', 3322, 'gestation'), ('PR_000045358', 'insulin family protein', 3522, 'insulin'), ('GO_0007565', 'female pregnancy', 4631, 'pregnant'), ('CHEBI_45267', 'praziquantel', 4722, 'random'), ('CHEBI_17234', 'glucose', 4729, 'glucose'), ('CHEBI_17234', 'glucose', 4780, 'glucose'), ('GO_0007567', 'parturition', 4791, 'birth'), ('GO_0007565', 'female pregnancy', 4817, 'gestation'), ('GO_0030164', 'protein denaturation', 5223, 'partumVisfatin'), ('CHEBI_17234', 'glucose', 5374, 'glucose'), ('CHEBI_17234', 'glucose', 5408, 'glucose'), ('CHEBI_17234', 'glucose', 5448, 'glucose'), ('PR_000045358', 'insulin family protein', 5500, 'insulin'), ('PR_000045358', 'insulin family protein', 5547, 'insulin'), ('CHEBI_17855', 'triglyceride', 5596, 'triglycerides'), ('GO_0007565', 'female pregnancy', 5709, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 5853, 'Pregnancy')]
PMC4800340	5/2016	S25-PMC4800340	["THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC5385921	4/2017	S13-PMC5385921	['within the domain of nutritional exposures, there is GROWING INTEREST in the POSSIBLE LINKS between Gestational Vitamin D deficiency and an INCREASED RISK of asd.3–6this research HAS BEEN inspired BY Birth cohort studies, which have provided EVIDENCE that Prenatal Vitamin D deficiency (as assessed in maternal Sera) is ASSOCIATED with a range of later Brain-related outcomes including impaired Language Development7,8and Cognitive Development in offspring.9,10ALTHOUGH SEVERAL STUDIES HAVE REPORTED that Vitamin D deficiency or insufficiency is MORE COMMON in children with asd compared with controls,11few STUDIES addressed the specific HYPOTHESIS that Vitamin D deficiency during Gestation, a CRUCIAL time point in Neurodevelopment, is RELATED to the risk of subsequent asd.']	[('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 140), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 242), ('SUPERFICIAL_RELATIONSHIP', 320), ('ANOMALY_CURIOUS_FINDING', 459), ('INCOMPLETE_EVIDENCE', 470), ('INCOMPLETE_EVIDENCE', 486), ('PROBABLE_UNDERSTANDING', 546), ('INCOMPLETE_EVIDENCE', 608), ('INCOMPLETE_EVIDENCE', 639), ('IMPORTANT_CONSIDERATION', 696), ('SUPERFICIAL_RELATIONSHIP', 739)]	16	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 200, 'birth'), ('GO_0007565', 'female pregnancy', 256, 'prenatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'sera'), ('UBERON_0000955', 'brain', 353, 'brain'), ('GO_0001763', 'morphogenesis of a branching structure', 395, 'language development7'), ('GO_0050787', 'detoxification of mercury ion', 422, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 505, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 655, 'vitamin D'), ('GO_0007565', 'female pregnancy', 683, 'gestation'), ('GO_0007399', 'nervous system development', 718, 'neurodevelopment')]
PMC5706533	11/2017	S154-PMC5706533	['two trials INDICATED that Vitamin D COULD enhance Postnatal linear growth, an outcome RELATED to growth plates for which a HYPOTHESISED ROLE of Vitamin D is logical,26and which is the primary focus of our AS YET unpublished trial in bangladesh.27in the FEW STUDIES reporting EFFECTS on infant bone mass, results were MIXED; the largest of these trials—the mavidos study in the uk, which excluded women with 25(Oh)D concentrations <25 nmol/l28—has scheduled follow-up of children at age 4 years.29infant rickets was NOT REPORTED in any trials; THOUGH RARE, this is one of the MOST LIKELY paediatric conditions to be directly caused by poor maternal and early infant Vitamin D status.30adverse events were infrequently REPORTED, resulting in unreliable meta-analyses.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 205), ('ANOMALY_CURIOUS_FINDING', 208), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 515), ('ANOMALY_CURIOUS_FINDING', 543), ('INCOMPLETE_EVIDENCE', 550), ('PROBABLE_UNDERSTANDING', 575), ('PROBABLE_UNDERSTANDING', 580), ('INCOMPLETE_EVIDENCE', 717)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 407, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 413, 'D'), ('CHEBI_27300', 'vitamin D', 665, 'vitamin D')]
PMC2913107	8/2010	S48-PMC2913107	['IF this THEORY is TRUE, the PATH TOWARDS EFFECTIVE PREVENTION – and PERHAPS a treatment EFFECT IF ADEQUATE physiological doses of Vitamin D are given – is so SIMPLE, so SAFE, so INEXPENSIVE, so READILY AVAILABLE and so easy, that it DEFIES IMAGINATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 98), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 194), ('ANOMALY_CURIOUS_FINDING', 233)]	15	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
PMC4973215	8/2016	S80-PMC4973215	['ALTHOUGH Cord Blood 25(Oh)D levels do CORRELATE to maternal levels, FACTORS that AFFECT fetal growth MAY not be uniform throughout Pregnancy and this DIFFERENCE in timing COULD AFFECT study FINDINGS.1,3,4,5,6in addition, maternal characteristics such as obesity or pre-eclampsia COULD also AFFECT results that MAY NOT HAVE BEEN SEEN IF Vitamin D samples were obtained during early Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 290), ('INCOMPLETE_EVIDENCE', 310), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 333)]	15	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 22, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0007565', 'female pregnancy', 381, 'pregnancy')]
PMC5014971	8/2016	S24-PMC5014971	['other researchers have QUESTIONED this FINDING, citing both a CONCERN that circulating levels of 25-Oh-D at 20\u2009ng/ml have not been shown to be sufficient for bone health for all populations and that OTHER nonskeletal functions of Vitamin D POTENTIALLY IMPORTANT for health, which the iom report DISCOUNTS BASED ON INADEQUATE evidence, MAY yet be shown to be IMPORTANT and REQUIRE higher circulating levels of 25-Oh-D [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 252), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 305), ('ANOMALY_CURIOUS_FINDING', 311), ('IMPORTANT_CONSIDERATION', 314), ('PROBLEM_COMPLICATION', 314), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 358), ('IMPORTANT_CONSIDERATION', 372)]	15	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 97, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 409, '25-OH-D')]
PMC5129897	10/2016	S177-PMC5129897	['for example, 50% of the clinical trials with baseline 25(Oh)D concentration <50\xa0nmol/l FOUND beneficial EFFECTS of Vitamin D on BIOMARKERS of inflammation, WHEREAS ONLY 26% of those with higher baseline 25(Oh)D concentrations did.3the DIFFERENT results with respect to baseline 25(Oh)D concentration MAY BE DUE TO the LIMITED accuracy of clinical trials but COULD also be DUE TO CONSIDERABLY less BENEFIT for those with 25(Oh)D concentrations above 50\xa0nmol/l.']	[('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('ANOMALY_CURIOUS_FINDING', 156), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('INCOMPLETE_EVIDENCE', 300), ('PROBLEM_COMPLICATION', 307), ('INCOMPLETE_EVIDENCE', 318), ('INCOMPLETE_EVIDENCE', 358), ('PROBLEM_COMPLICATION', 372), ('ANOMALY_CURIOUS_FINDING', 379), ('IMPORTANT_CONSIDERATION', 397)]	15	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 203, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 278, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D')]
PMC5827025	2/2018	S15-PMC5827025	['ALTHOUGH SOME POTENTIAL INFLUENT FACTORS for Vitamin D status, such as seasonality, age, smoking, race and ethnicity HAVE BEEN IDENTIFIED in SEVERAL case-control STUDIES6–8, research REPORTS on the INFLUENT FACTORS for Gestational Vitamin D status in a population-based cohort are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 207), ('FULL_UNKNOWN', 281), ('INCOMPLETE_EVIDENCE', 281)]	15	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]
PMC2290997	4/2008	S74-PMC2290997	['STILL to be resolved, HOWEVER, is the QUESTION of WHAT levels of Vitamin D are OPTIMAL for preventing the disease—and WHETHER the statistical ASSOCIATIONS REFLECT DIFFERENT Gene pools RATHER than DIFFERENT levels of 25(Oh)D. (INTERESTINGLY, holick REPORTED in the august 1988 issue of the journal of clinical endocrinology & Metabolism that no previtamin d3formed when Human skin was exposed to sunlight on cloudless days in boston, at 42.2°n, from november through february or in edmonton, at 52°n, from october through march.)']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('EXPLICIT_QUESTION', 38), ('EXPLICIT_QUESTION', 50), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('EXPLICIT_QUESTION', 118), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('ANOMALY_CURIOUS_FINDING', 226), ('INCOMPLETE_EVIDENCE', 248)]	14	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('SO_0000704', 'gene', 173, 'gene'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('GO_0008152', 'metabolic process', 325, 'Metabolism'), ('NCBITaxon_9606', 'Homo sapiens', 369, 'human')]
PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]
PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3659910	1/2013	S141-PMC3659910	['Vitamin D-deficiency in mothers have significantly INCREASED RISK of infantile rickets DUE TO INADEQUATE Maternal–fetal transfer of 25-Hydroxyvitamin D.[32] RECENT retrospective STUDIES FOUND a significant and PREVIOUSLY UNDETECTED ASSOCIATION of maternal Vitamin D deficiency with rickets-ASSOCIATED infant Heart Failure and with acute Lower Respiratory Tract infection,[33] a SERIOUS COMPLICATION OFTEN ASSOCIATED with sepsis without clinical signs of rickets.']	[('IMPORTANT_CONSIDERATION', 51), ('PROBABLE_UNDERSTANDING', 87), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 221), ('SUPERFICIAL_RELATIONSHIP', 232), ('SUPERFICIAL_RELATIONSHIP', 290), ('IMPORTANT_CONSIDERATION', 378), ('IMPORTANT_CONSIDERATION', 386), ('PROBABLE_UNDERSTANDING', 399), ('SUPERFICIAL_RELATIONSHIP', 405)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007618', 'mating', 105, 'maternal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 132, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0002081', 'cardiac atrium', 308, 'heart failure'), ('UBERON_0004905', 'articulation', 337, 'lower respiratory tract')]
PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]
PMC3347028	3/2012	S226-PMC3347028	['the health effects data from Vitamin D supplementation trials THUS FAR, WHILE TANTALIZING, are NOT CONCLUSIVE in SHOWING definitive “proof” for Vitamin D AS a POTENTIAL CANDIDATE in the reduction of comorbidities of Pregnancy, YET one CANNOT DISMISS the strong CORRELATION between reduced RISK with increased Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('ANOMALY_CURIOUS_FINDING', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('SUPERFICIAL_RELATIONSHIP', 261), ('IMPORTANT_CONSIDERATION', 289)]	13	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0001977', 'blood serum', 309, 'serum'), ('CHEBI_71657', 'versiconol acetate', 315, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 315, '25(OH)D')]
PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]
PMC3427192	4/2012	S66-PMC3427192	['in ONE STUDY, modest ASSOCIATIONS were NOTED between several Genes in the Vitamin D pathway and asthma and allergic sensitization in populations enriched for subjects with current asthma.86a separate study of asthmatics also FOUND Haplotype ASSOCIATIONS for Cyp24A1 , the primary enzyme ASSOCIATED with Calcidiol Metabolism, where a 5-point Haplotype was ASSOCIATED with asthma, allergic sensitization, and Vitamin D Metabolites in asthmatic subjects.92while these PRELIMINARY results SUGGEST that Genetic components MAY account for Vitamin D status in subjects with asthma, OTHER STUDIES ARE NEEDED to determine tease out the Genetic vs. environmental UNDERPINNINGS of Vitamin D status in this population.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 39), ('INCOMPLETE_EVIDENCE', 225), ('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 287), ('SUPERFICIAL_RELATIONSHIP', 355), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 517), ('FUTURE_WORK', 575), ('FUTURE_WORK', 581), ('SUPERFICIAL_RELATIONSHIP', 653)]	13	[('SO_0000704', 'gene', 61, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('SO_0001024', 'haplotype', 231, 'haplotype'), ('PR_000006101', 'cytochrome P450 1A1', 258, 'CYP24A1'), ('CHEBI_17933', 'calcidiol', 303, 'calcidiol'), ('GO_0008152', 'metabolic process', 313, 'metabolism'), ('SO_0001024', 'haplotype', 341, 'haplotype'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('CHEBI_25212', 'metabolite', 417, 'metabolites'), ('SO_0000704', 'gene', 498, 'genetic'), ('CHEBI_27300', 'vitamin D', 533, 'vitamin D'), ('SO_0000704', 'gene', 627, 'genetic'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D')]
PMC4377879	3/2015	S128-PMC4377879	['christian and stewart [52] have SUGGESTED a conceptual FRAMEWORK for HOW Maternal diet and Micronutrient status MAY EFFECT the development of chronic disease; the MOST LIKELY, GIVEN PRESENT KNOWLEDGE, SEEM to be Vitamin A, Folate, iron and zinc and PERHAPS calcium and magnesium AS SHOWN in their conceptual framework (figure 1).']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 55), ('EXPLICIT_QUESTION', 69), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 116), ('PROBABLE_UNDERSTANDING', 163), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 176), ('PROBABLE_UNDERSTANDING', 176), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 201), ('INCOMPLETE_EVIDENCE', 249), ('INCOMPLETE_EVIDENCE', 279)]	13	[('GO_0007618', 'mating', 73, 'maternal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate')]
PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 372, '25OHD')]
PMC4684854	12/2015	S57-PMC4684854	['LIMITATIONS of Vitamin D research as RELATED to Gestational outcomes\nALTHOUGH maternal-fetal outcomes in the presence of adequate Gestational Vitamin D are GENERALLY favorable as REPORTED in the medical literature, SOME reports HAVE BEEN INCONSISTENT and CAST DOUBT on the LINK between Gestational Vitamin D sufficiency and health.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 156), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 273)]	13	[('CHEBI_28384', 'vitamin K', 15, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'Gestational'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 286, 'gestational'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
PMC4949006	7/2016	S136-PMC4949006	['Vitamin B6Supplementation HAS BEEN shown in 3 SMALL STUDIES to give a modest gain in Birth weight.99Vitamin C supplementation has not been shown to be of value in improving Pregnancy outcomes,99but HAS SHOWN value for PREVENTION of wheezing and asthma in the children of smokers.100\n\nVitamin E\nONE STUDY CORRELATED risk of wheeze inversely to the level of Vitamin E as well as a linear RELATIONSHIP between the level and the forced Expiratory volume at 1 minute.101NO OTHER STUDIES APPEAR to support OR REFUTE this.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 294), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 468), ('ANOMALY_CURIOUS_FINDING', 482), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 503)]	13	[('CHEBI_10122', 'Zizyphine F', 0, 'Vitamin B6supplementation'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin B6supplementation'), ('GO_0007567', 'parturition', 85, 'birth'), ('CHEBI_65430', 'ardisiphenol A', 98, '99Vitamin C'), ('PR_000004900', 'complement C3', 108, 'C'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 284, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin E'), ('GO_0010467', 'gene expression', 432, 'expiratory')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
PMC5129897	10/2016	S118-PMC5129897	["“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\xa0weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\xa0y.83\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\n\nall-cause mortality rate\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment."]	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC3348565	4/2012	S138-PMC3348565	['ALTHOUGH Vitamin D overload is a theoretical POSSIBILITY, 100\u2008000 iu of Vitamin D3Has BEEN shown to provide the best protection against Vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of Vitamin D.16furthermore, single intramuscular injection of three times this dose (300\u2008000 iu) was safe in treating nutritional rickets in 6–30-month-old children residing in lower socioeconomic regions of sunny istanbul.35higher than RECOMMENDED doses of daily supplementation of Vitamin D (500–1000 iu per day, adding up to 120\u2008000 iu over 3 months) plus additional milk fortified with Vitamin D, HAS BEEN shown not to induce an overload,13including in infants starting with normal ranges of Vitamin D, EVEN when supplementation continued during the summer (in france) and when mothers had Antenatal Vitamin D supplementation.36it is IMPORTANT to note that in our study, where community supplementation was in a population with known high rates of Vitamin D deficiency, 1% of children tested had a Calcifediol concentration greater than 375 nmol/l—THOUGHT UNDESIRABLY high.6ALTHOUGH these did not produce any clinical signs and symptoms, these measurements raise a NEED for CAUTION with doses for population supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 492), ('INCOMPLETE_EVIDENCE', 656), ('ANOMALY_CURIOUS_FINDING', 762), ('IMPORTANT_CONSIDERATION', 893), ('INCOMPLETE_EVIDENCE', 1107), ('PROBLEM_COMPLICATION', 1115), ('ANOMALY_CURIOUS_FINDING', 1133), ('FUTURE_WORK', 1224), ('IMPORTANT_CONSIDERATION', 1233)]	12	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_35646', 'galanthan', 72, 'vitamin D3has'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 72, 'vitamin D3has'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 538, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 645, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 751, 'vitamin D'), ('GO_0007567', 'parturition', 849, 'antenatal'), ('CHEBI_27300', 'vitamin D', 859, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1007, 'vitamin D'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 1057, 'calcifediol')]
PMC3552819	12/2012	S222-PMC3552819	['HOWEVER, the unpredictability of the 25(Oh)D response at the individual level, PREVIOUS REPORTS of adverse EFFECTS of large single doses [23], and the THEORETICAL DISADVANTAGES of excessive fluctuations in Vitamin D status [29] SUGGEST that the use of large single or infrequent intermittent doses of Vitamin D3 MAY BE physiologically DISADVANTAGEOUS DESPITE its practical APPEAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 312), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 351), ('ANOMALY_CURIOUS_FINDING', 351), ('IMPORTANT_CONSIDERATION', 373)]	12	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 301, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 301, 'vitamin D3')]
PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]
PMC3717170	5/2013	S191-PMC3717170	['the iom EXPERT panel CONCLUDED that MOST americans (97.5%) had adequate levels of Vitamin D, BASED ON their CONCLUSION that a 25(Oh)d3of 20 ng/ml or greater was sufficient, RAISING the QUESTION of WHETHER supplementation was EVEN NEEDED.']	[('PROBABLE_UNDERSTANDING', 8), ('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 173), ('EXPLICIT_QUESTION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('EXPLICIT_QUESTION', 197), ('ANOMALY_CURIOUS_FINDING', 225), ('IMPORTANT_CONSIDERATION', 230)]	12	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 126, '25(OH)')]
PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
PMC4684854	12/2015	S132-PMC4684854	['it is APPARENT that training is REQUIRED to establish clinical competency in (i) understanding of the ROLE of various Nutrients in Human health, (ii) HOW TO ASSESS nutritional biochemistry in patients, and (iii) and HOW to intervene to secure Nutrient sufficiency for Individuals and population groups\nwith the MOUNTING EVIDENCE of several health sequelae ASSOCIATED with Gestational Vitamin D deficiency, the VALUE of Preconception education and care by health providers and PUBLIC HEALTH bodies to secure Vitamin D sufficiency throughout Gestation is EVIDENT.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 102), ('EXPLICIT_QUESTION', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('EXPLICIT_QUESTION', 216), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 356), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 476), ('PROBABLE_UNDERSTANDING', 553)]	12	[('CHEBI_33284', 'nutrient', 118, 'nutrients'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_33284', 'nutrient', 243, 'nutrient'), ('NCBITaxon_1', 'root', 268, 'individuals'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'preconception'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('GO_0007565', 'female pregnancy', 540, 'gestation')]
PMC4770602	1/2016	S75-PMC4770602	['[22] IN CONTRAST WITH our results OTHER study SHOWED that low Birth weight is NOTED in infants of mothers supplemented with Vitamin D.\nwe THINKS that some POSSIBLE LIMITATIONS of the present study that SHOULD BE addressed and noted in FUTURE STUDIES are included; unmeasured sun exposure, maternal baseline 25-Oh-D and Preconception, physical activity, local area and early Pregnancy dietary Intake to HELP realize the EFFECT of these FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 202), ('FUTURE_WORK', 235), ('FUTURE_WORK', 402), ('SUPERFICIAL_RELATIONSHIP', 419), ('SUPERFICIAL_RELATIONSHIP', 435)]	12	[('GO_0007567', 'parturition', 62, 'birth'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 307, '25-OH-D'), ('PR_000000164', 'BMP2', 309, '-OH'), ('PR_000006444', 'diacylglycerol kinase delta', 313, 'D'), ('GO_0007565', 'female pregnancy', 319, 'preconception'), ('GO_0007565', 'female pregnancy', 374, 'pregnancy'), ('GO_0007631', 'feeding behavior', 392, 'intake')]
PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]
PMC4832516	10/2015	S139-PMC4832516	['WHILE the ASSOCIATIONS between season of Birth, or ESTIMATED Antenatal sunshine exposure, with Birth weight are CONSISTENT with experimental EFFECTS of in utero Vitamin D exposure on fetal growth, differing patterns of seasonality and INDEPENDENT ASSOCIATIONS SUGGEST that OTHER mechanisms MAY LINK season of Birth to Adult height and also puberty timing in women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 247), ('INCOMPLETE_EVIDENCE', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 290), ('SUPERFICIAL_RELATIONSHIP', 294)]	12	[('GO_0007567', 'parturition', 41, 'birth'), ('GO_0007567', 'parturition', 61, 'antenatal'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007567', 'parturition', 309, 'birth'), ('UBERON_0007023', 'adult organism', 318, 'adult')]
PMC4989298	8/2016	S375-PMC4989298	['conclusions\nALTHOUGH the AVAILABLE literature data SUGGEST the existence of a RELATIONSHIP between latitude and its consequent degree of ultraviolet radiation exposure, Vitamin D levels and the prevalence and severity of allergic diseases, the data of OBSERVATIONAL studies are encouraging, BUT CONTROVERSIAL and the ONLY available rct FAILS to SHOW an EFFECT on allergic disease prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 252), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 317), ('PROBLEM_COMPLICATION', 336), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 353)]	12	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5405075	4/2017	S5-PMC5405075	['ALTHOUGH, the results of rcts SHOWED a POTENTIAL ASSOCIATION with asthma-RELATED phenotypes RATHER than asthma per se , the low toxicity of Vitamin D supplements make it TEMPTING to SPECULATE that Pregnant women at a high RISK of obtaining a child with asthma MAY BE benefited, ESPECIALLY if they are Vitamin D deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 260), ('ANOMALY_CURIOUS_FINDING', 278)]	12	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnant'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D')]
PMC5405075	4/2017	S89-PMC5405075	['moreover, it HAS BEEN PROPOSED that studies SHOULD focus on Vitamin D status in early Pregnancy and supplementary administration SHOULD BE initiated from the first Trimester of Gestation in order to observe the OPTIMAL EFFECT on RISK of childhood asthma, THOUGH EVIDENCE from chawes et al.’s clinical trial DID NOT CONFIRM this NOTION (75).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 44), ('FUTURE_WORK', 129), ('IMPORTANT_CONSIDERATION', 211), ('SUPERFICIAL_RELATIONSHIP', 219), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('INCOMPLETE_EVIDENCE', 328)]	12	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 164, 'trimester'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC2913107	8/2010	S15-PMC2913107	['even more INTRIGUING, BOTH PAPERS REPORT that the mental condition in rickets IMPROVED with Vitamin D.\nANOTHER of the MYSTERIES of autism is the APPARENT INCREASED INCIDENCE of autism in the children of richer college-educated parents, ESPECIALLY women, a FINDING announced a few months ago (12).']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FULL_UNKNOWN', 118), ('ANOMALY_CURIOUS_FINDING', 145), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 236), ('INCOMPLETE_EVIDENCE', 256)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3171895	9/2011	S149-PMC3171895	['FURTHER INVESTIGATIONS are REQUIRED AS the concentrations of these Vitamins REMAIN significantly reduced in women with Preeclampsia, but in the absence OF FURTHER EVIDENCE, routine supplementation with higher dose Vitamin C and E is not RECOMMENDED AS they CAN be POTENTIALLY dangerous in high concentrations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 27), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 155), ('FUTURE_WORK', 237), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 264)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 67, 'vitamins'), ('GO_0007128', 'meiotic prophase I', 119, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 228, 'E')]
PMC3271033	1/2012	S141-PMC3271033	['we CANNOT RULE OUT the POSSIBILITY that a SMALL NUMBER OF infants WILL be hypocalcemic in the first weeks of Life with this approach, BUT, this APPEARS TO BE UNCOMMON and MAY BE more RELATED to pth function than Vitamin D. further RESEARCH IS NEEDED relative to the etiology of symptomatic hypocalcemia in the first weeks of life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 48), ('FUTURE_PREDICTION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 183), ('FUTURE_WORK', 231)]	11	[('UBERON_0000104', 'life cycle', 109, 'life'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3277098	12/2011	S184-PMC3277098	['this data has the advantage of focussing on the Early Life Period and MAY THEREFORE provide INSIGHT into the aetiological ROLE of Vitamin D. DESPITE the OBSERVED PROTECTIVE ASSOCIATION of Serum 25(Oh)D and allergy, it has been NOTED that the widespread practice of supplementation COINCIDED with the rise in allergic disease [35].']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('ANOMALY_CURIOUS_FINDING', 141), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 281)]	11	[('UBERON_0019248', 'early embryo', 48, 'early life period'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('UBERON_0001977', 'blood serum', 188, 'serum'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 194, '25(OH)D')]
PMC3427192	4/2012	S21-PMC3427192	['INSTEAD, a number of environmental exposures MAY also alter the rate of Asthma Development.50-54of these modifiable environmental exposures, the ROLE of diet in asthma is of PARTICULAR INTEREST13,55since RECENT STUDIES SUGGEST that the Development Of Asthma in children MAY BE DUE to in utero exposure to Nutrients from the mother’s diet.56given the ROLE of Vitamin D in inflammation and Immunomodulation, SEVERAL STUDIES have focused on in utero Vitamin D exposure and subsequent asthma in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 174), ('ANOMALY_CURIOUS_FINDING', 185), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 219), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 277), ('SUPERFICIAL_RELATIONSHIP', 350), ('INCOMPLETE_EVIDENCE', 406)]	11	[('GO_0035801', 'adrenal cortex development', 72, 'asthma development'), ('GO_0009602', 'detection of symbiont', 236, 'development of asthma'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 388, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 447, 'vitamin D')]
PMC3760821	9/2013	S28-PMC3760821	['this APPARENT rise in 1,25(Oh)2D has LED TO the SUGGESTION that Pregnant women MAY REQUIRE higher cellular exposure to active Vitamin D during the second and third trimesters, and HAS BEEN interpreted by SOME as PROVIDING EVIDENCE for its POTENTIAL ROLE in obstetric well-Being[8].']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 212), ('INCOMPLETE_EVIDENCE', 222), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 249)]	11	[('CHEBI_17996', 'chloride', 23, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 24, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0016441', 'posttranscriptional gene silencing', 271, '-being')]
PMC3798907	8/2013	S139-PMC3798907	['a SMALL number ( n = 40) of Adult Pbmc samples were obtained to investigate a POSSIBLE age RELATED differential responsiveness to Vitamin E. consequently the concentrations of Ascorbate and Α-Tocopherol used to supplement these pbmc cultures, was the same as that used to supplement cbmc cultures, HOWEVER these levels are lower than those FOUND in the Plasma of healthy Adults, which COULD EXPLAIN the LACK OF EFFECTS SEEN in pbmc cultures.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 340), ('INCOMPLETE_EVIDENCE', 385), ('PROBABLE_UNDERSTANDING', 391), ('INCOMPLETE_EVIDENCE', 403), ('SUPERFICIAL_RELATIONSHIP', 411), ('INCOMPLETE_EVIDENCE', 419)]	11	[('UBERON_0007023', 'adult organism', 28, 'adult'), ('UBERON_2005026', 'primary head sinus', 34, 'PBMC'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin E'), ('CHEBI_22651', 'ascorbate', 176, 'ascorbate'), ('CHEBI_27725', 'butin', 190, 'α-tocopherol'), ('UBERON_0001969', 'blood plasma', 353, 'plasma'), ('UBERON_0007023', 'adult organism', 371, 'adults')]
PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
PMC3814422	10/2013	S137-PMC3814422	['ALTHOUGH Animal studies HAVE SHOWN that Vitamin D is INVOLVED in normal Fetal Lung Development31, OUR STUDY is IN GENERAL AGREEMENT with OTHER epidemiological STUDIES that have considered later offspring Lung function in the general population – two STUDIES HAVE REPORTED null ASSOCIATIONS of maternal 25(Oh)D13,32or dietary Vitamin D intake32with offspring Lung function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 98), ('INCOMPLETE_EVIDENCE', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 277)]	11	[('NCBITaxon_33208', 'Metazoa', 9, 'animal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007631', 'feeding behavior', 72, 'fetal'), ('GO_0030324', 'lung development', 78, 'lung development31'), ('UBERON_0002048', 'lung', 78, 'lung'), ('UBERON_0002048', 'lung', 204, 'lung'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 302, '25(OH)D13'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('UBERON_0002048', 'lung', 358, 'lung')]
PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]
PMC4377879	3/2015	S90-PMC4377879	['OTHER Vitamins : DEFICIENCIES of YET OTHER Vitamins such as Vitamin B12 and PERHAPS Vitamin A MAY BE IMPORTANT BUT EVIDENCE IS SPARSE OR CONFLICTING [22,43].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 17), ('ANOMALY_CURIOUS_FINDING', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 6, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 43, 'vitamins'), ('CHEBI_33279', 'vitamin D5', 60, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 60, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4383226	2/2015	S0-PMC4383226	['vitamin a Supplements, routine immunization, and the subsequent risk of plasmodium infection among children under 5 years in sub-saharan africa\n\nabstract\nRECENT STUDIES, PARTLY based on Murine MODELS, SUGGEST childhood immunization and Vitamin A Supplements MAY confer protection against malaria infection, ALTHOUGH STRONG EVIDENCE TO SUPPORT these THEORIES in Humans has so far BEEN LACKING.']	[('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 316), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 379)]	11	[('CHEBI_33341', 'titanium atom', 10, 'supplements'), ('NCBITaxon_39107', 'Murinae', 186, 'murine'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin A'), ('CHEBI_33341', 'titanium atom', 246, 'supplements'), ('NCBITaxon_9606', 'Homo sapiens', 361, 'humans')]
PMC4383226	2/2015	S147-PMC4383226	['WHILE the PROTECTIVE ASSOCIATION between Vitamin A and malaria REMAINED, the low prevalence of maternal hiv in our study population (and HENCE LOW statistical power) makes it DIFFICULT to RULE OUT POTENTIAL Vitamin A–hiv INTERACTIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 137), ('PROBLEM_COMPLICATION', 143), ('DIFFICULT_TASK', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 221)]	11	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4586451	10/2015	S212-PMC4586451	['there was also no evidence of an association between maternal Vitamin D status during Pregnancy and offspring bone Mineral content (table 3).24the SUGGESTION that maternal body fat stores are IMPORTANT for fetal bone Mineral deposition was investigated in a further study.25there was NO evidence of an independent association between maternal Prepregnancy bmi and offspring bone mass at age 9 years once adjustments were made for Birth weight and the current height and weight of the child.25\nthese data SUGGEST it is UNLIKELY that Pregnancy diet has an IMPORTANT EFFECT on any of the outcomes investigated in this section, ALTHOUGH the ASSOCIATIONS that were FOUND were with Nutrients that are most LIKELY to be inadequate in the diet of this population.8\n\nNeurocognitive and behavioral development Of the offspring\nBrain Cell Membranes have a high content of n-3 lc-pufas, and the predominant sources of these Nutrients in the diets of uk residents are fish and seafood.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 284), ('INCOMPLETE_EVIDENCE', 504), ('PROBABLE_UNDERSTANDING', 518), ('IMPORTANT_CONSIDERATION', 554), ('SUPERFICIAL_RELATIONSHIP', 564), ('ANOMALY_CURIOUS_FINDING', 624), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 660), ('PROBABLE_UNDERSTANDING', 700)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_46662', 'mineral', 115, 'mineral'), ('CHEBI_46662', 'mineral', 217, 'mineral'), ('GO_0007565', 'female pregnancy', 343, 'prepregnancy'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007565', 'female pregnancy', 532, 'pregnancy'), ('CHEBI_33284', 'nutrient', 676, 'nutrients'), ('GO_0043102', 'amino acid salvage', 758, 'Neurocognitive ... of ...'), ('UBERON_0000955', 'brain', 817, 'Brain'), ('GO_0005886', 'plasma membrane', 823, 'cell membranes'), ('CHEBI_33284', 'nutrient', 912, 'nutrients')]
PMC4595656	10/2015	S10-PMC4595656	['HOWEVER in RECENT YEARS, myriad OTHER functions and ROLES for Vitamin D HAVE BEEN gradually POSTULATED and VERIFIED, and its pleiotropic EFFECTS are now BEYOND DISPUTE (kalueff and tuohimaa,2007; mccann and ames,2008; lai and fang,2013; schlogl and holick,2014).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 137), ('IMPORTANT_CONSIDERATION', 153), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4600246	10/2015	S4-PMC4600246	['introduction\nVitamin K is a fat-soluble Vitamin, IMPORTANT for the function of numerous proteins within the body, such as the Coagulation factors (ii, vii, Ix, x and protein c and protein s), Osteocalcin (a bone-Forming Protein) and Matrix-Gla Protein (Mgp) (an anticalcification protein), to name a few.1–3vitamin K exists naturally as Vitamin K1(Phylloquinone) and Vitamin K2(Menaquinone, mk-4 through mk-10).2–5vitamin K1Is mainly found in green leafy vegetables as well as olive oil and soyabean oil, whereas Vitamin K2(Menaquinone) is found in small amounts in Chicken, butter, Egg Yolks, cheese and fermented soyabeans (BETTER KNOWN as natto).26–9\nVitamin K1And Vitamin K2Are REQUIRED for the γ-glutamyl carboxylation of all Vitamin K-dependent proteins.2DESPITE the fact that Mammalian bacterial Intestinal flora are able to produce Vitamin K2, the amount produced IS THOUGHT TO be negligible.2the adequate intake (ai) for Vitamin K HAS BEEN PROPOSED to be 90\u2005µg/day for women and 120\u2005µg/day for men.210HOWEVER, it HAS BEEN SPECULATED that the ai for Vitamin K (90–120\u2005µg/day) is not sufficient to induce complete carboxylation of all Vitamin K-dependent proteins.21112\n\nvitamin K deficiency\nthe measurement and treatment of Vitamin K deficiency based on Blood tests is not perfect.']	[('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 626), ('IMPORTANT_CONSIDERATION', 682), ('ANOMALY_CURIOUS_FINDING', 760), ('INCOMPLETE_EVIDENCE', 872), ('INCOMPLETE_EVIDENCE', 875), ('INCOMPLETE_EVIDENCE', 940), ('INCOMPLETE_EVIDENCE', 949), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1007), ('INCOMPLETE_EVIDENCE', 1022), ('INCOMPLETE_EVIDENCE', 1031)]	11	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 40, 'vitamin'), ('GO_0050817', 'coagulation', 126, 'coagulation'), ('PR_000008875', 'islet amyloid polypeptide', 156, 'IX'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 192, 'osteocalcin'), ('PR_000004759', 'Bloom syndrome protein', 211, '-forming protein'), ('GO_0031012', 'extracellular matrix', 233, 'matrix'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 233, 'matrix-Gla protein'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 253, 'MGP'), ('CHEBI_52071', 'dextran', 315, 'K'), ('CHEBI_33229', 'vitamin (role)', 337, 'vitamin'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 337, 'vitamin K1'), ('CHEBI_26124', 'phytosteroid', 348, 'phylloquinone'), ('CHEBI_28934', 'vitamin D2', 367, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 367, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 378, 'menaquinone'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 422, 'K1is'), ('CHEBI_28934', 'vitamin D2', 513, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 513, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 524, 'menaquinone'), ('NCBITaxon_33208', 'Metazoa', 566, 'chicken'), ('UBERON_0005079', 'eggshell', 583, 'egg yolks'), ('CHEBI_33229', 'vitamin (role)', 654, 'Vitamin'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 654, 'Vitamin K1and'), ('PR_000017209', 'utrophin', 668, 'vitamin K2are'), ('CHEBI_27300', 'vitamin D', 731, 'vitamin K'), ('NCBITaxon_40674', 'Mammalia', 783, 'mammalian'), ('UBERON_0000160', 'intestine', 803, 'intestinal'), ('CHEBI_28934', 'vitamin D2', 840, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 840, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1142, 'vitamin K'), ('CHEBI_52071', 'dextran', 1186, 'K'), ('CHEBI_27300', 'vitamin D', 1232, 'vitamin K'), ('UBERON_0000178', 'blood', 1262, 'blood')]
PMC4691762	12/2015	S118-PMC4691762	['it acts by inducing Antimicrobial peptides in Epithelial Cells, Neutrophils and Macrophages28And increases transcription of the innate Immune protein (hcap-18) which is capable of killing a wide variety of Viral and bacterial pathogens.29THESE FINDINGS are SUPPORTED by the observation that Vitamin D receptor polymorphisms (which decrease the bioavailability of Vitamin D to the cell) are ASSOCIATED with more SEVERE bronchiolitis30and that defective Control Of Vitamin D receptor-Mediated Cell Signalling PREDISPOSES to SEVERE Respiratory syncytial Virus bronchiolitis.31\n\nconclusions\ninternational enthusiasm for supplemental Vitamin D has OUTPACED AVAILABLE EVIDENCE on its EFFECTIVENESS32AND in fact ARGUMENT for routine supplementation is in equipoise.']	[('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 411), ('SUPERFICIAL_RELATIONSHIP', 507), ('IMPORTANT_CONSIDERATION', 522), ('ANOMALY_CURIOUS_FINDING', 643), ('ANOMALY_CURIOUS_FINDING', 643), ('INCOMPLETE_EVIDENCE', 652), ('SUPERFICIAL_RELATIONSHIP', 678), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 705)]	11	[('CHEBI_65381', 'albizoside C', 20, 'antimicrobial'), ('CL_0000066', 'epithelial cell', 46, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 46, 'epithelial'), ('CL_0000775', 'neutrophil', 64, 'neutrophils'), ('CL_0000091', 'Kupffer cell', 80, 'macrophages28and'), ('UBERON_0002405', 'immune system', 135, 'immune'), ('NCBITaxon_1', 'root', 206, 'viral'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('GO_0060070', 'canonical Wnt signaling pathway', 452, 'control of ... -mediated cell signalling'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 529, 'respiratory'), ('NCBITaxon_1', 'root', 551, 'virus'), ('CHEBI_27300', 'vitamin D', 629, 'vitamin D')]
PMC4770602	1/2016	S23-PMC4770602	['[518]\nbased ON the ROLE of maternal Vitamin D deficiency, AS a POTENTIAL in DEPENDENT RISK FACTOR for Preeclampsia, Vitamin D supplementation in early Pregnancy REMAINS a POSSIBLE intervention and POSSIBLE improved Pregnancy outcomes through PREVENTION or delay of Preeclampsia.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('SUPERFICIAL_RELATIONSHIP', 19), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 242)]	11	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 265, 'preeclampsia')]
PMC5035678	4/2016	S132-PMC5035678	['they FOUND that high dose supplementation for a mean of 14 weeks during Pregnancy was not beneficial to the patients’ plasma Glucose level or Insulin resistance during Pregnancy, BUT that their babies BENEFITTED from the supplementation with decreased neonatal hypovitaminosis D. the authors CONCLUDED that the commencement of Vitamin D supplementation MAY HAVE been too late to cause any observable EFFECTS on Β-Cell function, and they SUGGESTED that earlier supplementation, EVEN before Pregnancy, MIGHT be EFFECTIVE.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('IMPORTANT_CONSIDERATION', 201), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 353), ('IMPORTANT_CONSIDERATION', 357), ('SUPERFICIAL_RELATIONSHIP', 400), ('INCOMPLETE_EVIDENCE', 437), ('ANOMALY_CURIOUS_FINDING', 477), ('INCOMPLETE_EVIDENCE', 500), ('SUPERFICIAL_RELATIONSHIP', 509)]	11	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_17234', 'glucose', 125, 'glucose'), ('PR_000045358', 'insulin family protein', 142, 'insulin'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CL_0000623', 'natural killer cell', 411, 'β-cell'), ('GO_0007565', 'female pregnancy', 489, 'pregnancy')]
PMC5045784	10/2016	S86-PMC5045784	['mccarthy et al.29REPORTED that in a cohort of 274 preterm infants (<32 weeks) in ireland, levels of 25(Oh)D REMAINED under 20\u2009ng\u2009ml−1in 78% of subjects DESPITE 18 days on average of enteral Feeding and Vitamin D supplementation.29a RECENT intervention TRIAL by fort et al.17DEMONSTRATED that biochemical Vitamin D deficiency among EXTREMELY preterm infants CAN be reduced by additional supplementation with 200 units of Vitamin D daily, and PREVENTED by additional supplementation with 800 units of Vitamin D daily17and these two regimens were FOUND TO BE SAFE.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 232), ('PROBABLE_UNDERSTANDING', 272), ('PROBABLE_UNDERSTANDING', 272), ('IMPORTANT_CONSIDERATION', 331), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 441), ('ANOMALY_CURIOUS_FINDING', 544), ('IMPORTANT_CONSIDERATION', 556)]	11	[('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 106, 'D'), ('GO_0007631', 'feeding behavior', 190, 'feeding'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 420, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D')]
PMC5051327	9/2016	S54-PMC5051327	['IN FACT, the ONLY study PREVIOUSLY addressing THIS topic was performed in southern china, where Vitamin D deficiency is relatively UNCOMMON and no RELATION to Birth asphyxia was FOUND.19two randomised controlled studies of Antenatal Vitamin D supplementation REPORTED lower apgar score at 1 and 5\u2005min, respectively.2021in addition, in the latter study REPORTED, 13% of Vitamin D deficient newborn had apgar score at 5\u2005min <7, as compared TO 1.1% among those who were sufficient.21our observational study design disables us from investigating a causal RELATION between Vitamin D levels and fetal distress/Birth asphyxia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 259), ('INCOMPLETE_EVIDENCE', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 438), ('SUPERFICIAL_RELATIONSHIP', 551)]	11	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 159, 'birth'), ('GO_0007567', 'parturition', 223, 'antenatal'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('GO_0007567', 'parturition', 604, 'birth')]
PMC5129897	10/2016	S8-PMC5129897	['introduction\nduring the past 15\xa0years, CONSIDERABLE INTEREST in the health BENEFITS of Vitamin D has emerged BECAUSE People with higher ultraviolet-b (uvb) exposure and/or 25-Hydroxyvitamin D [25(Oh)D] concentrations have lower RISK of many diseases and conditions.1our analysis is LIMITED to the diseases with the greatest economic EFFECT and the STRONGEST evidence of PROTECTIVE ROLES of Vitamin D—namely, cancer, Cardiovascular disease (cvd), dementia, diabetes mellitus (dm), falls and fractures, multiple sclerosis (ms), and Respiratory Tract infections.']	[('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 75), ('PROBABLE_UNDERSTANDING', 109), ('IMPORTANT_CONSIDERATION', 228), ('INCOMPLETE_EVIDENCE', 282), ('SUPERFICIAL_RELATIONSHIP', 333), ('INCOMPLETE_EVIDENCE', 348), ('SUPERFICIAL_RELATIONSHIP', 370), ('SUPERFICIAL_RELATIONSHIP', 381)]	11	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'people'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 172, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 416, 'cardiovascular'), ('UBERON_0000065', 'respiratory tract', 530, 'respiratory tract')]
PMC5129897	10/2016	S176-PMC5129897	['the results of observational studies are GENERALLY not well-SUPPORTED by clinical trials of Vitamin D supplementation.94the primary REASON for that lack OF support SEEMS TO be that the trials were NOT WELL DESIGNED, being based LARGELY on the guidelines for Pharmaceutical Drugs RATHER than for Nutrients.2another WORRISOME POINT is that clinical trials have BEEN much more successful when baseline 25(Oh)D concentrations were low.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 132), ('ANOMALY_CURIOUS_FINDING', 153), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279), ('IMPORTANT_CONSIDERATION', 314), ('IMPORTANT_CONSIDERATION', 324), ('ANOMALY_CURIOUS_FINDING', 359)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 258, 'pharmaceutical'), ('CHEBI_23888', 'drug', 273, 'drugs'), ('CHEBI_33284', 'nutrient', 295, 'nutrients'), ('CHEBI_71657', 'versiconol acetate', 399, '25(OH)D')]
PMC5155676	12/2016	S115-PMC5155676	['this mechanism MIGHT be IMPORTANT in preventing hypervitaminosis D. HOWEVER, studies comparing the effectiveness of DIFFERING doses of Vitamin D in Pregnancy HAVE SHOWN that 4000 iu/d CAN achieve a higher 25(Oh)D than 400 iu/d (10,28), BUT WHETHER these higher doses are of clinical benefit is YET to be DEMONSTRATED (4,29) and at the general population level, lower doses would be compatible with keeping 25(Oh)D below a concentration which MIGHT be concerning.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 442)]	11	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 65, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D')]
PMC5155676	12/2016	S125-PMC5155676	['ALTHOUGH OUR FINDINGS are NOVEL, and MAY enable the development of individualized ADVICE for Antenatal Vitamin D supplementation, there are a NUMBER OF LIMITATIONS which SHOULD BE CONSIDERED in the INTERPRETATION of this study.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FULL_UNKNOWN', 26), ('INCOMPLETE_EVIDENCE', 37), ('FUTURE_WORK', 82), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 152), ('PROBLEM_COMPLICATION', 152), ('FUTURE_WORK', 170), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 198)]	11	[('GO_0007567', 'parturition', 93, 'antenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC5359891	3/2017	S108-PMC5359891	['omission from control group SUPPORTED by usual clinical practiceβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictionsfolic acid400\xa0μgstandard Preconception RECOMMENDATIONIRON12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, THOUGH WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard preconception recommendationprobiotictaking a combination of two Probiotics HAS BEEN LINKED with maintenance of healthy Glucose Metabolism in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 99), ('FUTURE_WORK', 218), ('ANOMALY_CURIOUS_FINDING', 305), ('INCOMPLETE_EVIDENCE', 312), ('PROBABLE_UNDERSTANDING', 380), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 458), ('PROBABLE_UNDERSTANDING', 613), ('INCOMPLETE_EVIDENCE', 755), ('SUPERFICIAL_RELATIONSHIP', 764)]	11	[('CHEBI_85000', '1-octadecenoyl-2-icosatetraenoyl-sn-glycero-3-phosphoethanolamine', 65, '-carotene720'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'preconception'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_17234', 'glucose', 470, 'glucose'), ('GO_0006006', 'glucose metabolic process', 470, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 492, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 528, 'calcium'), ('GO_0007565', 'female pregnancy', 568, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 744, 'probiotics'), ('CHEBI_17234', 'glucose', 799, 'glucose'), ('GO_0006006', 'glucose metabolic process', 799, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 821, 'pregnancy')]
PMC5640793	9/2017	S44-PMC5640793	["the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency."]	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S390-PMC5941617	['the EVIDENCES for a pathogenetic ROLE for Vitamin D in ad are STILL CONFLICTING EVEN THOUGH data in favour of such CORRELATION are increasingly stronger with MORE STUDIES in favour BUT OTHERS OPPOSING THIS HYPOTHESIS.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 115), ('FUTURE_WORK', 158), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206)]	11	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S95-BMJ_2010_Apr_29_340_c1640	['maternal exposure and health of offspring\nthis report adds to other work SHOWING that maternal exposure to ambient ultraviolet radiation during Pregnancy MIGHT INFLUENCE subsequent health in the offspring.30313233in a new zealand Birth cohort, infants whose mothers were exposed to peak sunshine during the first Trimester were significantly heavier at Birth than infants whose mothers experienced trough levels of sunshine during the same trimester.30in the united kingdom, maternal ambient Ultraviolet B exposure in the third trimester HAS BEEN positively RELATED to bone Mineral density and content at age 9 in offspring.34there is now GROWING INTEREST in the ROLE of maternal Vitamin D deficiency in Pregnancy and the Development of Central Nervous System and Immune disorders, PARTICULARLY schizophrenia,33type 1 diabetes, and other disorders.35ALTHOUGH active Vitamin D3Concentrations in the mother increase substantially during Pregnancy, early fetal supplies are lower36and directly DEPENDENT on the mother.']	[('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 538), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 639), ('SUPERFICIAL_RELATIONSHIP', 663), ('IMPORTANT_CONSIDERATION', 782), ('ANOMALY_CURIOUS_FINDING', 848), ('SUPERFICIAL_RELATIONSHIP', 991)]	10	[('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007567', 'parturition', 230, 'birth'), ('GO_0009294', 'DNA mediated transformation', 313, 'trimester'), ('GO_0007567', 'parturition', 353, 'birth'), ('CHEBI_72754', 'bisphenol AF', 492, 'ultraviolet B'), ('CHEBI_46662', 'mineral', 574, 'mineral'), ('CHEBI_27300', 'vitamin D', 680, 'vitamin D'), ('GO_0007565', 'female pregnancy', 704, 'pregnancy'), ('GO_0008289', 'lipid binding', 722, 'development'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 737, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 737, 'central nervous system'), ('UBERON_0002405', 'immune system', 764, 'immune'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 866, 'vitamin D3concentrations'), ('GO_0007565', 'female pregnancy', 935, 'pregnancy')]
PMC3075531	7/2010	S40-PMC3075531	['discussion\nwe FOUND the same results as studies in europe and north america, which IMPLICATES lower Serum Vitamin D level in ms patients than in normal population, IN SPITE of sufficient sun exposure in isfahan region.23815the HYPOTHESIS that Vitamin D deficiency is a RISK FACTOR for ms was first PROPOSED over 30 years ago4and GAINED CREDIBILITY after the discovery of the immunomodulatory EFFECTS of Vitamin D.5moreover, in the past few years, the epidemiological EVIDENCE of an increased ms risk among Individuals with low Vitamin D concentrations has ACHIEVED SUBSTANTIAL STRENGTH.']	[('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 83), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 298), ('PROBABLE_UNDERSTANDING', 329), ('SUPERFICIAL_RELATIONSHIP', 392), ('INCOMPLETE_EVIDENCE', 467), ('PROBABLE_UNDERSTANDING', 556)]	10	[('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 403, 'vitamin D'), ('NCBITaxon_1', 'root', 506, 'individuals'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D')]
PMC3395583	7/2012	S101-PMC3395583	['it is IMPORTANT TO NOTE that our uvb and Vitamin D CORRELATION analysis DOES NOT prove causation and that, ALTHOUGH the Vitamin D HYPOTHESIS is SUPPORTED by both epidemiological and functional OBSERVATIONS, seasonality dominates many features of the global environment and OTHER seasonal factors MAY play a ROLE in determining the risk of id.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 51), ('ANOMALY_CURIOUS_FINDING', 72), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 296), ('SUPERFICIAL_RELATIONSHIP', 307)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
PMC3427192	4/2012	S60-PMC3427192	['studies of Vitamin D status in Adults with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher Serum 25(Oh)D ASSOCIATED with increased Lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, history of asthma, and asthma exacerbationhigher serum 25(Oh)D ASSOCIATED with decreased odds of current wheezing and asthma as well as emergency visits for asthma and asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, total Serum igehigher 25(Oh)D ASSOCIATED with greater Lung function with no associations NOTED for igeoren832008290 (26)43cross-sectionalobese patientsasthma and allergic rhinitis25(Oh)D deficiency (< 25 ng/ml) ASSOCIATED with increased odds of atopic dermatitis BUT no associations with asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, Airway hyper-responsiveness, Glucocorticoid responsivenessdecreased 25(Oh)D ASSOCIATED with decreased Lung function, increased Airway hyperresponsiveness, and reduced Glucocorticoid responses\n\ngenetics of Vitamin D and asthma\nSOME STUDIES have FOCUSED on Genetic ASSOCIATIONS between Vitamin D and asthma in larger populations.']	[('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 388), ('SUPERFICIAL_RELATIONSHIP', 620), ('ANOMALY_CURIOUS_FINDING', 679), ('SUPERFICIAL_RELATIONSHIP', 801), ('ANOMALY_CURIOUS_FINDING', 853), ('SUPERFICIAL_RELATIONSHIP', 1034), ('INCOMPLETE_EVIDENCE', 1184), ('QUESTION_ANSWERED_BY_THIS_WORK', 1202), ('SUPERFICIAL_RELATIONSHIP', 1221)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0007023', 'adult organism', 31, 'adults'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 211, '25(OH)D'), ('UBERON_0002048', 'lung', 245, 'lung'), ('CHEBI_71657', 'versiconol acetate', 380, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 380, '25(OH)D'), ('UBERON_0001977', 'blood serum', 596, 'serum'), ('CHEBI_71657', 'versiconol acetate', 612, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 612, '25(OH)D'), ('UBERON_0002048', 'lung', 644, 'lung'), ('CHEBI_33010', 'chromide(1-)', 771, '(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 775, 'D'), ('UBERON_0001005', 'respiratory airway', 958, 'airway'), ('CHEBI_24261', 'glucocorticoid', 987, 'glucocorticoid'), ('CHEBI_71657', 'versiconol acetate', 1026, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 1029, 'OH ... D'), ('UBERON_0002048', 'lung', 1060, 'lung'), ('UBERON_0001005', 'respiratory airway', 1085, 'airway'), ('CHEBI_24261', 'glucocorticoid', 1125, 'glucocorticoid'), ('CHEBI_28384', 'vitamin K', 1163, 'Vitamin D'), ('SO_0000704', 'gene', 1213, 'genetic'), ('CHEBI_27300', 'vitamin D', 1242, 'vitamin D')]
PMC3515553	12/2012	S171-PMC3515553	['NONETHELESS, the fact that our OBSERVATIONAL ASSOCIATION of maternal dietary Intake attenuated NOTICEABLY with adjustment for CONFOUNDING FACTORS and that the Genetic ASSOCIATIONS are not very strong SUGGESTS that maternal Vitamin B-12 MAY not have an IMPORTANT causal EFFECT on offspring iq.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 95), ('PROBLEM_COMPLICATION', 126), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 200), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 252), ('SUPERFICIAL_RELATIONSHIP', 269)]	10	[('GO_0007631', 'feeding behavior', 77, 'intake'), ('SO_0000704', 'gene', 159, 'genetic'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 223, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 233, '12')]
PMC3613945	2/2013	S227-PMC3613945	['explored PREVIOUS epidemiological EVIDENCE SUGGESTING a reduced risk ASSOCIATED with Vitamin D. NO EVIDENCE for ASSOCIATION between dbp genotype and risk of Colorectal cancer was FOUND, ALTHOUGH ASSOCIATIONS between dbp Snps and microsatellite-unstable Colorectal cancer were REPORTED168.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 276)]	10	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0012652', 'colorectum', 157, 'colorectal'), ('SO_0000694', 'SNP', 220, 'SNPs'), ('UBERON_0012652', 'colorectum', 253, 'colorectal')]
PMC3717170	5/2013	S68-PMC3717170	['Vitamin D during Pregnancy and Lactation\nVitamin D as a preprohormone has EFFECTS that extend beyond Calcium Metabolism and Homeostasis throughout Life but which are most vivid during Pregnancy when Vitamin D Metabolism is disengaged from its usual constraints.12at no other time during the Lifecycle is 25(Oh)D3Linked directly to 1,25(Oh)2d3production, the latter rising more than 2.5 times above nonpregnant levels.12this elevation of 1,25(oh)2d3likely serves the purpose of Immune Regulation, THOUGH there HAVE BEEN ONLY a FEW STUDIES that have evaluated the EFFECT of Vitamin D status on Immune function during Pregnancy to SUPPORT THIS HYPOTHESIS.']	[('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 484), ('ANOMALY_CURIOUS_FINDING', 496), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 628), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 641)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('GO_0007595', 'lactation', 31, 'lactation'), ('CHEBI_28384', 'vitamin K', 41, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 101, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 124, 'homeostasis'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 199, 'vitamin D metabolism'), ('UBERON_0000104', 'life cycle', 291, 'lifecycle'), ('CHEBI_77914', '3-methylbut-1-ene', 304, '25(OH)D3linked'), ('CHEBI_63056', 'zinc cation', 333, '25(OH'), ('CHEBI_17996', 'chloride', 438, ','), ('GO_0002521', 'leukocyte differentiation', 477, 'immune regulation'), ('UBERON_0002405', 'immune system', 477, 'immune'), ('CHEBI_27300', 'vitamin D', 572, 'vitamin D'), ('UBERON_0002405', 'immune system', 592, 'immune'), ('GO_0007565', 'female pregnancy', 615, 'pregnancy')]
PMC3760821	9/2013	S35-PMC3760821	['IMPORTANTLY, this cohort was largely of white european origin and THEREFORE, less AT RISK of Vitamin D deficiency[15]; furthermore, the authors counselled that their FINDINGS SHOULD NOT BE taken to mean that individual 25Ohd concentrations are not an IMPORTANT DETERMINANT of bone health, and, moreover, that their study WAS NOT designed to examine non-bone health outcomes[14].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 175), ('ANOMALY_CURIOUS_FINDING', 186), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 261), ('INCOMPLETE_EVIDENCE', 321), ('ANOMALY_CURIOUS_FINDING', 325)]	10	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 219, '25OHD')]
PMC3798907	8/2013	S153-PMC3798907	['this DISPARITY, in conjunction with RECENT Antenatal intervention DATA [21] EMPHASISES the COMPLEX nature of ASSOCIATIONS between Nutrients and disease and the NEED carefully to CONSIDER the nature of any Vitamin E based Antenatal intervention intended to reduce the LIKELIHOOD of childhood asthma.']	[('ANOMALY_CURIOUS_FINDING', 5), ('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 76), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 109), ('FUTURE_WORK', 160), ('FUTURE_WORK', 178), ('PROBABLE_UNDERSTANDING', 267)]	10	[('GO_0007567', 'parturition', 43, 'antenatal'), ('CHEBI_33284', 'nutrient', 130, 'nutrients'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin E'), ('GO_0007567', 'parturition', 221, 'antenatal')]
PMC4072587	6/2014	S148-PMC4072587	['SOME authors have also SUGGESTED that the cut off for sufficient Vitamin D levels during Pregnancy SHOULD BE as high as 100–150 nmo/l[10],[11], and THEREFORE the PROBLEM of Vitamin D deficiency in vietnam and OTHER south east asian countries MAY BE EVEN more widespread than PREVIOUSLY THOUGHT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 148), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 242), ('ANOMALY_CURIOUS_FINDING', 249), ('INCOMPLETE_EVIDENCE', 275), ('INCOMPLETE_EVIDENCE', 286)]	10	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4113768	7/2014	S1445-PMC4113768	['suboptimal Vitamin D status APPEARS TO increase an Individual’s RISK of developing cvd, ALTHOUGH the OPTIMAL level REQUIRED is UNCLEAR and the results of intervention studies REMAIN HETEROGENEOUS and INCONCLUSIVE.']	[('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 127), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('DIFFICULT_TASK', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 51, 'individual')]
PMC4329404	10/2014	S148-PMC4329404	['it is CONSISTENT with FINDINGS from epidemiological studies which have FAILED TO SHOW reliable EFFECTS of Vitamin D deficiency or insufficiency on Lung function in children with asthma (6–8,11) ALTHOUGH ASSOCIATIONS are REPORTED in Adults (33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('DIFFICULT_TASK', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 220)]	10	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0002048', 'lung', 147, 'lung'), ('UBERON_0007023', 'adult organism', 232, 'adults')]
PMC4329404	10/2014	S149-PMC4329404	['overall, GIVEN OUR FINDINGS in a neonatal Mouse MODEL, and PREVIOUS REPORTS of Vitamin D deficiency in utero through Adulthood not resulting in significantly WORSE ahr, it SEEMS LIKELY that in the context of asthma in early Life, Vitamin D deficiency modifies Immunological Responses To Allergen by the induction of an exaggerated th2 skewed response and eosinophilia.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 158), ('ANOMALY_CURIOUS_FINDING', 172), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 178)]	10	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mouse'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 117, 'adulthood'), ('UBERON_0000104', 'life cycle', 224, 'life'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 260, 'immunological responses to allergen'), ('CHEBI_50904', 'allergen', 287, 'allergen')]
PMC4377870	3/2015	S94-PMC4377870	['THUS, in SUMMARY, WHILE OBSERVATIONAL data has SUGGESTED that Vitamin C is IMPORTANT for Lung health, intervention trials SHOWING efficacy are lacking and it APPEARS that supplementation with Vitamin C-rich whole foods, such as fruit and vegetables MAY BE more EFFECTIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 75), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 158), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 261)]	10	[('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('UBERON_0002048', 'lung', 89, 'lung'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin C')]
PMC4383226	2/2015	S43-PMC4383226	['the underlying mechanisms of these EFFECTS are UNCLEAR, ALTHOUGH it HAS BEEN THEORIZED that Vitamin A MAY act as Adjuvant to dtp, which is POSTULATED to cause DETRIMENTAL EFFECTS (jorgensen et al., 2011).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('FULL_UNKNOWN', 47), ('ANOMALY_CURIOUS_FINDING', 56), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 77), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('CHEBI_60809', 'adjuvant', 113, 'adjuvant')]
PMC4405493	4/2015	S178-PMC4405493	['ALTHOUGH OUR STUDY DID NOT DEMONSTRATE an association of Vitamin D Plasma concentration with select clinical outcomes, the prevalence of sub-optimal Vitamin D concentrations in patient plasma EMPHASIZES THE NEED for CONTINUED RESEARCH on hypovitaminosis d in Pregnancy and Reproductive health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 203), ('FUTURE_WORK', 207), ('FUTURE_WORK', 216)]	10	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0000003', 'reproduction', 273, 'reproductive')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4600246	10/2015	S44-PMC4600246	['furthermore, most Individuals taking warfarin are counselled to avoid Vitamin K-containing foods, such as green leafy vegetables, which MAY lead to an EVEN further increase in cac.36vitamin k deficiency CAN be exacerbated further when Warfarin is initiated.38the negative IMPACT that warfarin CAN have on the body HAS LONG BEEN RECOGNISED.39\nwarfarin HAS BEEN SHOWN to cause SEVERE Arterial calcifications in the Aorta and the Carotid Arteries of Rats.']	[('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 272), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 314), ('PROBABLE_UNDERSTANDING', 318), ('PROBABLE_UNDERSTANDING', 328), ('INCOMPLETE_EVIDENCE', 351), ('IMPORTANT_CONSIDERATION', 375)]	10	[('NCBITaxon_1', 'root', 18, 'individuals'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin K'), ('CHEBI_10033', 'warfarin', 235, 'warfarin'), ('UBERON_0001637', 'artery', 382, 'arterial'), ('UBERON_0000947', 'aorta', 413, 'aorta'), ('UBERON_0005396', 'carotid artery segment', 427, 'carotid arteries'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 447, 'rats')]
PMC4600246	10/2015	S74-PMC4600246	['combining Vitamin K2With an Ace Inhibitor (Perindopril) HAS SHOWN synergistic EFFECTS on hcc recurrence and survival, and THUS this combination SHOULD also BE FURTHER explored.60moreover, ADDITIONAL STUDIES SHOULD BE explored combining Vitamin K2With Acyclic Retinoids, AS this combination HAS also SHOWN positive results on Human Hcc cell lines.69the health benefits of Vitamin K have been summarised inbox 1.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 78), ('PROBABLE_UNDERSTANDING', 122), ('FUTURE_WORK', 144), ('ANOMALY_CURIOUS_FINDING', 156), ('FUTURE_WORK', 159), ('FUTURE_WORK', 188), ('FUTURE_WORK', 207), ('PROBABLE_UNDERSTANDING', 270), ('INCOMPLETE_EVIDENCE', 290)]	10	[('CHEBI_77570', 'tropisetron hydrochloride', 10, 'vitamin K2with'), ('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 28, 'ACE inhibitor'), ('CHEBI_8024', 'perindopril', 43, 'perindopril'), ('CHEBI_77570', 'tropisetron hydrochloride', 236, 'vitamin K2with'), ('CHEBI_33333', 'alkylidene group', 251, 'acyclic retinoids'), ('NCBITaxon_9606', 'Homo sapiens', 325, 'human'), ('CL_0000745', 'retina horizontal cell', 331, 'HCC'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin K')]
PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
PMC4691762	12/2015	S18-PMC4691762	['Vitamin D deficiency (currently defined as 25Ohd3<50\u2005nmol/l) has become MORE COMMON in modern communities over time, PRESUMABLY DUE TO INADEQUATE sun exposure resulting from indoor activities and skin cancer CONCERNS.13vitamin d deficiency is common in victoria, australia and also APPEARS TO BE increasing among Pregnant women14and infants.6in addition, the prevalence of infant Vitamin D deficiency was fourfold higher among fully Breastfed infants than fully formula Fed (p<0.001) EVEN at 12\u2005months after solid Food had been introduced.15\nUNLIKE OTHER countries in the northern hemisphere, australia does not RECOMMEND universal Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 72), ('PROBABLE_UNDERSTANDING', 117), ('PROBABLE_UNDERSTANDING', 128), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 282), ('ANOMALY_CURIOUS_FINDING', 484), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 542), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 549), ('FUTURE_WORK', 612)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_63058', '(2R,3S)-EHNA', 43, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 43, '25OHD3'), ('GO_0007565', 'female pregnancy', 313, 'pregnant'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('GO_0007567', 'parturition', 433, 'breastfed'), ('GO_0007631', 'feeding behavior', 470, 'fed'), ('CHEBI_33290', 'food', 514, 'food'), ('CHEBI_27300', 'vitamin D', 632, 'vitamin D')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4765528	12/2015	S123-PMC4765528	['studies using the alspac cohort SHOW that Bone Development of the child is clearly RELATED to the in utero environment, BUT that SOME of the ASSOCIATIONS CAN be explained IN PART by the shared ASSOCIATIONS with bone and body size, ALTHOUGH maternal Vitamin D status exerts persisting EFFECTS on bone mass development [19].']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 193), ('ANOMALY_CURIOUS_FINDING', 231), ('SUPERFICIAL_RELATIONSHIP', 284)]	10	[('GO_0048539', 'bone marrow development', 42, 'bone development'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4829940	5/2016	S19-PMC4829940	['ALTHOUGH a NUMBER OF STUDIES have REPORTED inverse ASSOCIATIONS between maternal Vitamin D status and Postnatal health outcomes, systematic reviews SHOW that there is STILL substantial heterogeneity between studies in terms of methodology and results, and FEW or NO randomized TRIALS HAVE BEEN performed[6],[8],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 148), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 256), ('FULL_UNKNOWN', 263), ('INCOMPLETE_EVIDENCE', 284)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'postnatal')]
PMC4829940	5/2016	S115-PMC4829940	['DESPITE the EXISTING HYPOTHESIS that maternal Vitamin D status MAY INFLUENCE offspring health[41], we FOUND NO EVIDENCE for any Dna Methylation based EFFECT in Cord Blood, EITHER Genome-wide or in four candidate Genes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	10	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0006306', 'DNA methylation', 128, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 160, 'cord'), ('UBERON_0000178', 'blood', 165, 'blood'), ('SO_0001026', 'genome', 179, 'genome'), ('SO_0000704', 'gene', 212, 'genes')]
PMC4864049	1/2016	S350-PMC4864049	['this is PARTICULARLY INTERESTING because it LINKS FINDINGS SHOWING decreased levels of Serotonin in asd patients\xa0[160] and reduced levels of Vitamin D. HOWEVER, a previous study FOUND LITTLE EVIDENCE that maternal Gestational Vitamin D levels are RELATED to the asd phenotype among offspring\xa0[161].']	[('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 184), ('SUPERFICIAL_RELATIONSHIP', 247)]	10	[('CHEBI_28790', 'serotonin', 87, 'serotonin'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestational'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4930210	7/2016	S142-PMC4930210	['ALTHOUGH PREVIOUS STUDIES HAVE SHOWN FACTORS like age, season, and Vitamin D supplementation AFFECT 3-Epi-25(Oh)D3[29,30], in OUR STUDY the ONLY FACTOR positively CORRELATED with level of the 3-Epi-25(Oh)D3Was Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 163)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_76629', '2-lysophosphatidic acid', 100, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 112, 'D3'), ('CHEBI_73839', 'D-Leu-D-Leu', 192, '3-epi-25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 204, 'D3was'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC4971719	8/2016	S152-PMC4971719	['the LACK OF association OBSERVED between Vitamin D level in early or late Pregnancy and the 6–8 week Postpartum bdi score MAY BE EXPLAINED by the COMPLEXITY of the pathogenesis of Postpartum depression symptoms, OR it MAY represent a TRUE negative FINDING.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 129), ('DIFFICULT_TASK', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('INCOMPLETE_EVIDENCE', 218), ('PROBABLE_UNDERSTANDING', 234), ('INCOMPLETE_EVIDENCE', 248)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 101, 'postpartum'), ('GO_0007565', 'female pregnancy', 180, 'postpartum')]
PMC5014971	8/2016	S111-PMC5014971	['a RECENT STUDY on a mother-offspring cohort in singapore FOUND NO EVIDENCE for an effect of Vitamin D status on Birth outcome, THOUGH the authors CAUTION that the population had a low prevalence of Vitamin D deficiency/insufficiency and THUS they MAY NOT HAVE BEEN able to detect small EFFECTS [29].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 237), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 286)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'birth'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5510234	7/2017	S78-PMC5510234	['the authors REPORTED that EVEN in regions where Vitamin A deficiency is a PUBLIC HEALTH CONCERN, Vitamin A supplementation for PREVENTION of Prenatal mtct is not RECOMMENDED.58finally a RECENT REVIEW done on the vitamin a supplementation for the reduction of the RISK of mother-to-child transmission of hiv, REPORTED that early observational studies FOUND an ASSOCIATION between Vitamin A deficiency and increased rates of mtct of hiv.']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 127), ('FUTURE_WORK', 162), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 263), ('INCOMPLETE_EVIDENCE', 308), ('INCOMPLETE_EVIDENCE', 350), ('SUPERFICIAL_RELATIONSHIP', 359)]	10	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin A')]
PMC5664622	9/2017	S77-PMC5664622	['our results are CONSISTENT with the FINDINGS of OTHER authors, who have also CONFIRMED Vitamin D deficiency among Pregnant women in poland [3,5,17,18,19], ALTHOUGH REPORTS in the polish literature on better Vitamin D saturation in the summer are LESS UNAMBIGUOUS.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 246), ('INCOMPLETE_EVIDENCE', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251)]	10	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5706533	11/2017	S163-PMC5706533	['MANY of the REPORTED doses, HOWEVER, DID NOT yield EFFECTS on maternal 25(Oh)D that would be expected BASED ON Vitamin D pharmacokinetics.3637the muted dose-25(Oh)D RELATION COULD BE ATTRIBUTED to high baseline 25(Oh)D, low precision of 25(Oh)D assays, low rates of adherence to supplementation regimens, or lower than labeled Vitamin D content of the Supplements.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 183)]	10	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 73, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 157, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 237, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 352, 'supplements')]
PMC5827025	2/2018	S103-PMC5827025	['ALTHOUGH a RECENT STUDY in northeast china DEMONSTRATED that vdd was more PREVALENT in the SEVERE preterm group than in the mildly preterm group and the in-term group, they DID NOT analyze the ASSOCIATION between vdd and an INCREASED RISK of Preterm Delivery BECAUSE Vitamin D status at prior to labor cannot be used to assess risk of Preterm Delivery39.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 74), ('IMPORTANT_CONSIDERATION', 91), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 224), ('PROBLEM_COMPLICATION', 259)]	10	[('GO_0007565', 'female pregnancy', 242, 'preterm'), ('GO_0007567', 'parturition', 250, 'delivery'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'preterm'), ('GO_0007567', 'parturition', 343, 'delivery39')]
PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
PMC5995352	6/2018	S38-PMC5995352	['IF low maternal or Cord 25Ohd is LINKED to diminished infant growth, especially of the Long Bones, DESPITE Vitamin D supplementation RECOMMENDATIONS, an IMPORTANT POTENTIAL for enforced PREVENTION STRATEGIES is SUGGESTED, EVEN in populations with low incidence of Vitamin D deficiency rickets.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 99), ('FUTURE_WORK', 133), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 186), ('FUTURE_WORK', 197), ('INCOMPLETE_EVIDENCE', 211), ('ANOMALY_CURIOUS_FINDING', 222)]	10	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 24, '25OHD'), ('UBERON_0002495', 'long bone', 87, 'long bones'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S87-BMJ_2010_Apr_29_340_c1640	['RECENT work by sayers et al also INDICATES that ambient erythemal ultraviolet radiation levels during Pregnancy, EVEN in a single location, CAN be used to INDICATE Vitamin D status.29further work COULD CONFIRM the timing of the OBSERVED EFFECT of Prenatal ultraviolet radiation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 113), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 237)]	9	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 247, 'prenatal')]
PMC2582131	11/2008	S100-PMC2582131	['OUR FINDINGS are also GENERALLY CONSISTENT with a relatively large body of LITERATURE documenting a significant and inverse ASSOCIATION of circulating Vitamin D concentrations with measurements of glycemia or presence of type 2 dm among non-Pregnant women, ALTHOUGH the majority of THESE FINDINGS are based ON cross-sectional/RETROSPECTIVE data.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 257), ('INCOMPLETE_EVIDENCE', 282), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
PMC2963768	10/2010	S125-PMC2963768	['Vitamin D Receptor, 24-hydroxylase\nDESPITE the current enthusiasm for Vitamin D supplementation in the usa (22), the EFFECTS of Vitamin D deficits during early infancy are STILL NOT FULLY UNDERSTOOD, and meaningful inflection points in 25(Oh)D-outcome RELATIONSHIPS have NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 172), ('IMPORTANT_CONSIDERATION', 172), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 252), ('FULL_UNKNOWN', 271), ('ANOMALY_CURIOUS_FINDING', 275)]	9	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 0, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 236, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 239, 'OH ... D')]
PMC3032617	5/2010	S102-PMC3032617	['INTERESTINGLY, ALTHOUGH the average weight gain was normal in the two groups during Pregnancy without any significant statistical difference, this was FOUND lower in the Vitamin C group COMPARED TO controls, and this COULD SUGGEST the POSSIBILITY of a better Fatty Acid Catabolism provided by high dose Vitamin C intake which IS KNOWN to enhance Carnitine synthesis, a fundamental long chain Fatty Acid transporter to the Mitochondrial site for energy production in form of atp, also, Ascorbic Acid is INVOLVED in the biosynthetic pathway of Thyroid hormones which are known regulators of the basal Metabolism.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 186), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 235), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 502)]	9	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C'), ('CHEBI_35366', 'fatty acid', 259, 'fatty acid'), ('GO_0009062', 'fatty acid catabolic process', 259, 'fatty acid catabolism'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin C'), ('CHEBI_17126', 'carnitine', 346, 'carnitine'), ('GO_0015915', 'fatty-acyl group transport', 392, 'fatty acid'), ('GO_0005739', 'mitochondrion', 422, 'mitochondrial'), ('CHEBI_22652', 'ascorbic acid', 485, 'ascorbic acid'), ('CHEBI_9437', 'temoporfin', 542, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 542, 'thyroid'), ('GO_0008152', 'metabolic process', 599, 'metabolism')]
PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]
PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
PMC3338544	4/2012	S161-PMC3338544	['there are AS YET no epidemiological studies DEMONSTRATING a direct ASSOCIATION between autistic spectrum disorders and developmental Vitamin D levels, YET there are EFFECTS of season of Birth, latitude of Birth, and migrant status that MAY INDICATE a POSSIBLE ASSOCIATION (for review,[39]).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 67), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 251), ('SUPERFICIAL_RELATIONSHIP', 260)]	9	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'birth'), ('GO_0007567', 'parturition', 205, 'birth')]
PMC3347028	3/2012	S97-PMC3347028	['WHILE okonofua, et al, SUGGEST that normalization of maternal calcium and pth would be useful endpoints in determining the success of Vitamin D supplementation during Pregnancy, more RECENT STUDIES SUGGEST that BECAUSE pth threshold ESTIMATES cannot be precisely defined, total circulating 25(Oh)D ALONE is a BETTER measure of maternal Vitamin D status [60,64,65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 198), ('PROBLEM_COMPLICATION', 211), ('INCOMPLETE_EVIDENCE', 233), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 298), ('INCOMPLETE_EVIDENCE', 309)]	9	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC3501517	11/2012	S226-PMC3501517	['THEREFORE, an UNANSWERED QUESTION is IF Vitamin D augmentation CAN be PROTECTIVE in our Lps MODEL for ali.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('EXPLICIT_QUESTION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 92)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 88, 'LPS')]
PMC3635901	4/2013	S35-PMC3635901	['this ROLE of Vitamin D SEEMS to be so IMPORTANT that ads show seasonality (due TO DIFFERENT levels of uv exposure), and EVEN the month of Birth MAY INFLUENCE the risk of onset of an ad, as SHOWN by disanto et al .']	[('SUPERFICIAL_RELATIONSHIP', 5), ('ANOMALY_CURIOUS_FINDING', 23), ('IMPORTANT_CONSIDERATION', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 189)]	9	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth')]
PMC3651971	5/2013	S139-PMC3651971	['the lack of EFFECT is UNLIKELY to be DUE TO a lack of Vitamin A deficiency among Pregnant women; ∼20% of mothers were NOTED to have a Serum Retinol concentration below 0.70\u2005µmol/l, a prevalence that fell to ∼3% with supplementation.20gestational night blindness of ∼10% also responded to Vitamin A supplementation,37and the risk of Maternal death was reduced by ∼40% through supplementation.20there was no lack of Cognitive or motor effect, which is LIKELY to be OWING TO the POOR response to supplementation among the offspring; infants Born to supplemented women had a higher Serum Retinol than infants Born to Placebo mothers by 3\u2005months of age.24the children Born to supplemented women also had better Lung function (as measured by the forced Expiratory volume at 1\u2005s and forced vital capacity)25and raised natural Antibody levels26in childhood, FURTHER EVIDENCE of a physiological EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 22), ('PROBLEM_COMPLICATION', 37), ('ANOMALY_CURIOUS_FINDING', 118), ('PROBABLE_UNDERSTANDING', 450), ('PROBLEM_COMPLICATION', 463), ('PROBLEM_COMPLICATION', 476), ('INCOMPLETE_EVIDENCE', 850), ('SUPERFICIAL_RELATIONSHIP', 886)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_26536', 'retinoic acid', 140, 'retinol'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin A'), ('GO_0007618', 'mating', 332, 'maternal'), ('GO_0050890', 'cognition', 414, 'cognitive'), ('GO_0007567', 'parturition', 538, 'born'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_26536', 'retinoic acid', 584, 'retinol'), ('GO_0007567', 'parturition', 605, 'born'), ('CHEBI_26130', 'biological pigment', 613, 'placebo'), ('GO_0007567', 'parturition', 663, 'born'), ('UBERON_0002048', 'lung', 706, 'lung'), ('GO_0010467', 'gene expression', 747, 'expiratory'), ('GO_0042571', 'immunoglobulin complex, circulating', 819, 'antibody')]
PMC3702245	6/2013	S24-PMC3702245	['further, a RECENT STUDY of the RELATIONSHIP between Serum 25(Oh)D and bone turnover in Pregnant women in istanbul, turkey, FOUND a negative CORRELATION between the second and third trimester and Postpartum 25(Oh)D concentrations and Serum cross-linked c-terminal telopeptide of Type 1 Collagen, which is a MARKER of Bone Resorption.58THESE studies SEEM to INDICATE a LINK between very low Vitamin D status and subclinical osteomalacia in the mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 306), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 348), ('INCOMPLETE_EVIDENCE', 356), ('SUPERFICIAL_RELATIONSHIP', 367)]	9	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 58, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('GO_0007565', 'female pregnancy', 195, 'postpartum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('UBERON_0001977', 'blood serum', 233, 'serum'), ('PR_000002123', 'C-C motif chemokine 3', 278, 'type 1 collagen'), ('GO_0045453', 'bone resorption', 316, 'bone resorption'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D')]
PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3717170	5/2013	S82-PMC3717170	['the EFFECTS of the hormonal form of Vitamin D, 1,25(Oh)2D3, on Apoptotic Cell Death are MEDIATED via multiple signaling pathways that involve common regulators and Effectors CONVERGING on cellular Ca2+.19,21sergeev and colleagues HAVE SHOWN that the CRITICAL characteristic of the apoptotic Ca2+signal is a sustained increase in the concentration of Intracellular Ca2+, reaching elevated BUT NOT cytotoxic levels.22HOWEVER, 1,25(Oh)2D3-Regulated, Ca2+-dependent apoptotic molecular targets HAVE NOT BEEN IDENTIFIED in Adipose Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 230), ('IMPORTANT_CONSIDERATION', 250), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('ANOMALY_CURIOUS_FINDING', 392), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('FULL_UNKNOWN', 490)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 47, '1,25(OH)2D3'), ('CL_0000445', 'apoptosis fated cell', 63, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 63, 'apoptotic cell death'), ('CHEBI_35224', 'effector', 164, 'effectors'), ('CHEBI_29108', 'calcium(2+)', 197, 'Ca2+.'), ('CHEBI_29108', 'calcium(2+)', 291, 'Ca2+'), ('GO_0005622', 'intracellular anatomical structure', 350, 'intracellular'), ('CHEBI_3312', 'calcium dichloride', 364, 'Ca2+,'), ('CHEBI_17996', 'chloride', 425, ','), ('CHEBI_73394', 'Ala-Ser', 426, '25(OH)2D3'), ('GO_0065007', 'biological regulation', 436, 'regulated'), ('CHEBI_81233', 'Schizonepetoside B', 447, 'Ca2+-'), ('UBERON_0001013', 'adipose tissue', 518, 'adipose tissue')]
PMC3717170	5/2013	S102-PMC3717170	['in RELATION to the systemic pathology of copd the ROLE of Vitamin D has generated interest, AS Vitamin D deficiency is OFTEN present in patients with copd,24dependent on the severity of copd.25indeed, the prevalence of Vitamin D deficiency, defined as Plasma 25(Oh) D3Concentrations below 20 ng/ml (50 nmol/l), was 58% in a cross-sectional study of 151 copd patients entering Pulmonary rehabilitation during summer.26in the bergen copd cohort study, the prevalence of Vitamin D deficiency was INDEED higher in the copd patients than in the control subjects, INDEPENDENT of season, age, smoking, comorbidity, and body mass index.27several POTENTIAL EXPLANATIONS for the increased risk of Vitamin D deficiency in patients with copd include poor diet, less outdoor activity and THUS less exposure to sunlight, accelerated Skin Aging due to smoking, Renal dysfunction, and treatment with Corticosteroids.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 92), ('PROBABLE_UNDERSTANDING', 119), ('ANOMALY_CURIOUS_FINDING', 493), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 638), ('PROBABLE_UNDERSTANDING', 648), ('PROBABLE_UNDERSTANDING', 775)]	9	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('CHEBI_73735', 'gadoterate', 259, '25(OH) D3concentrations'), ('PR_000016555', 'thymocyte selection-associated high mobility group box protein TOX', 259, '25(OH) D3concentrations'), ('UBERON_0002048', 'lung', 376, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 468, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 687, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 819, 'skin'), ('GO_0007568', 'aging', 824, 'aging'), ('UBERON_0002113', 'kidney', 846, 'renal'), ('CHEBI_50850', 'etabonate ester', 884, 'corticosteroids')]
PMC3717170	5/2013	S176-PMC3717170	['CONSISTENTLY, in the longitudinal Aging study amsterdam, low Vitamin D and high Parathyroid hormone were strong, INDEPENDENT RISK FACTORS for loss of muscle strength and muscle mass (sarcopenia).49low Vitamin D levels also APPEAR TO BE CORRELATED with collagen deposition and are RELATED to Arterial stiffness.50the ROLE of Vitamin D in energetics has BEEN LESS THOROUGHLY INVESTIGATED.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 113), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 223), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 280), ('SUPERFICIAL_RELATIONSHIP', 316), ('ANOMALY_CURIOUS_FINDING', 352), ('INCOMPLETE_EVIDENCE', 357)]	9	[('GO_0007568', 'aging', 34, 'Aging'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 80, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('UBERON_0001637', 'artery', 291, 'arterial'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D')]
PMC3760821	9/2013	S172-PMC3760821	['WHILE josefson et al ., REPORTED an IMPACT of maternal age and neonatal adiposity, directly measured by air displacement plethysmography, on Cord Vitamin D levels, in the CURRENT STUDY, ALTHOUGH neonatal bmi sds was significantly negatively CORRELATED with Cord 25Ohd in subjects with t1dm, regression analysis INDICATED that maternal age at Delivery and SURROGATE measures of neonatal adiposity (Subscapular Skinfold, Triceps Skinfold, and sds bmi) did not impact significantly on Cord Blood 25Ohd.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 171), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 241), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 355)]	9	[('UBERON_0002240', 'spinal cord', 141, 'cord'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD'), ('GO_0007567', 'parturition', 342, 'delivery'), ('UBERON_0007191', 'anterior paracentral gyrus', 397, 'subscapular skinfold'), ('UBERON_0005299', 'prepuce of clitoris', 419, 'triceps skinfold'), ('UBERON_0002240', 'spinal cord', 482, 'cord'), ('UBERON_0000178', 'blood', 487, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 493, '25OHD')]
PMC3814422	10/2013	S130-PMC3814422	['ALTHOUGH we COULD NOT directly investigate the ASSOCIATION of maternal 25(Oh)D with Early Life Respiratory infections, the LACK OF ASSOCIATION with transient early wheezing phenotype ARGUES AGAINST a PROTECTIVE EFFECT of Prenatal Vitamin D on Respiratory Viral infections in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 12), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 211)]	9	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('UBERON_0001847', 'lobule of pinna', 84, 'early life'), ('UBERON_0001004', 'respiratory system', 95, 'respiratory'), ('GO_0007565', 'female pregnancy', 221, 'prenatal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 243, 'respiratory'), ('NCBITaxon_1', 'root', 255, 'viral')]
PMC3827489	10/2013	S79-PMC3827489	['SOME obesity-related health consequences HAVE BEEN CORRELATED with Vitamin D deficiency or insufficiency5,52-54), and RECENT reports have SUGGESTED that Vitamin D supplementation MAY reduce these RISKS, ALTHOUGH the data are INCONSISTENT55,56).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 196), ('ANOMALY_CURIOUS_FINDING', 203), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225)]	9	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3873449	12/2013	S62-PMC3873449	['ALTHOUGH there HAS BEEN DEBATE over WHICH level of Serum 25(Oh)D REFLECTS optimum Vitamin D status, it is GENERALLY ACCEPTED that Serum 25(Oh)d level of < 30ng/ml(75nmol/l) is the cut-off value for insufficiency [15-17], which is ASSOCIATED with maximal suppression of Parathyroid hormone [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('EXPLICIT_QUESTION', 36), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 230)]	9	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid')]
PMC4171568	9/2014	S142-PMC4171568	['THEREFORE, the RELATIONSHIP between Vitamin D and schizophrenia NEEDS FURTHER INVESTIGATION, EVEN THOUGH a RECENT review of the EVIDENCE CONCLUDED that adequate levels of Vitamin D are needed for normal Brain Development and function and furthermore that at-risk groups SHOULD BE offered supplementation [112].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 64), ('FUTURE_WORK', 70), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 137), ('FUTURE_WORK', 270)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007420', 'brain development', 203, 'brain development'), ('UBERON_0000955', 'brain', 203, 'brain')]
PMC4251419	12/2014	S71-PMC4251419	['YET, DESPITE PLAUSIBLE immunological pathways whereby Vitamin D (through stimulation of tregsand dampening of T Helper Type 1 over-reactivity) COULD diminish the risk of multiple sclerosis or disease activity, Vitamin D supplementation trials HAVE SHOWN immunological [42] and radiological [43], BUT NOT CLINICAL, benefit for People with multiple sclerosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 243), ('FULL_UNKNOWN', 296), ('ANOMALY_CURIOUS_FINDING', 300)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0002061', 'T-helper 9 cell', 110, 'T helper'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 110, 'T helper type 1'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 326, 'people')]
PMC4256222	12/2014	S121-PMC4256222	['IF a TRUE UNDERLYING beneficial EFFECT of maternal Vitamin D status on offspring bone health exists and is LIMITED to very low levels, we MAY not be able to detect such a RELATIONSHIP in our data, where ONLY 6.3% of the study population had a Vitamin D status below 25 nmol/l and 25.5% had a status below 50 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 203), ('INCOMPLETE_EVIDENCE', 203)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4377879	3/2015	S87-PMC4377879	['DESPITE its IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System, the IMPACT of Antenatal Vitamin D is STILL poorly understood [40], not LEAST BECAUSE of uncertainties with appropriate BIOMARKERS and cut-off points.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 140), ('PROBABLE_UNDERSTANDING', 174), ('PROBABLE_UNDERSTANDING', 180), ('PROBLEM_COMPLICATION', 180), ('SUPERFICIAL_RELATIONSHIP', 222)]	9	[('GO_0055064', 'chloride ion homeostasis', 30, 'bone homeostasis'), ('GO_0007420', 'brain development', 48, 'brain development'), ('UBERON_0000955', 'brain', 48, 'brain'), ('GO_0002022', 'detection of dietary excess', 70, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 88, 'immune system'), ('GO_0007567', 'parturition', 117, 'antenatal'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4427001	4/2015	S150-PMC4427001	['conclusions\nour study in Pregnant women of central european population DID NOT REPLICATE sporadic PREVIOUS FINDINGS of significantly decreased levels of Vitamin D in Gdm Pregnancy; HOWEVER, results SEEM TO BE criteria-sensitive (who versus iadpsg) and the topic WARRANTS FURTHER STUDY.']	[('INCOMPLETE_EVIDENCE', 71), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 198), ('FUTURE_WORK', 262), ('FUTURE_WORK', 271)]	9	[('GO_0007565', 'female pregnancy', 25, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0070477', 'endospore core', 166, 'GDM'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]
PMC4452099	6/2015	S27-PMC4452099	['the REPORTED REASON to initiate mandatory fortification was the need to substitute the lack of Vitamin D in Margarine COMPARED to butter, WHILE the decision to cancel mandatory margarine fortification was justified by the low Vitamin D doses added to the Margarine products—an ARGUMENT which, HOWEVER, DID NOT SEEM TO BE EVIDENCE-BASED.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('INCOMPLETE_EVIDENCE', 302), ('ANOMALY_CURIOUS_FINDING', 310), ('INCOMPLETE_EVIDENCE', 315)]	9	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_6784', 'mestranol', 108, 'margarine'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_6784', 'mestranol', 255, 'margarine')]
PMC4476607	1/2015	S147-PMC4476607	['ALTHOUGH antioxidant treatments in Animal MODELS are encouraging, researchers PREMATURELY terminated a clinical trial utilizing high doses of Vitamins C and E in women with Alcohol-exposed Pregnancies BECAUSE of SAFETY CONCERNS (goh et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 42), ('PROBLEM_COMPLICATION', 78), ('PROBLEM_COMPLICATION', 201), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 219), ('PROBLEM_COMPLICATION', 219)]	9	[('NCBITaxon_33208', 'Metazoa', 35, 'animal'), ('CHEBI_27300', 'vitamin D', 142, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 157, 'E'), ('CHEBI_30879', 'alcohol', 173, 'alcohol'), ('GO_0007565', 'female pregnancy', 189, 'pregnancies')]
PMC4516377	6/2015	S74-PMC4516377	['ON THE OTHER HAND, this gender DIFFERENCE was NOT FOUND in ANOTHER study.20\nthe mechanism by which Vitamin D INFLUENCES adiposity is not COMPLETELY understood, but there are LINES OF RESEARCH that try to explain this phenomenon.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109), ('PROBABLE_UNDERSTANDING', 137), ('INCOMPLETE_EVIDENCE', 174)]	9	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4586450	10/2015	S544-PMC4586450	['overall, the diets of children in the alspac were adequate for most Nutrients, with the NOTABLE EXCEPTION of Vitamin D. at age 1.5 years and age 3.5 years, all of the alspac children were found to be below the united kingdom dietary recommendations for Vitamin D intake, and children who had low intakes at age 1.5 years were twice as LIKELY to have low intakes at age 3.5 years.24ALTHOUGH it HAS BEEN RECOMMENDED for 25 years or more that children aged <5 years SHOULD BE given Vitamin D supplements,93only a minority in either the alspac24or the national surveys actually were supplemented.101it IS POSSIBLE that a fortification program COULD be a good option to improve this situation.']	[('ANOMALY_CURIOUS_FINDING', 88), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 335), ('ANOMALY_CURIOUS_FINDING', 379), ('INCOMPLETE_EVIDENCE', 393), ('FUTURE_WORK', 402), ('FUTURE_WORK', 463), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 639)]	9	[('CHEBI_33284', 'nutrient', 68, 'nutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 479, 'vitamin D')]
PMC4600246	10/2015	S12-PMC4600246	['a broad amount of DATA SEEMS to INDICATE substantial POTENTIAL for supplementary Vitamin K. HOWEVER, currently FEW GUIDELINES RECOMMEND Vitamin K therapy for PREVENTION or treatment of osteoporosis.']	[('FUTURE_WORK', 18), ('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 115), ('FUTURE_WORK', 126), ('SUPERFICIAL_RELATIONSHIP', 158)]	9	[('CHEBI_27300', 'vitamin D', 81, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin K')]
PMC4764019	1/2016	S83-PMC4764019	['african nationals living under ancestral conditions exhibit Vitamin D status values in the middle of this range (ie, approximately 46 ng/ml).16\nin conclusion, WHILE one cannot say that the barker HYPOTHESIS HAS BEEN definitively ESTABLISHED for each of the delayed Vitamin D inadequacy outcomes DESCRIBED HERE, it would SEEM that the PRUDENT course, both for oneself as an Individual and for one’s patients and clients, is to assume the applicability of the HYPOTHESIS and, accordingly, to ensure a Vitamin D status approximating that of ancestral Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 295), ('QUESTION_ANSWERED_BY_THIS_WORK', 305), ('ANOMALY_CURIOUS_FINDING', 320), ('FUTURE_WORK', 334), ('INCOMPLETE_EVIDENCE', 458)]	9	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('NCBITaxon_1', 'root', 373, 'individual'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 548, 'humans')]
PMC4848664	4/2016	S132-PMC4848664	['the Folic Acid ul MAY BE MISINTERPRETED as an “upper limit”, but SHOULD ONLY BE CONSIDERED a tolerable upper intake level for Individuals with a Vitamin B-12 deficiency.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('FUTURE_WORK', 65), ('INCOMPLETE_EVIDENCE', 72), ('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 80)]	9	[('CHEBI_30751', 'formic acid', 4, 'folic acid'), ('NCBITaxon_1', 'root', 126, 'individuals'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin B')]
PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]
PMC4889866	5/2016	S132-PMC4889866	['ALTHOUGH OUR study DID NOT SHOW maternal Vitamin D concentration to have a significant IMPACT on the magnitude or functional capacity of the young infant to defend against infection, we BELIEVE OUR STUDY MAY contribute to a BETTER understanding of the EFFECT of Prenatal Vitamin D status on neonatal Innate Immunity and infectious disease during early Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 252)]	9	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 262, 'prenatal'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0045087', 'innate immune response', 300, 'innate immunity'), ('UBERON_0000104', 'life cycle', 352, 'life')]
PMC4930210	7/2016	S144-PMC4930210	['ALTHOUGH the physiological ROLE of the c3-epimerization pathway has NOT YET BEEN ELUCIDATED, there are INDICATIONS that it has SOME anti-proliferative activity and differentiation activity ONLY at levels of APPROXIMATELY 10%-30%, respectively, COMPARED TO non-epimeric Vitamin D Metabolites [11,12].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('FULL_UNKNOWN', 68), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 127), ('ANOMALY_CURIOUS_FINDING', 189), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 244)]	9	[('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('CHEBI_25212', 'metabolite', 279, 'metabolites')]
PMC4930210	7/2016	S165-PMC4930210	['ANOTHER RECENT canadian STUDY [35] SHOWED summer sun exposure was a PREDICTOR of 25(Oh)D3Concentration BUT fall sun exposure was NOT, which MAY BE RELATED to lower Vitamin D-weighted climatological uv in toronto during the fall.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ANOMALY_CURIOUS_FINDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 81, '25(OH)D3concentration'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 81, '25('), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 86, ')D3concentration'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4934634	11/2015	S89-PMC4934634	['ALTHOUGH the amount of Vitamin D provided through the Supplement is lower than the current rdas set by EITHER the iom or Endocrine society, this study SHOULD provide new INSIGHTS into HOW Periconceptional dietary interventions CAN IMPACT Female and Male Fertility, a RESEARCH area that is presently LACKING.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FUTURE_WORK', 151), ('INCOMPLETE_EVIDENCE', 170), ('EXPLICIT_QUESTION', 184), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 231), ('INCOMPLETE_EVIDENCE', 267), ('INCOMPLETE_EVIDENCE', 299)]	9	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 54, 'supplement'), ('UBERON_0005063', 'left ventricular compact myocardium', 121, 'Endocrine'), ('GO_0007565', 'female pregnancy', 188, 'periconceptional'), ('GO_0007601', 'visual perception', 238, 'female ...'), ('GO_0007141', 'male meiosis I', 249, 'male fertility')]
PMC4934634	11/2015	S184-PMC4934634	['using dietary Intake data ALONE CAN be PROBLEMATIC SINCE uvb-induced skin Formation of Vitamin D CAN significantly alter Serum 25(Oh)D, THUS, dietary Intakes MIGHT not be a reliable INDICATOR of overall Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 32), ('PROBLEM_COMPLICATION', 39), ('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 51), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 182)]	9	[('GO_0007631', 'feeding behavior', 14, 'intake'), ('GO_0009057', 'macromolecule catabolic process', 74, 'formation'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('GO_0007631', 'feeding behavior', 150, 'intakes'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC5039809	10/2016	S17-PMC5039809	['THERE IS EVIDENCE in Adults that Vitamin A intake is ASSOCIATED with measures of bone health, BUT NOTABLY, the DIFFERENT forms of dietary Vitamin A HAVE BEEN demonstrated to have OPPOSING ASSOCIATIONS with fracture risk (6).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 94), ('ANOMALY_CURIOUS_FINDING', 98), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 188)]	9	[('UBERON_0007023', 'adult organism', 21, 'adults'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC5129897	10/2016	S14-PMC5129897	['FEW well-designed clinical TRIALS SHOW beneficial EFFECTS of Vitamin D MAINLY BECAUSE many such trials were BASED ON GUIDELINES for Pharmaceutical Drugs.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 71), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 108), ('ANOMALY_CURIOUS_FINDING', 114), ('ANOMALY_CURIOUS_FINDING', 114), ('PROBABLE_UNDERSTANDING', 117)]	9	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 132, 'pharmaceutical drugs')]
PMC5133057	10/2016	S18-PMC5133057	['in brazil, vad HAS BEEN DOCUMENTED in the northeast and in SOME parts of the southeast [16]; HOWEVER, there are STILL ONLY a FEW STUDIES that evaluate the Consumption of Vitamin A by Pregnant women [17], and there are EVEN FEWER STUDIES investigating the occurrence of vad among Pregnant teenagers.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 125), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 223)]	9	[('GO_0007631', 'feeding behavior', 155, 'consumption'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin A'), ('GO_0007565', 'female pregnancy', 183, 'pregnant'), ('GO_0007565', 'female pregnancy', 279, 'pregnant')]
PMC5513133	7/2017	S240-PMC5513133	['DESPITE EVIDENCE that low Vitamin D levels increase RISK for pe early in Pregnancy, VERY FEW STUDIES have tried TO RELATE this EFFECT with the Regulation Of Angiogenic or anti-Angiogenic factors.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 143)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0006110', 'regulation of glycolytic process', 143, 'regulation of angiogenic'), ('GO_0001525', 'angiogenesis', 176, 'angiogenic')]
PMC5513133	7/2017	S241-PMC5513133	['ALTHOUGH CURRENT EVIDENCE SUPPORTS an ASSOCIATION between Angiogenic factors and pe, these STUDIES have NOT FOUND an ASSOCIATION between Vitamin D levels and Angiogenic factors [14,15].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 117)]	9	[('GO_0001525', 'angiogenesis', 58, 'angiogenic'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0001525', 'angiogenesis', 158, 'angiogenic')]
PMC5659607	10/2017	S131-PMC5659607	['INTERPRETATION\nthis combined analysis of our two Vitamin D rcts SHOWED a significant 26% reduced risk of the primary end-point asthma/recurrent wheeze during the first 3 years of Life, which SUGGESTS that the non-significant/borderline significant trial responses OBSERVED in the individual intent-to-treat analyses were PARTLY due to LACK OF power caused by an OVERESTIMATION of the treatment effect, RATHER than lack of an intervention effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 321), ('INCOMPLETE_EVIDENCE', 335), ('ANOMALY_CURIOUS_FINDING', 340), ('PROBLEM_COMPLICATION', 362), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 402)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
PMC5707701	11/2017	S177-PMC5707701	['HOWEVER, our results INDICATED that neither Vitamin A nor E intakes from one 24-h dietary Recall was associated with Vitamin A and E in Human milk, which MAY BE DUE TO the inherent Intake variability of one single 24-h dietary Recall questionnaire, which DID NOT ALLOW for estimations of an Individual’s usual diet, and THEREFORE, it is LIKELY to under- OR overestimate some Nutrient intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 154), ('PROBLEM_COMPLICATION', 161), ('DIFFICULT_TASK', 255), ('ANOMALY_CURIOUS_FINDING', 259), ('PROBABLE_UNDERSTANDING', 320), ('PROBABLE_UNDERSTANDING', 337), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 354)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0060033', 'anatomical structure regression', 90, 'recall'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 131, 'E'), ('NCBITaxon_9606', 'Homo sapiens', 136, 'human'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0060033', 'anatomical structure regression', 227, 'recall'), ('NCBITaxon_1', 'root', 291, 'individual'), ('CHEBI_33284', 'nutrient', 375, 'nutrient')]
PMC5732505	12/2017	S152-PMC5732505	['maternal Vitamin D status ASSOCIATED with Birth size: Pregnancy 25(Oh)D SHOWED a positive ASSOCIATION towards Birth weight, BUT ucb 25(Oh)D an inverse ASSOCIATION with Head circumference, WHILE ONLY the inverse ASSOCIATION with Head circumference was VERIFIED with linear model.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 90), ('ANOMALY_CURIOUS_FINDING', 124), ('SUPERFICIAL_RELATIONSHIP', 151), ('ANOMALY_CURIOUS_FINDING', 188), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 251)]	9	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('UBERON_0000033', 'head', 168, 'head'), ('UBERON_0000033', 'head', 228, 'head')]
PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
PMC2290997	4/2008	S16-PMC2290997	['ALTHOUGH most of the health-promoting benefits of sun exposure are THOUGHT TO occur through Vitamin D Photosynthesis, there MAY BE OTHER health benefits that have gone largely OVERLOOKED in the DEBATE over HOW much sun is NEEDED for good health [see “other sun-dependent pathways,” p. a165].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('EXPLICIT_QUESTION', 206), ('IMPORTANT_CONSIDERATION', 222)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 102, 'photosynthesis')]
PMC2290997	4/2008	S76-PMC2290997	['“NEVERTHELESS, considering the SAFETY of Vitamin D EVEN in high doses, there is NO CLEAR contraindication, and BECAUSE Vitamin D deficiency is very PREVALENT, especially among ms patients, taking Vitamin D supplements and getting moderate sun exposure is more LIKELY to be beneficial than not.”\nas with ms, there APPEARS TO be a latitudinal gradient for type 1 diabetes, with a higher incidence at higher latitudes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 1), ('IMPORTANT_CONSIDERATION', 31), ('ANOMALY_CURIOUS_FINDING', 51), ('FULL_UNKNOWN', 80), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 148), ('PROBABLE_UNDERSTANDING', 260), ('ANOMALY_CURIOUS_FINDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC2606998	6/2007	S84-PMC2606998	['from this perspective, the most STRIKING result from THIS STUDY was the CONSIDERABLY lower than RECOMMENDED intakes of Folate and Vitamin\u2009D, both before and during Pregnancy, EVEN when PROBABLE UNDERREPORTING was taken INTO ACCOUNT.']	[('ANOMALY_CURIOUS_FINDING', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('ANOMALY_CURIOUS_FINDING', 72), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 175), ('PROBABLE_UNDERSTANDING', 185), ('PROBLEM_COMPLICATION', 194), ('INCOMPLETE_EVIDENCE', 219)]	8	[('CHEBI_30863', '5-azaorotic acid', 119, 'folate'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC2685863	5/2009	S1-PMC2685863	['dietary Vitamin D intake HAS BEEN ASSOCIATED with lower ms risk, and Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED RISK, BUT direct LINKS between Vitamin D and ms have NOT BEEN IDENTIFIED.']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 131), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 178)]	8	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC2798111	12/2010	S95-PMC2798111	['WHILE not powered to assess SAFETY at this juncture, it is IMPORTANT TO NOTE that, thus FAR, there HAVE BEEN no increased rates of infection in the infants or adverse health EFFECTS that COULD BE ATTRIBUTED to Vitamin D supplementation in this cohort.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 88), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	8	[('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC2963768	10/2010	S139-PMC2963768	['the Vitamin D receptor HAS BEEN FOUND within VIRTUALLY every Organ-System (55), and the active Metabolite of Vitamin D is WELL-DESCRIBED as a potent mediator of Cell Proliferation and Differentiation, PARTICULARLY NOTED for its range of EFFECTS on Immune function in laboratory MODELS (56).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 45), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 201), ('ANOMALY_CURIOUS_FINDING', 214), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 278)]	8	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000062', 'organ', 61, 'organ'), ('UBERON_0000467', 'anatomical system', 67, 'system'), ('CHEBI_39382', 'flufenoxuron', 95, 'metabolite'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 117, 'D'), ('GO_0030154', 'cell differentiation', 161, 'cell proliferation ... differentiation'), ('UBERON_0002405', 'immune system', 248, 'immune')]
PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]
PMC3075531	7/2010	S55-PMC3075531	['in a pooled analysis of data from canada, uk, denmark, and sweden including more than 40,000 Individuals with ms, significantly fewer (8.5%) People with ms were Born in november and significantly more (9.1%) were Born in may.39THIS FINDING SUGGESTS that Prenatal exposures or exposures in the first months of Life COULD BE IMPORTANT in ms etiology, BUT the LINK to Vitamin D is UNCLEAR.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 314), ('IMPORTANT_CONSIDERATION', 323), ('ANOMALY_CURIOUS_FINDING', 349), ('SUPERFICIAL_RELATIONSHIP', 357), ('FULL_UNKNOWN', 378)]	8	[('NCBITaxon_1', 'root', 93, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'people'), ('GO_0007567', 'parturition', 161, 'born'), ('GO_0007567', 'parturition', 213, 'born'), ('GO_0007565', 'female pregnancy', 254, 'prenatal'), ('UBERON_0000104', 'life cycle', 309, 'life'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC3171895	9/2011	S145-PMC3171895	['a CONSIDERABLE INTEREST exists regarding PREVENTION of Maternal and Perinatal Morbidity with Vitamins C and E. HOWEVER, the most RECENT meta-analysis of ten trials (6533 women) published in 2008 of antioxidant supplementation (including Vitamin C and e but also OTHER supplements such as Lycopene) SHOWED no difference in the relative risk (rr) of Preeclampsia (rr 0.73, 95% ci 0.51 to 1.06), Preterm Birth (before 37 weeks) (rr 1.10, 95% ci 0.99 to 1.22), sga infants (rr 0.83, 95% ci 0.62 to 1.11), or any baby death (rr 1.12, 95% ci 0.81 to 1.53) [7].']	[('ANOMALY_CURIOUS_FINDING', 2), ('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 298)]	8	[('GO_0007618', 'mating', 55, 'maternal ...'), ('GO_0019230', 'proprioception', 68, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 68, 'perinatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('PR_000004900', 'complement C3', 102, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin C'), ('CHEBI_15948', 'lycopene', 288, 'lycopene'), ('GO_0007128', 'meiotic prophase I', 348, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 393, 'preterm'), ('GO_0007567', 'parturition', 401, 'birth')]
PMC3271033	1/2012	S116-PMC3271033	['these extremely low values are NOT COMMONLY reported in the united states, ALTHOUGH we SPECULATE that an increasing NUMBER OF cases MAY BE reported in the FUTURE DUE TO INCREASED AWARENESS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 132), ('FUTURE_PREDICTION', 155), ('PROBABLE_UNDERSTANDING', 162), ('IMPORTANT_CONSIDERATION', 169)]	8	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3277098	12/2011	S3-PMC3277098	['there is a GROWING BODY of LITERATURE LINKING Vitamin D (Serum 25(Oh)D, Oral Intake and SURROGATE indicators such as latitude) to various immune-RELATED conditions, including allergy, ALTHOUGH the nature of this RELATIONSHIP is STILL UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 184), ('SUPERFICIAL_RELATIONSHIP', 212), ('FULL_UNKNOWN', 228)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 57, 'serum'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 63, '25 ... OH ... D'), ('UBERON_0000165', 'mouth', 72, 'oral'), ('GO_0007631', 'feeding behavior', 77, 'intake')]
PMC3347028	3/2012	S70-PMC3347028	['[23], SHOWED that Ifn-Γ-mediated Antimicrobial activity of Human Macrophages, especially IMPORTANT in hiv and tuberculosis patients, is DEPENDENT on Vitamin D. BOTH STUDY findings have IMPLICATIONS for the Pregnant woman and her developing fetus, BUT our understanding of such processes following maternal exposure to a pathogen or maternal infection REMAINS SCANT.']	[('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 185), ('ANOMALY_CURIOUS_FINDING', 247), ('INCOMPLETE_EVIDENCE', 351), ('INCOMPLETE_EVIDENCE', 359)]	8	[('PR_000008920', 'interferon alpha-7', 18, 'IFN-γ'), ('CHEBI_65381', 'albizoside C', 33, 'antimicrobial'), ('NCBITaxon_9606', 'Homo sapiens', 59, 'human'), ('CL_0000235', 'macrophage', 65, 'macrophages'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnant')]
PMC3356951	4/2012	S15-PMC3356951	['black People Absorb more uvb in the Melanin of their skin than do white People and, THEREFORE, require more sun exposure to produce the same amount of vitamin D.[4]\nthe high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('PROBABLE_UNDERSTANDING', 84), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 230), ('IMPORTANT_CONSIDERATION', 240), ('PROBLEM_COMPLICATION', 254), ('PROBABLE_UNDERSTANDING', 260), ('SUPERFICIAL_RELATIONSHIP', 292), ('SUPERFICIAL_RELATIONSHIP', 304)]	8	[('NCBITaxon_10088', 'Mus <genus>', 6, 'people'), ('GO_0040011', 'locomotion', 13, 'absorb'), ('CHEBI_25179', 'melanins', 36, 'melanin'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'people'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 159, 'D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D')]
PMC3427192	4/2012	S42-PMC3427192	['studies of Vitamin D status in school-age children with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsbrehm412009616 (60)8.7cross-sectionalmild-to-severe persistent asthmaasthma exacerbationsincreased 25(Oh)D ASSOCIATED with reduced hospitalization, reduced Anti-Inflammatory Medication use and reduced Airway hyperresponsivenessbrehm6920101024 (60)8.9prospective cohortmild-to-moderate persistent asthmahospitalization or emergency Department visitbaseline 25(Oh)D levels < 30 ng/ml ASSOCIATED with higher odds of hospitalization or emergency department over 4 ychinellato70201175 (60)9.6cross-sectionalwell-controlled and POORLY controlled asthmaspirometry, asthma controlpositive CORRELATIONS NOTED between 25(Oh)d and asthma controlchinellato71201145 (60)10cross-sectionalintermittent asthmalung function and Airway hyperresponsivenesslower Serum 25(Oh)D ASSOCIATED with decreased Lung function and increased Airway hyperresponsiveness with exercisefreishtat72201092 (63)11.1cross-sectionalafrican americans with and without asthmaphysician-diagnosed asthmadecreased 25(Oh)D in asthmatics vs. controlsmajak73201148 (67)11.5randomized, double-blind, parallel arm clinical trialnewly diagnosed asthmaasthma exacerbationsfewer exacerbations in children with Vitamin D3Supplementation added to inhaled Budesonidesearing742010100 (64)7cross-sectionalmoderate to severe persistent asthmacorticosteroid use and Airflow limitationdecreased 25(Oh)D ASSOCIATED with lower Lung function and higher Corticosteroid requirementsurashima752010217 (57)10.0randomized, double-blind clinical trialschoolchildren (allcomers), subgroup with physician-diagnosed asthmaasthma exacerbationsreduced risk of asthma exacerbations in the subgroup with asthma after Vitamin D3Supplementation\nother cross-sectional studies of Vitamin D status have also examined the ASSOCIATIONS between 25(Oh)D concentrations and asthma Control in school-age children.']	[('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 516), ('PROBLEM_COMPLICATION', 656), ('SUPERFICIAL_RELATIONSHIP', 715), ('ANOMALY_CURIOUS_FINDING', 728), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1476), ('SUPERFICIAL_RELATIONSHIP', 1873)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH)D'), ('CHEBI_60426', 'dioleoyl phosphatidylglycerol', 290, 'anti-inflammatory medication'), ('UBERON_0001005', 'respiratory airway', 335, 'airway'), ('UBERON_0008247', 'tube foot', 465, 'department'), ('CHEBI_71657', 'versiconol acetate', 490, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 490, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 742, '25(OH'), ('UBERON_0001005', 'respiratory airway', 845, 'airway'), ('UBERON_0001977', 'blood serum', 877, 'serum'), ('CHEBI_71657', 'versiconol acetate', 883, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 885, '(OH ... D'), ('UBERON_0002048', 'lung', 917, 'lung'), ('UBERON_0001005', 'respiratory airway', 945, 'airway'), ('CHEBI_71657', 'versiconol acetate', 1103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1103, '25(OH)D'), ('CHEBI_52915', 'phosphatediyl group', 1291, 'vitamin D3supplementation'), ('CHEBI_72362', 'phosphatidylethanolamine 44:1-OH', 1334, 'budesonideSearing742010100'), ('UBERON_0001005', 'respiratory airway', 1440, 'airflow'), ('CHEBI_71657', 'versiconol acetate', 1468, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1468, '25(OH)D'), ('UBERON_0002048', 'lung', 1498, 'lung'), ('CHEBI_36916', 'cation', 1523, 'corticosteroid'), ('CHEBI_52915', 'phosphatediyl group', 1774, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 1833, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1894, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1900, 'D'), ('GO_0065007', 'biological regulation', 1928, 'control')]
PMC3427192	4/2012	S52-PMC3427192	['in these sub-analyses, Vitamin D3Supplementation was ASSOCIATED with a decreased risk of exacerbations compared with Placebo, with a relative risk of 0.17.75similarly, in a more RECENT randomized, double-blind 6-mo trial where 800 µg of inhaled Budesonide was administered daily to a small group of 48 children with asthma in the presence or absence of 500 iu/day of Vitamin D3, children receiving supplemental Vitamin D did not have a reduction in 25(Oh)D during the winter months and also had a reduced risk of asthma exacerbations triggered by acute Respiratory Viral infections.73these INITIAL FINDINGS SUGGEST that Vitamin D supplementation MAY have therapeutic benefit children with asthma, ALTHOUGH ADDITIONAL randomized, double-blind, placebo-controlled STUDIES ARE NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 607), ('INCOMPLETE_EVIDENCE', 646), ('ANOMALY_CURIOUS_FINDING', 697), ('FUTURE_WORK', 706), ('FUTURE_WORK', 762)]	8	[('CHEBI_52915', 'phosphatediyl group', 23, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D3supplementation'), ('CHEBI_26130', 'biological pigment', 117, 'placebo'), ('CHEBI_3219', 'bupropion', 245, 'budesonide'), ('CHEBI_33279', 'vitamin D5', 367, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 367, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 449, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 455, 'D'), ('UBERON_0001004', 'respiratory system', 553, 'respiratory'), ('NCBITaxon_1', 'root', 565, 'viral'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D')]
PMC3470091	9/2012	S94-PMC3470091	['conclusion\nthe FINDINGS of the study INDICATE that intramuscular administration of a single dose of 300,000 iu of Vitamin D is EFFECTIVE and SAFE to improve Vitamin D status, and to ameliorate the FACTORS RELATED to the health of mothers and infants, PARTICULARLY in the regions with SEVERE Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 197), ('SUPERFICIAL_RELATIONSHIP', 205), ('ANOMALY_CURIOUS_FINDING', 251), ('IMPORTANT_CONSIDERATION', 284)]	8	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC3488410	10/2012	S114-PMC3488410	['INTERESTINGLY, SOME of the Vitamin D deficiency EFFECTS COULD BE RELATED to later Gestational periods THUS POSSIBLY expanding the HAZARDOUS time window for the neurobiological development of schizophrenia [129].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 107), ('IMPORTANT_CONSIDERATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'gestational')]
PMC3509518	11/2012	S116-PMC3509518	['the POTENTIAL PROTECTIVE EFFECTS of Vitamin C and antioxidant rich foods on allergic disease HAVE BEEN NOTED in a NUMBER OF PREVIOUS STUDIES, including LINKS between higher intakes of antioxidant rich Foods, better Pulmonary function and reduced risk of wheeze [21].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 152)]	8	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('CHEBI_33290', 'food', 201, 'foods'), ('UBERON_0002048', 'lung', 215, 'pulmonary')]
PMC3515553	12/2012	S135-PMC3515553	['FINDINGS in the context of existing literature\ntcn2 rs1801198 was ASSOCIATED with maternal Vitamin B-12 Consumption, with heterozygotes showing a higher intake than both homozygotes, ALTHOUGH this COULD WELL be a chance FINDING SINCE this Snp’s PUTATIVE action has not been RELATED to Intake[13].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 220), ('PROBLEM_COMPLICATION', 228), ('PROBABLE_UNDERSTANDING', 245), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 104, 'consumption'), ('SO_0000694', 'SNP', 239, 'SNP'), ('GO_0007631', 'feeding behavior', 285, 'intake')]
PMC3521768	12/2012	S32-PMC3521768	['DESPITE the existence of MANY rcts and OBSERVATIONAL studies which evaluated the EFFECT of Prenatal zinc and Vitamin A status on Birthweight, THE CURRENT STUDY is WORTH documentable as it HAS BEEN conducted in area with high prevalence of zinc and Vitamin A deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('GO_0007596', 'blood coagulation', 129, 'birthweight'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC3582478	2/2013	S10-PMC3582478	['changes in Fatty Acid composition during Pregnancy quickly return to the normal range following Parturition HOWEVER, an increase in the Omega-6/3 ratio increases the risk of Ppd11,12low maternal Omega-3 Polyunsaturated Fatty Acid Intake is SUGGESTED to CONTRIBUTE to decreased maternal and fetal health, INTERACTING with the Serotonin transporter Alleles to CONTRIBUTE TO ppd.13\ndecreased Pregnancy Vitamin D ASSOCIATES with many RISK FACTORS for ppd, including Preeclampsia,14SUGGESTING that it will indirectly Modulate ppd susceptibility.']	[('ANOMALY_CURIOUS_FINDING', 108), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 253), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 358), ('SUPERFICIAL_RELATIONSHIP', 409), ('SUPERFICIAL_RELATIONSHIP', 430), ('INCOMPLETE_EVIDENCE', 475)]	8	[('CHEBI_35366', 'fatty acid', 11, 'fatty acid'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0019230', 'proprioception', 96, 'parturition'), ('CHEBI_30823', 'oleate', 136, 'omega'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 174, 'PPD11'), ('CHEBI_79370', 'ibho#10', 195, 'omega-3'), ('GO_0033576', 'protein glycosylation in cytosol', 203, 'polyunsaturated fatty acid intake'), ('CHEBI_35366', 'fatty acid', 219, 'fatty acid'), ('CHEBI_28790', 'serotonin', 325, 'serotonin'), ('SO_0001023', 'allele', 347, 'alleles'), ('GO_0007565', 'female pregnancy', 389, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 462, 'preeclampsia'), ('GO_0065007', 'biological regulation', 512, 'modulate')]
PMC3641012	4/2013	S163-PMC3641012	['ALTHOUGH δ25(Oh)D was inversely ASSOCIATED with baseline Vitamin D status, and ABOUT 24% of the variance in δ25(Oh)D in the Vitamin D group was EXPLAINED by baseline 25(Oh)D, this ASSOCIATION APPEARED TO BE due to regression to the mean, SINCE similar TRENDS were observed in both the Vitamin D and placebo groups.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 79), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 180), ('ANOMALY_CURIOUS_FINDING', 192), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 252)]	8	[('CHEBI_33010', 'chromide(1-)', 12, '(OH)D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 111, '(OH)D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 166, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
PMC3659910	1/2013	S131-PMC3659910	['RESEARCH has FOUND direct CONNECTIONS between Vitamin D and the Genes KNOWN to be INVOLVED in ms, BUT exact pathology and WHETHER Vitamin D supplements during Pregnancy OR childhood can lessen the likelihood of the child developing ms later in Life is NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 82), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('FULL_UNKNOWN', 252)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genes'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC3668200	5/2013	S1-PMC3668200	['ALTHOUGH the authors STATED SOME exclusion criteria, the study lacks SOME guidelines for CONSIDERATIONS in the evaluation of Vitamin D deficiency, especially those pertaining to FACTORS that can AFFECT the Vitamin concentration in the body.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 69), ('FUTURE_WORK', 89), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 206, 'vitamin')]
PMC3672018	5/2013	S44-PMC3672018	['BOTH STUDIES SUGGEST that Prenatal malnutrition strongly IMPACTS Adult health, ALTHOUGH neither INDICATES specific EFFECTS from the lack of Vitamin D. the EFFECT of Vitamin D levels during Gestation, THUS, has never previously been followed in large populations.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 155), ('PROBABLE_UNDERSTANDING', 200)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('UBERON_0007023', 'adult organism', 65, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'gestation')]
PMC3705146	5/2013	S219-PMC3705146	['it is WELL KNOWN that a lack of Vitamin D causes rickets, which would have had a negative IMPACT the ability to perform the physical work NECESSARY to survive in historical times, BUT more IMPORTANTLY, frequently caused fatal outcomes during Delivery BECAUSE of the improper configuration of Pelvis in SEVERE rickets (harrison,1966; cruickshank,1967; konje and ladipo,2000).']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('PROBLEM_COMPLICATION', 251), ('IMPORTANT_CONSIDERATION', 302)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 242, 'delivery'), ('UBERON_0002355', 'pelvic region of trunk', 292, 'pelvis')]
PMC3705146	5/2013	S262-PMC3705146	['the need for Vitamin D MAY have AFFECTED NOT ONLY Gene frequencies of relevance to schizophrenia BUT MAY ALSO have Modulated Gene-environment INTERACTIONS that CAN occur in differing light regimes.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 41), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 160)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 50, 'gene'), ('GO_0065007', 'biological regulation', 115, 'modulated'), ('SO_0000704', 'gene', 125, 'gene')]
PMC3717170	5/2013	S0-PMC3717170	['Vitamin D: beyond bone\n\nabstract\nin RECENT YEARS, Vitamin D HAS BEEN received INCREASED ATTENTION due TO the resurgence of Vitamin D deficiency and rickets in developed countries and the IDENTIFICATION of Extraskeletal EFFECTS of Vitamin D, SUGGESTING UNEXPECTED benefits of Vitamin D in health and disease, beyond bone health.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 219), ('INCOMPLETE_EVIDENCE', 241), ('ANOMALY_CURIOUS_FINDING', 252)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 205, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3717170	5/2013	S73-PMC3717170	['YET, before such FINDINGS are fully EMBRACED, the mechanism(s) of action of Vitamin D and its PROTECTIVE EFFECT during Pregnancy MUST BE BETTER delineated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 137)]	8	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3739737	8/2013	S176-PMC3739737	['FURTHER REFINEMENTS to the MODEL, such as combined with second hit exposures, MAY BE NECESSARY to MORE adequately MODEL the EFFECTS of Vitamin D deficiency in Human populations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 85), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC3773018	4/2013	S82-PMC3773018	['OF NOTE, OUR FINDINGS from the stratified analyses SUGGESTED stronger ASSOCIATIONS between low Vitamin D status and high RISK of fs among children Born Preterm, which NEEDS to be FURTHER explored in a larger sample.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 167), ('FUTURE_WORK', 179), ('INCOMPLETE_EVIDENCE', 179)]	8	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('GO_0007565', 'female pregnancy', 152, 'preterm')]
PMC3798907	8/2013	S16-PMC3798907	['BASED ON these FINDINGS, there HAVE BEEN CALLS FOR trials of Vitamin E based intervention during Pregnancy [14].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC3798907	8/2013	S125-PMC3798907	['we FOUND NO CONVINCING evidence of differential responsiveness of cbmc and Adult Pbmc to Vitamin E supplementation; HOWEVER the dose of Vitamin E used in THE current study was CONSIDERABLY LESS than that REPORTED in PREVIOUS work [4].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ANOMALY_CURIOUS_FINDING', 176), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 216)]	8	[('UBERON_0007023', 'adult organism', 75, 'adult'), ('UBERON_2005026', 'primary head sinus', 81, 'PBMC'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3809191	1/2013	S53-PMC3809191	['THIS EVIDENCE is CONSISTENT with low Vitamin D levels in either Pregnant or non-Pregnant Individuals in our country as in the rest of the world.11,12HOWEVER we did not FIND significant association of low levels of Serum 25 (Oh) D with elevated RISK for gdm EVEN after adjustment for conventional risk FACTORS for diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('IMPORTANT_CONSIDERATION', 244), ('ANOMALY_CURIOUS_FINDING', 257), ('SUPERFICIAL_RELATIONSHIP', 301)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('UBERON_0001977', 'blood serum', 214, 'serum'), ('CHEBI_71657', 'versiconol acetate', 220, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25 (OH) D')]
PMC3827489	10/2013	S65-PMC3827489	['THUS, the QUESTION has BEEN RAISED as to WHETHER Vitamin D status INFLUENCES the RISK of Respiratory Tract infections such as common Viral infections or Pulmonary tuberculosis in children.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 10), ('ANOMALY_CURIOUS_FINDING', 23), ('EXPLICIT_QUESTION', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 81)]	8	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 89, 'respiratory tract'), ('NCBITaxon_1', 'root', 133, 'viral'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
PMC4113768	7/2014	S17-PMC4113768	['sex-specific ASSOCIATIONS between 25-Hydroxy Vitamin D3And Serum Lipids in elderly german subjects without intake of Lipid-modifying Drugs\n\njungert, a.; neuhäuser-berthold, m.\nbackground: ALTHOUGH EMERGING EVIDENCE INDICATES an ASSOCIATION between Vitamin D and Serum Lipids, the data are STILL INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 289), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295)]	8	[('CHEBI_668', '1-Phenyl-5-heptene-1,3-diyne', 34, '25-Hydroxy Vitamin D3and'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 45, 'Vitamin D3and'), ('UBERON_0001977', 'blood serum', 59, 'Serum'), ('CHEBI_18059', 'lipid', 65, 'Lipids'), ('CHEBI_18059', 'lipid', 117, 'Lipid'), ('CHEBI_23888', 'drug', 133, 'Drugs'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('UBERON_0001977', 'blood serum', 262, 'serum'), ('CHEBI_18059', 'lipid', 268, 'lipids')]
PMC4113768	7/2014	S2517-PMC4113768	['THESE FINDINGS SUGGEST that; (1) there is no additional BENEFIT to calcium absorption or bone mineralisation from a Blood level for 25(Oh)D above ~75 nmol/l; (2)DESPITE adequate Vitamin D and regular physical activity lower dietary Calcium intake is STILL a PREDICTOR of lower total body bmd and bmc; and (3) in certain population groups with baseline 25(Oh)D > 75 nmol/l, Vitamin D supplementation of 50,000 iu/month does not significantly increase 25(Oh)D concentrations over a 12 month period, but POSSIBLY PREVENTS seasonal decline.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 161), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 258), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 510)]	8	[('UBERON_0000178', 'blood', 116, 'blood'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 352, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 450, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 450, '25(OH)D')]
PMC4251419	12/2014	S27-PMC4251419	['DESPITE these relatively COHERENT FINDINGS from ecologic and OBSERVATIONAL studies, and PLAUSIBLE biological mechanisms, trials of Vitamin D supplementation for the PREVENTION of Immune-related diseases have LARGELY returned null results [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 208)]	8	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0002405', 'immune system', 179, 'immune')]
PMC4251419	12/2014	S149-PMC4251419	['most RECENT Vitamin D supplementation TRIALS use Vitamin D3, SUGGESTING that any DIFFERENCES between d2and d3do NOT ACCOUNT for the DIFFERENT findings from OBSERVATIONAL and Vitamin D supplementation trials.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ANOMALY_CURIOUS_FINDING', 112), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('INCOMPLETE_EVIDENCE', 156)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 49, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4256222	12/2014	S145-PMC4256222	['FURTHER STUDIES on this subject ARE NEEDED, BUT such STUDIES MUST BE conducted in study populations large enough to allow for INVESTIGATION of seasonal variation, subdivision of fractures and further stratification of study participants by Vitamin D status.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 66), ('FUTURE_WORK', 126)]	8	[('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4383226	2/2015	S42-PMC4383226	['ON THE OTHER HAND, CONCERN HAS BEEN RAISED by an APPARENT increase in levels of parasitemia within Mouse MODELS, when combining Vitamin A supplements with dtp vaccination; an EFFECT THOUGHT TO be stronger among female Mice (jorgensen et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 27), ('EXPLICIT_QUESTION', 36), ('ANOMALY_CURIOUS_FINDING', 49), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 175), ('INCOMPLETE_EVIDENCE', 182)]	8	[('NCBITaxon_10088', 'Mus <genus>', 99, 'mouse'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'mice')]
PMC4383226	2/2015	S100-PMC4383226	['STILL, it CONTRADICTS SUGGESTIONS that when combined with dtp (jorgensen et al., 2011), Vitamin A MAY increase the RISK of malaria infection.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 115)]	8	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4448820	5/2015	S212-PMC4448820	['INTERESTINGLY, this RELATION and its correction are PROPOSED as a POTENTIAL BIOMARKER for znd in a manner ANALOGOUS TO SOME of the classic enzyme stimulation assay for Vitamins (Vitamin B-6, Thiamin, and riboflavin).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 119)]	8	[('CHEBI_33277', 'gamma-tocotrienol', 168, 'vitamins'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin B'), ('CHEBI_26948', 'vitamin B1', 191, 'thiamin')]
PMC4448820	5/2015	S1039-PMC4448820	['Vitamin D\n\n● POOR Prenatal Vitamin D status HAS BEEN IMPLICATED in increased asthma risk and severity in the offspring, ALTHOUGH EVIDENCE TO SUPPORT an IMPORTANT RELATION remains CONTROVERSIAL (577).']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4488777	5/2015	S31-PMC4488777	['research on the ROLE of Vitamin D in Reproduction Process Modulation SEEMS ESPECIALLY INTERESTING; their CONCLUSIONS PRESUMABLY have a significant practical meaning in infertility treatment, a SERIOUS medical PROBLEM affecting up to 53 million people worldwide [8].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 75), ('ANOMALY_CURIOUS_FINDING', 86), ('PROBABLE_UNDERSTANDING', 105), ('PROBABLE_UNDERSTANDING', 117), ('IMPORTANT_CONSIDERATION', 193), ('IMPORTANT_CONSIDERATION', 209)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0003301', 'physiological cardiac muscle hypertrophy', 37, 'reproduction process modulation')]
PMC4516377	6/2015	S70-PMC4516377	['it is NOTEWORTHY that ALTHOUGH 25 (Oh) D3 (Calcidiol) is not the most active Metabolite, is the most COMMONLY ASSESSED, AS Plasma levels of active Vitamin D, 1,25 Dihydroxyvitamin D (1,25 (Oh) 2D3), are regularly maintained at normal concentrations; furthermore, Plasma levels of 25 (Oh) D3 are APPROXIMATELY 100 times higher than those of 1,25 (Oh) 2D3 and the half-life of 1,25 (Oh) 2D3 is APPROXIMATELY six hours, whereas that of 25 (Oh) D3 is two to three weeks.11\nwhen comparing Serum levels of Vitamin D in the children assessed in the study carried out by lourenço21in brazil with a study carried out in the usa,35higher levels were observed in brazil.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 295), ('INCOMPLETE_EVIDENCE', 392)]	8	[('CHEBI_62946', 'ammonium sulfate', 31, '25 (OH) D3'), ('CHEBI_17933', 'calcidiol', 43, 'calcidiol'), ('CHEBI_39382', 'flufenoxuron', 77, 'metabolite'), ('UBERON_0001969', 'blood plasma', 123, 'plasma'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_67469', '15-hydroxyajubractin C', 158, '1,25 dihydroxyvitamin D'), ('CHEBI_72779', '11-trans-LTE4', 183, '1,25 (OH) 2D3'), ('UBERON_0001969', 'blood plasma', 263, 'plasma'), ('CHEBI_62946', 'ammonium sulfate', 280, '25 (OH) D3'), ('CHEBI_73394', 'Ala-Ser', 342, '25 (OH) 2D3'), ('CHEBI_34898', 'OM-174', 381, 'OH) 2D3'), ('CHEBI_62946', 'ammonium sulfate', 433, '25 (OH) D3'), ('UBERON_0001977', 'blood serum', 484, 'serum'), ('CHEBI_27300', 'vitamin D', 500, 'vitamin D')]
PMC4600246	10/2015	S68-PMC4600246	['IN SUMMARY, Vitamin K MAY improve Insulin sensitivity in men with diabetes.40\n\nVitamin K and cancer\nVitamin K2Has BEEN SHOWN to inhibit the growth of Human cancer cell lines, including Hepatoma lines, as well as to treat myelodysplastic syndrome.50–53two trials SEEM to INDICATE that Vitamin K245\u2005mg/day reduces the Development Of Hepatocellular Carcinoma (Hcc) in patients with Liver cirrhosis and that Vitamin K2Significantly reduces the recurrence of hcc in patients following the curative treatment of hcc with an ASSOCIATED reduction in all-cause mortality in these patients.54–61the POSSIBLE reduction in mortality with Vitamin K2May be EXPLAINED by multiple mechanisms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 262), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 518), ('INCOMPLETE_EVIDENCE', 589), ('PROBABLE_UNDERSTANDING', 643)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin K'), ('PR_000045358', 'insulin family protein', 34, 'insulin'), ('CHEBI_28384', 'vitamin K', 79, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 100, 'Vitamin'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 108, 'K2has'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('UBERON_0004705', 'fenestra', 185, 'hepatoma'), ('CHEBI_86324', 'quinolone antibiotic', 284, 'vitamin K245'), ('GO_0002234', 'detection of endoplasmic reticulum overloading', 316, 'development of hepatocellular carcinoma'), ('UBERON_0012474', 'hepatic cecum', 331, 'hepatocellular'), ('GO_0000724', 'double-strand break repair via homologous recombination', 357, 'HCC'), ('UBERON_0002107', 'liver', 379, 'liver'), ('CHEBI_64387', 'thiosultap(1-)', 404, 'vitamin K2significantly'), ('CHEBI_27325', 'xanthophyll', 626, 'vitamin K2may'), ('PR_000017209', 'utrophin', 626, 'vitamin K2may')]
PMC4684854	12/2015	S58-PMC4684854	['specifically, supplementation of Vitamin D in Pregnancy in SOME studies APPEARS TO SUGGEST marked BENEFIT WHILE research in OTHER publications does NOT APPEAR TO confer significant improvement in maternal-fetal outcomes [44].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 72), ('INCOMPLETE_EVIDENCE', 83), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ANOMALY_CURIOUS_FINDING', 148), ('ANOMALY_CURIOUS_FINDING', 152)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC4684854	12/2015	S61-PMC4684854	['the APPARENT DISPARITY between findings in VARIOUS STUDIES has caused SOME to reflexively CONCLUDE that Vitamin D status in Pregnancy is IRRELEVANT to maternal-fetal outcomes.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ANOMALY_CURIOUS_FINDING', 13), ('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 137)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy')]
PMC4689556	12/2015	S20-PMC4689556	['thus FAR there HAS BEEN a LACK OF randomised controlled trial evidence to definitively confirm OR REFUTE the RELATIONSHIP between Prenatal Vitamin D and childhood health outcomes FOUND in OBSERVATIONAL studies.']	[('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 130, 'prenatal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4764019	1/2016	S40-PMC4764019	['WHILE this ASSOCIATION MIGHT initially SEEM far-fetched, it is IMPORTANT TO NOTE that the great famine in china in 1958 to 1961 was ASSOCIATED with a subsequent rise in the incidence of schizophrenia in famine victims.2measured Vitamin D status values in these Individuals are NOT AVAILABLE, but it HAS long BEEN KNOWN that rickets was endemic in china and certainly was so at the time of the famine.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 132), ('INCOMPLETE_EVIDENCE', 277), ('INCOMPLETE_EVIDENCE', 299)]	8	[('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('NCBITaxon_1', 'root', 261, 'individuals')]
PMC4877864	6/2015	S87-PMC4877864	['WHILE, the results of THIS STUDY SHOWED that Vitamin C and Folate contents were ranged between borderline and inadequate Intake in both groups (group 1 and group 2) COMPARED TO their rdas (p<0.005), HOWEVER Vitamin A was ON THE OTHER HAND adequate.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 165), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('ANOMALY_CURIOUS_FINDING', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	8	[('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 59, 'folate'), ('GO_0007631', 'feeding behavior', 121, 'intake'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4903143	5/2016	S98-PMC4903143	['in addition, Gestational Vitamin D levels MAY EVEN IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the Development Of Adult-onset multiple Sclerosis [33].']	[('INCOMPLETE_EVIDENCE', 42), ('ANOMALY_CURIOUS_FINDING', 46), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adult'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0048513', 'animal organ development', 172, 'development of ... sclerosis'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
PMC4934634	11/2015	S261-PMC4934634	['ALTHOUGH both single and daily doses of Vitamin D3Seem to be SAFE, CAUTION SHOULD BE CONSIDERED when supplementing at these high doses in Pregnant women, PARTICULARLY if baseline Vitamin D status is sufficient.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 61), ('FUTURE_WORK', 67), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 75), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 154), ('IMPORTANT_CONSIDERATION', 154)]	8	[('CHEBI_64387', 'thiosultap(1-)', 40, 'vitamin D3seem'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4944244	7/2016	S27-PMC4944244	['healthcare workers USUALLY ENCOURAGE Pregnant women to increase calcium intake BUT they are LESS AWARE that without sufficient Vitamin D, calcium intake will not have much EFFECT ESPECIALLY during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 97), ('SUPERFICIAL_RELATIONSHIP', 172), ('ANOMALY_CURIOUS_FINDING', 179)]	8	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy')]
PMC5014971	8/2016	S108-PMC5014971	['EVEN researchers SKEPTICAL of the causality of Vitamin D EFFECTS on Pregnancy outcomes POINT to a knowledge deficit that NEEDS ADDRESSING, ESPECIALLY in areas such as maternal and neonatal infections (e.g., [21]).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 121), ('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 127), ('IMPORTANT_CONSIDERATION', 139)]	8	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5051327	9/2016	S59-PMC5051327	['this was CONNECTED to the Cyclic Adenosine Monophosphate (Camp) pathway and RELATED to accelerated relaxation.2829this EFFECT was not seen in Vitamin D Receptor knockout Mice, which IMPLIES that the EFFECT is MEDIATED by the Vitamin D receptor which SEEMS IMPORTANT for Cardiac muscle function.2830using a state Cardiac diagram, asphyxia is slowing the Relaxation phase in the fetal Heart.3132pregnancy is a condition with increased Oestrogen levels.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 119), ('PROBABLE_UNDERSTANDING', 182), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 209), ('ANOMALY_CURIOUS_FINDING', 250), ('IMPORTANT_CONSIDERATION', 256)]	8	[('CHEBI_23447', 'cyclic nucleotide', 26, 'cyclic adenosine monophosphate'), ('CHEBI_17489', "3',5'-cyclic AMP", 58, 'cAMP'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 142, 'vitamin D receptor'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'mice'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000948', 'heart', 270, 'cardiac'), ('UBERON_0000948', 'heart', 312, 'cardiac'), ('GO_0032809', 'neuronal cell body membrane', 353, 'relaxation'), ('UBERON_0000948', 'heart', 383, 'heart'), ('CHEBI_50114', 'estrogen', 433, 'oestrogen')]
PMC5372327	3/2017	S57-PMC5372327	['ALTHOUGH PRELIMINARY results POINT to IMPORTANCE of early Life exposure, the ROLE of Vitamin D in Cognitive Development during childhood and Adolescence REMAINS LARGELY UNSTUDIED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 169)]	8	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 98, 'cognitive development'), ('GO_0048848', 'neurohypophysis morphogenesis', 141, 'adolescence')]
PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]
PMC5405075	4/2017	S44-PMC5405075	['OF NOTE, Food base approaches MAY BE ASSUMED AS a better representative of long-term Vitamin D Intake, which MIGHT INFLUENCE the fetus during all stages of Gestation and EVEN ex utero .']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('ANOMALY_CURIOUS_FINDING', 170)]	8	[('CHEBI_33290', 'food', 9, 'food'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 95, 'intake'), ('GO_0007565', 'female pregnancy', 156, 'gestation')]
PMC5418719	5/2017	S98-PMC5418719	['CONSIDERING the high prevalence of Vitamin D deficiency in Pregnant mothers, sufficient Vitamin D supply in preterm infants COULD BE IMPORTANT to quickly correct the fetal low Plasma levels of Vitamin D. a Vitamin D intake of 800\xa0iu to 1000\xa0iu per day during first Months Of Life is RECOMMENDED BASED ON european GUIDELINES [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 133), ('FUTURE_WORK', 283), ('PROBABLE_UNDERSTANDING', 295), ('ANOMALY_CURIOUS_FINDING', 301), ('PROBABLE_UNDERSTANDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 176, 'plasma'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0005445', 'segment of pes', 265, 'months of life')]
PMC5426325	4/2017	S20-PMC5426325	['GIVEN that low bone Mineral density (bmd) is PREDICTIVE of increased fracture risk, AS SHOWN in both case–control and prospective studies – THOUGH principally in Adults(13–20)– maternal Vitamin D insufficiency MAY POTENTIALLY also INFLUENCE fracture RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 250)]	8	[('CHEBI_46662', 'mineral', 20, 'mineral'), ('UBERON_0007023', 'adult organism', 162, 'adults'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5474873	6/2017	S161-PMC5474873	['we had NO biological DATA on Vitamin D levels, which COULD have established a clear LINK to Vitamin D, ALTHOUGH it is WELL KNOWN that sun exposure is the MOST IMPORTANT DETERMINANT of Vitamin D status (9,13).']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 169)]	8	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5513133	7/2017	S145-PMC5513133	['ALTHOUGH these STUDIES FIND an inverse ASSOCIATION between Vitamin D levels and pe, this ASSOCIATION MAY BE CONFOUNDED by the Gestational age at Serum collection.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 101), ('DIFFICULT_TASK', 108)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestational'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC5513133	7/2017	S254-PMC5513133	['BUT this Vitamin D level was maintained in ONLY 74% of Pregnancies in the supplementation group by weeks 32 to 38 of Gestation, SUGGESTING that supplementation at EVEN earlier time-points or before Pregnancy MAY BE NECESSARY to maintain sufficient Vitamin D levels that are PROTECTIVE against pe.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 43), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 208), ('IMPORTANT_CONSIDERATION', 215), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancies'), ('GO_0007565', 'female pregnancy', 117, 'gestation'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
PMC5638722	8/2017	S101-PMC5638722	['BECAUSE of this, it is NOT SURPRISING that the results of OUR STUDY DID not SHOW Vitamin D level AS an INDEPENDENT risk FACTOR for neonatal sepsis.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 120)]	8	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5664622	9/2017	S118-PMC5664622	['it SEEMS that the ESTIMATED Vitamin D consumption is a RELIABLE result AS it is CONSISTENT with OTHER REPORTS, which for years have INDICATED a consistently low amount of Vitamin D in the diet of polish Pregnant women (2.6–2.8 µg/day) [13,35].']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 55), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 132)]	8	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC5706533	11/2017	S148-PMC5706533	['THOUGH SOME OBSERVATIONAL STUDIES HAVE SHOWN ASSOCIATIONS between maternal Vitamin D deficiency and Gestational diabetes and pre-eclampsia,22we DID NOT FIND ROBUST corroborating evidence from randomised controlled trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 157)]	8	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational')]
PMC5838372	3/2018	S78-PMC5838372	['discussion\nvitamin D deficiency LEADS TO IMPORTANT health PROBLEMS, NOT ONLY in mothers BUT ALSO in their infants, BECAUSE the Vitamin D store of the mother is the MAJOR source of Vitamin D for the fetus (9).']	[('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('ANOMALY_CURIOUS_FINDING', 88), ('PROBABLE_UNDERSTANDING', 115), ('IMPORTANT_CONSIDERATION', 164)]	8	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 19, 'D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC5941617	5/2018	S431-PMC5941617	['ALTHOUGH SOME SUGGESTIVE and encouraging data on epidemiological observational studies and pilot clinical studies of intervention, the LACK OF EVIDENCE deriving by rcts DOES NOT ALLOW to ENCOURAGE treatment with Cholecalciferol or other Vitamin D Metabolites in patients with t1dm or subjects at higher RISK.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 135), ('DIFFICULT_TASK', 169), ('FUTURE_WORK', 187), ('IMPORTANT_CONSIDERATION', 303)]	8	[('CHEBI_52550', 'theopalauamide', 212, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_25212', 'metabolite', 247, 'metabolites')]
PMC5952272	5/2018	S146-PMC5952272	['it is IMPORTANT TO MENTION in this context that the PREVALENCE of autism in somali children Born in sweden was FOUND TO BE 3 to 4 times higher than in the non-somali group (0.7% vs 0.19%).39as somalis have high levels of Melanin, during migration to northern latitudes, such as sweden, they would REQUIRE 5 to 10 times more uv-b exposure than light-skinned Individuals OR an ALTERNATIVE Vitamin D source, such as from the diet or supplementation.40moreover, saad et al41reported that 57% Vitamin D deficient and 30% insufficient patients who received Vitamin D3 (300\u2009iu/kg/day not to exceed 5000\u2009iu/day) for 3\u2009months SHOWED significant improved outcomes (80.72 %), which were MAINLY in the sections of the childhood autism rating scale (cars) and aberrant behaviour checklist subscales that measure behaviour, stereotypy, Eye contact, and attention span.']	[('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 52), ('ANOMALY_CURIOUS_FINDING', 111), ('FUTURE_WORK', 297), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 375), ('INCOMPLETE_EVIDENCE', 617), ('PROBABLE_UNDERSTANDING', 676)]	8	[('GO_0007567', 'parturition', 92, 'born'), ('CHEBI_25179', 'melanins', 221, 'melanin'), ('NCBITaxon_1', 'root', 357, 'individuals'), ('CHEBI_27300', 'vitamin D', 387, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 488, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 551, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 551, 'vitamin D3'), ('UBERON_0000970', 'eye', 822, 'eye')]
PMC6043562	7/2018	S15-PMC6043562	['OTHER STUDIES have FOUND PROTECTIVE ASSOCIATIONS of maternal Antenatal Vitamin D or antioxidant Nutrient intake with later allergic or Respiratory outcomes8–12, THOUGH their findings have NOT always been reproducible13–16.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('ANOMALY_CURIOUS_FINDING', 161), ('ANOMALY_CURIOUS_FINDING', 188)]	8	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_33284', 'nutrient', 96, 'nutrient'), ('UBERON_0001004', 'respiratory system', 135, 'respiratory')]
BMJ_2010_Apr_29_340_c1640	4/2010	S17-BMJ_2010_Apr_29_340_c1640	['this latitudinal gradient SEEMS environmentally RELATED BECAUSE the risk ASSOCIATED with latitude alters if People move after Birth.45a strong environmental CANDIDATE is the level of ambient regional ultraviolet radiation, acting EITHER directly OR through the generation of Vitamin D.6higher exposure to ultraviolet radiation,7higher Vitamin D intake,8and also higher Serum Vitamin D concentrations9seem to be ASSOCIATED with a reduced risk of onset of multiple sclerosis.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230), ('SUPERFICIAL_RELATIONSHIP', 411)]	7	[('NCBITaxon_10088', 'Mus <genus>', 108, 'people'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('UBERON_0001977', 'blood serum', 369, 'serum'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
PMC2290997	4/2008	S83-PMC2290997	['SOME STUDIES have DEMONSTRATED high prevalence of low Vitamin D levels in People with type 2 diabetes, ALTHOUGH it is NOT CLEAR WHETHER this is a cause of the disease or an EFFECT of another causative FACTOR—for example, lower levels of physical activity (in this case, outdoor activity in particular).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ANOMALY_CURIOUS_FINDING', 103), ('FULL_UNKNOWN', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('SUPERFICIAL_RELATIONSHIP', 173), ('SUPERFICIAL_RELATIONSHIP', 201)]	7	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'people')]
PMC2581757	11/2008	S198-PMC2581757	['the activities of antioxidant enzymes were also INFLUENCED by the use of Vitamins C and E. the reduction of sod activity during the development of Preeclampsia was controlled as a CONSEQUENCE of Vitamin consumption: the decrease was FOUND TO BE 14% WHEREAS it was 23% in patients who had not used Vitamins C and E. the most prominent EFFECT of the use of these Vitamins was FOUND TO BE ASSOCIATED with the activity of Glutathione reductase.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('SUPERFICIAL_RELATIONSHIP', 334), ('ANOMALY_CURIOUS_FINDING', 374), ('SUPERFICIAL_RELATIONSHIP', 386)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamins C'), ('PR_000004900', 'complement C3', 82, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 88, 'E'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia'), ('CHEBI_33229', 'vitamin (role)', 195, 'vitamin'), ('CHEBI_27300', 'vitamin D', 297, 'vitamins C'), ('PR_000004900', 'complement C3', 306, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 312, 'E'), ('CHEBI_33277', 'gamma-tocotrienol', 361, 'vitamins'), ('CHEBI_16856', 'glutathione', 418, 'glutathione')]
PMC2996405	11/2010	S163-PMC2996405	['DESPITE the consistence of this RELATIONSHIP, TO OUR KNOWLEDGE studies CONNECTING schizophrenia and Vitamin D at a molecular level are NOT YET AVAILABLE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 135), ('FUTURE_WORK', 139)]	7	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3257641	3/2010	S140-PMC3257641	['seasonal PATTERNS of Birth in Adults [114] and children [115] with Brain tumors and epilepsy [116] HAVE BEEN NOTED and COULD BE evidence of an EFFECT of low Vitamin D status, BUT this is far from CONCLUSIVE.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 99), ('ANOMALY_CURIOUS_FINDING', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196)]	7	[('GO_0007567', 'parturition', 21, 'birth'), ('UBERON_0007023', 'adult organism', 30, 'adults'), ('UBERON_0000955', 'brain', 67, 'brain'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC3271033	1/2012	S146-PMC3271033	['HOWEVER, the FINDINGS in OUR STUDY APPEAR MEANINGFUL in that the provision of Vitamin D at a dose of 400 iu/day LED TO mean values that were above 30 ng/ml REGARDLESS OF starting value or ethnicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ANOMALY_CURIOUS_FINDING', 35), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 156)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3277098	12/2011	S43-PMC3277098	['HOWEVER, just as with the epidemiological ASSOCIATIONS, the EFFECTS of Vitamin D on Th2 Cells HAVE also BEEN CONTRADICTORY, with REPORTS of both enhancement and inhibition [29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 129)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CL_0000546', 'T-helper 2 cell', 84, 'Th2 cells')]
PMC3347028	3/2012	S87-PMC3347028	['it IS NOT SURPRISING, then that during Pregnancy pth as a MARKER of Vitamin D status is a LESS RELIABLE PREDICTOR than in nonpregnant Adults [60,61,62].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 6), ('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 104)]	7	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3347028	3/2012	S125-PMC3347028	['YET, it was THOUGHT for the MOST PART that Vitamin D deficiency was RARE and COULD BE avoided through some sunlight exposure and a daily Vitamin D intake of 200 iu (5 μg) [80].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77)]	7	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3355895	1/2011	S50-PMC3355895	['the Regulation of this process is AS YET UNKNOWN, but at least one of the Isoforms of Pmca HAS BEEN shown to be Regulated by 1,25(Oh)-Vitamin D (kip and strehler,2004), and in SOME Animals, BUT NOT OTHERS, 1,25(Oh)2-Vitamin D APPEARS necessary for maintenance of the maternofetal calcium gradient (lester,1986).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 34), ('FULL_UNKNOWN', 37), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('ANOMALY_CURIOUS_FINDING', 226)]	7	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('SO_0001060', 'sequence_variant', 74, 'isoforms'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 86, 'PMCA'), ('GO_0065007', 'biological regulation', 112, 'regulated'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 130, 'OH)-'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 181, 'animals'), ('CHEBI_75874', 'para-terphenyl', 206, '1,25(OH)2-'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC3356951	4/2012	S3-PMC3356951	['high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('ANOMALY_CURIOUS_FINDING', 48), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 85), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 135)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 115, 'D')]
PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]
PMC3395583	7/2012	S21-PMC3395583	['DESPITE these DIFFERENCES, an abnormal Activation Of the Immune System is a common thread LINKING these conditions and several OBSERVATIONS INDICATE that similar Genetic pathways and environmental agents, such as Vitamin D deficiency, smoking behaviour and various infections, are INVOLVED in the pathogenesis of these disorders [18-20,22-25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 281)]	7	[('GO_0000103', 'sulfate assimilation', 39, 'activation of ... immune system'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('SO_0000704', 'gene', 162, 'genetic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3407995	7/2012	S261-PMC3407995	['maternal Vitamin D status early in Pregnancy was ASSOCIATED with risk of low Birth weight and small-for-Gestational age infants in ONE STUDY, WHEREAS another study FOUND this RELATION ONLY among white women [141].']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 184), ('INCOMPLETE_EVIDENCE', 184)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007567', 'parturition', 77, 'birth'), ('GO_0007565', 'female pregnancy', 104, 'gestational')]
PMC3424155	8/2012	S16-PMC3424155	['HOWEVER, NEW EVIDENCE SUGGESTS that Vitamin D COULD BE VITAL to normal fetal Development and that Vitamin D restriction in this period MAY AFFECT chronic disease susceptibility post-Natal Life[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 139)]	7	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007567', 'parturition', 182, 'natal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC3427192	4/2012	S23-PMC3427192	['SEVERAL of THESE STUDIES NOTED an inverse RELATIONSHIP between maternal Vitamin D intake and the RISK of subsequent wheezing in young infants and preschool children.58,61,62,64HOWEVER, Vitamin D intakes varied CONSIDERABLY between geographic locations, from 548 iu/day in the united states58and 260 iu/day in finland62to 248 and 137 iu/day in japan64and scotland,61respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 210)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3470091	9/2012	S18-PMC3470091	['these CAN cause Vitamin D deficiency in mothers’ Milk as the only source of Vitamin D for babies.6\nthere are EVIDENCES SHOWING the ROLE of Vitamin D in keeping normal Glucose Homeostasis.7-10resistance to Insulin and destruction of Insulin secretion in Human and Animal MODELS has CONSIDERABLY been RELATED to Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 270), ('ANOMALY_CURIOUS_FINDING', 281), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001913', 'milk', 49, 'milk'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_17234', 'glucose', 167, 'glucose'), ('GO_0042593', 'glucose homeostasis', 167, 'glucose homeostasis'), ('PR_000045358', 'insulin family protein', 205, 'insulin'), ('PR_000045358', 'insulin family protein', 232, 'insulin'), ('NCBITaxon_9606', 'Homo sapiens', 253, 'human'), ('NCBITaxon_33208', 'Metazoa', 263, 'animal'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D')]
PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]
PMC3613945	2/2013	S210-PMC3613945	['Breast cancer\necological case-control studies INDICATE an inverse CORRELATION between Vitamin D status and Breast cancer RISK, HOWEVER, the RELATIONSHIP is LESS CLEAR in longitudinal studies150,151.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('SUPERFICIAL_RELATIONSHIP', 140), ('FULL_UNKNOWN', 156)]	7	[('UBERON_0000310', 'breast', 0, 'Breast'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000310', 'breast', 107, 'breast')]
PMC3641012	4/2013	S20-PMC3641012	['SIMILARLY, the 25(Oh)D THRESHOLD to define Vitamin D sufficiency is DEBATED; the iom set 50\xa0nmol/l as a lower limit of sufficiency [7], YET OTHER expert bodies such as the american academy of pediatrics have SUGGESTED that Pregnant women attain Serum 25(Oh)D >80\xa0nmol/l [14].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('ANOMALY_CURIOUS_FINDING', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('INCOMPLETE_EVIDENCE', 208)]	7	[('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnant'), ('UBERON_0001977', 'blood serum', 245, 'serum'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 251, '25(OH)D')]
PMC3659910	1/2013	S173-PMC3659910	['HOWEVER this RECOMMENDED level, which was LARGELY ARBITRARILY set, SEEMS TO BE LESS HELPFUL to improve the nutritional Vitamin D status of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('ANOMALY_CURIOUS_FINDING', 67), ('FUTURE_PREDICTION', 73), ('IMPORTANT_CONSIDERATION', 79)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnant')]
PMC3659910	1/2013	S194-PMC3659910	['FUTURE STUDIES are ESSENTIAL to determine the true Vitamin D REQUIREMENT during Pregnancy NOT ONLY for maternal Skeletal preservation and fetal Skeletal Formation, BUT ALSO for fetal “Imprinting" that MAY AFFECT Neurodevelopment, Immune function and chronic disease SUSCEPTIBILITY soon after Birth as well as later in Life.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 90), ('FUTURE_PREDICTION', 201), ('SUPERFICIAL_RELATIONSHIP', 205), ('IMPORTANT_CONSIDERATION', 266)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0004288', 'skeleton', 112, 'skeletal'), ('GO_0001501', 'skeletal system development', 144, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('GO_0071514', 'genetic imprinting', 184, 'imprinting'), ('GO_0007399', 'nervous system development', 212, 'neurodevelopment'), ('UBERON_0002405', 'immune system', 230, 'immune'), ('GO_0007567', 'parturition', 292, 'birth'), ('UBERON_0000104', 'life cycle', 318, 'life')]
PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
PMC3691177	6/2013	S137-PMC3691177	['ALTHOUGH THESE FINDINGS cannot automatically be generalised to OTHER populations of Pregnant women, one MIGHT expect Prenatal Vitamin D supplementation to SHOW its clearest clinical EFFECTS in a deficient population such as this.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 182)]	7	[('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 117, 'prenatal'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3702245	6/2013	S45-PMC3702245	['CONSISTENT with THIS report, a systematic review and meta-analysis of seven observational studies performed between 2008 and 2011 FOUND Serum 25(Oh)D < 50 nmol/l to be ASSOCIATED with Gestational diabetes BUT with an overall lower odds ratio of 1.61 (ci 1.19–2.17).86another meta-analysis of maternal Vitamin D status and Pregnancy outcomes,87which included 24 studies up to 2012, FOUND an overall INCREASED RISK of Preeclampsia (odds ratio 2.09; ci 1.50–2.90) and Gestational diabetes (odds ratio 1.38; ci 1.12–1.70).']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 205), ('INCOMPLETE_EVIDENCE', 381), ('IMPORTANT_CONSIDERATION', 398)]	7	[('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 142, '25(OH)D'), ('GO_0007565', 'female pregnancy', 184, 'gestational'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 322, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 416, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 465, 'gestational')]
PMC3705320	3/2013	S201-PMC3705320	['NONETHELESS, increases in the mean calcium concentration (within the normal range) and suppression of pth secretion among Pregnant women receiving the higher-dose regimen (70,000 iu initial dose followed by weekly doses of 35,000 iu) HIGHLIGHTED the physiological IMPACT of the intervention and the NEED to cautiously address POTENTIAL Pregnancy-specific sensitivities to Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 264), ('FUTURE_WORK', 299), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3728489	7/2013	S317-PMC3728489	['NOTABLY, breastfed infants are at ESPECIALLY high RISK of Vitamin D deficiency DUE TO POOR penetrance of Vitamin D Metabolites in milk (kovacs,2013; thiele et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 50), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_25212', 'metabolite', 115, 'metabolites')]
PMC3798907	8/2013	S122-PMC3798907	['ALTHOUGH the main FOCUS of our work was the supplementation of cbmc, we included a parallel study of Adult pbmc TO EXAMINE the EFFECT of the same in vitro Vitamin E supplementation on Adult Pbmc IN LIGHT OF the REPORTS of age RELATED differential responsiveness.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 127), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('UBERON_0007023', 'adult organism', 101, 'adult'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('UBERON_0007023', 'adult organism', 184, 'adult'), ('UBERON_2005026', 'primary head sinus', 190, 'PBMC')]
PMC3809191	1/2013	S64-PMC3809191	['ALTHOUGH there is NO CONSENSUS for routine Vitamin D screening in Pregnancy, being ALERT about the vitamin\xa0d deficiency and its symptoms and optimising when NECESSARY by replacement and/or through taking lifestyle measures MAY BE RECOMMENDED to prevent the Birth of Vitamin D-deficient infants from Vitamin D-deficient mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 223), ('FUTURE_WORK', 230)]	7	[('CHEBI_28384', 'vitamin K', 43, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007567', 'parturition', 257, 'birth'), ('CHEBI_28384', 'vitamin K', 266, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 266, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3827489	10/2013	S33-PMC3827489	['IN LINE WITH THESE data, a study FOCUSING on adolescents aged 12-13 years REPORTED that 98.9% of boys and 100% of girls showed Vitamin D insufficiency or deficiency; 5.3% had 25(Oh)D insufficiency (20.0-29.9 ng/ml), 94.2% had deficient concentrations (<20.0 ng/ml), and ONLY 1 boy (1.1%) had OPTIMAL concentrations of 25(Oh)d6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 74), ('ANOMALY_CURIOUS_FINDING', 270), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 292)]	7	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 175, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 318, '25(OH')]
PMC3827489	10/2013	S92-PMC3827489	['this FINDING MAY BE EXPLAINED BY PREVIOUS STUDIES SUGGESTING that higher Vitamin D levels or appropriate Vitamin D intake in Pregnant women is ASSOCIATED with increased infant Birth weight66,67).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 17), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('GO_0007567', 'parturition', 176, 'birth')]
PMC4113768	7/2014	S162-PMC4113768	['ALTHOUGH there is SOME SUGGESTION that SELF-REPORTED sleep quality and sleep latency MIGHT be ASSOCIATED with Vitamin D status, results APPEAR TO vary by ethnicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 94), ('ANOMALY_CURIOUS_FINDING', 136)]	7	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4251419	12/2014	S6-PMC4251419	['over the last 10-15 years, INCREASED RISK of a WIDE RANGE of health outcomes HAS BEEN LINKED to Vitamin D deficiency, ALTHOUGH in many cases the LINKS REMAIN rather weak.']	[('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('ANOMALY_CURIOUS_FINDING', 118), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 151)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4251419	12/2014	S86-PMC4251419	['ALTHOUGH childhood Vitamin D levels and sun exposure APPEAR TO BE IMPORTANT DETERMINANTS of the risk of disease onset, higher 25(Oh)D levels early in the disease course MAY PREDICT the rate of disease progression in multiple sclerosis [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 53), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC4329404	10/2014	S185-PMC4329404	['THEREFORE, ALTHOUGH it does not SEEM LIKELY that Vitamin D deficiency per se causes asthma in early Life, it is LIKELY that Vitamin D deficiency CONTRIBUTES to increased disease severity in children with asthma and that supplementation MAY reduce severity.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 236)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4377870	3/2015	S88-PMC4377870	['DESPITE the OBSERVATIONAL data LINKING Vitamin C to Lung health, supplementation with Vitamin C has not been shown to reduce the RISK of asthma [66] which MAY be RELATED to the interdependence of Nutrients found in Foods, resulting in lack OF efficacy when supplementing with isolated Nutrients.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('ANOMALY_CURIOUS_FINDING', 240)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin C'), ('UBERON_0002048', 'lung', 52, 'lung'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('CHEBI_33284', 'nutrient', 196, 'nutrients'), ('CHEBI_33290', 'food', 215, 'foods'), ('CHEBI_33284', 'nutrient', 285, 'nutrients')]
PMC4377870	3/2015	S146-PMC4377870	['epidemiological EVIDENCE LINKS low levels of Vitamin D with wheeze and Respiratory infections, THOUGH EVIDENCE for the LINK with asthma onset is weak and INCONSISTENT [111].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 71, 'respiratory')]
PMC4377888	3/2015	S69-PMC4377888	['ALTHOUGH the ROLE of Vitamin A is well ESTABLISHED, OTHER maternal Micronutrient deficiencies are ASSOCIATED with abnormal Kidney structure or function in her offspring; BUT with LESS clear mechanisms lisle et al.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('INCOMPLETE_EVIDENCE', 179)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('UBERON_0002113', 'kidney', 123, 'kidney')]
PMC4417995	4/2015	S68-PMC4417995	['in CONCLUSION, ALTHOUGH there is a predominance of PAPERS POINTING TO Vitamin D as a PROTECTIVE FACTOR, VARIOUS STUDIES actually IDENTIFY it as a risk factor for ad.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 129)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4448820	5/2015	S291-PMC4448820	['ALTHOUGH SOME EFFECTS of Vitamin D are MEDIATED independently of vdr, the large MAJORITY of the activity of Vitamin D CAN be EXPLAINED via binding of the Vitamin D Metabolite [1,25(Oh)2D] to a single, zinc-finger containing, ligand-activated transcription factor, vdr.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 125)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 164, 'metabolite'), ('CHEBI_17996', 'chloride', 177, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 178, '25(OH)2D')]
PMC4448820	5/2015	S586-PMC4448820	['also, ALTHOUGH it IS CLEAR that inflammation is ASSOCIATED with decreased Serum Retinol and rbp concentrations, the ROLE of Vitamin A supplementation on inflammation and its MARKERS is LESS CLEAR.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 174), ('FULL_UNKNOWN', 185), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_26536', 'retinoic acid', 80, 'retinol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC4598849	10/2015	S60-PMC4598849	['ALTHOUGH the neonatal 25(Oh)D levels at Birth cannot fully represent the Vitamin D status during CRITICAL times of Gestation DUE TO a half-life of several weeks of 25(Oh)D34, IT was quite POSSIBLE that the neonates with lower or higher Cord Blood 25(Oh)D levels MAY also have lower or higher average levels of 25(Oh)D during the whole Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 97), ('PROBLEM_COMPLICATION', 125), ('ANOMALY_CURIOUS_FINDING', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('CHEBI_79189', 'D-ribofuranose-2,5-bisphosphate', 164, '25(OH)D34'), ('PR_000001177', 'D(2) dopamine receptor', 170, 'D34'), ('UBERON_0002240', 'spinal cord', 236, 'cord'), ('UBERON_0000178', 'blood', 241, 'blood'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 253, 'D'), ('CHEBI_71657', 'versiconol acetate', 310, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 316, 'D'), ('GO_0007565', 'female pregnancy', 335, 'pregnancy')]
PMC4624803	10/2015	S17-PMC4624803	['EVEN IF it is PROBABLE that the Vitamin D levels of the mother is close to the levels of the foetus, it is of INTEREST to compare these results with a study of Vitamin D levels in the child AS a hypothetical RISK FACTOR for later development of adhd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 14), ('ANOMALY_CURIOUS_FINDING', 110), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 190), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4632418	10/2015	S129-PMC4632418	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and gdm STILL REMAINS (or = 1.67; 95% ci, 1.31, 2.13; i2= 25.6%, p = 0.251) EVEN after adjusting for maternal age, bmi and ethnicity (supplementary figure s4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ANOMALY_CURIOUS_FINDING', 62), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 68), ('ANOMALY_CURIOUS_FINDING', 130)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4684854	12/2015	S3-PMC4684854	['ALTHOUGH immediate costs for obstetric COMPLICATIONS RELATED to Gestational Vitamin D insufficiency MAY BE modest, the short- and long-term costs for pediatric healthcare resulting from such Gestational COMPLICATIONS MAY BE enormous and present an enduring BURDEN on Healthcare systems.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 217), ('IMPORTANT_CONSIDERATION', 257)]	7	[('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'gestational'), ('UBERON_0004151', 'cardiac chamber', 267, 'healthcare')]
PMC4684854	12/2015	S4-PMC4684854	['with INCREASING EVIDENCE POINTING TO fetal origins of SOME later Life disease, securing Vitamin D sufficiency in Pregnancy APPEARS TO BE a simple, SAFE, and cost-EFFECTIVE measure that CAN be incorporated into routine Preconception and Prenatal Care in the offices of primary care clinicians.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 123), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 162), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0000104', 'life cycle', 65, 'life'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007565', 'female pregnancy', 218, 'preconception'), ('GO_0008283', 'cell proliferation', 236, 'prenatal care')]
PMC4684854	12/2015	S60-PMC4684854	['FOUND that Gestational Vitamin D supplementation was ASSOCIATED with increased Birth weight and Birth length BUT, UNLIKE SOME OTHER RESEARCH, was not associated with other beneficial maternal and neonatal outcomes such as reductions in preeclampsia, Gestational diabetes, small for Gestational age infants, Preterm Birth, or rates of cesarean Delivery [44].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('ANOMALY_CURIOUS_FINDING', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126)]	7	[('GO_0007565', 'female pregnancy', 11, 'gestational'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'birth'), ('GO_0007567', 'parturition', 96, 'birth'), ('GO_0007565', 'female pregnancy', 250, 'gestational'), ('GO_0007565', 'female pregnancy', 282, 'gestational'), ('GO_0007565', 'female pregnancy', 307, 'preterm birth'), ('GO_0007567', 'parturition', 343, 'delivery')]
PMC4689556	12/2015	S142-PMC4689556	['we FOUND NO CONSISTENT evidence for a treatment effect on overall or disease-specific unscheduled healthcare utilisation in the first three years, ALTHOUGH it should be NOTED that neither of the intervention regimens resulted in adequate Vitamin D levels in mothers or Cord Blood, JUDGED by current international Vitamin D RECOMMENDATIONS [36,37].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ANOMALY_CURIOUS_FINDING', 147), ('ANOMALY_CURIOUS_FINDING', 169), ('PROBABLE_UNDERSTANDING', 281), ('FUTURE_WORK', 323)]	7	[('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D')]
PMC4689556	12/2015	S183-PMC4689556	['ALTHOUGH our confidence in the findings is LIMITED by the SMALL SAMPLE size, these data SUGGEST that IF Prenatal Vitamin D is used to promote improved child health outcome, then a Postnatal component to treatment, and/or or higher doses MAY BE NEEDED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 244)]	7	[('GO_0007565', 'female pregnancy', 104, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 180, 'postnatal')]
PMC4764019	1/2016	S49-PMC4764019	['this is BECAUSE, EVEN IF there were no connection between the Vitamin D status and the observed Learning difficulty, the group of Pregnant women to be studied would HAVE TO BE placed and maintained on a Vitamin D status, which is recognized to be INADEQUATE on OTHER grounds (ie, <18 ng/ml) and THEREFORE productive of harmful outcomes.']	[('PROBLEM_COMPLICATION', 8), ('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('IMPORTANT_CONSIDERATION', 165), ('IMPORTANT_CONSIDERATION', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 261), ('PROBABLE_UNDERSTANDING', 295)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007612', 'learning', 96, 'learning'), ('GO_0007565', 'female pregnancy', 130, 'pregnant'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4770602	1/2016	S58-PMC4770602	['cases included 68 pregnant women who received supplementation contain Vitamin D (600 iu/d) and control group included 70 pregnant women who received supplementation without Vitamin D. differences between both groups were not statistically significant ( p -value = 0.84)\n\ndiscussion\nEVIDENCE TO EVALUATE the effectiveness of Vitamin D in Pregnancy is no enough and much of what we KNOW comes from observational RATHER than experimental design, THEREFORE, AT PRESENT Vitamin D supplementation is NOT routinely offered to all pregnant women.']	[('INCOMPLETE_EVIDENCE', 282), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('INCOMPLETE_EVIDENCE', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 410), ('PROBABLE_UNDERSTANDING', 443), ('INCOMPLETE_EVIDENCE', 454), ('ANOMALY_CURIOUS_FINDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D'), ('GO_0007565', 'female pregnancy', 337, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D')]
PMC4859539	5/2016	S97-PMC4859539	["in MODELS 1 and 4, there was also a TREND NOTED with the child’s percent fat being positively ASSOCIATED with Cathelicidin (beta = 0.028, p = 0.052 and beta = 0.025, p = 0.087).10.1371/journal.pone.0152711.t003\n\ncaption (table-wrap): table 3\nmultivariable linear regression models assessing factors associated with natural logarithm for Cathelicidin.model 1 \xa0\xa0independent variablesbetase1p valuerace/ethnicity\xa0\xa0black-0.0390.230.864white---------hispanic-0.1490.2000.459genderfemale---------male0.3180.16 0.047 age0.1450.065 0.028 percent fat0.0280.0140.052child's current 25(Oh)D-0.0050.010.598 model 2 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicityblack0.0350.210.868white---------hispanic-0.1490.210.470genderfemale---------male0.2750.170.104age0.2120.07 0.004 percent fat0.0250.020.087child's 25(Oh)D at Birth-0.0030.010.748 model 3 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0410.180.821white---------hispanic-0.1220.160.458genderfemale---------male0.0910.140.507age0.1550.07 0.023 percent fat0.0120.010.359maternal 25(Oh)D throughout Pregnancy<-0.000100.999 model 4 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0460.1990.816white---------hispanic-0.0800.1850.669genderfemale---------male0.3180.158 0.047 age0.1510.064 0.021 percent fat0.0260.010.069maternal 25(Oh)D 1-month before Delivery0.0030.010.606\n1se represents standard error\n\ndiscussion\nin THIS STUDY of healthy children whose mothers had participated in a Vitamin D supplementation trial during Pregnancy, DESPITE DIFFERENCES in both maternal and childhood Vitamin D status, there were no significant differences in Cathelicidin concentration between the three racial/ethnic groups studied."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 42), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 1391), ('ANOMALY_CURIOUS_FINDING', 1508), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1516)]	7	[('CHEBI_3364', 'Canthiumine', 110, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 110, 'cathelicidin'), ('CHEBI_3461', 'Casuarictin', 337, 'Cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 572, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 572, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 801, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 807, 'D'), ('GO_0007567', 'parturition', 812, 'birth'), ('CHEBI_71657', 'versiconol acetate', 1042, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1048, 'D'), ('GO_0007565', 'female pregnancy', 1061, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 1300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1300, '25(OH)D'), ('GO_0007567', 'parturition', 1323, 'delivery0'), ('CHEBI_27300', 'vitamin D', 1458, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1497, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1559, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 1618, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 1618, 'cathelicidin')]
PMC4889866	5/2016	S19-PMC4889866	['THUS, DESPITE a WIDE VARIETY of studies that acknowledged the immunomodulatory ROLE of Vitamin D, the results HAVE BEEN CONFLICTING.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	7	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4910734	6/2015	S86-PMC4910734	['HOWEVER, SOME reports INDICATE that the same children do not have night blindness,53and SOME reports SUGGEST that asd symptoms are reduced by Retinol treatment.54the lack of night blindness in asd cases of Vitamin A deficiencies SUGGESTS that Retinal is present, but conversion to Retinoic Acid is blocked.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 229)]	7	[('CHEBI_26536', 'retinoic acid', 142, 'retinol'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A'), ('UBERON_0000966', 'retina', 243, 'retinal'), ('CHEBI_26536', 'retinoic acid', 281, 'retinoic acid')]
PMC4910734	6/2015	S189-PMC4910734	['HOWEVER, SOME reports INDICATE that the same children do not have night blindness53and SOME SUGGEST that asd symptoms are reduced by Retinol treatment.54the lack of night blindness in asd cases of Vitamin A deficiencies SUGGESTS that Retinal is present, but conversion to Retinoic Acid is blocked.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 220)]	7	[('CHEBI_26536', 'retinoic acid', 133, 'retinol'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin A'), ('UBERON_0000966', 'retina', 234, 'retinal'), ('CHEBI_26536', 'retinoic acid', 272, 'retinoic acid')]
PMC4930210	7/2016	S164-PMC4930210	['THUS, it APPEARS that ALTHOUGH winter uvr exposure MAY BE insufficient, VARIATIONS in summer sun exposure will alter fall 25(Oh)D concentration and THUS indirectly INFLUENCE winter Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 51), ('DIFFICULT_TASK', 72), ('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 122, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4949006	7/2016	S195-PMC4949006	['there is NO GOOD current EVIDENCE to SHOW value in supplementation for iron and vitamins A, B6, B12, A, e, or D at this time, ALTHOUGH there are many SUGGESTIVE STUDIES for Vitamin D. all Pregnant women SHOULD BE ENCOURAGED to eat a balanced diet rich in fresh or frozen fruits and vegetables, high-quality Carbohydrates including whole grains, and with a good mix of proteins from beans, lean meats, fish, and seafood.']	[('FULL_UNKNOWN', 9), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 150), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	7	[('PR_000004370', 'asialoglycoprotein receptor 2', 89, 'A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 92, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 96, 'B12'), ('PR_000004370', 'asialoglycoprotein receptor 2', 101, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 110, 'D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnant'), ('CHEBI_16646', 'carbohydrate', 307, 'carbohydrates')]
PMC4973215	8/2016	S87-PMC4973215	['IMPORTANTLY, OUR STUDY ILLUSTRATES the ADDITIVE EFFECT of maternal RISK FACTORS and their PREDICTIVE probabilities for Vitamin D deficiency and sga.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 90)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4976416	7/2016	S85-PMC4976416	['conclusion\nDESPITE development of new Formulations for use in cosmetics and skin care products, there is a LACK OF controlled clinical trials providing a rationale for well-defined dosages and clinical indications for oral and topical Vitamin E. after so MANY YEARS of RESEARCH on Vitamin E, it is STILL UNCLEAR as to WHETHER millions of dollars worth of Vitamin E products paid for by patients and consumers have been of any benefit.']	[('ANOMALY_CURIOUS_FINDING', 11), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 269), ('FULL_UNKNOWN', 298), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 318)]	7	[('CHEBI_38864', 'propetamphos', 38, 'formulations'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC4990268	8/2016	S315-PMC4990268	['meta-analyses do not SUPPORT this intervention as a Maternal survival strategy[101,108] HOWEVER the most RECENT such analysis NOTED significant heterogeneity in trial outcomes (i2 = 52%, p = 0.04) MOST LIKELY due TO VARIATIONS in underlying population levels of Vitamin A deficiency between studies[101].']	[('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('DIFFICULT_TASK', 216)]	7	[('GO_0007618', 'mating', 52, 'maternal'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A')]
PMC5051327	9/2016	S68-PMC5051327	['in the logistic regression analysis of Vitamin D levels in women who underwent caesarean section due to suspected fetal distress/Birth asphyxia, we DID NOT adjust for maternal bmi SINCE it SEEMS to be INVOLVED in a causal pathway.35HOWEVER, SIMILAR results were FOUND in stratified analysis of lean women (≤25 in bmi).']	[('INCOMPLETE_EVIDENCE', 148), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('SUPERFICIAL_RELATIONSHIP', 201), ('ANOMALY_CURIOUS_FINDING', 230), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5064894	10/2016	S28-PMC5064894	['DESPITE these SUGGESTIVE results from observational studies, there HAVE BEEN FEW prospective randomized controlled trials examining the IMPACT of Vitamin D supplementation on RISK of ari in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 175)]	7	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC5064894	10/2016	S171-PMC5064894	['in secondary analyses, we will consider aggregation of multiple Vitamin D arms (e.g., group d and e), which will have the benefit of increasing the sample size; HOWEVER, for the a priori primary outcome analysis, we have decided to retain the separation of the groups (according to the design of the mdig trial) to LIMIT the POSSIBILITY of increasing a type ii ERROR IF a TRUE effect of the longer duration or higher-dose intervention were diluted by the lack OF effect of the other group(s).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('INCOMPLETE_EVIDENCE', 315), ('INCOMPLETE_EVIDENCE', 325), ('PROBLEM_COMPLICATION', 361), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('PROBABLE_UNDERSTANDING', 372), ('ANOMALY_CURIOUS_FINDING', 460)]	7	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5085625	9/2016	S109-PMC5085625	['ALTHOUGH preeclampsia HAS BEEN LINKED to maternal Vitamin D insufficiency/deficiency, STILL LITTLE IS KNOWN on POTENTIAL differences in Placental Metabolism Of this Vitamin in uncomplicated and preeclamptic Pregnancies [32].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 86), ('IMPORTANT_CONSIDERATION', 86), ('FULL_UNKNOWN', 92), ('INCOMPLETE_EVIDENCE', 111)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'placental'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 146, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 165, 'vitamin'), ('GO_0007565', 'female pregnancy', 207, 'pregnancies')]
PMC5129897	10/2016	S6-PMC5129897	['HOWEVER, the EFFECTS on disease incidence, economic BURDEN, and mortality rate would be phased in gradually over several years PRIMARILY because once a chronic disease is established, Vitamin D AFFECTS its progression ONLY modestly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 194), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5129897	10/2016	S70-PMC5129897	['a meta-analysis of Lung cancer incidence versus 25(Oh)D concentration at the time of enrollment FOUND that relative risk decreased from 1.0 at 20\xa0nmol/l to 0.86 at 40\xa0nmol/l and 0.84 at 50\xa0nmol/l, after which the 95% confidence intervals became very large.47most of the 13 studies were prospective studies with long follow-up times, and ONE STUDY involved smokers who had taken large doses of Vitamin A, which MAY have AFFECTED cancer risk since it competes with Vitamin D.50thus, doubling the calculated change in relative risk to 0.72 at 40\xa0nmol/l and 0.68 at 50\xa0nmol/l and higher SEEMS REASONABLE.']	[('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 337), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 419), ('ANOMALY_CURIOUS_FINDING', 583), ('PROBABLE_UNDERSTANDING', 583), ('PROBABLE_UNDERSTANDING', 589)]	7	[('UBERON_0002048', 'lung', 19, 'lung'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 54, 'D'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D')]
PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC5133057	10/2016	S108-PMC5133057	['it is IMPORTANT TO NOTE that EVEN IF the reduction occurs with more intensity in the second and third quarter due to Plasma volume expansion and increased Vitamin A transfer from the mother to the fetus, special ATTENTION throughout Pregnancy is NECESSARY, PARTICULARLY in the first trimester, when the major changes in the Fetal Development occur.']	[('IMPORTANT_CONSIDERATION', 6), ('ANOMALY_CURIOUS_FINDING', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 257)]	7	[('UBERON_0001969', 'blood plasma', 117, 'plasma'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 324, 'fetal development')]
PMC5155676	12/2016	S108-PMC5155676	['weight gain in Pregnancy REPRESENTS NOT ONLY increased fat mass BUT ALSO Feto-Placental Tissues and hemodilution (16); our data, THEREFORE, SUGGEST that overall volume of dilution, and not just adiposity, MAY BE IMPORTANT for response to Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 36), ('ANOMALY_CURIOUS_FINDING', 64), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 212)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('UBERON_0000981', 'femur', 73, 'feto'), ('UBERON_0002483', 'trabecular bone tissue', 78, 'placental tissues'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5155676	12/2016	S112-PMC5155676	['HOWEVER, it is NOTABLE that there were marked DIFFERENCES in baseline 25(Oh)D concentrations between these investigations, and we OBSERVED that initial 25(Oh)D status was positively ASSOCIATED with both the LIKELIHOOD of achieving Vitamin D replete status and absolute 25(Oh)D status at 34 weeks of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 182), ('PROBABLE_UNDERSTANDING', 207)]	7	[('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 76, 'D'), ('CHEBI_63056', 'zinc cation', 152, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('GO_0007565', 'female pregnancy', 299, 'gestation')]
PMC5155676	12/2016	S124-PMC5155676	['AS such, young Pregnant women MIGHT PARTICULARLY REQUIRE ADVICE on the need for, and compliance with, Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 36), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 49), ('IMPORTANT_CONSIDERATION', 49), ('FUTURE_WORK', 57)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5167470	12/2016	S44-PMC5167470	['HOWEVER, daily ingestion of multivitamin tablets that include around 6,000–8,000 u/d of Vitamin A do not SEEM to increase the rate of malformations RELATED to Isotretinoine (13-Cis Retinoic) exposure, and this result is from SEVERAL long-term case-control STUDIES.25,26for Vitamin D, exposure to high doses increased the rate of fetal Cardiac malformations, especially Aortic stenosis, which HAS BEEN ASSOCIATED with an intake of 4,000 iu/d.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 225), ('INCOMPLETE_EVIDENCE', 256), ('INCOMPLETE_EVIDENCE', 392), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A'), ('CHEBI_31719', 'ipriflavone', 159, 'isotretinoine'), ('CHEBI_33804', 'gluconates', 174, '13-cis'), ('CHEBI_26537', 'retinoid', 181, 'retinoic'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('UBERON_0000948', 'heart', 335, 'cardiac'), ('UBERON_0000947', 'aorta', 369, 'aortic')]
PMC5351212	3/2017	S10-PMC5351212	['conclusions\nthis work RAISES the POSSIBILITY that early dietary supplementation with Vitamin D MAY open NEW AVENUES for a successful attenuation or EVEN PREVENTION of Neurodevelopmental disorders following maternal inflammation during Pregnancy.']	[('EXPLICIT_QUESTION', 22), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 95), ('FULL_UNKNOWN', 104), ('FUTURE_WORK', 108), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 153)]	7	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007399', 'nervous system development', 167, 'neurodevelopmental'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy')]
PMC5371920	3/2017	S137-PMC5371920	['Vitamin D supplementation APPEARED SAFE; THESE FINDINGS SUPPORT current RECOMMENDATIONS in uk and elsewhere, and MAY SUGGEST the basis for more stratified approaches to Vitamin D supplementation in Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 35), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 56), ('FUTURE_WORK', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 117)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
PMC5405075	4/2017	S13-PMC5405075	['HOWEVER, it REMAINS UNCLEAR WHETHER maternal Vitamin D deficiency MAY CONTRIBUTE to the development of childhood asthma OR it is the consequence of a GENERALLY altered biochemistry.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 150)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5634602	10/2017	S147-PMC5634602	['IN FACT, SOME authors, including heaney, have ARGUED that a physiological reference for optimal Vitamin D status would be between 100 and 130 nmol/l stating that BASED ON physiological outcomes such as normalization of pth and adequate Vitamin D supply in Breast Milk this level is SAFE for disease prevention without ASSOCIATION of toxicity [56].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 162), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 282), ('SUPERFICIAL_RELATIONSHIP', 318)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 256, 'breast milk')]
PMC5664622	9/2017	S132-PMC5664622	['conclusions\nON THE BASIS OF the FINDINGS of OUR STUDY, conducted among polish Pregnant women, it SEEMS SAFE to conclude that significantly low levels of Vitamin D concentration among Pregnant women in poland MAY in FACT be a common occurrence.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 97), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 208), ('ANOMALY_CURIOUS_FINDING', 215)]	7	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnant')]
PMC5732505	12/2017	S26-PMC5732505	['POOR maternal Vitamin D status HAS BEEN RELATED to fetal growth restriction [15] BUT it is UNKNOWN WHETHER maternal Vitamin D status ASSOCIATES with Birth size in infants with normal Birth weight.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 81), ('FULL_UNKNOWN', 91), ('EXPLICIT_QUESTION', 99), ('SUPERFICIAL_RELATIONSHIP', 133)]	7	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC5941617	5/2018	S109-PMC5941617	['caption (table-wrap): table 5\n\ndietary reference values of Vitamin D in infants, children, and adolescents as PROPOSED by various organizations and societiesorganization/societyyearcountry/countriesdietary reference value for Vitamin D0–12\xa0months, iu/day1–18\xa0years, iu/dayeuropean Food safety authority [26]2016europeai400 (7–11\xa0months)600 (1–17\xa0years)scientific advisory committee on nutrition [25]2016united kingdomsafe intake (<\u20094\xa0years)340–400400rni (4–18\xa0years)nordic nutrition recommendations [16]2012denmark, finland, iceland, norway, sweden, faroe islands, greenland, åland islandsri400400german nutrition society [17]2012germany, austria, switzerlandai400 (infants)800a(children)health council of the netherlands [18]2012the netherlandsai400400italian society of nutrition [89]2012italyai (<\u2009 12\xa0months)400 (6–12\xa0months)600pri (1–18\xa0years)institute of medicine [10]2011north america, canadaai (<\u2009 12\xa0months)400600rda (1–18\xa0years)the Endocrine society [11]2011worldwidedaily requirementb400–1000600–1000\nai adequate intake, the average observed daily level of Intake by a population group of apparently healthy People that is ASSUMED to be adequate\nsafe intake , a level or range of intakes considered to pose no risk of deficiency and below a level where there is a risk of undesirable EFFECTS\nrni reference Nutrient intake, the amount of a Nutrient that is LIKELY to meet the needs of 97.5% of the population\nri recommended intake, the amount of a Nutrient that meets the known REQUIREMENT and maintains good nutritional status among practically all (97–98%) healthy Individuals in a particular Life Stage or gender group\npri population reference intake, the level of Nutrient intake sufficient to satisfy the needs of ALMOST all (97.5%) healthy subjects in one specific population group\nrda recommended dietary allowance, the estimated intake capable of satisfying the needs of 97.5% of the population\naadequate intake with missing Endogenous Synthesis Of Vitamin D\nbrecommended REQUIREMENTS for subjects at risk of Vitamin D deficiency\nin accordance with the european society for paediatric gastroenterology hepatology and nutrition [espghan] [19] and the european academy of pediatrics [30], we endorsed tolerable upper intake levels of Vitamin D proposed by efsa in 2012 (1000\xa0iu/day for infants: 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years) [90].']	[('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 1134), ('SUPERFICIAL_RELATIONSHIP', 1295), ('PROBABLE_UNDERSTANDING', 1367), ('IMPORTANT_CONSIDERATION', 1488), ('ANOMALY_CURIOUS_FINDING', 1729), ('IMPORTANT_CONSIDERATION', 1990)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D0'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D0'), ('CHEBI_33290', 'food', 281, 'Food'), ('UBERON_0005063', 'left ventricular compact myocardium', 942, 'Endocrine'), ('GO_0007631', 'feeding behavior', 1068, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 1119, 'people'), ('CHEBI_33284', 'nutrient', 1317, 'Nutrient'), ('CHEBI_33284', 'nutrient', 1350, 'nutrient'), ('CHEBI_33284', 'nutrient', 1458, 'nutrient'), ('NCBITaxon_1', 'root', 1577, 'individuals'), ('UBERON_0000105', 'life cycle stage', 1605, 'life stage'), ('CHEBI_33284', 'nutrient', 1678, 'nutrient'), ('GO_0009790', 'embryo development', 1943, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 1954, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1967, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1975, 'D'), ('CHEBI_27300', 'vitamin D', 2027, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2250, 'vitamin D')]
PMC5941617	5/2018	S537-PMC5941617	['AS literature SHOWS CONTRASTING results because of DIFFERENT methods and study designs, MORE STUDIES ARE NEEDED to define the ROLE of Vitamin D in pathogenesis and severity of depression, particularly in the pediatric age.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 126)]	7	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5941617	5/2018	S568-PMC5941617	['we do not RECOMMEND routine screening of Serum 25(Oh)D levels in all Pregnant and breastfeeding women, BUT we SUGGEST to CONSIDER Vitamin D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation.']	[('FUTURE_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 110), ('FUTURE_WORK', 121), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 210)]	7	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 47, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5941617	5/2018	S720-PMC5941617	['we SUGGEST to CONSIDER serum 25(Oh)D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation, and/or with specific conditions POSSIBLY AFFECTING Pregnancy course (table\xa09).']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 68), ('ANOMALY_CURIOUS_FINDING', 107), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 205)]	7	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC2290997	4/2008	S115-PMC2290997	['so when you ESTIMATE the number of deaths LIKELY to be attributable to uv light or Vitamin D, it does is not APPEAR TO BE the BEST policy to ADVISE People to simply keep out of the sun just to prevent skin cancer.”\nto maximize protection against cancer, grant RECOMMENDS raising 25(Oh)D levels to between 40 and 60 ng/ml.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 42), ('ANOMALY_CURIOUS_FINDING', 109), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 141), ('FUTURE_WORK', 260)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'people'), ('CHEBI_71657', 'versiconol acetate', 279, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 279, '25(OH ... D')]
PMC2396486	6/2008	S102-PMC2396486	['Calbindin is strongly induced by Vitamin D[29], and THUS it is FEASIBLE that the reduction in this protein MAY BE a consequence of the Early Life reduction in Vitamin D. the POTENTIAL LINKS between Vitamin D and Neuronal calcium binding proteins HAS BEEN NOTED in a recent review article[30]\ntwo members of the dynamin family (Dynamin 1 and Dynamin 1-Like proteins) were also significantly down-regulated.']	[('PROBABLE_UNDERSTANDING', 52), ('PROBABLE_UNDERSTANDING', 63), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 184), ('ANOMALY_CURIOUS_FINDING', 246)]	6	[('PR_000004967', 'calbindin', 0, 'Calbindin'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 135, 'early life'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CL_0000540', 'neuron', 212, 'neuronal'), ('PR_000006501', 'dickkopf-related protein 3', 327, 'dynamin 1'), ('PR_000006609', 'DNA (cytosine-5)-methyltransferase 3-like', 341, 'dynamin 1-like')]
PMC2679409	5/2009	S499-PMC2679409	['the largest rct reporting the IMPACT of Vitamin A on stillbirths [101] also INDICATES no benefit of vitamin a for fetal or early infant survival, ALTHOUGH vitamin a does APPEAR TO BE of benefit to maternal health and survival, and Vitamin A deficiencies are KNOWN to CO-exist with iron deficiency [98].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 146), ('ANOMALY_CURIOUS_FINDING', 170), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin A')]
PMC2913107	8/2010	S37-PMC2913107	['WHILE the Omega-3 and mercury content of fish is WELL KNOWN, LESS WELL KNOWN is THE FACT THAT fish is one of the few Foods with SIGNIFICANT amounts of Vitamin D, which, as referenced earlier, PROTECTS the Genome from damage by Toxins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 80), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 192)]	6	[('CHEBI_79370', 'ibho#10', 10, 'omega-3'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0001026', 'genome', 205, 'genome'), ('CHEBI_27026', 'toxin', 227, 'toxins')]
PMC2963768	10/2010	S118-PMC2963768	['THEREFORE, much remains to be learnt about the DETERMINANTS of Vitamin D status throughout infancy and childhood, PARTICULARLY where 25(Oh)D APPEARS DISCREPANT from that which would be expected BASED ON latitude.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 114), ('ANOMALY_CURIOUS_FINDING', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D')]
PMC3004407	12/2010	S146-PMC3004407	['using both circulating 25(Oh)D and pth as MARKERS of Vitamin D deficiency, THESE FINDINGS UNDERSCORE RECENT REPORTS of widespread Vitamin D deficiency among Pregnant women, EVEN in areas of the world with ample sunlight.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant')]
PMC3034879	12/2010	S201-PMC3034879	['it SEEMS UNLIKELY, THEREFORE, that IMPROVING Vitamin D intake merely in infancy would revert the CONSEQUENCES of POOR Vitamin D status during the Fetal Period.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('FUTURE_WORK', 35), ('PROBLEM_COMPLICATION', 97), ('IMPORTANT_CONSIDERATION', 113)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 146, 'fetal period')]
PMC3034879	12/2010	S202-PMC3034879	['based ON these OBSERVATIONS, ADDITIONAL EFFORTS SHOULD BE MADE to improve Vitamin D status during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 29), ('FUTURE_WORK', 40), ('FUTURE_WORK', 48)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
PMC3075531	7/2010	S46-PMC3075531	['the REASONS WHY Vitamin D deficiency is THOUGHT TO be a RISK FACTOR for ms are as follows: first, ms frequency increases with increasing latitude, which is strongly inversely CORRELATED with duration and intensity of uvb from sunlight and Vitamin D concentrations.2830–35second, prevalence of ms is lower than EXPECTED at high latitudes in populations with high Consumption of Vitamin-D-rich Fatty fish43536.']	[('PROBABLE_UNDERSTANDING', 4), ('EXPLICIT_QUESTION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 310)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0007631', 'feeding behavior', 362, 'consumption'), ('CHEBI_83326', 'tedizolid phosphate', 377, 'vitamin-D'), ('CHEBI_33250', 'atom', 392, 'fatty')]
PMC3099599	5/2011	S211-PMC3099599	['HOWEVER, Vitamin D deficiency (vdd) and its bony manifestation, rickets, CAN lead to deformation of the weakened Skull during Birth resulting in psdh, and CONTRIBUTE to bony FINDINGS that SEEMINGLY CONFIRM the child abuse etiology.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 174), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 198)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0003129', 'skull', 113, 'skull'), ('GO_0007567', 'parturition', 126, 'birth')]
PMC3272870	12/2011	S45-PMC3272870	['moreover, the usual RECOMMENDATIONS to avoid sun exposure reduces dermal Synthesis Of Vitamin D3Although Vitamin D is UNDOUBTEDLY IMPORTANT for foetal Bone Development, we KNOW that it plays a much wider ROLE in health and disease prevention.']	[('FUTURE_WORK', 20), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 204)]	6	[('GO_0030474', 'spindle pole body duplication', 73, 'synthesis of ... D3Although'), ('CHEBI_83701', '8-PAHSA(1-)', 86, 'vitamin D3Although'), ('PR_000027594', 'histone H3', 86, 'vitamin D3Although'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048539', 'bone marrow development', 151, 'bone development')]
PMC3277098	12/2011	S194-PMC3277098	['there is also SOME EVIDENCE that the EFFECT of supplementation MAY depend ON WHETHER Vitamin D is administered in a fat- OR Water-soluble form.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 63), ('ANOMALY_CURIOUS_FINDING', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_15377', 'water', 124, 'water')]
PMC3296991	2/2012	S100-PMC3296991	['conclusion\nTHIS STUDY PROVIDES EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, cord pth and balp, and neonatal wbbmc, THOUGH neither Cord nor maternal 25(Oh)D were directly CORRELATED with wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 135), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 150, 'cord'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
PMC3347007	4/2012	S170-PMC3347007	['EVEN THOUGH the differences in diet between women with sufficient vs. women with insufficient total Vitamin D intake are statistically significant, IT IS POSSIBLE that the differences are clinically trivial, since the ESTIMATES in absolute numbers ONLY differ very LITTLE.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 218), ('ANOMALY_CURIOUS_FINDING', 248), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 265)]	6	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3347028	3/2012	S58-PMC3347028	['DESPITE these OBSERVATIONS, it was CONCLUDED that the condition of Vitamin D deficiency LED TO weakness and malnutrition and was not a direct EFFECT of Vitamin D on the Immune System.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
PMC3347028	3/2012	S191-PMC3347028	['EVEN in the latter trial where women were randomized to either 2000 iu (50 μg) or 4000 iu (100 μg) Vitamin D3/day, there were no safety ISSUES surrounding Vitamin D supplementation and there was a TREND where specific health COMPLICATIONS of Pregnancy such as Preterm Birth, Preterm Labor, hypertensive orders of Pregnancy, Gestational diabetes, and infection were higher in the 400 iu-compared with the 4000 iu-group, but did not reach statistical significance [149].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 136), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 225), ('PROBLEM_COMPLICATION', 225)]	6	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 260, 'preterm birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 275, 'preterm labor'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('GO_0007565', 'female pregnancy', 324, 'gestational')]
PMC3347028	3/2012	S233-PMC3347028	['looking carefully at the INCREASING NUMBER OF epidemiological STUDIES involving women with Preeclampsia: is there a LINK with Vitamin D deficiency where PERHAPS in certain women, there is loss of the Vitamin D-mediated Suppression Of T Cells that leads to a profound inflammatory reaction REMINISCENT of graft- vs. -host disease?']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 289), ('EXPLICIT_QUESTION', 328)]	6	[('GO_0007128', 'meiotic prophase I', 91, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0048469', 'cell maturation', 219, 'suppression of T cells'), ('CL_0000084', 'T cell', 234, 'T cells')]
PMC3348565	4/2012	S18-PMC3348565	['HOWEVER, the risk of repeated pneumonia in the subsequent 3 months was 13% (relative risk [rr] 0·78, 95% ci 0·64–0·94; p=0·01) lower in the Vitamin D3Compared with the placebo group.3OTHER more RECENT STUDIES assessing different outcomes in children or Adults have CONFLICTING findings on the effectiveness of Vitamin D.\nthere is GROWING EVIDENCE of the Vitamin D parancrine system enhancing Innate Immunity:4the activation of toll-like receptors on Monocytes and Macrophages by Microbial pathogens results in increased Expression of Cyp27B1 and Vitamin D Receptor ( vdr ) Genes within these cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('INCOMPLETE_EVIDENCE', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('INCOMPLETE_EVIDENCE', 330)]	6	[('CHEBI_59884', 'XDP(3-)', 140, 'vitamin D3compared'), ('UBERON_0007023', 'adult organism', 253, 'adults'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0045087', 'innate immune response', 392, 'innate immunity'), ('CL_0000576', 'monocyte', 450, 'monocytes'), ('CL_0000235', 'macrophage', 464, 'macrophages'), ('NCBITaxon_10088', 'Mus <genus>', 479, 'microbial'), ('GO_0010467', 'gene expression', 520, 'expression'), ('PR_000006101', 'cytochrome P450 1A1', 534, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 546, 'vitamin D receptor'), ('SO_0000704', 'gene', 573, 'genes')]
PMC3427192	4/2012	S34-PMC3427192	['this finding is SIMILAR TO OTHER STUDIES where an INCREASED risk of allergic sensitization was NOTED in infants who received Vitamin D supplementation.67,68likewise, gale et al.63NOTED that maternal 25(Oh)D concentrations greater than 75\u2009nmol/l (30 ng/ml) were ASSOCIATED with 5-fold increased odds of asthma at 9 y of age in the exposed children.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 50), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 199, '25(OH)D')]
PMC3427250	8/2012	S130-PMC3427250	['in addition the current Vitamin D content of multivitamins for Pregnancy, 400 iu, do not EVEN comply with the current belgian RECOMMENDATIONS of 800 iu per day, THEREFORE a PRUDENT step SHOULD AT LEAST be to increase the Vitamin D content in multivitamins for Pregnant women to 800 iu.']	[('ANOMALY_CURIOUS_FINDING', 89), ('FUTURE_WORK', 126), ('PROBABLE_UNDERSTANDING', 161), ('FUTURE_WORK', 173), ('FUTURE_WORK', 186), ('PROBABLE_UNDERSTANDING', 193)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 260, 'pregnant')]
PMC3476426	8/2012	S0-PMC3476426	['reduced Serum concentrations of 25-Hydroxy Vitamin D in children with autism: RELATION to autoimmunity\n\nabstract\n\nbackground\naside from the Skeletal health affection, Vitamin D deficiency has BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering for SOME Autoimmune disorders.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 192), ('SUPERFICIAL_RELATIONSHIP', 197), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 259)]	6	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 32, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0004288', 'skeleton', 140, 'skeletal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 264, 'autoimmune')]
PMC3509518	11/2012	S131-PMC3509518	['we could not confirm PREVIOUS FINDINGS that reduced maternal Vitamin E intakes were ASSOCIATED with increased risk of developing childhood wheeze [9,10,11,12] DESPITE the fact that almost 50% of Pregnant mothers did not meet the rdi when intakes from diet alone were TAKEN INTO ACCOUNT, and 20% of the mothers did not meet the rdi when total Vitamin E intakes were analysed [18].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ANOMALY_CURIOUS_FINDING', 159), ('IMPORTANT_CONSIDERATION', 267)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 195, 'pregnant'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin E')]
PMC3668200	5/2013	S41-PMC3668200	['THEREFORE, daily supplementation with 400 iu of Vitamin D during the last Trimester of Pregnancy HAS BEEN practiced, ALBEIT with MINIMAL EFFECT on circulating 25(Oh)D concentrations in the mother and infant at term.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 159, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 165, 'D')]
PMC3672018	5/2013	S35-PMC3672018	['obesity MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third Trimester when Adipose Tissue is formed; fractures MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third and/or second trimester [13]; and t1d with low Vitamin D during the first trimester.']	[('INCOMPLETE_EVIDENCE', 8), ('ANOMALY_CURIOUS_FINDING', 15), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 126), ('ANOMALY_CURIOUS_FINDING', 133), ('SUPERFICIAL_RELATIONSHIP', 146)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 75, 'trimester'), ('UBERON_0001013', 'adipose tissue', 90, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC3672018	5/2013	S47-PMC3672018	['to study the INFLUENCE of seasonal variation and timing of fetal exposure in RELATION to later EFFECTS of Vitamin D on health outcomes, one REQUIRES EVEN larger numbers of subjects to be followed over long time.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 140), ('ANOMALY_CURIOUS_FINDING', 149)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3685533	6/2013	S124-PMC3685533	['after Birth ONLY fs newborns unsupplemented SHOWED Vitamin D levels higher than lob and mbb; no differences were found in case of maternal supplementation in Pregnancy, MOST LIKELY DUE TO a specific ROLE of supplementation in neonates.']	[('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 169), ('PROBABLE_UNDERSTANDING', 181), ('PROBLEM_COMPLICATION', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC3695234	7/2013	S74-PMC3695234	['AS OUR STUDY is LIMITED by its retrospective cross-sectional design, we COULD NOT analyze the RELATIONSHIP between sun exposure and Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 72), ('ANOMALY_CURIOUS_FINDING', 78), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3705146	5/2013	S223-PMC3705146	['ALTHOUGH no Genetic associations between Vitamin-D receptors or enzymes INVOLVED in its formation or degradation HAVE yet BEEN IDENTIFIED for schizophrenia, that outcome does not NECESSARILY mean that Vitamin D is without effect in modifying the phenotypic plasticity that is obviously present in the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 179)]	6	[('SO_0000704', 'gene', 12, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 41, 'vitamin-D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC3717170	5/2013	S104-PMC3717170	['and WHILE Vitamin D concentration HAS BEEN RELATED to Lung function in the general population, the RELATION between Lung function and Vitamin D concentration has YET to be investigated in copd patients ONLY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 99), ('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 202)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002048', 'lung', 54, 'lung'), ('UBERON_0002048', 'lung', 116, 'lung'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3760821	9/2013	S173-PMC3760821	['a KEY FINDING of THE CURRENT STUDY is that in t1dm Pregnancy, maternal Vitamin D levels EXHIBIT an INDEPENDENT inverse RELATIONSHIP with hba1clevels.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ANOMALY_CURIOUS_FINDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 119)]	6	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3773018	4/2013	S63-PMC3773018	['OUR FINDINGS SUGGEST that both Prenatal and early Postnatal Vitamin D levels APPEAR TO play an IMPORTANT ROLE in the development of fs, ESPECIALLY among those with specific genotypes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 77), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 136)]	6	[('GO_0007565', 'female pregnancy', 31, 'prenatal'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3773018	4/2013	S86-PMC3773018	['it SHOULD BE NOTED that four Snps SHOWED significant INTERACTION EFFECTS with Vitamin D deficiency at Birth on fs in our PREVIOUS report (18).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 121)]	6	[('SO_0000694', 'SNP', 29, 'SNPs'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'birth')]
PMC3798907	8/2013	S65-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin E supplementation are shown on the RELEVANT panels.nutrients-05-03337-t001_table 1\n\ncaption (table-wrap): table 1\n\nsummary table representing the mean responses of cbmc and Peripheral Blood Mononuclear Cell (Pbmc) samples to control stimuli and Allergens, after supplementation with Vitamin E or Vitamin C. the mean change in response is shown for 70 cbmc samples and 18 pbmc samples, after supplementation with Vitamin E, and for 51 cbmc and 18 pbmc samples, after supplementation with Vitamin C. significant p values for differences in responses between paired samples in cultures with or without Vitamin E/Vitamin C supplementation are shown on the RELEVANT panels.Vitamin eprolififn-γil-4il-10Tgf-βvitamin cprolififn-γil-4il-10tgf-β cordcord tg↑ p< 0.05↓ p< 0.05↓↓↑tg↑↑↑ p< 0.05↓↓hdm↓↓↓↓↑hdm↓↑↑↓ p< 0.05↓con a↓↑↓↓↑con a↓ p< 0.05↑↑↓↓ppd↓ p< 0.001↓↑↓↑ppd↓↑ p< 0.05↑ p< 0.05↓ p< 0.05↓klh↓ p< 0.001↓↓↓↑klh↓↑↑ p< 0.05↓↓ adultadult tg↓↑↑↑↑tg↑ p< 0.05↑↑↓↑hdm↓↑↑↑↑ p< 0.05hdm↓↑↑↓↑con a↓↓↑↓↑ p< 0.05con a↑↓ p< 0.05↑↓ p< 0.05↑ppd↑↓↑↓↑ppd↓↑↑↓↑klh↓↓↑↑↑klh↓↑↑ p< 0.05↓↑\noverall, there was a TREND for Antigen or allergen cbmc cultures supplemented with Vitamin E to exhibit decreased secretion of the cytokines Ifn-Γ, il-10 and Il-4 (figure 1andtable 1), ALTHOUGH Production Of Tgf-Β did NOT fit this pattern and was GENERALLY increased.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 1191), ('ANOMALY_CURIOUS_FINDING', 1355), ('ANOMALY_CURIOUS_FINDING', 1388), ('PROBABLE_UNDERSTANDING', 1417)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CL_0000111', 'peripheral neuron', 282, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 282, 'peripheral blood'), ('GO_0031097', 'medial cortex', 299, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 317, 'PBMC'), ('CHEBI_33663', 'cyclic hydrocarbon', 354, 'allergens'), ('CHEBI_27300', 'vitamin D', 392, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 405, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 521, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 596, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 708, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 718, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 777, 'Vitamin'), ('PR_000000037', 'BMP receptor type-2', 803, '-10TGF'), ('CHEBI_59132', 'antigen', 1201, 'antigen'), ('CHEBI_27300', 'vitamin D', 1253, 'vitamin E'), ('PR_000008920', 'interferon alpha-7', 1311, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 1328, 'IL-4'), ('GO_0036309', 'protein localization to M-band', 1364, 'production of TGF-β'), ('PR_000000046', 'TGF-beta', 1378, 'TGF-β')]
PMC3798907	8/2013	S100-PMC3798907	['discussion\nTHIS STUDY was BASED ON our novel OBSERVATION in a general population study, that low maternal Vitamin E intake during Pregnancy is INDEPENDENTLY ASSOCIATED with increased in vitro Proliferative Responses by cbmc and an increased LIKELIHOOD of asthma in children aged 5 years.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 45), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('PROBABLE_UNDERSTANDING', 241)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('GO_0001780', 'neutrophil homeostasis', 192, 'proliferative responses')]
PMC3798907	8/2013	S106-PMC3798907	['HOWEVER, ALTHOUGH direct supplementation of cbmc with Vitamin E was ASSOCIATED with decreased proliferative responses to ppd, klh and hdm, there was an OPPOSITE EFFECT on Proliferation to the allergen tg.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('SUPERFICIAL_RELATIONSHIP', 161)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin E'), ('GO_0008283', 'cell proliferation', 171, 'proliferation')]
PMC3798907	8/2013	S109-PMC3798907	['a further POSSIBILITY raised by THE CURRENT STUDY is that isolated maternal Vitamin E supplementation during Pregnancy MAY have MIXED or EVEN adverse CONSEQUENCES for atopic sensitisation to different Allergens.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ANOMALY_CURIOUS_FINDING', 137), ('PROBLEM_COMPLICATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_33663', 'cyclic hydrocarbon', 201, 'allergens')]
PMC3798907	8/2013	S114-PMC3798907	['this SEEMS an UNLIKELY EXPLANATION for the DIFFERENTIAL EFFECTS of Vitamin E supplementation on tg and hdm responses SEEN in the current work because, as in our original observational study, cbmc samples were collected throughout the year [12].']	[('ANOMALY_CURIOUS_FINDING', 5), ('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E')]
PMC3798907	8/2013	S148-PMC3798907	['in THE CURRENT STUDY, the EFFECTS of in vitro Vitamin E supplementation on cbmc and pbmc Effector cytokine responses did DIFFER, BUT the EFFECTS of in vitro Vitamin C supplementation were broadly SIMILAR in neonates and Adults.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('CHEBI_35224', 'effector', 89, 'effector'), ('CHEBI_33229', 'vitamin (role)', 157, 'vitamin'), ('CHEBI_18245', 'carboxylato group', 165, 'C'), ('UBERON_0007023', 'adult organism', 220, 'adults')]
PMC3798907	8/2013	S151-PMC3798907	['conclusions\noverall, THIS WORK DEMONSTRATES that in vitro supplementation of cbmc with Vitamins E or C CAN INFLUENCE their Immune function but NOT in the simple and consistent manner predicted by models arising from observational epidemiological studies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107), ('ANOMALY_CURIOUS_FINDING', 143)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 101, 'C'), ('UBERON_0002405', 'immune system', 123, 'immune')]
PMC3814422	10/2013	S119-PMC3814422	['furthermore, from a PUBLIC HEALTH perspective Maternal Pregnancy Vitamin D as a risk FACTOR for future offspring atopy or Respiratory health would only be of MAJOR IMPORTANCE IF it was relevant to most of the population and not ONLY those members at the extremes.']	[('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 85), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 228)]	6	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 122, 'respiratory')]
PMC3814422	10/2013	S134-PMC3814422	['by way of analogy, in a study of Vitamin D and Adult Lung function we FOUND that, WHILST there were APPARENT ASSOCIATIONS with dietary Vitamin D intake, there was NO EVIDENCE for an association with Blood 25(Oh)D concentrations29.']	[('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 82), ('ANOMALY_CURIOUS_FINDING', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 47, 'adult'), ('UBERON_0002048', 'lung', 53, 'lung'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('UBERON_0000178', 'blood', 199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH)D')]
PMC3829803	11/2013	S32-PMC3829803	['a SURPRISING spin-OFF from these Vitamin A supplementation STUDIES was the re-discovery that Vitamin A ‘treatment’ CAN significantly decrease the morbidity and mortality ASSOCIATED with acute Mev infection [16]–[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('ANOMALY_CURIOUS_FINDING', 2), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'MeV')]
PMC3873449	12/2013	S180-PMC3873449	['HOWEVER, EVEN with supplementation, ONLY a SMALL percentage of women and babies were Vitamin D sufficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 36), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 43)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3991049	11/2013	S70-PMC3991049	['all of this SUPPORTS that 400 iu of Vitamin D MAY BE INADEQUATE to raise the maternal Vitamin D level to optimum level PARTICULARLY for women living in northern latitude, women with darker skin or covered women, as well as for women who are not exposed to sunlight, not on dietary supplements or have absorption and metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 53), ('PROBLEM_COMPLICATION', 53), ('ANOMALY_CURIOUS_FINDING', 119), ('PROBLEM_COMPLICATION', 326)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4034700	5/2014	S6-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4034700	5/2014	S258-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4072587	6/2014	S1-PMC4072587	['it has an IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System and YET the IMPACT of Antenatal Vitamin D deficiency on infant outcomes is POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 104), ('SUPERFICIAL_RELATIONSHIP', 112), ('FULL_UNKNOWN', 175), ('PROBABLE_UNDERSTANDING', 182)]	6	[('GO_0055064', 'chloride ion homeostasis', 28, 'bone homeostasis'), ('GO_0007420', 'brain development', 46, 'brain development'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0002022', 'detection of dietary excess', 68, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('GO_0007567', 'parturition', 122, 'antenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4072587	6/2014	S121-PMC4072587	['our finding of an ASSOCIATION between maternal Vitamin D and infant Language composite scores, that was ONLY observed when maternal Vitamin D levels fell below 37.5 nmol/l in late Pregnancy, RAISES the POSSIBILITY that there is a threshold EFFECT, and that Language impairment is a feature of more marked Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 191), ('INCOMPLETE_EVIDENCE', 202), ('SUPERFICIAL_RELATIONSHIP', 240)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0006266', 'DNA ligation', 68, 'language'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy'), ('GO_0006266', 'DNA ligation', 257, 'language'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
PMC4072587	6/2014	S126-PMC4072587	['we OBSERVED an inverse RELATIONSHIP between length-for-age z scores at 6 months of age and overall maternal Vitamin D concentration, ALTHOUGH the ESTIMATED magnitude of change ASSOCIATED with an increase in Vitamin D of 25 nmol/l was SMALL.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 23), ('ANOMALY_CURIOUS_FINDING', 133), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 234)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4113768	7/2014	S386-PMC4113768	['THUS, RECENT dietary Vitamin D REQUIREMENT ESTIMATES will cover the Vitamin D NEEDS of EVEN those in the population who do not have adequate Calcium intakes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 78), ('ANOMALY_CURIOUS_FINDING', 87)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium')]
PMC4113768	7/2014	S476-PMC4113768	['overall reductions in Lung cancer RISKS in never-smokers in the women’s health initiative (1771 cases in 128,779 women) were seen with vitamin D intakes >400 iu/day (or = 0.37, 95% ci: 0.18–0.77); HOWEVER, rct data for the 12% of women given Vitamin D supplements SHOWED lower Lung cancer risk ONLY in those with low intakes of Retinol (or = 0.69, 95% ci, 0.5–0.96).']	[('IMPORTANT_CONSIDERATION', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 264), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 294)]	6	[('UBERON_0002048', 'lung', 22, 'lung'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0002048', 'lung', 277, 'lung'), ('CHEBI_26536', 'retinoic acid', 328, 'retinol')]
PMC4113768	7/2014	S829-PMC4113768	['the staff were asked WHETHER they knew WHY Vitamin D is IMPORTANT, WHO should BE offered Vitamin D supplementation and at WHAT dose.']	[('EXPLICIT_QUESTION', 21), ('EXPLICIT_QUESTION', 39), ('IMPORTANT_CONSIDERATION', 56), ('EXPLICIT_QUESTION', 67), ('ANOMALY_CURIOUS_FINDING', 78), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S1321-PMC4113768	['IN CONTRAST, both Vitamin D doses caused a rapid increase in 25(Oh)D, reaching a plateau of 65[20] nmol/l for 400 iu, and 76[19] nmol/l for 1000 iu Vitamin D. we REPORTED that 1000 iu Vitamin D3But not 400 iu attenuated bone mineral density loss, WHEREAS the increase in 25(Oh)D for the 1000 iu dose was ONLY 25% above that for the 400 iu dose (2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('ANOMALY_CURIOUS_FINDING', 247), ('ANOMALY_CURIOUS_FINDING', 304), ('INCOMPLETE_EVIDENCE', 304)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 61, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_82668', 'DH335(1+)', 184, 'vitamin D3but'), ('PR_000017209', 'utrophin', 184, 'vitamin D3but'), ('CHEBI_71657', 'versiconol acetate', 271, '25(OH)D')]
PMC4113768	7/2014	S1535-PMC4113768	['IMPORTANTLY, it is SEEMED that low risk carriers with adequate S-25(Oh)D concentrations achieved EVEN higher S-25(Oh)D concentrations with increasing Vitamin D intake WHEREAS high risk carriers did NOT.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('PROBABLE_UNDERSTANDING', 19), ('ANOMALY_CURIOUS_FINDING', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('ANOMALY_CURIOUS_FINDING', 198)]	6	[('CHEBI_82715', 'PH 797804', 63, 's-25(OH)D'), ('CHEBI_82715', 'PH 797804', 109, 's-25(OH)D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4113768	7/2014	S2725-PMC4113768	['OF CONCERN is that People taking 10,000 iu/day or less are SHOWING high to toxic levels of 25Ohd, ALTHOUGH we do NOT KNOW HOW many, if any, of these users are displaying signs of Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 3), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 98), ('FULL_UNKNOWN', 113), ('EXPLICIT_QUESTION', 122)]	6	[('NCBITaxon_10088', 'Mus <genus>', 19, 'people'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 91, '25OHD'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4113768	7/2014	S3096-PMC4113768	['ALTHOUGH Vitamin D HAS BEEN ASSOCIATED with the development of tb in Adults, LITTLE RESEARCH has EXAMINED the IMPORTANCE of Vitamin D levels in children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('IMPORTANT_CONSIDERATION', 110)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 69, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4113768	7/2014	S3194-PMC4113768	['; pearce, s.; rasvi, s.; jagger, c.\nbackground: DESPITE RECENT concerns about the high prevalence of low Vitamin D status in much of the british Adult and pediatric population, there is a dearth of data on Vitamin D status and its PREDICTORS in very old Adults, a sub-group of the population which is at INCREASED RISK of POOR Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ANOMALY_CURIOUS_FINDING', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 304), ('IMPORTANT_CONSIDERATION', 322)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0007023', 'adult organism', 254, 'adults'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D')]
PMC4169453	9/2014	S135-PMC4169453	['the EFFECT of group (Vitamin D dose) x time INTERACTION ( p \u200a=\u200a0.12) and the EFFECT of group ( p \u200a=\u200a0.45) on infants’ Serum 25(Oh)D levels was not statistically significant, WHILE the EFFECT of time was statistically significant ( p<0.0001) (fig.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 174), ('SUPERFICIAL_RELATIONSHIP', 184)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 124, '25(OH)D')]
PMC4169453	9/2014	S142-PMC4169453	['a CORRELATION between maternal and breastfed infants’ 25(Oh)D levels was STILL significant after 3 and 6 months of Vitamin D supplementation BUT APPEARED weaker than the Postpartum CORRELATION: in the 400 iu/d group at v3 r\u200a=\u200a0.35 ( p \u200a=\u200a0.003) and at v6 r\u200a=\u200a0.4 ( p \u200a=\u200a0.0009), and in the 1200 iu/d group at v3 r\u200a=\u200a0.3 ( p \u200a=\u200a0.01) and at v6 r\u200a=\u200a0.39 ( p \u200a=\u200a0.0007), respectively.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('ANOMALY_CURIOUS_FINDING', 73), ('IMPORTANT_CONSIDERATION', 73), ('ANOMALY_CURIOUS_FINDING', 141), ('ANOMALY_CURIOUS_FINDING', 145), ('SUPERFICIAL_RELATIONSHIP', 181)]	6	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 60, 'D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'postpartum')]
PMC4169453	9/2014	S184-PMC4169453	['there is GROWING EVIDENCE SHOWING Serum 25(Oh)D levels higher than 30 ng/ml, or EVEN higher than 40 ng/ml as EFFECTIVE for expression of Extra-Skeletal EFFECTS RELATED to proper Vitamin D status[1],[34],[35].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 160)]	6	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 40, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 137, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4169453	9/2014	S223-PMC4169453	['the INFLUENCE of Vitamin D status and bone mass in nursing women MIGHT BE evaluated FURTHER BUT higher Vitamin D doses are NECESSARY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 71), ('FUTURE_WORK', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 123)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4171568	9/2014	S141-PMC4171568	['HOWEVER, THERE IS EVIDENCE that high doses of Vitamin D are NOT NECESSARILY PROTECTIVE; in 424 matched pairs from a population-based cohort, a bi-modal RELATIONSHIP APPEARED in which the participants with the lowest and highest levels of Vitamin D had increased risk of schizophrenia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 152), ('ANOMALY_CURIOUS_FINDING', 165)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC4256222	12/2014	S110-PMC4256222	['[6]were UNABLE TO detect any RELEVANT ASSOCIATION between maternal Vitamin D status and bmc and bmd shortly after Birth, ALTHOUGH they did indeed find a positive CORRELATION between maternal Vitamin D status and fetal Femur volume measured by three-dimensional ultrasound.']	[('DIFFICULT_TASK', 8), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 162)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 114, 'birth'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000981', 'femur', 218, 'femur')]
PMC4329404	10/2014	S18-PMC4329404	['a RECENT unselected cohort of over 2000 children OBSERVED no association between Serum Vitamin D and asthma or Lung function; HOWEVER, higher Serum Vitamin D was ASSOCIATED with a greater RISK of wheeze (11).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('ANOMALY_CURIOUS_FINDING', 126), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 188)]	6	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]
PMC4377870	3/2015	S251-PMC4377870	['it APPEARS that Vitamin D is IMPORTANT in Respiratory diseases and infections, HOWEVER the temporal ROLE of Vitamin D deficiency in disease onset, pathogenesis and exacerbations and WHETHER supplementation is indicated is yet to be clarified.']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 42, 'respiratory'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4377879	3/2015	S141-PMC4377879	['there DOES NOT APPEAR TO BE EVIDENCE to RECOMMEND supplementation with Vitamins C and E.\n\n7.']	[('INCOMPLETE_EVIDENCE', 6), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 40)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamins C'), ('PR_000004900', 'complement C3', 80, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'E')]
PMC4377879	3/2015	S262-PMC4377879	['the provision of balanced energy protein supplementary Foods to underweight Pregnant women was also considered to have enough EVIDENCE of reduction in sga and stillbirths and improved Birthweights for widespread implementation, WHEREAS maternal Vitamin D and zinc supplementation, WHILE promising, were CONSIDERED to have INSUFFICIENT evidence [18].']	[('INCOMPLETE_EVIDENCE', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('ANOMALY_CURIOUS_FINDING', 281), ('INCOMPLETE_EVIDENCE', 303), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_33290', 'food', 55, 'foods'), ('GO_0007565', 'female pregnancy', 76, 'pregnant'), ('GO_0007596', 'blood coagulation', 184, 'birthweights'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC4383226	2/2015	S101-PMC4383226	["NOT ONLY did we identify a PROTECTIVE ASSOCIATION between Vitamin A and malaria in a study population with high immunization coverage for bcg, dtp, and poliomyelitis, we also FOUND in unadjusted MODELS that dtp did not modify Vitamin A's ASSOCIATION with malaria."]	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('SUPERFICIAL_RELATIONSHIP', 238)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A')]
PMC4396835	1/2015	S126-PMC4396835	['this is IN LINE WITH OTHER scandinavian RESEARCH, SHOWING that somali born women have the lowest Vitamin D levels of all ethnic groups REPORTED in sweden [37], EVEN lower than in turkish and pakistani mothers living in norway [59].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 135), ('ANOMALY_CURIOUS_FINDING', 160)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4427001	4/2015	S109-PMC4427001	['CONTRADICTORY results COULD BE EXPLAINED by seasonal, geographical, or ethnic Vitamin D variation; the paper does NOT UNFORTUNATELY mention in WHAT season women were included in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 114), ('IMPORTANT_CONSIDERATION', 118), ('EXPLICIT_QUESTION', 143)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4448820	5/2015	S581-PMC4448820	['ALTHOUGH Vitamin A MAY have a preventive EFFECT on the incidence or severity of diarrhea and measles in community trials, it has had LITTLE or the OPPOSITE EFFECT on Respiratory infections (105).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 166, 'respiratory')]
PMC4448820	5/2015	S1135-PMC4448820	['in SOME conditions, supplementation with Vitamins A, d, and e and copper and Selenium was PROTECTIVE against mastitis (652), BUT others REPORTED in hiv-infected women that antioxidant Micronutrient supplementation did not lower (660), and MIGHT EVEN increase the risk of scm (661).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 239), ('ANOMALY_CURIOUS_FINDING', 245)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamins A'), ('CHEBI_27568', 'selenium atom', 77, 'selenium'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 184, 'micronutrient')]
PMC4448820	5/2015	S1473-PMC4448820	['HOWEVER, recent data from a subset of women recruited as part of a national survey in cameroon INDICATE that Human-milk Vitamin A concentrations (casual samples at ≥1 mo Postpartum) were ASSOCIATED with crp, and this ASSOCIATION SEEMED TO BE EXPLAINED by a decrease in Plasma rbp (776).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 217), ('ANOMALY_CURIOUS_FINDING', 229), ('PROBABLE_UNDERSTANDING', 242)]	6	[('NCBITaxon_9606', 'Homo sapiens', 109, 'human'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007565', 'female pregnancy', 170, 'postpartum'), ('UBERON_0001969', 'blood plasma', 269, 'plasma')]
PMC4488777	5/2015	S36-PMC4488777	['an OPTIMAL level of Vitamin D concentration in Blood Serum SHOULD range between 50 and 125 nmol/l [10], EVEN THOUGH SOME environmental STUDIES IMPLY that the target level SHOULD BE set much higher—up to 250, or even at 300 nmol/l [11,12].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 116), ('PROBABLE_UNDERSTANDING', 143), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001977', 'blood serum', 53, 'serum')]
PMC4514967	12/2014	S74-PMC4514967	['first, ra can synergize with the activity of Tgf-Β to promote development of induced Foxp3+Tregcells,55,59–61ALTHOUGH it should be NOTED that neither the frequency nor number of Tregcells are reduced in Vitamin A–deficient Mice.62second, ra is REQUIRED to mount protective Immune Responses to infection by Organisms such as toxoplasma gondii .62third, Vitamin A–deficient Mice lack th17 cells63,64and display IMPAIRED th1 and th17 responses to t. gondii infection and oral administration of escherichia coli heat-labile enterotoxin.62vitamin A is also required for conditioning of Dcs and promoting the stereotypical phenotypic features of Intestinal Cd103+Dcs,58highlighting the fact that multiple cell types are Modulated by Vitamin A and underscoring the IMPORTANT ROLE it plays in Immunity.']	[('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 409), ('IMPORTANT_CONSIDERATION', 758), ('SUPERFICIAL_RELATIONSHIP', 768)]	6	[('PR_000000046', 'TGF-beta', 45, 'TGF-β'), ('PR_000017653', 'zinc finger protein ZFPM2', 85, 'FoxP3'), ('CL_0000960', 'T3 B cell', 91, 'Tregcells'), ('CL_0000960', 'T3 B cell', 178, 'Tregcells'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 223, 'mice'), ('GO_0006955', 'immune response', 273, 'immune responses'), ('UBERON_0002405', 'immune system', 273, 'immune'), ('NCBITaxon_1', 'root', 306, 'organisms'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 372, 'mice'), ('PR_000004370', 'asialoglycoprotein receptor 2', 542, 'A'), ('CL_0000990', 'conventional dendritic cell', 581, 'DCs'), ('UBERON_0000160', 'intestine', 640, 'intestinal'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 651, 'CD103'), ('CL_0000990', 'conventional dendritic cell', 657, 'DCs'), ('GO_0065007', 'biological regulation', 714, 'modulated'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin A'), ('GO_0007566', 'embryo implantation', 785, 'immunity')]
PMC4516488	9/2009	S188-PMC4516488	['ALTHOUGH this FINDING WAS NOT discussed or followed-up, it is IN LINE WITH the Vitamin D dependency of Pea-15 OUTLINED in OUR STUDY.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 110), ('QUESTION_ANSWERED_BY_THIS_WORK', 122)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_39015', 'apolipoprotein', 103, 'PEA'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 103, 'PEA-15')]
PMC4600246	10/2015	S36-PMC4600246	['DESPITE the fact that Vitamin K1Has a beneficial EFFECT on cac in older men and women, LARGER STUDIES powered for clinical end points (stroke, Myocardial infarction and death) ARE NEEDED TO ASSESS the risks and benefits of Vitamin K therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('FUTURE_WORK', 87), ('FUTURE_WORK', 176), ('FUTURE_WORK', 187)]	6	[('CHEBI_26871', 'terpene alkaloid', 22, 'vitamin K1has'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 30, 'K1has'), ('UBERON_0002349', 'myocardium', 143, 'myocardial'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin K')]
PMC4632418	10/2015	S115-PMC4632418	['in words, there is a CONNECTION between Glucose Metabolism and Vitamin D pathways, EVEN IF FURTHER STUDIES based on larger population ARE NEEDED to get more evidence about the topic.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('FUTURE_WORK', 91), ('FUTURE_WORK', 99), ('FUTURE_WORK', 134)]	6	[('CHEBI_17234', 'glucose', 40, 'glucose'), ('GO_0006006', 'glucose metabolic process', 40, 'glucose metabolism'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4684854	12/2015	S137-PMC4684854	["as discussed, individual Vitamin D indices CAN be INFLUENCED by various DETERMINANTS DESPITE specific levels of supplementation; it is THUS the author's RECOMMENDATION that a personalized medical approach be taken via individual screening for 25(Oh)D as a routine part of Preconception and Prenatal care."]	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 85), ('PROBABLE_UNDERSTANDING', 135), ('FUTURE_WORK', 153)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('GO_0007565', 'female pregnancy', 272, 'preconception'), ('GO_0007565', 'female pregnancy', 290, 'prenatal')]
PMC4684854	12/2015	S140-PMC4684854	['the ONGOING personal health BURDEN ASSOCIATED with Gestational Vitamin D insufficiency throughout many parts of the world has the POTENTIAL to be ameliorated CONSIDERABLY by straightforward educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Pregnancy.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 28), ('PROBLEM_COMPLICATION', 28), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 130), ('ANOMALY_CURIOUS_FINDING', 158)]	6	[('GO_0007565', 'female pregnancy', 51, 'gestational'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'preconception'), ('GO_0007565', 'female pregnancy', 251, 'prenatal'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy')]
PMC4764019	1/2016	S36-PMC4764019	['pregnancy complications\none of the most STRIKING and SURPRISING findings to emerge from the finnish Birth cohort study DESCRIBED PREVIOUSLY was the fact that 20+ years after their infancy exposure to Vitamin D, women in the cohort who, as Adults, became Pregnant exhibited an APPROXIMATE 50% reduction in risk of Preeclampsia in their own first Pregnancies,8once again, relative to women who had not received the then RECOMMENDED 2000 iu/d of Vitamin D in infancy.']	[('ANOMALY_CURIOUS_FINDING', 40), ('ANOMALY_CURIOUS_FINDING', 53), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 418)]	6	[('GO_0007567', 'parturition', 100, 'birth'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 239, 'adults'), ('GO_0007565', 'female pregnancy', 254, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 313, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 345, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D')]
PMC4764019	1/2016	S82-PMC4764019	['in closing, it would SEEM IMPORTANT TO EMPHASIZE that the LIKELY Vitamin D status values (and the corresponding daily intakes) ASSOCIATED with protection from the delayed outcomes DISCUSSED HERE are entirely physiological, not Pharmacological (ie, in the range of 40–60 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 21), ('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 227, 'pharmacological')]
PMC4778858	3/2016	S102-PMC4778858	['as addressed PREVIOUSLY by our group [12] and others [27], obese women MAY REQUIRE larger amounts of Vitamin D supplementation compared to normal weight women to provide their neonates with sufficient levels of Vitamin D. YET the definition of neonatal Vitamin D sufficiency has NOT BEEN DETERMINED.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('ANOMALY_CURIOUS_FINDING', 222), ('FULL_UNKNOWN', 279)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC4785305	3/2016	S22-PMC4785305	['WHILE the total Calcitriol levels double in the first trimester, free Calcitriol levels do not increase until the third trimester and remain so until Lactation.24conversely, Parathyroid hormone (pth) levels decrease early on and increase back to mid-normal range by term.2the total calcium level decreases during Pregnancy, due to haemodilution, WHILE the ionised calcium level remains stable.2vitamin D binding proteins also increase during Pregnancy secondary to high Oestrogen levels,45but the 25-Hydroxyvitamin D (25(Oh)D) level, the single best nutritional INDICATOR of Vitamin D status,6remains stable.7the changes in Calcitriol levels led to the description of Pregnancy as a state of ‘absorptive hypercalciuria’.12the above Adaptive physiology is KEY to SAFETY CONSIDERATIONS when using Vitamin D supplementation during Pregnancy, as well as to determining key biochemical and hormonal parameters to be monitored.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 346), ('SUPERFICIAL_RELATIONSHIP', 562), ('IMPORTANT_CONSIDERATION', 755), ('IMPORTANT_CONSIDERATION', 762), ('IMPORTANT_CONSIDERATION', 769)]	6	[('CHEBI_17823', 'calcitriol', 16, 'calcitriol'), ('CHEBI_17823', 'calcitriol', 70, 'calcitriol'), ('GO_0007595', 'lactation', 150, 'lactation'), ('UBERON_0001132', 'parathyroid gland', 174, 'parathyroid'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('PR_000006444', 'diacylglycerol kinase delta', 402, 'D'), ('GO_0007565', 'female pregnancy', 442, 'pregnancy'), ('CHEBI_50114', 'estrogen', 470, 'oestrogen'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 497, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 518, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 575, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 624, 'calcitriol'), ('GO_0007565', 'female pregnancy', 668, 'pregnancy'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 732, 'adaptive'), ('CHEBI_27300', 'vitamin D', 795, 'vitamin D'), ('GO_0007565', 'female pregnancy', 828, 'pregnancy')]
PMC4800340	5/2016	S40-PMC4800340	['in the boston Birth cohort study, Cord Blood Vitamin D deficiency [25(Oh)D concentration <11 ng/ml] was not FOUND TO be ASSOCIATED with Food sensitization to eight common Food Allergen in children.67HOWEVER, when individual Genetic variant of 4 CANDIDATE Genes INVOLVED in Ige synthesis and Vitamin D Metabolism were jointly considered, there is a statistically strong Gene-Vitamin D INTERACTION (pinteraction=9×10-6) on Food sensitization.']	[('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 120), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 384)]	6	[('GO_0007567', 'parturition', 14, 'birth'), ('UBERON_0002240', 'spinal cord', 34, 'cord'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('CHEBI_33290', 'food', 136, 'food'), ('CHEBI_33290', 'food', 171, 'food'), ('CHEBI_50904', 'allergen', 176, 'allergen'), ('SO_0000704', 'gene', 224, 'genetic'), ('SO_0000704', 'gene', 255, 'genes'), ('GO_0007630', 'jump response', 273, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 273, 'IgE'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 299, 'D metabolism'), ('SO_0000704', 'gene', 369, 'gene'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33290', 'food', 421, 'food')]
PMC4811107	3/2016	S109-PMC4811107	["NOT ONLY do these studies INDICATE that use of the Prenatal level of 25(Oh)D to represent the child's early Life Vitamin D level is not specific, but also the data SUGGEST that a maternal THRESHOLD exists below which the mother LIMITS her CONTRIBUTION of 25(Oh)D to the fetus."]	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 188), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 257, '(OH)D')]
PMC4811441	3/2016	S29-PMC4811441	['poorer Vitamin D status (measured as 25-Hydroxyvitamin D (25(Oh)D) during Pregnancy HAS BEEN ASSOCIATED with INCREASED RISKS of pe and Gestational hypertension in SOME [11,12] BUT NOT ALL observational studies [13,14].']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('ANOMALY_CURIOUS_FINDING', 180)]	6	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational')]
PMC4846845	4/2016	S156-PMC4846845	['a RECENT meta-analysis did NOT see a positive change in ptb, lbw, pre-eclampsia, and Gestational diabetes rates with Vitamin D supplementation, THOUGH they did CONCLUDE that Vitamin D has “PLAUSIBLE EFFECTS” on many Perinatal outcomes [119].']	[('INCOMPLETE_EVIDENCE', 2), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007565', 'female pregnancy', 85, 'gestational'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0036268', 'swimming', 216, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 216, 'perinatal')]
PMC4889866	5/2016	S102-PMC4889866	['the DIFFERENCE between OUR FINDINGS and those of published reports MIGHT BE EXPLAINED by distinctive study design, AS ours assessed cytokine response to tlr ligands under different Vitamin D concentrations, and not cytokine response to direct Vitamin D stimulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 115)]	6	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4896250	4/2016	S7522-PMC4896250	['a531 the ASSOCIATION between Serum Vitamin D levels and allergic diseases in elementary schoolchildren\n\nhea-kyoung yang1, ji young lee1, minji kim1, kangmo ahn2, jihyun kim1, young-min kim1, hye-young kim3, yong mean park4, woo kyung kim5, so-yeon lee6\n\n1samsung medical center, south korea;2samsung;3medical research institute of pusan national university hospital;4konkuk university school of medicine;5seoul paik hospital/inje university college of medicine;6department of pediatrics, hallym sacred Heart hospital, hallym university college of medicine\n\ncorrespondence: hea-kyoung yang – samsung medical center, south korea\npurpose: there are CONTROVERSIES about the RELATIONSHIP between Vitamin D and allergic diseases, ALTHOUGH there HAS BEEN GROWING INTEREST in Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 646), ('SUPERFICIAL_RELATIONSHIP', 670), ('ANOMALY_CURIOUS_FINDING', 724), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 748)]	6	[('UBERON_0001977', 'blood serum', 29, 'Serum'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('UBERON_0000948', 'heart', 502, 'Heart'), ('CHEBI_27300', 'vitamin D', 691, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 768, 'vitamin D')]
PMC4897157	5/2016	S92-PMC4897157	['ALTHOUGH results are EQUIVOCAL, a CONSIDERABLE body of EVIDENCE SUGGESTS that Vitamin D has an IMPORTANT IMPACT on the progression of allergic diseases11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4897157	5/2016	S106-PMC4897157	['ALTHOUGH the UNDERLYING mechanism REMAINS TO BE CLEARLY ESTABLISHED, seasonal differences in Ultraviolet B exposure, and PERHAPS also Vitamin D levels, MAY BE INVOLVED in the development of allergic diseases718).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 34), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_72754', 'bisphenol AF', 93, 'ultraviolet B'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4930210	7/2016	S22-PMC4930210	['THIS REVIEW HIGHLIGHTED the extremely HETEROGENEOUS evidence in regards to definition of Serum Vitamin D concentration THRESHOLD and the LACK OF high-quality interventional studies [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 38), ('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 137), ('ANOMALY_CURIOUS_FINDING', 142)]	6	[('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4933715	7/2016	S598-PMC4933715	['(4) ALTHOUGH SOMETIMES SUGGESTED, there SEEMS to be sufficient EVIDENCE that there is no association with asd for many Maternal infections in Pregnancy (i.e., herpes viruses, epstein barr virus, varicella—Zoster Virus, Parvovirus), smoking, exposure to heavy metals or Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ANOMALY_CURIOUS_FINDING', 4), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 40), ('INCOMPLETE_EVIDENCE', 63)]	6	[('GO_0007618', 'mating', 119, 'maternal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('NCBITaxon_10088', 'Mus <genus>', 205, 'zoster virus'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'parvovirus'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4934634	11/2015	S40-PMC4934634	['ILLUSTRATIVE of this, Vitamin D Nuclear receptors (vdr) HAVE BEEN IDENTIFIED in numerous Tissues including Organs INVOLVED in Reproduction and infant growth such as the Ovary, Testis, Placenta and Mammary Gland [14,15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0005634', 'nucleus', 32, 'nuclear'), ('UBERON_0000479', 'tissue', 89, 'tissues'), ('UBERON_0000062', 'organ', 107, 'organs'), ('GO_0000003', 'reproduction', 126, 'reproduction'), ('UBERON_0000992', 'ovary', 169, 'ovary'), ('UBERON_0000473', 'testis', 176, 'testis'), ('UBERON_0001987', 'placenta', 184, 'placenta'), ('UBERON_0001911', 'mammary gland', 197, 'mammary gland')]
PMC4934634	11/2015	S80-PMC4934634	['the positive RELATIONSHIP between maternal Vitamin D status and post-Ivf Pregnancy in non-hispanic white, BUT NOT in asian women, SUGGESTS that genetics play a ROLE in the RELATIONSHIP between Vitamin D and fertility.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ANOMALY_CURIOUS_FINDING', 106), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 160), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0002006', 'vasoconstriction by vasopressin involved in systemic arterial blood pressure control', 69, 'IVF'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4971719	8/2016	S37-PMC4971719	['BY CONTRAST, the RECENT nielsen case-control danish national Birth cohort FOUND that high levels of Vitamin D in mid Pregnancy were ASSOCIATED with antidepressant use in the Postpartum Period, an UNEXPECTED FINDING [29].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 132), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 207)]	6	[('GO_0007567', 'parturition', 61, 'Birth'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('GO_0007565', 'female pregnancy', 174, 'postpartum'), ('UBERON_2001055', 'pronephric duct opening', 185, 'period')]
PMC4976416	7/2016	S23-PMC4976416	['[16]\nheadache is a RECOGNIZED EFFECT of methemoglobinemia, and reduction of previously elevated methemoglobin concentration is PRESUMABLY the mechanism by which Vitamin E improves this symptom, AS improved methemoglobin concentration SEEMS to be the most CONSISTENT laboratory parameter in studies of Vitamin E for protection against dapsone side effects.']	[('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 194), ('ANOMALY_CURIOUS_FINDING', 234), ('INCOMPLETE_EVIDENCE', 255)]	6	[('CHEBI_27300', 'vitamin D', 161, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin E')]
PMC4982007	8/2016	S280-PMC4982007	['THUS, based ON a LIMITED NUMBER OF observational studies evidence LINKING maternal Vitamin D deficiency with reduced offspring Cognitive function is NOT CONCLUSIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0050890', 'cognition', 127, 'cognitive')]
PMC4997421	8/2016	S139-PMC4997421	['MORE RESEARCH IS NEEDED to determine WHAT type of INTERVENTIONS will be best for specific populations, ESPECIALLY the low-income and minority populations that bear a greater BURDEN of Vitamin A inadequacy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('EXPLICIT_QUESTION', 37), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 174)]	6	[('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 192, 'A')]
PMC5024513	9/2016	S127-PMC5024513	['the summary results SHOW that there MAY BE areas of CONCERN in adolescent’s nutritional intake during Pregnancy, PARTICULARLY COMPARED to us RECOMMENDATIONS, with regard to calcium, Vitamin D, Vitamin E, Folate, potassium and magnesium.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 52), ('IMPORTANT_CONSIDERATION', 113), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 141)]	6	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC5028238	10/2016	S83-PMC5028238	['in addition, BENEFITS from Prenatal Vitamin D supplementation are also Modulated by geographic location and OTHER FACTORS.47THEREFORE biological mechanisms that maximize Vitamin D production and absorption would be selected for in the north.']	[('IMPORTANT_CONSIDERATION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('SUPERFICIAL_RELATIONSHIP', 114), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122)]	6	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0065007', 'biological regulation', 71, 'modulated'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5062906	10/2016	S16-PMC5062906	['WHILE the biological IMPORTANCE of these subtle changes REMAINS UNCLEAR, they WARRANT AN INVESTIGATION of epigenome-wide EFFECTS of maternal Vitamin D depletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 21), ('FULL_UNKNOWN', 56), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 121)]	6	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5062906	10/2016	S243-PMC5062906	['WHILE maternal Vitamin D deficiency resulted in both phenotypic and epigenetic changes in both generations, it REMAINS UNCLEAR WHETHER the Dna Methylation changes are causally LINKED to the phenotypic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('EXPLICIT_QUESTION', 127), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0006306', 'DNA methylation', 139, 'DNA methylation')]
PMC5062906	10/2016	S250-PMC5062906	['ALTHOUGH Vitamin D deficiency HAS BEEN LINKED to adverse Pregnancy/Birth outcomes [14,46–52], there is currently NO STANDARD practice of screening women for Vitamin D deficiency during Pregnancy nor are there standard RECOMMENDATIONS beyond Prenatal Vitamins for supplementation during this CRITICAL time [53,54].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 218), ('IMPORTANT_CONSIDERATION', 291)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 57, 'pregnancy ...'), ('GO_0007567', 'parturition', 67, 'birth'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 250, 'vitamins')]
PMC5064894	10/2016	S35-PMC5064894	['HOWEVER, the researchers identified multiple LIMITATIONS in their study including lack OF blinding of participants and subjective outcomes, SMALL sample size and LIMITED statistical power, and dosages of Vitamin D that lead to ONLY 13\xa0% of the daily group and 3\xa0% of the bolus group having Cord Serum 25 (Oh) D levels considered to be in a sufficient range.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 87), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 162), ('ANOMALY_CURIOUS_FINDING', 227)]	6	[('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 290, 'cord'), ('UBERON_0001977', 'blood serum', 295, 'serum'), ('CHEBI_71657', 'versiconol acetate', 301, '25 (OH) D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 305, 'OH ... D')]
PMC5084016	10/2016	S132-PMC5084016	['DESPITE the LACK OF CONSENSUS on adequate intakes among DIFFERENT countries (table 3), supplementation with Vitamin D is RECOMMENDED for all Pregnant women at a dose of 600 iu/day (15 µg/day) [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC5129897	10/2016	S168-PMC5129897	['for some intermediate situations, such as cancer, survival rates are better with higher 25(Oh)D concentrations.12,93thus, EVEN IF all canadians achieved concentrations of > 100\xa0nmol/l immediately, the beneficial EFFECTS would accrue slowly, PERHAPS over 10–20\xa0y because for many health outcomes, the beneficial EFFECTS of Vitamin D are much stronger for PREVENTION than for treatment.']	[('ANOMALY_CURIOUS_FINDING', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('SUPERFICIAL_RELATIONSHIP', 212), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 311), ('SUPERFICIAL_RELATIONSHIP', 354)]	6	[('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 94, 'D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D')]
PMC5129897	10/2016	S180-PMC5129897	['BUT SOME STUDIES FOUND that Vitamin D AFFECTS mortality rates more than incidence rates.94our ESTIMATES also do NOT take into account prevalence rates for the various diseases.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 112)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5146866	12/2016	S0-PMC5146866	['prevalence and RISK factors for Vitamin D insufficiency and deficiency at Birth and ASSOCIATED outcome\n\nabstract\n\nbackground\noccurrence and consequence of Cord Blood (Cb) Vitamin D insufficiency/deficiency has not BEEN ADEQUATELY explored DESPITE rising CONCERN regarding THIS topic in pediatrics.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 214), ('ANOMALY_CURIOUS_FINDING', 239), ('PROBLEM_COMPLICATION', 254), ('QUESTION_ANSWERED_BY_THIS_WORK', 272)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('UBERON_0002240', 'spinal cord', 155, 'cord'), ('UBERON_0000178', 'blood', 160, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 167, 'CB'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5146866	12/2016	S80-PMC5146866	['WHILE a Vitamin D level of 20\xa0ng/ml IS CONSIDERED sufficient, maintenance of 30\xa0ng/ml is RECOMMENDED for better health in children and Adults [24] DESPITE the LACK OF CLEAR EVIDENCE of an OPTIMAL concentration of Vitamin D for bone and general health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5155676	12/2016	S20-PMC5155676	['ALTHOUGH Vitamin D supplementation CAN improve maternal 25(Oh)D status (10), LITTLE IS KNOWN about HOW maternal characteristics MIGHT INFLUENCE the 25(Oh)d achieved after supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35), ('FULL_UNKNOWN', 77), ('EXPLICIT_QUESTION', 99), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 148, '25(OH)')]
PMC5155676	12/2016	S133-PMC5155676	['ALTHOUGH this Genetic information CAN enable a more COMPREHENSIVE understanding of the biochemical response to Vitamin D supplementation, the current inability to undertake genotyping on a widespread population basis means this additional information WOULD NOT ALLOW for alterations to current clinical PRACTICE regarding Vitamin D supplementation in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 52), ('DIFFICULT_TASK', 251), ('INCOMPLETE_EVIDENCE', 303)]	6	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('GO_0007565', 'female pregnancy', 351, 'pregnancy')]
PMC5223368	12/2016	S185-PMC5223368	['one of the LIMITATIONS of THIS STUDY was that FACTORS which COULD AFFECT Birth size such as maternal dietary information and maternal Vitamin D status during Pregnancy were NOT available.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('GO_0007567', 'parturition', 73, 'birth'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC5340372	3/2017	S117-PMC5340372	['in THIS STUDY, infants with low 25(Oh)D had higher rrs BUT SIMILAR vmaxfrc, which IMPLIES that low Perinatal Vitamin D levels MIGHT be ASSOCIATED with a higher resistance of the Extrathoracic Airway.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('GO_0036268', 'swimming', 99, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 99, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0001601', 'extra-ocular muscle', 178, 'extrathoracic airway')]
PMC5351212	3/2017	S306-PMC5351212	['HOWEVER, our results clearly SHOW no effect of Poly(I:C) on both major Circulatory measures of Vitamin D, RULING OUT this POSSIBILITY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('INCOMPLETE_EVIDENCE', 122)]	6	[('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 47, 'poly(I:C'), ('UBERON_0001009', 'circulatory system', 71, 'circulatory'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5372327	3/2017	S39-PMC5372327	['THEREFORE, Vitamin D does NOT ONLY have a ROLE in Modulating Host Defence To Infections, BUT is LIKELY to Control FACTORS in autoimmunity, also in allergic disease.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 89), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'modulating'), ('GO_0030989', 'dynein-driven meiotic oscillatory nuclear movement', 61, 'host defence to infections'), ('GO_0065007', 'biological regulation', 106, 'control')]
PMC5385921	4/2017	S40-PMC5385921	['ALTHOUGH there is SOME DEBATE about the definition of these strata,21there is no DEBATE that children with 25Ohd concentrations of <25 nmol/l have Vitamin D deficiency (AS defined by an increased risk of rickets and increased Parathyroid hormone).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 169)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 107, '25OHD'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 226, 'parathyroid')]
PMC5418719	5/2017	S101-PMC5418719	['preterm infants with radiologic evidence of rickets or high alkaline phosphatase (>800\xa0iu/l) are GENERALLY given the upper intake total of 800\xa0iu/day of Vitamin D. DESPITE Vitamin D supplementation, it is DIFFICULT to maintain the RECOMMENDED daily Vitamin D intake from dietary in preterm infants, and there are FEW EVIDENCE-based data to support Vitamin D supplementation to meet a desired Serum 25(Oh)D ACCORDING to Vitamin D status at Birth in preterm infants.']	[('PROBABLE_UNDERSTANDING', 97), ('ANOMALY_CURIOUS_FINDING', 164), ('DIFFICULT_TASK', 205), ('FUTURE_WORK', 231), ('INCOMPLETE_EVIDENCE', 313), ('SUPERFICIAL_RELATIONSHIP', 406)]	6	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('UBERON_0001977', 'blood serum', 392, 'serum'), ('CHEBI_71657', 'versiconol acetate', 398, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 401, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('GO_0007567', 'parturition', 439, 'birth')]
PMC5418719	5/2017	S105-PMC5418719	['the DIFFERENT response to Vitamin D supplementation COULD BE EXPLAINED by vdr Gene polymorphism INVOLVED in Vitamin D Receptor, which results in Vitamin D deficiency at 36 pma in SOME babies after supplementation [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 58), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 96), ('INCOMPLETE_EVIDENCE', 179)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 78, 'gene'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 108, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5474873	6/2017	S27-PMC5474873	['mcgrath and colleagues REPORTED that “both low and high concentrations of neonatal Vitamin D were ASSOCIATED with INCREASED RISK of schizophrenia.” SIMILARLY, absence of supplementation with Vitamin d before the age of one was FOUND TO BE ASSOCIATED with later schizophrenia in males (19).']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 148), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 191, 'vitamin')]
PMC5510234	7/2017	S79-PMC5510234	['HOWEVER, another DID NOT FIND a benefit for Vitamin A in decreasing mtct rates.59\nlow maternal Vitamin D level (<32 ng/ml) HAS BEEN SHOWN to be ASSOCIATED with a 50% higher risk of mtct of hiv at 6 weeks in tanzanian women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5524288	7/2017	S120-PMC5524288	['this INDICATES that IMPROVING the Vitamin D status of non-white women, who are known to have PARTICULARLY low Vitamin D concentrations, COULD DRAMATICALLY decrease racial DISPARITIES in ptb rates.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 20), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_PREDICTION', 136), ('ANOMALY_CURIOUS_FINDING', 142), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5546866	8/2017	S11-PMC5546866	['conclusions:\nGenetic variation in Dhcr7 , which encodes 7-Dehyrocholesterol reductase in the Epidermal Vitamin D Biosynthesis pathway, APPEARS to modify baseline 25(Oh)D. IN CONTRAST, the response to Antenatal Cholecalciferol supplementation was ASSOCIATED with Snps in Cyp2R1 , which MAY alter 25-hydroxylase activity, and gc , which MAY AFFECT Vitamin D binding Protein Synthesis or Metabolite affinity.']	[('ANOMALY_CURIOUS_FINDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171), ('SUPERFICIAL_RELATIONSHIP', 246), ('INCOMPLETE_EVIDENCE', 285), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 339)]	6	[('SO_0000704', 'gene', 13, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 34, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 56, '7-dehyrocholesterol'), ('UBERON_0007376', 'outer epithelium', 93, 'epidermal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 103, 'vitamin D biosynthesis'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 210, 'cholecalciferol'), ('SO_0000694', 'SNP', 262, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 270, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('GO_0006412', 'translation', 364, 'protein synthesis'), ('CHEBI_39382', 'flufenoxuron', 385, 'metabolite')]
PMC5546866	8/2017	S132-PMC5546866	['we FOUND that the rs10741657 Snp was not associated with baseline 25(Oh)D BUT was ASSOCIATED with the response to Gestational Vitamin D supplementation, THEREFORE SUGGESTING that this Snp ONLY modifies 25(Oh)D status when the substrate is more readily available and that at the baseline measurement, saturation of the enzyme had not been reached.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBABLE_UNDERSTANDING', 153), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 188)]	6	[('SO_0000694', 'SNP', 29, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 66, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('SO_0000694', 'SNP', 184, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D')]
PMC5638722	8/2017	S105-PMC5638722	['BUT we PROPOSE that, MORE prospective STUDIES regarding to the RELATIONSHIP of Vitamin D and sepsis in premature infants ARE NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 21), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 63), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5659607	10/2017	S136-PMC5659607	['this FINDING is CONTRARY to what MANY have SUGGESTED that ONLY those who are deficient in Vitamin D would BENEFIT from supplementation.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 58), ('IMPORTANT_CONSIDERATION', 106)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5664622	9/2017	S50-PMC5664622	['in the summer group, the number of subjects with Vitamin D deficiency was almost 50% lower, WHILE the recommended level was DETECTED in almost 3-times more subjects as compared to the winter group, BUT STILL in ONLY 16% of the group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('ANOMALY_CURIOUS_FINDING', 92), ('ANOMALY_CURIOUS_FINDING', 124), ('ANOMALY_CURIOUS_FINDING', 198), ('ANOMALY_CURIOUS_FINDING', 202), ('ANOMALY_CURIOUS_FINDING', 211)]	6	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC5664622	9/2017	S94-PMC5664622	['REGARDLESS, DESPITE Vitamin/Mineral supplementation in Pregnancy, maternal intake of Vitamin D REMAINS below the RECOMMENDED levels, MOSTLY BECAUSE 75% of the multi-component Supplements for Pregnant women which are available in poland contain small amount of Vitamin D (5–10 µg) [14], as compared to the recommended dose of 37.5–50 µg [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 95), ('FUTURE_WORK', 113), ('PROBABLE_UNDERSTANDING', 133), ('PROBABLE_UNDERSTANDING', 140)]	6	[('CHEBI_33229', 'vitamin (role)', 20, 'vitamin'), ('CHEBI_46662', 'mineral', 28, 'mineral'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 175, 'supplements'), ('GO_0007565', 'female pregnancy', 191, 'pregnant'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D')]
PMC5664622	9/2017	S133-PMC5664622	['during the summer season, EVEN DESPITE visible improvement, a large group of women STILL REMAINS AT RISK for Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 26), ('ANOMALY_CURIOUS_FINDING', 31), ('ANOMALY_CURIOUS_FINDING', 83), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 97)]	6	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC5706533	11/2017	S107-PMC5706533	['biochemical safety outcomes (hypercalcaemia, hypercalciuria, hypocalcaemia) were RARE; ONLY four trials met our minimum criteria for case definitions and methods of ascertainment based on routine monitoring of maternal Serum calcium (table 2; tables s9-s11in appendix 10), YET ignoring the these criteria did not change the inference that there was no significant EFFECT of Vitamin D supplementation on the RISK of hypercalcaemia, which is a primary INDICATOR of toxicity of Vitamin D supplementation (table s9 and fig s18 in Appendix 10).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 273), ('SUPERFICIAL_RELATIONSHIP', 364), ('IMPORTANT_CONSIDERATION', 407), ('SUPERFICIAL_RELATIONSHIP', 450)]	6	[('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin D'), ('UBERON_0001154', 'vermiform appendix', 526, 'appendix')]
PMC5758521	1/2018	S144-PMC5758521	['REPORTED that maternal Α-Tocopherol concentrations were positively ASSOCIATED with Birth weight, BUT poston and colleagues FOUND that Prenatal supplementation with Α-Tocopherol and Vitamin C was ASSOCIATED with elevated risk of low Birth weight8.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 195)]	6	[('CHEBI_27725', 'butin', 23, 'α-tocopherol'), ('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007565', 'female pregnancy', 134, 'prenatal'), ('CHEBI_27725', 'butin', 164, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin C'), ('GO_0007567', 'parturition', 232, 'birth')]
PMC5758521	1/2018	S155-PMC5758521	['it SHOULD be NOTED that the normal reference values for Vitamins A and E in Cord Blood are NOT AVAILABLE, and our OBSERVED ASSOCIATIONS were MOSTLY moderate.']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 141)]	6	[('CHEBI_27300', 'vitamin D', 56, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 56, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 71, 'E'), ('UBERON_0009472', 'axilla', 76, 'cord blood')]
PMC5841533	2/2018	S19-PMC5841533	['supplementation with single Micronutrients during Pregnancy APPEARS TO have little influence on children’s Cognitive outcomes: 10 trials conducted in high-income, middle-income and low-income settings FOUND no effects of Antenatal iron, zinc, Vitamin A or Choline supplementation on Cognitive functions.13–20supplementation with mmn, on the OTHER HAND, COULD AFFECT children’s Cognitive functions via three RELATED pathways.']	[('ANOMALY_CURIOUS_FINDING', 60), ('INCOMPLETE_EVIDENCE', 201), ('ANOMALY_CURIOUS_FINDING', 341), ('INCOMPLETE_EVIDENCE', 353), ('SUPERFICIAL_RELATIONSHIP', 359), ('SUPERFICIAL_RELATIONSHIP', 407)]	6	[('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0050890', 'cognition', 107, 'cognitive'), ('GO_0007567', 'parturition', 221, 'antenatal'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin A'), ('CHEBI_15354', 'choline', 256, 'choline'), ('GO_0050890', 'cognition', 283, 'cognitive'), ('GO_0050890', 'cognition', 377, 'cognitive')]
PMC5941617	5/2018	S3-PMC5941617	['THUS, Vitamin D deficiency MAY AFFECT NOT ONLY Musculoskeletal health BUT ALSO a POTENTIALLY WIDE range of acute and chronic conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 38), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	6	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 47, 'musculoskeletal')]
PMC5941617	5/2018	S67-PMC5941617	['other italian data are present in literature, ALTHOUGH they SHOW SOME LIMITATIONS, regarding SMALL populations, analytic methods for 25(Oh)D, the season of recruitment, the prevalence of overweight/obesity, Vitamin D supplements, sunscreens, ethnicity, and uncovered areas of latitude.']	[('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 70), ('PROBLEM_COMPLICATION', 70), ('INCOMPLETE_EVIDENCE', 93)]	6	[('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 133, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5941617	5/2018	S117-PMC5941617	['ON THE CONTRARY, Vitamin D supplementation at higher dosages SEEMED TO BE ASSOCIATED with increased RISK of hypervitaminosis D with hypercalciuria and hypercalcemia [62].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ANOMALY_CURIOUS_FINDING', 7), ('ANOMALY_CURIOUS_FINDING', 61), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 125, 'D')]
PMC5941617	5/2018	S126-PMC5941617	['DESPITE this GLOBAL agreement on Vitamin D supplementation in the first year of Life, several barriers to adherence STILL exist, such as reluctance of mothers to give their children daily supplementation, lack OF knowledge about Vitamin D actions and the RISK of nutritional rickets, lack of awareness by health care professionals, ASSUMPTION that both breast milk and formula milk provide sufficient Vitamin D intake [116,117].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 116), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 332)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000104', 'life cycle', 80, 'life'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 401, 'vitamin D')]
PMC5941617	5/2018	S613-PMC5941617	['MORE STUDIES, particularly rcts, ARE NEEDED to confirm the PROMISING ROLE of Vitamin D in the promotion of the GLOBAL health of children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5952272	5/2018	S112-PMC5952272	['while all Nutrients are IMPORTANT for Brain Development, certain Nutrients (eg, protein, Long-Chain polyunsaturated Fatty Acids, iron, copper, zinc, Iodine, Folate, Choline, and Vitamins A, B6, and B12) have particularly large EFFECTS early in Life and exhibit CRITICAL or sensitive periods for Neurodevelopment.8all highly Metabolic, rapidly developing Organs have high iron requirements BECAUSE iron supports fundamental Metabolic Processes.9early-Life id is PARTICULARLY DETRIMENTAL as this is a period of rapid Neurodevelopment.']	[('IMPORTANT_CONSIDERATION', 24), ('SUPERFICIAL_RELATIONSHIP', 227), ('IMPORTANT_CONSIDERATION', 261), ('PROBABLE_UNDERSTANDING', 389), ('ANOMALY_CURIOUS_FINDING', 461), ('IMPORTANT_CONSIDERATION', 474)]	6	[('CHEBI_33284', 'nutrient', 10, 'nutrients'), ('GO_0007420', 'brain development', 38, 'brain development'), ('UBERON_0000955', 'brain', 38, 'brain'), ('CHEBI_33284', 'nutrient', 65, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 89, 'long-chain'), ('CHEBI_35366', 'fatty acid', 116, 'fatty acids'), ('CHEBI_24859', 'iodine atom', 149, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 157, 'folate'), ('CHEBI_15354', 'choline', 165, 'choline'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 178, 'vitamins A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 190, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 198, 'B12'), ('UBERON_0000104', 'life cycle', 244, 'life'), ('GO_0007399', 'nervous system development', 295, 'neurodevelopment'), ('GO_0008152', 'metabolic process', 324, 'metabolic'), ('UBERON_0000062', 'organ', 354, 'organs'), ('GO_0008152', 'metabolic process', 423, 'metabolic processes'), ('UBERON_0000104', 'life cycle', 450, 'life'), ('GO_0007399', 'nervous system development', 515, 'neurodevelopment')]
PMC5952272	5/2018	S151-PMC5952272	['on the community level, it was NOTICED that diet plays a MAJOR ROLE in the manifestation of anaemia and Vitamin E and D deficiency; HOWEVER, OTHER factors MAY interfere to make such a deficiency multifactorial.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 118, 'D')]
PMC6011374	6/2018	S63-PMC6011374	['HOWEVER, after adjusting for maternal age, bmi, sei, smoking status and Alcohol consumption at 15\u2009±\u20091\xa0weeks’ Gestation, ethnicity, recreational walking and season, the women recruited in adelaide STILL had significantly lower Serum 25(Oh)D when compared with those in auckland (adelaide: 58.4\u2009±\u200950.3 vs. auckland: 70.2\u2009±\u200954.5\xa0nmol/l, p\u2009<\u20090.001) INDICATING the INFLUENCE of OTHER CONFOUNDERS not measured as part of the study on Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 373), ('PROBLEM_COMPLICATION', 379)]	6	[('CHEBI_30879', 'alcohol', 72, 'alcohol'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('UBERON_0001977', 'blood serum', 226, 'serum'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 232, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC6043562	7/2018	S107-PMC6043562	['IN CONTRAST with OTHER Nutrients, total Vitamin E intake in Pregnancy APPEARED TO amplify the adverse EFFECT of Prenatal exposure to Pm2.5on Feno measured in adolescence, SUGGESTING a synergy between these two exposures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 102), ('INCOMPLETE_EVIDENCE', 171)]	6	[('CHEBI_33284', 'nutrient', 23, 'nutrients'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0007565', 'female pregnancy', 112, 'prenatal'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 133, 'PM2'), ('CHEBI_32035', 'potassium hydroxide', 141, 'FeNO')]
PMC1448690	4/2006	S301-PMC1448690	['in an investigation of WHETHER reduction in childhood infections OR change in diet COULD explain increases in asthma and atopic disease, seaton and devereux [178] FOUND that low intake of Vitamin C was ASSOCIATED with a sevenfold increase in the risk of bronchial hyper-reactivity; by CONTRAST, those with the lowest intake of saturated fats had a tenfold lower risk.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 202), ('ANOMALY_CURIOUS_FINDING', 285)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin C')]
PMC2290997	4/2008	S130-PMC2290997	['“many elderly, ESPECIALLY those living in nursing homes, are Vitamin D deficient, [EVEN] those living in areas CONSIDERED to have adequate sunshine.”\nmany EXPERTS are now RECOMMENDING a middle-ground approach that focuses on modest sun exposures.']	[('IMPORTANT_CONSIDERATION', 15), ('ANOMALY_CURIOUS_FINDING', 83), ('IMPORTANT_CONSIDERATION', 111), ('PROBABLE_UNDERSTANDING', 155), ('FUTURE_WORK', 171)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC2798111	12/2010	S97-PMC2798111	['infant Vitamin D levels in exclusively breastfed infants REFLECT maternal Vitamin D status, and GIVEN that the majority of the mothers in this cohort present with circulating 25(Oh)D levels <30\u2009ng/ml, it is NOT SURPRISING that the infants who are almost solely DEPENDENT on the mother for their Vitamin D have corresponding deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('PROBABLE_UNDERSTANDING', 96), ('PROBABLE_UNDERSTANDING', 207), ('ANOMALY_CURIOUS_FINDING', 211), ('SUPERFICIAL_RELATIONSHIP', 261)]	5	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 178, 'OH)D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC2821652	2/2010	S19-PMC2821652	['at the time of Birth, Cord Blood AS a direct reflection of fetal Vitamin D status will contain APPROXIMATELY 50–60% of the maternal circulating levels of 25(Oh)D. this RELATIONSHIP APPEARS TO BE linear EVEN at Pharmacological intakes of Vitamin D [12].']	[('PROBABLE_UNDERSTANDING', 33), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 181), ('ANOMALY_CURIOUS_FINDING', 202)]	5	[('GO_0007567', 'parturition', 15, 'birth'), ('UBERON_0009472', 'axilla', 22, 'cord blood'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('CHEBI_52217', 'pharmaceutical', 210, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC2821652	2/2010	S21-PMC2821652	['INTERESTINGLY, there APPEARS TO BE LITTLE, if ANY, RELATIONSHIP with respect to the parent Vitamin, Vitamin D [11].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 51)]	5	[('CHEBI_33229', 'vitamin (role)', 91, 'vitamin'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC2873552	4/2010	S128-PMC2873552	["caption (table-wrap): table 2\n\nfunctions and diseases related to both ceu and yri Signaturesceuyri diabetes 1.70e-172.70e-20 Coronary Artery disease 3.78e-173.12e-13 Genetic disorder 1.09e-144.53e-14 Cardiovascular disease 1.34e-144.78e-11 non-Insulin-dependent diabetes mellitus 1.03e-128.66e-15 Endocrine System disorder 1.91e-121.25e-18 hypertension 2.13e-122.83e-11 Neurological disorder 2.49e-123.27e-12 crohn's disease 7.59e-127.25e-09 bipolar affective disease 3.50e-115.24e-09 Metabolic disorder 5.66e-119.83e-16 inflammatory disorder 2.56e-091.08e-08 Digestive System disorder 2.66e-091.31e-07 Skeletal and muscular disorder 1.49e-081.58e-08 progressive motor neuropathy 2.53e-085.59e-12 Autoimmune disease 7.28e-081.09e-12 immunological disorder 2.46e-073.66e-13 rheumatoid arthritis 3.78e-072.54e-07 shape change of Epithelial Cells 8.86e-07 alzheimer's disease 3.60e-062.27e-07 parkinson's disease 7.24e-065.29e-06 shape change of Dermal Cells 9.33e-06 Insulin-dependent diabetes mellitus 3.76e-15 neuropathy 5.38e-12 amyotrophic lateral sclerosis 1.36e-09 arthritis 1.44e-07\n\nVitamin D HYPOTHESIS\nan INTERESTING HYPOTHESIS HAS BEEN PROPOSED by mcgrace [28] claiming that low Prenatal Vitamin D increases the risk of a wide range of diseases such as multiple sclerosis, diabetes, schizophrenia, Prostate cancer, Breast cancer and Colorectal cancer because of its versatile function in normal development."]	[('INCOMPLETE_EVIDENCE', 1099), ('ANOMALY_CURIOUS_FINDING', 1113), ('INCOMPLETE_EVIDENCE', 1125), ('INCOMPLETE_EVIDENCE', 1136), ('INCOMPLETE_EVIDENCE', 1145)]	5	[('GO_0036367', 'light adaption', 82, 'signaturesCEUYRI'), ('UBERON_0001621', 'coronary artery', 125, 'Coronary artery'), ('SO_0000704', 'gene', 166, 'Genetic'), ('UBERON_0004535', 'cardiovascular system', 200, 'Cardiovascular'), ('PR_000045358', 'insulin family protein', 244, 'insulin'), ('UBERON_0000949', 'endocrine system', 297, 'Endocrine system'), ('UBERON_0001016', 'nervous system', 370, 'Neurological'), ('GO_0008152', 'metabolic process', 485, 'Metabolic'), ('UBERON_0004854', 'gastrointestinal system mesentery', 560, 'Digestive system'), ('UBERON_0004288', 'skeleton', 603, 'Skeletal'), ('UBERON_0005445', 'segment of pes', 697, 'Autoimmune'), ('CL_0000066', 'epithelial cell', 827, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 827, 'epithelial'), ('CL_0000346', 'hair follicle dermal papilla cell', 943, 'dermal cells'), ('PR_000045358', 'insulin family protein', 965, 'Insulin'), ('CHEBI_28384', 'vitamin K', 1089, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1188, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1197, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 1307, 'prostate'), ('UBERON_0000310', 'breast', 1324, 'breast'), ('UBERON_0012652', 'colorectum', 1342, 'colorectal')]
PMC2913107	8/2010	S6-PMC2913107	['even more INTERESTING, SOME of the patients SEEMED to IMPROVE when treated with an average dose of ABOUT 4000 iu of Vitamin D/day.']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 44), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 99)]	5	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2963768	10/2010	S107-PMC2963768	['to FURTHER EXPLAIN the APPARENT ‘Vitamin D paradox’ in south asia (3), a range of hypothetical mechanisms CAN BE PROPOSED (table 3).']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 11), ('ANOMALY_CURIOUS_FINDING', 23), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3004407	12/2010	S143-PMC3004407	['after accounting for the EFFECT of Gestational age through multivariable regression, 25(Oh)D status retained a significant negative ASSOCIATION with pth, CONFIRMING that EVEN during Pregnancy, pth is a PREDICTOR of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 132), ('PROBABLE_UNDERSTANDING', 154), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('GO_0007565', 'female pregnancy', 35, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 87, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC3032617	5/2010	S117-PMC3032617	['ALTHOUGH we DID not achieve the expected 50% of patients not hospitalized in the Vitamin C group, the difference between the Vitamin C group and controls, 42% vs. 28% was FOUND significant, also is to note the higher amount of drop-outs in the Vitamin C group which MIGHT have INFLUENCED the results (13 vs. 3).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin C')]
PMC3034879	12/2010	S10-PMC3034879	['DESPITE DISCREPANT S-25-Ohd at baseline (median 36.3 vs. 52.5\xa0nmol/l, p \u2009<\u20090.001), the values at 14\xa0months were SIMILAR (63 vs. 66\xa0nmol/l, p \u2009=\u20090.58) in low d and high d. Serum 25-ohd increased more in low D ( p \u2009<\u20090.001) DESPITE SIMILAR total intake of Vitamin D (mean 12.3\xa0μg/day).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 222), ('SUPERFICIAL_RELATIONSHIP', 230)]	5	[('CHEBI_16786', 'vestitone', 19, 'S-'), ('1', 'A1BG (human)', 20, '-'), ('CHEBI_72765', 'verruculogen', 21, '25-OHD'), ('UBERON_0001977', 'blood serum', 171, 'Serum'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 206, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC3075531	7/2010	S49-PMC3075531	['in norway, a study comprising 119 ms cases and 251 controls living above the arctic circle, where Fatty Fish is a MAJOR CONTRIBUTOR to Vitamin D intake, REPORTED a lower risk of ms for Individuals who Ate fish three or more times per week at 16–20 years of age compared with those with a lower Consumption (odds ratio=0.57 [95%ci 0.33-0.93]; p=0.024).19supplementation with codliver oil was also ASSOCIATED with lower risk of ms, BUT ONLY among Individuals with low summer outdoor activity.']	[('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 396), ('ANOMALY_CURIOUS_FINDING', 430)]	5	[('CHEBI_38677', 'famphur', 98, 'fatty fish'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_1', 'root', 185, 'individuals'), ('GO_0009636', 'response to toxic substance', 201, 'ate'), ('GO_0007631', 'feeding behavior', 294, 'consumption'), ('NCBITaxon_1', 'root', 445, 'individuals')]
PMC3257641	3/2010	S98-PMC3257641	['the media REPORTED on a reduction in both Preterm Birth and small-for-dates babies, with Vitamin D supplementation [41], BUT formal publication of the FINDINGS had not occurred at the time of writing this review, THUS these reports cannot BE formally evaluated.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('INCOMPLETE_EVIDENCE', 151), ('PROBABLE_UNDERSTANDING', 213), ('ANOMALY_CURIOUS_FINDING', 239)]	5	[('GO_0007565', 'female pregnancy', 42, 'preterm'), ('GO_0007567', 'parturition', 50, 'birth'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3257641	3/2010	S121-PMC3257641	['low Vitamin D intake during Pregnancy HAS BEEN ASSOCIATED with an increased risk of asthma, eczema or hay fever [92,93], WHILE winter Birth was ASSOCIATED with higher Ige levels and lower Il-10 than summer Birth [57].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('GO_0007567', 'parturition', 134, 'birth'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 167, 'IgE'), ('PR_000001470', 'interleukin-28B', 188, 'IL-10'), ('GO_0007567', 'parturition', 206, 'birth')]
PMC3296991	2/2012	S0-PMC3296991	['EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, Cord Parathyroid Hormone and bone-specific alkaline phosphatase, and newborn Whole body bone Mineral content\n\nabstract\nin SPITE of a high prevalence of Vitamin D inadequacy in Pregnant women and neonates, RELATIONSHIPS among Vitamin D status (25(Oh)D), Parathyroid hormone (pth), bone specific alkaline phosphatase (balp), and Whole body bone Mineral content (wbbmc) in the newborn are POORLY characterized.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('ANOMALY_CURIOUS_FINDING', 187), ('SUPERFICIAL_RELATIONSHIP', 270), ('PROBLEM_COMPLICATION', 451)]	5	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('UBERON_0000948', 'heart', 65, 'Cord'), ('UBERON_0001132', 'parathyroid gland', 70, 'Parathyroid'), ('CHEBI_5762', 'hordatine A', 82, 'Hormone'), ('UBERON_0004043', 'semicircular canal ampulla', 142, 'Whole'), ('CHEBI_46662', 'mineral', 158, 'Mineral'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 308, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 318, 'parathyroid'), ('UBERON_0007688', 'anlage', 392, 'whole'), ('CHEBI_46662', 'mineral', 408, 'mineral')]
PMC3347007	4/2012	S138-PMC3347007	['when looking at the total Vitamin D intake in the dnbc we FOUND that as many as 55.6% had insufficient intakes EVEN THOUGH 67.6% REPORT use of Vitamin D supplements in SOME dose.']	[('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 111), ('ANOMALY_CURIOUS_FINDING', 116), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 168)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3347007	4/2012	S148-PMC3347007	['in OTHER studies, maternal age was also FOUND TO BE inversely ASSOCIATED with Vitamin D intake and the use of Supplements, SUGGESTING that younger Individuals MAY BE less conscious about health matters [17,18,27,28,29].']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 40), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 159)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 110, 'supplements'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC3347028	3/2012	S110-PMC3347028	['in addition, BASED on rickets and osteoporosis data, it APPEARS that bone health, which is LINKED with Renal production of 1,25(Oh)2D and Calcium Metabolism is maintained at significantly lower levels of circulating Vitamin D concentrations COMPARED to OTHER health factors such as Immune function, which is dependent on delivery of 25(Oh)D to cells of the target Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ANOMALY_CURIOUS_FINDING', 56), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	[('UBERON_0002113', 'kidney', 103, 'renal'), ('CHEBI_37958', 'dye', 123, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 125, '25(OH)2D'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 138, 'calcium metabolism'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('UBERON_0002405', 'immune system', 282, 'immune'), ('CHEBI_71657', 'versiconol acetate', 333, '25(OH)D'), ('UBERON_0000479', 'tissue', 364, 'tissue')]
PMC3347028	3/2012	S126-PMC3347028	['THEREFORE, it came AS quite a SURPRISE when the FIRST REPORT of widespread Vitamin D deficiency in u.s. women of Childbearing age was REPORTED by the center for disease control (cdc) in 2002 [81].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('ANOMALY_CURIOUS_FINDING', 30), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 134)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 113, 'childbearing')]
PMC3347028	3/2012	S143-PMC3347028	['from the prior sections, IT IS CLEAR that Vitamin D deficiency during Pregnancy is common throughout the world YET WHAT EFFECT does deficiency have on the mother and her developing fetus?']	[('PROBABLE_UNDERSTANDING', 25), ('ANOMALY_CURIOUS_FINDING', 111), ('EXPLICIT_QUESTION', 115), ('SUPERFICIAL_RELATIONSHIP', 120), ('EXPLICIT_QUESTION', 186)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC3347028	3/2012	S196-PMC3347028	['secondary analysis INDICATED that Preterm Birth and labor were inversely RELATED to pre-Delivery Vitamin D status (Preterm Birth or = 0.50 per 10 ng/ml, p = 0.002; Preterm Labor or Birth or = 0.72 per 10 ng/ml, p = 0.012), an EFFECT that PERSISTED EVEN after controlling for race.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 226), ('INCOMPLETE_EVIDENCE', 238), ('ANOMALY_CURIOUS_FINDING', 248)]	5	[('GO_0007565', 'female pregnancy', 34, 'preterm'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007567', 'parturition', 88, 'delivery'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'preterm'), ('GO_0007567', 'parturition', 123, 'birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 164, 'preterm labor'), ('GO_0007567', 'parturition', 181, 'birth')]
PMC3347028	3/2012	S218-PMC3347028	['we can conservatively say that WHILE we do not understand completely the ROLE of 1,25(Oh)2D during Pregnancy, achieving OPTIMAL production can be done SAFELY with 4000 iu Vitamin D3/day, which APPEARS TO BE the amount of Vitamin D that would be conservatively generated by the body with adequate sunlight exposure over the duration of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 151), ('ANOMALY_CURIOUS_FINDING', 193)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 83, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 171, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 171, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'gestation')]
PMC3347028	3/2012	S220-PMC3347028	['unanswered questions and direction of FUTURE RESEARCH endeavors\nthere are many UNANSWERED QUESTIONS about Vitamin D’s “true” ROLE during Pregnancy: at no other time during the Lifecycle is 25(Oh)D so closely LINKED with 1,25(Oh)2D [6].']	[('FUTURE_WORK', 38), ('ANOMALY_CURIOUS_FINDING', 79), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0000104', 'life cycle', 176, 'lifecycle'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 222, '25(OH)2D')]
PMC3356951	4/2012	S147-PMC3356951	['caption (table-wrap): table 1\n\nrecommended dietary intakes of Vitamin D for patients AT RISK for Vitamin D deficiency[103]\nescp SUGGESTS that the maintenance tolerable upper limits (ul) of Vitamin D, which is not to BE exceeded without medical supervision, SHOULD BE 1000 iu/d for infants up to 6 months, 1500 iu/d for infants from 6 months to 1 year, AT LEAST 2500 iu/d for children aged 1–3 years, 3000 iu/d for children aged 4–8 years, and 4000 iu/d for everyone over 8 years.']	[('IMPORTANT_CONSIDERATION', 85), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 216), ('FUTURE_WORK', 257), ('PROBABLE_UNDERSTANDING', 352)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC3395583	7/2012	S86-PMC3395583	['THESE FINDINGS are INTERESTING since SEVERAL LINES OF EVIDENCE now SUPPORT a ROLE for Vitamin D deficiency in the pathogenesis of id [23,24].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 77)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3395583	7/2012	S92-PMC3395583	['NOTABLY, schizophrenia is also INFLUENCED by the season of Birth and a RECENT STUDY HAS SHOWN that neonatal Vitamin D levels are significantly ASSOCIATED with risk of schizophrenia later in Life [49,50].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 143)]	5	[('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 190, 'life')]
PMC3407995	7/2012	S85-PMC3407995	['HOWEVER, a recent global review of Vitamin D status HAS SHOWN that its Intake is OFTEN TOO low TO sustain healthy circulating 25(Oh)D in countries without mandatory staple Food fortification and is EVEN too low in countries that do fortify due to low Milk Consumption, vegetarianism, non-supplement use and low fish Intake [46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 81), ('DIFFICULT_TASK', 87), ('ANOMALY_CURIOUS_FINDING', 198)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007631', 'feeding behavior', 71, 'intake'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 126, '25(OH ... D'), ('CHEBI_33290', 'food', 172, 'food'), ('UBERON_0001913', 'milk', 251, 'milk'), ('GO_0007631', 'feeding behavior', 256, 'consumption'), ('GO_0007631', 'feeding behavior', 316, 'intake')]
PMC3407995	7/2012	S492-PMC3407995	['maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine within RECOMMENDED SAFE intake quantities in a large segment of the population that is currently DEFICIENT in these Nutrients, COULD significantly prevent many Brain and Central Nervous System malfunctions and EVEN enhance Brain Development and function in future generations.']	[('FUTURE_WORK', 75), ('IMPORTANT_CONSIDERATION', 87), ('IMPORTANT_CONSIDERATION', 165), ('INCOMPLETE_EVIDENCE', 195), ('ANOMALY_CURIOUS_FINDING', 278)]	5	[('CHEBI_17874', 'dihydrozeatin', 30, 'DHA'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_30751', 'formic acid', 46, 'folic acid'), ('CHEBI_24859', 'iodine atom', 61, 'iodine'), ('CHEBI_33284', 'nutrient', 184, 'nutrients'), ('UBERON_0000955', 'brain', 228, 'brain'), ('UBERON_0001017', 'central nervous system', 238, 'central nervous system'), ('GO_0007420', 'brain development', 291, 'brain development'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC3424155	8/2012	S165-PMC3424155	['HOWEVER, Vitamin D insufficiency is STILL UNDER-RECOGNIZED and UNDER-TREATED, DESPITE its prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 63), ('ANOMALY_CURIOUS_FINDING', 78)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC3424155	8/2012	S173-PMC3424155	['maternal Nutrient restriction causes adiposity in offspring[26], and RECENT DATA SUGGEST that maternal Vitamin D deficiency AFFECTS adiposity, ALTHOUGH the mechanisms are NOT yet FULLY UNDERSTOOD[23].']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 143), ('INCOMPLETE_EVIDENCE', 171)]	5	[('CHEBI_33284', 'nutrient', 9, 'nutrient'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3424155	8/2012	S179-PMC3424155	['in Rats, it has been OBSERVED that maternal Vitamin D deficiency LEADS to a significant increase in the number of Glomeruli, which is a UNIQUE and IMPORTANT EFFECT of Vitamin D restriction during fetal development[13].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 65), ('ANOMALY_CURIOUS_FINDING', 136), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 114, 'glomeruli'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC3427192	4/2012	S45-PMC3427192	['WHILE these studies SHOW INTRIGUING ASSOCIATIONS between Vitamin D insufficiency (or deficiency) and asthma Control, the cross-sectional nature of the 25(Oh)D measurement and outcome assessment prevents causal INTERPRETATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 210)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0065007', 'biological regulation', 108, 'control'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D')]
PMC3427192	4/2012	S58-PMC3427192	['THUS, Vitamin D MAY have therapeutic EFFECTIVENESS in Adults with asthma, but MORE STUDIES ARE CLEARLY NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 78), ('FUTURE_WORK', 83)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adults')]
PMC3427250	8/2012	S18-PMC3427250	['HOWEVER there is so far NO CONCLUSIVE EVIDENCE about the causality of these RELATIONSHIPS, as NO randomised controlled TRIALS of Vitamin D supplementation with an appropriate assessment of a VARIETY of health outcomes have been carried out to date[21].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 94), ('DIFFICULT_TASK', 191)]	5	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3427250	8/2012	S119-PMC3427250	['HOWEVER, the Vitamin D content of multivitamins for Pregnant women in belgium is ONLY 400 iu INDICATING EVEN this RECOMMENDATION is not followed as Pregnant women only take one Multivitamin pill a day.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 81), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 104), ('FUTURE_WORK', 114)]	5	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 148, 'pregnant'), ('CHEBI_7025', 'mupirocin', 177, 'multivitamin')]
PMC3472720	8/2012	S53-PMC3472720	['NONETHELESS, to date, NOT a single study has yet DEMONSTRATED a Pirna- or a Mirna-ASSOCIATED action of Vitamin D on the Immune or the Nervous system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('SO_0001035', 'piRNA', 64, 'piRNA'), ('SO_0000276', 'miRNA', 76, 'miRNA'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('UBERON_0001016', 'nervous system', 134, 'nervous')]
PMC3509518	11/2012	S117-PMC3509518	['this is CONSISTENT with the FINDINGS in the PRESENT STUDY that SUGGEST a reduced risk of wheeze with higher maternal dietary Vitamin C intake, ALTHOUGH the inverse linear trend fell short of the significance level.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('INCOMPLETE_EVIDENCE', 63), ('ANOMALY_CURIOUS_FINDING', 143)]	5	[('CHEBI_27300', 'vitamin D', 125, 'vitamin C')]
PMC3515553	12/2012	S15-PMC3515553	['DESPITE the IMPORTANCE of Vitamin B-12 to Neuronal Development and the dependency of the developing foetus and infant on maternal Vitamin B-12 status, it is UNKNOWN WHETHER variation in maternal Pregnancy Vitamin B-12, across the normal range, INFLUENCES offspring Neurodevelopment.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('FULL_UNKNOWN', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('SUPERFICIAL_RELATIONSHIP', 244)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 26, 'vitamin B-12'), ('CL_0000540', 'neuron', 42, 'neuronal'), ('GO_0007399', 'nervous system development', 42, 'neuronal development'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 130, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('GO_0007399', 'nervous system development', 265, 'neurodevelopment')]
PMC3613945	2/2013	S56-PMC3613945	['OF more immediate clinical INTEREST, PERHAPS, was our OBSERVATION that this Allele was also CORRELATED with the response of Serum 25(Oh)D levels to long-term Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 27), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('SO_0001023', 'allele', 76, 'allele'), ('UBERON_0001977', 'blood serum', 124, 'serum'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 130, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3641012	4/2013	S0-PMC3641012	['randomized placebo-controlled trial of high-dose Prenatal third-Trimester Vitamin D3 supplementation in bangladesh: the avidd trial\n\nabstract\n\nbackground\nantenatal Vitamin D status MAY be ASSOCIATED with the RISK of adverse Pregnancy and neonatal outcomes; HOWEVER, the benefits of Vitamin D supplementation during Pregnancy remain UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 188), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 257), ('FULL_UNKNOWN', 332)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('CHEBI_33279', 'vitamin D5', 74, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 74, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('GO_0007565', 'female pregnancy', 315, 'pregnancy')]
PMC3651971	5/2013	S157-PMC3651971	['the post hoc analyses REPORTED in THIS PAPER HINTED AT differences in motor skills after in utero Vitamin A supplementation, but did so ONLY after excluding children who never attended school and those who repeated a grade.']	[('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 136), ('INCOMPLETE_EVIDENCE', 136)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin A')]
PMC3668200	5/2013	S28-PMC3668200	['Breast Milk ALONE can meet the Nutrient REQUIREMENT during the first 6 months of Life, with the POSSIBLE EXCEPTION of Vitamin D. the Vitamin A and Vitamin E contents of the Breast Milk are CORRELATED with the amount of the Vitamins in the dietary intake of Lactating mothers.']	[('ANOMALY_CURIOUS_FINDING', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 189)]	5	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_33284', 'nutrient', 31, 'nutrient'), ('UBERON_0000104', 'life cycle', 81, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin E'), ('UBERON_0001348', 'brown adipose tissue', 173, 'breast milk'), ('CHEBI_33277', 'gamma-tocotrienol', 223, 'vitamins'), ('GO_0007594', 'puparial adhesion', 257, 'lactating')]
PMC3668200	5/2013	S45-PMC3668200	['the authors DID NOT TAKE into CONSIDERATION the height profiles of the newborns EVEN IF Minerals and Vitamin D are key FACTORS of bony growth.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_46751', 'quinolizidine', 88, 'minerals'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3691177	6/2013	S127-PMC3691177	['it HAS RECENTLY BEEN SHOWN that doses of 4000 iu of Vitamin D daily are SAFE and effective for short term treatment of Vitamin D deficiency during Pregnancy[30], ALTHOUGH the long term EFFECTS on child health have NOT BEEN STUDIED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 162), ('SUPERFICIAL_RELATIONSHIP', 185), ('FULL_UNKNOWN', 214)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3695234	7/2013	S51-PMC3695234	['ALTHOUGH there was no healthy control group, OUR FINDINGS SHOWED lower normal levels of Serum Vitamin D (15.61±5.67 ng/ml) irrespective of ad severity, which SUGGESTS a CORRELATION between ad and the absorption and Metabolism Of Vitamin D.\nthis Metabolism begins with two processes: absorption into the skin as Vitamin D3And via the Gut as either Vitamin D2Or Vitamin D3.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 169)]	5	[('UBERON_0001977', 'blood serum', 88, 'serum'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 215, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0008152', 'metabolic process', 245, 'metabolism'), ('CHEBI_61991', 'maltotriose trisaccharide', 311, 'vitamin D3and'), ('PR_000027594', 'histone H3', 311, 'vitamin D3and'), ('UBERON_0001555', 'digestive tract', 333, 'gut'), ('CHEBI_27329', 'xanthosine phosphate', 347, 'vitamin D2or'), ('PR_000017209', 'utrophin', 347, 'vitamin D2or'), ('CHEBI_33279', 'vitamin D5', 360, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 360, 'vitamin D3')]
PMC3702245	6/2013	S15-PMC3702245	['IN GENERAL, Cord Blood 25(Oh)D concentrations are APPROXIMATELY 60%–89% of the maternal value.11,17,35,41–47THEREFORE, maintaining optimum Vitamin D nutrition during Pregnancy is ESSENTIAL for PREVENTION of hypovitaminosis D in the fetus and Vitamin D deficiency at Birth and in early infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 223, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('GO_0007567', 'parturition', 266, 'birth')]
PMC3702245	6/2013	S70-PMC3702245	['OF NOTE, in two of the five studies, the mean concentration of 25(Oh)D after supplementation was <50 nmol/l,33,78and Serum 25(Oh)D WAS NOT MEASURED in ONE STUDY.73all these STUDIES underscore the uncertainty about the amount of Vitamin D supplementation REQUIRED to optimize Vitamin D status in Pregnancy and which would be generalizable worldwide.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 254)]	5	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy')]
PMC3717170	5/2013	S178-PMC3717170	['INTERESTINGLY, a RECENT STUDY FOUND that vdrs are highly concentrated in the Cristae of the Mitochondria Inner Membrane.51the ROLE of Vitamin D in Homeostatic Signaling is COMPLEX and pervasive.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 126), ('DIFFICULT_TASK', 172)]	5	[('UBERON_0004721', 'crista ampullaris', 77, 'cristae'), ('GO_0005743', 'mitochondrial inner membrane', 92, 'mitochondria inner membrane'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0038128', 'ERBB2 signaling pathway', 147, 'homeostatic signaling')]
PMC3760821	9/2013	S15-PMC3760821	['maternal Vitamin D levels EXHIBIT a significant negative RELATIONSHIP with hba1clevels, SUPPORTING a POTENTIAL ROLE for this Vitamin in maintaining Glycaemic Control.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 125, 'vitamin'), ('GO_0051162', 'L-arabitol metabolic process', 148, 'glycaemic control')]
PMC3760821	9/2013	S160-PMC3760821	['EVEN given the LACK OF EVIDENCE SUPPORTING a causal LINK between low Vitamin D and a range of non-bone health outcomes, assessment and supplementation are ESSENTIAL with respect to the optimal bone health of both mother and off-spring.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('IMPORTANT_CONSIDERATION', 155)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3798907	8/2013	S85-PMC3798907	['HOWEVER, as was the case for cbmc, in general, Vitamin C supplementation was ASSOCIATED with a TREND for an increase in cytokines characteristic of Th Effector Cells; Ifn-Γ and Il-4, which was significant for the Il-4 response to klh, (10 of 16 cultures) ALTHOUGH this trend was not universal and there was decreased Ifn-Γ after stimulation with con a (figure 4andtable 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 95), ('ANOMALY_CURIOUS_FINDING', 255)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin C'), ('CL_0000635', "Deiter's cell", 148, 'Th effector cells'), ('CHEBI_35224', 'effector', 151, 'effector'), ('PR_000008920', 'interferon alpha-7', 167, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 177, 'IL-4'), ('PR_000001470', 'interleukin-28B', 213, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 317, 'IFN-γ')]
PMC3827489	10/2013	S96-PMC3827489	['IN GENERAL, the OBSERVATIONAL EVIDENCE LINKING low maternal Vitamin D status during Pregnancy to an increase in the risk of allergic diseases in the offspring SEEMS more convincing.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 159)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy')]
PMC3973641	4/2014	S35-PMC3973641	['DESPITE these STUDIES, LITTLE IS KNOWN about the EFFECTS of Vitamin B deficiency in fetuses and neonates on their Methionine-Homocysteine Metabolism programming and subsequent consequences to the Brain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('FULL_UNKNOWN', 23), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('GO_0006555', 'methionine metabolic process', 114, 'methionine- ... metabolism'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 125, 'homocysteine'), ('UBERON_0000955', 'brain', 196, 'brain')]
PMC4034700	5/2014	S137-PMC4034700	['HOWEVER, DESPITE encouraging in vitro DATA and cohort trials, clinical trials aimed to treat women AT RISK of Preeclampsia with Vitamins C and E (poston et al., 2006;rumbold et al., 2006) SHOWED no reduction in the incidence of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('FUTURE_WORK', 38), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 188)]	5	[('GO_0007128', 'meiotic prophase I', 110, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'E')]
PMC4051754	6/2014	S35-PMC4051754	['Calcium, gamma-Glutamyl transpeptidase (ggt), Bilirubin, and Creatinine concentrations had a significant diet × time INTERACTION WHILE Vitamin A and Vitamin E concentrations TENDED to have a significant INTERACTION.']	[('SUPERFICIAL_RELATIONSHIP', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 203)]	5	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_24322', 'glutamoyl group', 15, 'glutamyl'), ('CHEBI_16990', 'bilirubin IXalpha', 46, 'bilirubin'), ('CHEBI_16737', 'creatinine', 61, 'creatinine'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin E')]
PMC4072587	6/2014	S16-PMC4072587	['ALTHOUGH the current RECOMMENDED dietary intake of Vitamin D during Pregnancy ranges from 600 to 2000 international units (iu) per day[8], a standardised definition of Vitamin D deficiency during Pregnancy REMAINS CONTROVERSIAL[4],[9],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC4072587	6/2014	S99-PMC4072587	['HOWEVER, lower language composite scores were SEEN in infants Born to women with Vitamin D deficiency (<37.5 nmol/l) compared to those Born to women who were Vitamin D replete (≥75 nmol/l) (md −3.48, 95% ci −5.52 to −1.44) (table 5).10.1371/journal.pone.0099005.t004\n\ncaption (table-wrap): table 4\ndevelopmental composite scores at 6 months of age ASSOCIATED with maternal Serum 25-Ohd concentration (nmol/l) at 32 weeks Gestation.unadjusted modeladjusted model 1adjusted model 2domainmean developmental composite score [sd]mean difference1,2(95% ci)p valuemean difference1,3(95% ci)p valuemean difference1,4(95% ci)p valuecognitive104.5 [10.1]−0.47 (−1.22 to 0.27)0.21−0.39 (−1.19 to 0.40)0.30−0.43 (−1.23 to 0.370.29language97.8 [7.6]−0.02 (−0.58 to 0.55)0.960.04 (−0.51 to 0.59)0.890.08 (−0.47 to 0.63)0.77motor110.9 [13.4]0.03 (−0.97 to 1.03)0.950.25 (−0.71 to 1.21)0.610.05 (−0.92 to 0.64)0.92socio-emotional79.6 [9.8]−0.12 (−0.85 to 0.61)0.75−0.06 (−0.81 to 0.70)0.88−0.14 (−0.92 to 0.64)0.71\nvalues are ESTIMATED mean difference for each outcome associated with a 25 nmol/l increase in Vitamin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 348), ('INCOMPLETE_EVIDENCE', 1010)]	5	[('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001977', 'blood serum', 373, 'serum'), ('CHEBI_72765', 'verruculogen', 379, '25-OHD'), ('GO_0007565', 'female pregnancy', 421, 'gestation'), ('CHEBI_33229', 'vitamin (role)', 1093, 'vitamin')]
PMC4072587	6/2014	S138-PMC4072587	['an inverse ASSOCIATION between Birth Head circumference and maternal Vitamin D was OBSERVED, HOWEVER this FINDING DID NOT persist at 6 months of age.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 83), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 114)]	5	[('GO_0007567', 'parturition', 31, 'birth'), ('UBERON_0000033', 'head', 37, 'head'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S244-PMC4113768	['conclusions: OUR FINDINGS SUGGEST that Vitamin D deficiency at Birth is ASSOCIATED with INCREASED RISK of lrti PARTICULARLY in infants Born to mothers without allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 88), ('ANOMALY_CURIOUS_FINDING', 111)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'birth'), ('GO_0007567', 'parturition', 135, 'born')]
PMC4113768	7/2014	S253-PMC4113768	['hiv progression, which is ASSOCIATED with excessive Immune Activation and impaired T-Cell Immunity, is also ASSOCIATED with low Serum Vitamin D level ALTHOUGH biological PLAUSIBILITY and causality have yet to be established.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('ANOMALY_CURIOUS_FINDING', 150), ('INCOMPLETE_EVIDENCE', 170)]	5	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 52, 'immune activation'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CL_0000084', 'T cell', 83, 'T-cell'), ('GO_0002456', 'T cell mediated immunity', 83, 'T-cell immunity'), ('GO_0005622', 'intracellular anatomical structure', 84, '-cell'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4113768	7/2014	S286-PMC4113768	['BASED ON the Skeletal and non Skeletal EFFECTS of Vitamin D (vd), it SEEMS REASONABLE to optimize their vd status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 75)]	5	[('UBERON_0004288', 'skeleton', 13, 'skeletal'), ('UBERON_0004288', 'skeleton', 30, 'skeletal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4113768	7/2014	S843-PMC4113768	['knowledge levels APPEAR TO CORRELATE with use of Vitamin D supplementation, SUGGESTING that APPROPRIATE information provision is VITAL.']	[('ANOMALY_CURIOUS_FINDING', 17), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 129)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S1692-PMC4113768	['AS sun is a rich source of Vitamin D so ONCE IT WAS THOUGHT that Vitamin D deficiency is RARE in asia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 40), ('ANOMALY_CURIOUS_FINDING', 45), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 89)]	5	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S1801-PMC4113768	['HOWEVER, 25(Oh)D3Levels at year one SHOWED an INDEPENDENT TREND: due to the general rickets prophylaxis within the first year (87% of the children were supplemented with Vitamin D at least during the first 3 months), absolute 25(Oh)D3Was generally higher with almost no variations due to seasonal sunlight exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 58)]	5	[('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 9, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 15, 'D3levels'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 226, '25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 232, 'D3was')]
PMC4113768	7/2014	S1810-PMC4113768	['DUE to pleiotropic Vitamin D EFFECTS it INFLUENCES NOT ONLY physical and mental health status BUT ALSO the quality of Life.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 51), ('ANOMALY_CURIOUS_FINDING', 94)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC4113768	7/2014	S2272-PMC4113768	['background: ACCUMULATING EVIDENCE has stipulated a strong CORRELATION between Vitamin D (vitd) deficiency and Cardiovascular disease (cvd) HOWEVER a mechanistic LINK is missing.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ANOMALY_CURIOUS_FINDING', 139), ('SUPERFICIAL_RELATIONSHIP', 161)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 110, 'cardiovascular')]
PMC4113768	7/2014	S2638-PMC4113768	['THERE IS EVIDENCE TO SUPPORT a ROLE for Vitamin D in muscle function, YET LITTLE IS KNOWN about the ROLE of Antenatal 25(Oh)D exposure in programming muscle development.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 70), ('FULL_UNKNOWN', 74), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC4169453	9/2014	S11-PMC4169453	['conclusions\nVitamin D supplementation at a dose of 400 iu/d was not sufficient to maintain 25(Oh)D >20 ng/ml in nursing women, WHILE 1200 iu/d APPEARED more EFFECTIVE, but had no effect on Breastfed offspring Vitamin D status, or changes in the bone mass and the body composition OBSERVED in both during breastfeeding.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('ANOMALY_CURIOUS_FINDING', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 280)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('GO_0007567', 'parturition', 189, 'breastfed'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4169453	9/2014	S197-PMC4169453	['taking into account the maternal REQUIREMENT, 1200 iu/d of Vitamin D MAY PROTECT against Vitamin D deficiency, but SEEMS TOO low TO fully replenish Vitamin D insufficiency (20 ng/ml<25(Oh)D <30 ng/ml).']	[('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 73), ('ANOMALY_CURIOUS_FINDING', 115), ('DIFFICULT_TASK', 121)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 182, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 182, '25 ... OH ... D')]
PMC4169453	9/2014	S210-PMC4169453	['INTERESTINGLY, the fish Intake was not associated with Serum 25(Oh)D level in that study, DESPITE fish being CONSIDERED a rich source of Vitamin D. ON THE OTHER HAND, a mean skin synthesis of Vitamin D was 200–650 iu/d at the summer peak, but it accounted for ONLY 10–25% of total basal Vitamin D input[37].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 90), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('ANOMALY_CURIOUS_FINDING', 260)]	5	[('GO_0007631', 'feeding behavior', 24, 'intake'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_74268', "N(1)-methylguanosine 5'-monophosphate", 61, '25(OH)d'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 61, '25(OH)d'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC4169453	9/2014	S212-PMC4169453	['ANOTHER INTERESTING OBSERVATION RELATES to pth as a functional MARKER of Vitamin D status in Adults, children and infants but not necessarily in neonates[44]–[47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults')]
PMC4169453	9/2014	S241-PMC4169453	['Vitamin D3 supplementation at a dose of 1200 iu/d is more EFFECTIVE at improving Vitamin D status of nursing women, but STILL SEEMS TOO low TO fully replenish Vitamin D deficiency/insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 120), ('IMPORTANT_CONSIDERATION', 120), ('ANOMALY_CURIOUS_FINDING', 126), ('DIFFICULT_TASK', 132)]	5	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4221707	11/2014	S24-PMC4221707	['THUS, the low intake of Folate, Vitamin D, and iron FOUND in swedish women who are of Childbearing age is of SPECIAL CONCERN, as women do not SEEM to improve the quality of their overall diet during Pregnancy [7,15].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 109), ('PROBLEM_COMPLICATION', 117), ('ANOMALY_CURIOUS_FINDING', 142)]	5	[('CHEBI_30863', '5-azaorotic acid', 24, 'folate'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 86, 'childbearing'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4258799	11/2014	S307-PMC4258799	['BASED ON their findings, it SEEMS that a combination of Vitamin E and Selenium had a more significant IMPACT on motility compared to morphology.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 70, 'selenium')]
PMC4289064	1/2015	S154-PMC4289064	['WHILE the risk of Nutrient deficiency did not change substantially for most Nutrients when pollinators were removed, the increased risk we ESTIMATED for Vitamin A carries concerning PUBLIC HEALTH IMPLICATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 196)]	5	[('CHEBI_33284', 'nutrient', 18, 'nutrient'), ('CHEBI_33284', 'nutrient', 76, 'nutrients'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin A')]
PMC4302429	1/2015	S125-PMC4302429	['high Vitamin D3 concentrations inhibited the Production of proinflammatory cytokine Il-6 and increased production of anti-inflammatory cytokine Il-10, WHILE Ifn-Γ production in the Cns stayed unaffected\nPREVIOUS investigations REVEALED that Vitamin D plays IMPORTANT ROLES in signaling in both the Adaptive and Innate Immune Response To Viral and bacterial Infection [16,25].']	[('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 227), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267)]	5	[('CHEBI_33279', 'vitamin D5', 5, 'vitamin D3'), ('GO_0007128', 'meiotic prophase I', 45, 'production'), ('PR_000001470', 'interleukin-28B', 84, 'IL-6'), ('PR_000001470', 'interleukin-28B', 144, 'IL-10'), ('PR_000008920', 'interferon alpha-7', 157, 'IFN-γ'), ('UBERON_0001017', 'central nervous system', 181, 'CNS'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0051886', 'negative regulation of timing of anagen', 298, 'adaptive ...'), ('GO_0045048', 'protein insertion into ER membrane', 311, 'innate immune response to ... infection'), ('UBERON_0002405', 'immune system', 318, 'immune'), ('NCBITaxon_1', 'root', 337, 'viral')]
PMC4329404	10/2014	S180-PMC4329404	['it MAY BE that ONLY alterations in circulating T Regulatory Cells are apparent following supplementation with Vitamin D.\nwe have PREVIOUSLY SHOWN that transfer of T Regulatory Cells prevented Development Of Airway Remodelling in an Adult Mouse MODEL of aad (40).']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CL_0000902', 'induced T-regulatory cell', 47, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 49, 'regulatory'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 163, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 165, 'regulatory'), ('GO_0032498', 'detection of muramyl dipeptide', 192, 'development of airway remodelling'), ('UBERON_0001005', 'respiratory airway', 207, 'airway'), ('UBERON_0007023', 'adult organism', 232, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 238, 'mouse')]
PMC4377870	3/2015	S103-PMC4377870	['the CONFLICTING results from these supplementation studies are LIKELY to be INFLUENCED by baseline Tissue levels of Vitamin E [72], with Α-Tocopherol supplementation leading to improved Lung function and wheeze in europe, where Γ-Tocopherol levels are low [78,79,80], BUT NOT in the us, where γ-Tocopherol Intake is high due to Soybean oil Consumption [81,82,83].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 268), ('ANOMALY_CURIOUS_FINDING', 272)]	5	[('UBERON_0000479', 'tissue', 99, 'tissue'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin E'), ('CHEBI_27725', 'butin', 137, 'α-tocopherol'), ('UBERON_0002048', 'lung', 186, 'lung'), ('CHEBI_27725', 'butin', 228, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 295, 'tocopherol'), ('GO_0007631', 'feeding behavior', 306, 'intake'), ('CHEBI_36933', 'oxygen-19 atom', 328, 'soybean'), ('GO_0007631', 'feeding behavior', 340, 'consumption')]
PMC4377870	3/2015	S134-PMC4377870	['THOUGH like Vitamin C, it MAY BE DIFFICULT to disentangle the EFFECTS of Flavonoids from OTHER Nutrients in Flavonoid-rich foods.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin C'), ('PR_000004900', 'complement C3', 20, 'C'), ('CHEBI_72544', 'flavonoids', 73, 'flavonoids'), ('CHEBI_33284', 'nutrient', 95, 'nutrients'), ('CHEBI_47916', 'flavonoid', 108, 'flavonoid')]
PMC4377870	3/2015	S163-PMC4377870	['copd exacerbations are GENERALLY caused by Viral or bacterial Lung infections, and THOUGH Vitamin D has a positive ROLE in reducing infection, there is NO EVIDENCE to support that Vitamin D is ASSOCIATED with ameliorating exacerbations in copd patients [129].']	[('PROBABLE_UNDERSTANDING', 23), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('NCBITaxon_1', 'root', 43, 'viral'), ('UBERON_0002048', 'lung', 62, 'lung'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC4377879	3/2015	S93-PMC4377879	['observational or experimental data LINKING Water-soluble Vitamins to any risk of maternal mortality are APPARENTLY unavailable [21]; these Vitamins, such as Vitamin C, Thiamin, niacin and riboflavin and others, do HOWEVER APPEAR to decline in Serum or Plasma levels, LIKELY due to extra uptake by the foetus or haemodilution, or in the case of niacin also increased Urinary Excretion [21].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('ANOMALY_CURIOUS_FINDING', 222), ('PROBABLE_UNDERSTANDING', 267)]	5	[('CHEBI_15377', 'water', 43, 'water'), ('CHEBI_33277', 'gamma-tocotrienol', 57, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 139, 'vitamins'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('CHEBI_26948', 'vitamin B1', 168, 'thiamin'), ('UBERON_0001977', 'blood serum', 243, 'serum'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('GO_0046802', 'exit of virus from host cell nucleus by nuclear egress', 366, 'urinary excretion'), ('UBERON_0001088', 'urine', 366, 'urinary')]
PMC4383226	2/2015	S102-PMC4383226	['we FOUND no indication of an elevated gender EFFECT for either dtp or Vitamin A, ALTHOUGH the latter SEEMED TO BE more PROTECTIVE among children living in communities with higher Allele frequencies for x-linked g6pdd.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 81), ('ANOMALY_CURIOUS_FINDING', 101), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A'), ('SO_0001023', 'allele', 179, 'allele')]
PMC4396835	1/2015	S128-PMC4396835	['ACCORDINGLY, the swedish somali women and women from the middle east SEEM PARTICULARLY vulnerable to low Vitamin D levels, AFFECTING the Vitamin D status of the offspring, PRESUMABLY due to both dark skin [32] and covered clothing.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 172)]	5	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4405493	4/2015	S119-PMC4405493	['the PREVALENCE of Vitamin D deficiency in Reproductive aged women APPEARS TO BE increasing worldwide over the past two decades.1,3,13recent STUDIES INDICATE the prevalence of Vitamin D insufficiency and deficiency in nulliparous women, a result CORROBORATED by our study [40].']	[('IMPORTANT_CONSIDERATION', 4), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 245)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0000003', 'reproduction', 42, 'reproductive'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4417995	4/2015	S110-PMC4417995	['[30] also EVIDENCED that breastfeeding is GENERALLY ASSOCIATED with low Vitamin D intake, AS OPPOSED TO replacement formulas and dairy drinks fortified with Vitamin D, which provide a CONSIDERABLY higher Intake.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC4417995	4/2015	S154-PMC4417995	['HOWEVER, DESPITE all of the above EVIDENCES, no significant difference in ad severity after Vitamin D supplementation compared with Placebo was FOUND in a 2012 systematic literature review [65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 144)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 132, 'placebo')]
PMC4427001	4/2015	S97-PMC4427001	['ALTHOUGH there is NO GENERAL CONSENSUS on the criteria for Vitamin D deficiency in Pregnant women, in OUR STUDY we have FOUND high prevalence of deficiency (when using cut-off < 50\u2009nmol/l) in overall study sample: 95.7% of women with gdm and 93.1% of controls were Vitamin D deficient during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 120)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0007565', 'female pregnancy', 292, 'pregnancy')]
PMC4448820	5/2015	S578-PMC4448820	['one POSSIBLE EXPLANATION for the APPARENT lack of benefit of Vitamin A supplementation below 6 mo of age is that infants in SUCH studies are PROTECTED from infection by maternally derived Immune factors (e.g., Serum Igg, factors in Breast Milk) to a greater degree than are older infants.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 33), ('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('UBERON_0002405', 'immune system', 188, 'immune'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 216, 'IgG'), ('UBERON_0001348', 'brown adipose tissue', 232, 'breast milk')]
PMC4595656	10/2015	S74-PMC4595656	['HOWEVER the phenotype did not extend into Adulthood, SUGGESTING that EITHER normal Postnatal development OR the reintroduction of Vitamin D at Birth MAY have corrected the deficit (harms et al.,2012).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 149)]	5	[('UBERON_0000113', 'post-juvenile adult stage', 42, 'adulthood'), ('GO_0007567', 'parturition', 83, 'postnatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 143, 'birth')]
PMC4595656	10/2015	S91-PMC4595656	['two STUDIES have investigated the EFFECT of a single treatment of 50 μg of Vitamin D on Neurotransmitter concentrations in offspring of Rats, and FOUND that within the hippocampus, levels of Serotonin and 5h1aa, BUT NOT Dopamine or hva, were negatively AFFECTED by the single treatment, which the authors referred to as Hormonal Imprinting (tekes et al.,2009a,b).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 146), ('ANOMALY_CURIOUS_FINDING', 212), ('SUPERFICIAL_RELATIONSHIP', 253)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 88, 'neurotransmitter'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 136, 'rats'), ('CHEBI_28790', 'serotonin', 191, 'serotonin'), ('CHEBI_18243', 'dopamine', 220, 'dopamine'), ('GO_0007601', 'visual perception', 320, 'hormonal'), ('GO_0071514', 'genetic imprinting', 329, 'imprinting')]
PMC4595656	10/2015	S107-PMC4595656	['ALTHOUGH the concentration of hormone used to supplement in vitro is higher than that DETECTED in standard Rat Chow, Vitamin D levels in Humans HAVE BEEN FOUND in more than ONE STUDY to be elevated in Pregnancy (seki et al.,1991; ardawi et al.,1997).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 86), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 173)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 107, 'rat'), ('CHEBI_33290', 'food', 111, 'chow'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 137, 'humans'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy')]
PMC4595656	10/2015	S112-PMC4595656	['this CONTRASTS with the restoration of normal development following Vitamin D repletion in whole Animals (féron et al.,2005), and highlights the POTENTIAL DISPARITY between in vitro and in vivo FINDINGS.']	[('ANOMALY_CURIOUS_FINDING', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 97, 'animals')]
PMC4600246	10/2015	S5-PMC4600246	['Plasma Phylloquinone concentrations fluctuate BASED on recent dietary intakes.213DESPITE the fact that a high percentage of undercarboxylated osteocalcin INDICATES poor Vitamin K status, this value can also vary based on recent Vitamin K intake and supplementation214and MAY not INDICATE chronic Vitamin K status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 279)]	5	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_26124', 'phytosteroid', 7, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin K')]
PMC4632418	10/2015	S24-PMC4632418	['CONTRADICTORILY, SOME STUDIES SUGGESTED that no significant differences in Vitamin D status were FOUND between women with gdm and normal Glucose tolerance [15,16].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_17234', 'glucose', 137, 'glucose')]
PMC4632418	10/2015	S118-PMC4632418	['apart from diet and Supplements, ANOTHER way of keeping OPTIMAL level of body Vitamin D is from skin exposure to sunlight, which is REMARKABLY INFLUENCED by geographical location, season, dark skin tone, sunscreen use and EVEN the air pollution [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 132), ('SUPERFICIAL_RELATIONSHIP', 143), ('ANOMALY_CURIOUS_FINDING', 222)]	5	[('CHEBI_33341', 'titanium atom', 20, 'supplements'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4645901	8/2014	S14-PMC4645901	['WHILE an increase in government advertising would have CONTRIBUTED to the rise in uptake of Vitamin D supplementation, a leaflet proved to be a simple YET EFFECTIVE INTERVENTION in improving Vitamin uptake in babies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 55), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 155), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 191, 'vitamin')]
PMC4673623	11/2015	S118-PMC4673623	['IN CONTRAST, ALTHOUGH absolute Vitamin B-12 Intake MAY HAVE been slightly lower among the hf-hed (vs. control) group, this modestly lower Intake would not be expected to cause the functional B-12 deficiency OBSERVED in the hf-hed moms.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 207)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 31, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 44, 'intake'), ('GO_0007631', 'feeding behavior', 138, 'intake'), ('PR_000004770', 'Polycomb complex protein BMI-1', 191, 'B-12')]
PMC4684854	12/2015	S138-PMC4684854	['with EVIDENCE that a major proportion of the Adult population [38], particularly in northern climates [39], is POTENTIALLY deficient in Vitamin D, it APPEARS that, at minimum, one out of every few expectant mothers will have INADEQUATE levels of this ESSENTIAL Nutrient.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 111), ('ANOMALY_CURIOUS_FINDING', 150), ('IMPORTANT_CONSIDERATION', 225), ('IMPORTANT_CONSIDERATION', 251)]	5	[('UBERON_0007023', 'adult organism', 45, 'adult'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33284', 'nutrient', 261, 'nutrient')]
PMC4719746	1/2016	S20-PMC4719746	['DESPITE the CONTROVERSIES RELATED to adverse outcomes, and LACK OF EVIDENCE of clear benefits of routine supplementation, most western countries RECOMMEND Vitamin D supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 145)]	5	[('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy')]
PMC4719746	1/2016	S155-PMC4719746	['HOWEVER, it SHOULD BE NOTED that severe Vitamin D deficiency was STILL FOUND in 15-20\xa0% of the high risk groups.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 12), ('ANOMALY_CURIOUS_FINDING', 22), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 71)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4764019	1/2016	S75-PMC4764019	['BUT the fact is that HOW we function after Birth does APPEAR TO BE SUSCEPTIBLE to INFLUENCE by Perinatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 21), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('GO_0007567', 'parturition', 43, 'birth'), ('GO_0036268', 'swimming', 95, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 95, 'perinatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4770602	1/2016	S21-PMC4770602	['[5] deficiency of Vitamin D is diagnosed at level of <32 ng/ml and using the secriteria,[10] Vitamin D deficiency is very common in Pregnancy with up to 50% of Individuals,[111213] THOUGH, DEPENDING ON the country of residence and local clothing customs, a prevalence ranges from 18-84% is REPORTED by PREVIOUS STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189), ('INCOMPLETE_EVIDENCE', 290), ('INCOMPLETE_EVIDENCE', 302)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('NCBITaxon_1', 'root', 160, 'individuals')]
PMC4784858	3/2016	S87-PMC4784858	['EVEN IF national GUIDELINES RECOMMEND the use of dietary supplements to meet REQUIREMENTS for some Nutrients (Folate, Vitamin D, iron or Iodine) during Pregnancy, Nutrient intakes from dietary supplements were not included in the pandiet calculation, like in other studies using diet quality indexes for Pregnancy [11–13].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 17), ('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 77)]	5	[('CHEBI_33284', 'nutrient', 99, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 110, 'folate'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 137, 'iodine'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0007565', 'female pregnancy', 304, 'pregnancy')]
PMC4785305	3/2016	S28-PMC4785305	['rcts of Vitamin D supplementation during Pregnancy\ntwo landmark rcts HAVE BEEN conducted in the usa35and the uk.36hollis et al 35SHOWED that in Pregnant women in the usa, with a baseline 25(Oh)D level around 60\u2005nmol/l, a Vitamin dose of 4000\u2005iu daily allowed 82% of participants to reach a 25(Oh)D level of 80\u2005nmol/l, WHILE ONLY 70% and 50% reached this TARGET in the intermediate (2000\u2005iu daily) and low (400\u2005iu daily) doses, respectively.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 127), ('ANOMALY_CURIOUS_FINDING', 318), ('ANOMALY_CURIOUS_FINDING', 324), ('FUTURE_WORK', 354)]	5	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0007565', 'female pregnancy', 144, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 221, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D')]
PMC4889866	5/2016	S21-PMC4889866	['because of the APPARENT IMPORTANCE of Vitamin D in Immune Development, we AIMED TO INVESTIGATE the EFFECT of maternal and/or cord Vitamin D level on tlr-triggered cytokine response in neonates at time of Birth and disease outcome in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 99)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0001822', 'kidney development', 51, 'immune development'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 204, 'birth')]
PMC4889866	5/2016	S90-PMC4889866	['DESPITE extensive investigations on Vitamin D, its ROLE in Neonatal Immune Development and health outcome REMAINS INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 59, 'neonatal'), ('GO_0001822', 'kidney development', 68, 'immune development'), ('UBERON_0002405', 'immune system', 68, 'immune')]
PMC4889866	5/2016	S96-PMC4889866	["ANOTHER RECENT publication had DEMONSTRATED that ALTHOUGH low levels of Vitamin D in the Cord Blood were ASSOCIATED with higher Airway resistance in childhood, maternal Vitamin D level was not related to the children's Airway resistance [20]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 49), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 89, 'cord'), ('UBERON_0000178', 'blood', 94, 'blood'), ('UBERON_0001005', 'respiratory airway', 128, 'airway'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 219, 'airway')]
PMC4889866	5/2016	S111-PMC4889866	['HOWEVER, in present analyses, ALBEIT an ASSOCIATION between maternal Vitamin D level and Viral Tlr-Triggered Il-10 Response, there was no effect on the PREVALENCE of infectious diseases during the first 12 months of Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 40), ('IMPORTANT_CONSIDERATION', 152)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'viral'), ('GO_0033153', 'T cell receptor V(D)J recombination', 95, 'TLR-triggered ... -10 response'), ('PR_000001470', 'interleukin-28B', 109, 'IL-10'), ('UBERON_0000104', 'life cycle', 216, 'life')]
PMC4889866	5/2016	S115-PMC4889866	['DEMONSTRATED an ASSOCIATION between low Cord Blood Vitamin D level and increased Respiratory syncytial Virus infections in infancy, HOWEVER, UNLIKE our participants, around 50% of their neonates were Vitamin D sufficient [27–29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141)]	5	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 81, 'respiratory'), ('NCBITaxon_1', 'root', 103, 'virus'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4889866	5/2016	S122-PMC4889866	['it has also LIMITED the applicability of our result in representing the general population, ALTHOUGH INADEQUATE Vitamin D concentration SEEMS PARTICULARLY common among Pregnant woman [3,19].']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 92), ('IMPORTANT_CONSIDERATION', 101), ('ANOMALY_CURIOUS_FINDING', 136), ('ANOMALY_CURIOUS_FINDING', 142)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant')]
PMC4897157	5/2016	S148-PMC4897157	['third, we COULD NOT directly examine the RELATIONSHIP between Vitamin D status and allergic disease prevalence BECAUSE Serum Vitamin D levels were NOT RECORDED.']	[('DIFFICULT_TASK', 10), ('SUPERFICIAL_RELATIONSHIP', 41), ('PROBLEM_COMPLICATION', 111), ('ANOMALY_CURIOUS_FINDING', 147), ('FULL_UNKNOWN', 147)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4930210	7/2016	S10-PMC4930210	['there is also EVIDENCE that Pregnancy RISKS MAY BE mitigated by Vitamin D supplementation, ALTHOUGH the optimal daily dose is NOT CLEAR [2].']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 38), ('INCOMPLETE_EVIDENCE', 44), ('ANOMALY_CURIOUS_FINDING', 91), ('FULL_UNKNOWN', 126)]	5	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4934634	11/2015	S31-PMC4934634	['CONSISTENT with this, it HAS BEEN REPORTED that obese Pregnant women have lower Vitamin D levels THAN non-obese women, EVEN when they have higher Vitamin D Intakes during the first trimester [9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ANOMALY_CURIOUS_FINDING', 119)]	5	[('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007631', 'feeding behavior', 156, 'intakes')]
PMC4934634	11/2015	S294-PMC4934634	['a RECENT report by the 2015 dietary guidelines advisory committee NOTED that EVEN with careful Food choices and following RECOMMENDED amounts from each Food group in the (current) usda Food patterns, the rda for Vitamin D cannot be met [103].']	[('INCOMPLETE_EVIDENCE', 2), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 66), ('ANOMALY_CURIOUS_FINDING', 77), ('FUTURE_WORK', 122)]	5	[('CHEBI_33290', 'food', 95, 'food'), ('CHEBI_33290', 'food', 152, 'food'), ('CHEBI_33290', 'food', 185, 'food'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC4969253	8/2016	S61-PMC4969253	['a meta-analysis of these data [21] SHOWED that at 36\xa0weeks of age, there was a significant reduction in oxygen use in the preterm infants treated with Vitamin A supplementation COMPARED TO the control (placebo) group, ALTHOUGH ONLY a TREND towards reduction of death or chronic Lung disease was observed.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 177), ('ANOMALY_CURIOUS_FINDING', 218), ('ANOMALY_CURIOUS_FINDING', 227), ('INCOMPLETE_EVIDENCE', 234)]	5	[('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0002048', 'lung', 278, 'lung')]
PMC4971719	8/2016	S146-PMC4971719	['CONVERSELY, we FOUND that ALTHOUGH there was a TREND toward an ASSOCIATION of most recent Vitamin D levels with the bdi score in later Pregnancy and Postpartum, this trend was not significant and largely disappeared after adjustment for the baseline Bdi score.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'postpartum'), ('PR_000004717', "transcription factor TFIIIB component B''", 250, 'BDI')]
PMC4973215	8/2016	S63-PMC4973215	['we FOUND that black race was ASSOCIATED with a significantly greater incidence of sga, and that black race and Vitamin D deficiency TOGETHER were ASSOCIATED with EVEN greater odds of sga.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 146), ('ANOMALY_CURIOUS_FINDING', 162)]	5	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4973215	8/2016	S75-PMC4973215	['IN CONTRAST TO the above-mentioned studies, our results SHOW that the combination of black race and Vitamin D deficiency was ASSOCIATED with increased odds of sga, BUT this RELATIONSHIP was not preserved for white infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 164), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4973215	8/2016	S84-PMC4973215	['the increased odds of Vitamin D deficiency in neonates relative to maternal bmi level were SEEN in both blacks and whites in our study population and SUPPORTS SIMILAR FINDINGS SEEN in a study done by bodnar et al.38ALTHOUGH Prenatal Vitamin use was not significantly different between blacks and whites in our study, Prenatal Vitamin use was significant among those with and without Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 176), ('ANOMALY_CURIOUS_FINDING', 215)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 233, 'vitamin'), ('GO_0007565', 'female pregnancy', 317, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 326, 'vitamin'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D')]
PMC4976416	7/2016	S16-PMC4976416	['[8]\nALTHOUGH many cosmeceuticals contain Vitamins C and e, VERY FEW are actually EFFECTIVE in topical application because the stability is COMPROMISED as soon as the product is opened and exposed to air and light.']	[('ANOMALY_CURIOUS_FINDING', 4), ('IMPORTANT_CONSIDERATION', 59), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 139)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamins C')]
PMC4976416	7/2016	S77-PMC4976416	['[58]\n\nvitamin e intake during pregnancy and childhood\nVitamin E supplements in Pregnancy USUALLY contain only small doses of Vitamin E, ALTHOUGH adverse EFFECTS have not been OBSERVED EVEN at higher doses.']	[('INCOMPLETE_EVIDENCE', 89), ('ANOMALY_CURIOUS_FINDING', 136), ('SUPERFICIAL_RELATIONSHIP', 153), ('INCOMPLETE_EVIDENCE', 175), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin E'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin E')]
PMC4990268	8/2016	S297-PMC4990268	['IN FACT, the CURRENT EVIDENCE provides SOME SUPPORT for this RELATED to Vitamin A supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy')]
PMC4992225	8/2016	S1-PMC4992225	['researchers have studied the RELATIONSHIP between low Serum Vitamin D concentration and Perinatal depression, ALTHOUGH NO clinical trial HAS BEEN CONDUCTED on Vitamin D’s EFFECTS on depression RELATED to Childbirth.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 110), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0036268', 'swimming', 88, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 88, 'perinatal'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 204, 'childbirth')]
PMC4997567	8/2016	S94-PMC4997567	['hollis and wagner (2004) [21] NOTICED that ALTHOUGH Breast Milk is adequate for growth and bone mineralization in the first year of Life, it is lacking adequate concentration of Vitamin D. THEREFORE, Vitamin D supplementation MUST BE NECESSARY for Breast-Fed infants.']	[('ANOMALY_CURIOUS_FINDING', 30), ('ANOMALY_CURIOUS_FINDING', 43), ('PROBABLE_UNDERSTANDING', 189), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 234)]	5	[('UBERON_0000310', 'breast', 52, 'breast'), ('UBERON_0001913', 'milk', 59, 'milk'), ('UBERON_0000104', 'life cycle', 132, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0000310', 'breast', 248, 'breast'), ('GO_0007631', 'feeding behavior', 255, 'fed')]
PMC5014971	8/2016	S33-PMC5014971	['Vitamin D supplementation during Pregnancy is GENERALLY CONSIDERED SAFE, THOUGH rigorous studies on high doses of Vitamin D supplementation are LACKING [25].']	[('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('INCOMPLETE_EVIDENCE', 144)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5014971	8/2016	S123-PMC5014971	['the majority of respondents would consider screening for specific patient conditions (e.g., Gastric bypass surgery); a lesser proportion would consider screening BECAUSE of obesity or for african american women DESPITE both of these patient characteristics being KNOWN RISK FACTORS for INADEQUATE Vitamin D status.']	[('PROBLEM_COMPLICATION', 162), ('ANOMALY_CURIOUS_FINDING', 211), ('INCOMPLETE_EVIDENCE', 263), ('SUPERFICIAL_RELATIONSHIP', 269), ('IMPORTANT_CONSIDERATION', 286)]	5	[('UBERON_0001844', 'cochlea', 92, 'gastric'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC5035678	4/2016	S160-PMC5035678	['IN SPITE of these LIMITATIONS, THIS is currently the ONLY study in the literature that evaluates the INFLUENCE of Vitamin D supplementation during Pregnancy on Postpartum dysglycemia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0007565', 'female pregnancy', 160, 'postpartum')]
PMC5084016	10/2016	S170-PMC5084016	['a systematic review of the literature HIGHLIGHTED an INCREASED RISK of iron and Vitamin B 12 deficiency and low Birth weight in ASSOCIATION with vegetarian or strictly vegan diets, DESPITE the absence of adverse EFFECTS for the fetus [79].']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 128), ('ANOMALY_CURIOUS_FINDING', 181), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 80, 'vitamin B 12'), ('GO_0007567', 'parturition', 112, 'birth')]
PMC5085625	9/2016	S38-PMC5085625	['ALTHOUGH the biological ROLE of Vitamin D HAS BEEN studied extensively, the consequences of its deficiency for maternal, fetal and neonatal health are STILL UNCLEAR [4,22,24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 151)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5095257	11/2016	S82-PMC5095257	['this HYPOTHESIS is PARTICULARLY PLAUSIBLE in the case of aad because of the KNOWN ASSOCIATION of the disease with polymorphisms in both the Vitamin D Receptor ( Vdr ) Gene and the Cyp27B1 Gene encoding 1-α-hydroxylase converting 25-Hydroxyvitamin D into its active form 1,25-Dihydroxyvitamin D (8,27,33).']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 140, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 161, 'VDR'), ('SO_0000704', 'gene', 167, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 180, 'CYP27B1'), ('SO_0000704', 'gene', 188, 'gene'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 229, '25-hydroxyvitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 270, '1,25-dihydroxyvitamin D')]
PMC5095257	11/2016	S97-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period coupled with Vitamin D deficiency leading to dysregulation of innate immunity COULD BE the POTENTIAL initial triggers for the eventual development of aad, ALTHOUGH this REQUIRES FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 240)]	5	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5118763	12/2016	S184-PMC5118763	['the presence of OTHER Micronutrients in Mmns such as Vitamins C and a, which CAN improve the absorption of iron (26), MAY EXPLAIN this equivalence DESPITE the lower content of iron in the Mmn.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 147)]	5	[('CHEBI_33839', 'macromolecule', 22, 'micronutrients'), ('UBERON_0002544', 'digit', 40, 'MMNs'), ('CHEBI_27300', 'vitamin D', 53, 'vitamins C'), ('PR_000004900', 'complement C3', 62, 'C'), ('UBERON_0003109', 'parapophysis', 188, 'MMN')]
PMC5118763	12/2016	S203-PMC5118763	['in conclusion, women assigned to the mmn regimen had a higher concentration of Plasma Vitamin B-12, ALTHOUGH the PUBLIC HEALTH SIGNIFICANCE of the size of the EFFECT is UNCERTAIN.']	[('ANOMALY_CURIOUS_FINDING', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 127), ('SUPERFICIAL_RELATIONSHIP', 159), ('FULL_UNKNOWN', 169)]	5	[('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 86, 'vitamin B-12')]
PMC5129897	10/2016	S178-PMC5129897	['ANOTHER LIMITATION of clinical trials is that they are of short duration—GENERALLY a few months to a few years—YET chronic diseases MAY develop slowly over decades, and the half-life of Vitamin D is about 3\xa0weeks, requiring several months of supplementation to show benefit.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 73), ('ANOMALY_CURIOUS_FINDING', 111), ('INCOMPLETE_EVIDENCE', 132)]	5	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5137891	12/2016	S144-PMC5137891	['HOWEVER, SIMILAR TO the low levels of iron deficiency in our population ONLY 4% of women were Vitamin A deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ANOMALY_CURIOUS_FINDING', 72), ('INCOMPLETE_EVIDENCE', 72)]	5	[('CHEBI_27300', 'vitamin D', 94, 'vitamin A')]
PMC5146866	12/2016	S24-PMC5146866	['DESPITE numerous publications that explored Vitamin D status in cb, FURTHER RESEARCH is REQUIRED to determine the LIKELIHOOD for detection of Vitamin D insufficiency in cb of infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 114)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5146866	12/2016	S79-PMC5146866	['IMPORTANTLY, the upper limit of Vitamin D that is defined as sufficient [8] COULD BE SUBOPTIMAL BECAUSE Vitamin D levels of <30\xa0ng/ml have been ASSOCIATED with increased secretion of intact Parathyroid hormone and reduced Intestinal calcium absorption in healthy Adults [22,23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 85), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 190, 'parathyroid'), ('UBERON_0000160', 'intestine', 222, 'intestinal'), ('UBERON_0007023', 'adult organism', 263, 'adults')]
PMC5155676	12/2016	S22-PMC5155676	['during Pregnancy, maternal hemodilution is ACCOMPANIED by a number OF physiological changes to both Vitamin D Metabolism (15) and maternal body composition (16); such adaptations MIGHT lead to DIFFERENCES in the DETERMINANTS of response to Vitamin D supplementation between Pregnant and nonpregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 67), ('INCOMPLETE_EVIDENCE', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007601', 'visual perception', 100, 'vitamin D'), ('GO_0008152', 'metabolic process', 110, 'metabolism'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0007565', 'female pregnancy', 274, 'pregnant')]
PMC5155676	12/2016	S113-PMC5155676	['IMPORTANTLY, the difference between the 25(Oh)D achieved at 34 weeks of Gestation in women randomized to Placebo compared with Cholecalciferol decreased with increasing baseline 25(Oh)D. this is CONSISTENT with PREVIOUS STUDIES in Adults, which HAVE SHOWN that the incremental response to Vitamin D supplementation is higher in Vitamin D insufficient than replete subjects (13,14) and that the increase in 25(Oh)D relative to supplementation dose is negatively ASSOCIATED with dose of vitamin D supplement (26).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 461)]	5	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('GO_0007565', 'female pregnancy', 72, 'gestation'), ('CHEBI_26130', 'biological pigment', 105, 'placebo'), ('CHEBI_52550', 'theopalauamide', 127, 'cholecalciferol'), ('CHEBI_33010', 'chromide(1-)', 180, '(OH)D'), ('UBERON_0007023', 'adult organism', 231, 'adults'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 493, 'D')]
PMC5167470	12/2016	S100-PMC5167470	['in this regard, the most FREQUENTLY DESCRIBED maternal Micronutrient deficiency is that of Folic Acid, which entails a high risk of fetal Neural Tube defects.68moreover, there HAVE BEEN case reports of maternal and fetal hypercoagulability due to Vitamin K deficiency following bpd, Ophthalmic and Renal malformations due to SEVERE maternal and fetal Vitamin a deficiency, and megaloblastic anemia due to Vitamin B12 deficiency.69–71\n\nconclusion\nPregnancy after bs is SAFE, both for the mother and for the fetus.']	[('ANOMALY_CURIOUS_FINDING', 25), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 176), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 468)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 55, 'micronutrient'), ('CHEBI_30751', 'formic acid', 91, 'folic acid'), ('UBERON_0001049', 'neural tube', 138, 'neural tube'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin K'), ('UBERON_0000970', 'eye', 283, 'ophthalmic'), ('UBERON_0002113', 'kidney', 298, 'renal'), ('CHEBI_33229', 'vitamin (role)', 351, 'vitamin'), ('CHEBI_33279', 'vitamin D5', 405, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 405, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 446, 'Pregnancy')]
PMC5340372	3/2017	S147-PMC5340372	['ALTHOUGH Cord Vitamin D levels are STRONGLY CORRELATED with maternal Vitamin D levels, the extent of the IMPACT on later Respiratory function is DISTINCTIVE.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 35), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 145)]	5	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0045333', 'cellular respiration', 121, 'respiratory'), ('UBERON_0001004', 'respiratory system', 121, 'respiratory')]
PMC5351212	3/2017	S9-PMC5351212	['HOWEVER, Prenatal administration of Vitamin D had no effect on pro-inflammatory cytokine levels in dams or in fetal Brains SUGGESTING the anti-inflammatory actions of Vitamin d are not the CRITICAL mechanism for its preventive actions in this asd Animal MODEL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 123), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 254)]	5	[('GO_0007565', 'female pregnancy', 9, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000955', 'brain', 116, 'brains'), ('CHEBI_33229', 'vitamin (role)', 167, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 247, 'animal')]
PMC5372327	3/2017	S48-PMC5372327	['HOWEVER, findings have NOT been CONSISTENT [39] and RECENT STUDIES on Prenatal Vitamin D supplementation have not demonstrated an EFFECT on wheezing at 3\xa0years of age [40,41].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 130)]	5	[('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5405075	4/2017	S31-PMC5405075	['the most cited adverse outcome of maternal Vitamin D deficiency is neonatal rickets, WHILE mild hypovitaminosis D COULD BE more pronounced in exclusively Breast-Fed infants, on the BASIS that Breast Milk constitutes a POOR source of Vitamin D compared with formulas (34–36).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 181), ('IMPORTANT_CONSIDERATION', 218)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 112, 'D'), ('GO_0007567', 'parturition', 154, 'breast'), ('UBERON_0000310', 'breast', 154, 'breast'), ('GO_0007631', 'feeding behavior', 161, 'fed'), ('UBERON_0001348', 'brown adipose tissue', 192, 'breast milk'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC5418719	5/2017	S104-PMC5418719	['ALTHOUGH a number of Vitamin D deficiency was significantly lower after supplementation than before supplementation in the PRESENT STUDY, supplementation with 800\xa0iu MIGHT not be sufficient to achieve optimal Vitamin D levels in preterm infants with UNDERLYING level of Vitamin D deficiency from Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007567', 'parturition', 296, 'birth')]
PMC5489519	6/2017	S20-PMC5489519	['HOWEVER, it is UNKNOWN WHETHER Vitamin D deficiency in Lactating mothers Modulates the Expression of cellular factor(s) in Human Milk that is ASSOCIATED with Immune health and Skeletal Development in breastfeeding infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 55, 'lactating'), ('GO_0065007', 'biological regulation', 73, 'modulates'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001913', 'milk', 129, 'milk'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('GO_0001501', 'skeletal system development', 176, 'skeletal development'), ('UBERON_0004288', 'skeleton', 176, 'skeletal')]
PMC5513133	7/2017	S71-PMC5513133	['there is currently NOT enough data to strongly SUPPORT the HYPOTHESIS that impaired Angiogenesis EXPLAINS the ASSOCIATION between Vitamin D deficiency and pe [60].']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 59), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('GO_0001525', 'angiogenesis', 84, 'angiogenesis'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5513133	7/2017	S169-PMC5513133	['OF NOTE, Omega-3 Fatty Acids found along with Vitamin D in cod Liver oil are LIKELY to play an INDEPENDENT ROLE in PREVENTING pe [92,93].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 9, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002107', 'liver', 63, 'liver')]
PMC5579643	8/2017	S61-PMC5579643	['NEVERTHELESS, the POTENTIAL EFFECT of Vitamin D on Th1/Th2 Adaptive Immune Response is of INTEREST and RELATED to Food allergy [21,22,23].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 103)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0042639', 'telogen', 51, 'Th1 ...'), ('GO_0002290', 'gamma-delta T cell activation involved in immune response', 55, 'Th2 adaptive immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_33290', 'food', 114, 'food')]
PMC5659607	10/2017	S120-PMC5659607	['DESPITE these DIFFERENCES, the trials SIMILARLY SHOWED that the Vitamin D supplementation resulted in significantly increased post-interventional 25(Oh)D levels in the mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 48)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 146, '25(OH ... D')]
PMC5659607	10/2017	S125-PMC5659607	['finally, vdaart included a large group of african-american women in the trial, who are WELL-KNOWN to have a higher RISK of developing asthma and allergy[25] and had lower Vitamin D levels at randomization COMPARED to the OTHER ethnic groups[12].']	[('FUTURE_WORK', 87), ('PROBABLE_UNDERSTANDING', 92), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]
PMC5659607	10/2017	S144-PMC5659607	['we OBSERVED that the Vitamin D supplement resulted in a significant increase in post-interventional maternal 25(Oh)D level in both trials, BUT levels ≥ 30 ng/ml were ONLY achieved in 75% of the supplemented mothers in vdaart and 82% in copsac2010underscoring that too low a dose MAY have attenuated the trial results in both trials but to a greater extent in vdaart POSSIBLY because of the increased african american enrollment.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 139), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 366)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 109, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 109, '25(OH ... D')]
PMC5659607	10/2017	S154-PMC5659607	['Prenatal care STRATEGIES targeted at raising Vitamin D levels in Pregnant women SHOULD THEREFORE BE CONSIDERED.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 80), ('PROBABLE_UNDERSTANDING', 87), ('ANOMALY_CURIOUS_FINDING', 97), ('FUTURE_WORK', 100)]	5	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnant')]
PMC5679631	11/2017	S130-PMC5679631	['ALTHOUGH Vitamin D promotes Immune tolerance, adequate Adaptive Immune Response, as measured by Igg Production in response to infection or vaccination, HAS BEEN observed in patients with relatively high Serum 25(Oh)D levels, SUGGESTING that Vitamin D maintains Immune stability by preventing excessive Immune Responses in EITHER direction [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 322)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('GO_0002250', 'adaptive immune response', 55, 'adaptive immune response'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('GO_0032608', 'interferon-beta production', 96, 'IgG production'), ('GO_0071735', 'IgG immunoglobulin complex', 96, 'IgG'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('GO_0006955', 'immune response', 302, 'immune responses'), ('UBERON_0002405', 'immune system', 302, 'immune')]
PMC5707701	11/2017	S184-PMC5707701	['thirdly, SINCE our design was a cross-sectional study, we COULD NOT collect DIRECT EVIDENCE about changes in Vitamins A and E with Lactation stages.']	[('PROBLEM_COMPLICATION', 9), ('DIFFICULT_TASK', 58), ('ANOMALY_CURIOUS_FINDING', 64), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 83)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 109, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 124, 'E'), ('GO_0007595', 'lactation', 131, 'lactation')]
PMC5732505	12/2017	S136-PMC5732505	['INTERESTINGLY, Pregnancy Vitamin D status ASSOCIATED positively with Birth weight, BUT an inverse ASSOCIATION was OBSERVED between newborn Vitamin D status and Head circumference at Birth.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 114)]	5	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007567', 'parturition', 69, 'birth'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0000033', 'head', 160, 'head'), ('GO_0007567', 'parturition', 182, 'birth')]
PMC5732505	12/2017	S157-PMC5732505	['HOWEVER, the clinical RELEVANCE, if any, of the inverse RELATIONSHIP between maternal Vitamin D status and Head circumference at Birth REMAINS UNEXPLAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 143)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000033', 'head', 107, 'head'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5784894	1/2018	S138-PMC5784894	['IMPORTANTLY, and for the FIRST TIME, we have DEMONSTRATED that for those with early Life Vitamin D deficiency, the Anabolic response of bone to mechanical loading is reduced in Growing bone, AFFECTING both Cortical and Trabecular Bone, with the EFFECT on Cortical bone persisting into “Adult” Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 191), ('SUPERFICIAL_RELATIONSHIP', 245)]	5	[('UBERON_0000104', 'life cycle', 84, 'life'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 115, 'anabolic'), ('GO_0040007', 'growth', 177, 'growing'), ('UBERON_0001851', 'cortex', 206, 'cortical'), ('UBERON_0002483', 'trabecular bone tissue', 219, 'trabecular bone'), ('UBERON_0001851', 'cortex', 255, 'cortical'), ('UBERON_0007023', 'adult organism', 286, 'adult'), ('UBERON_0000104', 'life cycle', 293, 'life')]
PMC5812027	2/2018	S145-PMC5812027	['DESPITE FEW cases of iufd in the gravid cohort, our results SUGGEST that Vitamin D deficiency in early Pregnancy MAY BE LINKED to iufd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 120)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
PMC5941617	5/2018	S114-PMC5941617	['the IMPORTANCE of Vitamin D supplementation during the first year of Life HAS BEEN CONFIRMED by the FINDING that children not receiving supplementation have reduced Serum 25(Oh)d levels, PARTICULARLY if exclusively Breastfed and during winter season [94–96].']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 100), ('ANOMALY_CURIOUS_FINDING', 187)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('GO_0007567', 'parturition', 215, 'breastfed')]
PMC5941617	5/2018	S226-PMC5941617	['the global CONSENSUS on nutritional rickets RECOMMENDED the administration of 2000\xa0iu/day of Vitamin D in patients aged less than 1\xa0year, 3000–6000\xa0iu/day in patients aged 1 to 12\xa0years and 6000\xa0iu/day in patients older than 12\xa0years for a minimum of 3\xa0months, EVEN IF some children MAY require a longer treatment duration [28].']	[('PROBABLE_UNDERSTANDING', 11), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 261), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 266), ('INCOMPLETE_EVIDENCE', 283)]	5	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5941617	5/2018	S251-PMC5941617	['among these, three italian STUDIES assessed bone Mineral status in infants using quantitative ultrasound [201–203], SUGGESTING that Vitamin D supplementation is IMPORTANT to provide an adequate Bone Development, PARTICULARLY in exclusively breastfed infants.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 212), ('IMPORTANT_CONSIDERATION', 212)]	5	[('CHEBI_46662', 'mineral', 49, 'mineral'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0048539', 'bone marrow development', 194, 'bone development')]
PMC5941617	5/2018	S393-PMC5941617	['it is STILL a matter for full DEBATE WHETHER supplementation with Vitamin D in pediatric ad is WORTH, PARTICULARLY in deficient patients.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('ANOMALY_CURIOUS_FINDING', 95), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5941617	5/2018	S423-PMC5941617	['CONVERSELY, neonatal Vitamin D status SEEMS TO BE ASSOCIATED to the RISK of t1dm in some [382] BUT NOT all the populations [383].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5956785	5/2018	S21-PMC5956785	['CONSEQUENTLY, low Vitamin D concentrations are ASSOCIATED with an increase in pro-Inflammatory Mediators and more active disease [6,10] CONSISTENT, for example, with the OBSERVATION that low Serum 25(Oh)D is ASSOCIATED with increased disease activity in rheumatoid arthritis [11].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_64664', '(2-nitrophenyl)azo group', 81, '-inflammatory mediators'), ('UBERON_0001977', 'blood serum', 191, 'serum'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D')]
PMC1888711	5/2007	S123-PMC1888711	['Albendazole HAS BEEN SHOWN to reduce the decline in haemoglobin during Pregnancy, but there is NO CONCLUSIVE EVIDENCE for an EFFECT of Vitamin A or other Micronutrients on anemia during Pregnancy, PARTICULARLY when compared with Iron and Folate supplementation [60,61].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 197)]	4	[('CHEBI_16664', 'albendazole', 0, 'Albendazole'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_33839', 'macromolecule', 154, 'micronutrients'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_24870', 'ion', 229, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate')]
PMC2290997	4/2008	S104-PMC2290997	['EVEN in the sun-rich environment of the middle east, insufficient Vitamin D is a SEVERE PROBLEM among Breast-Fed infants of women who wear a burqa (a traditional garment that covers the body from Head to Foot), as reported in the february 2003 journal of pediatrics .']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 81), ('IMPORTANT_CONSIDERATION', 88), ('PROBLEM_COMPLICATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'breast'), ('GO_0007631', 'feeding behavior', 109, 'fed'), ('UBERON_0000033', 'head', 196, 'head'), ('UBERON_0002387', 'pes', 204, 'foot')]
PMC2582131	11/2008	S26-PMC2582131	['in the PRESENT STUDY, we EVALUATED the ASSOCIATION between maternal Plasma Vitamin D concentrations in early Pregnancy and subsequent risk of gdm based ON a prospective cohort study of Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 152)]	4	[('UBERON_0001969', 'blood plasma', 68, 'plasma'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('GO_0007565', 'female pregnancy', 185, 'pregnant')]
PMC2779500	11/2009	S42-PMC2779500	['for example, ALTHOUGH reduced mortality HAS BEEN SHOWN in hiv-positive children receiving Vitamin A supplementation [30], the administration of Vitamin A supplements to women has BEEN IMPLICATED in increased Vaginal Viral shedding (no effect on risk was observed from Vitamins B, C, and E) [31], a heightened risk of Mother-To-Child Hiv Transmission [32], and hastened progression of child mortality [30].']	[('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 40), ('ANOMALY_CURIOUS_FINDING', 179), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin A'), ('UBERON_0001987', 'placenta', 208, 'vaginal'), ('NCBITaxon_1', 'root', 216, 'viral'), ('CHEBI_27300', 'vitamin D', 268, 'vitamins B'), ('PR_000000037', 'BMP receptor type-2', 277, 'B'), ('CHEBI_18245', 'carboxylato group', 280, 'C'), ('PR_000004900', 'complement C3', 280, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 287, 'E'), ('GO_0048870', 'cell motility', 317, 'mother-to-child'), ('GO_0007228', 'positive regulation of hh target transcription factor activity', 333, 'HIV transmission')]
PMC2821652	2/2010	S29-PMC2821652	['DESPITE an expanding Intravascular volume during Pregnancy, maternal Vitamin D status SHOWS seasonal variation but beyond the typical FACTORS that INFLUENCE Vitamin D status in Adults (such as sunlight exposure and bmi), Vitamin D status does not fluctuate during Pregnancy and once supplemented, maternal Blood levels reach steady-state within 2 months [15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('GO_0005622', 'intracellular anatomical structure', 21, 'intravascular'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy'), ('UBERON_0000178', 'blood', 306, 'blood')]
PMC2963768	10/2010	S0-PMC2963768	['Vitamin D status of infants in northeastern rural bangladesh: preliminary observations and a review of potential determinants\n\nabstract\nVitamin D deficiency is a GLOBAL PUBLIC-HEALTH CONCERN, EVEN in tropical regions where the risk of deficiency was PREVIOUSLY ASSUMED to be low due to cutaneous Vitamin D Synthesis stimulated by exposure to sun.']	[('IMPORTANT_CONSIDERATION', 162), ('ANOMALY_CURIOUS_FINDING', 192), ('INCOMPLETE_EVIDENCE', 250), ('PROBABLE_UNDERSTANDING', 261)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 136, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 296, 'vitamin D synthesis')]
PMC2963768	10/2010	S72-PMC2963768	['in this group, age was the ONLY FACTOR that was significantly ASSOCIATED with Vitamin D deficiency DEFINED by 25(Oh)D <25 nmol/l (table 3).']	[('ANOMALY_CURIOUS_FINDING', 27), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 62), ('PROBABLE_UNDERSTANDING', 99)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 110, '25(OH ... D')]
PMC2963768	10/2010	S154-PMC2963768	['THEREFORE, RECOMMENDATIONS for universal Antenatal and/or infant Vitamin D supplementation in bangladesh BASED ON biochemical data ALONE would be premature.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 131)]	4	[('GO_0007567', 'parturition', 41, 'antenatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3004407	12/2010	S21-PMC3004407	['THEORETICALLY, women at lower latitudes, DESPITE darker pigmentation, SHOULD have less Vitamin D deficiency because of the greater LIKELIHOOD of effective sunlight exposure to induce endogenous Vitamin d synthesis [33].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 41), ('FUTURE_WORK', 70), ('PROBABLE_UNDERSTANDING', 131)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3004407	12/2010	S24-PMC3004407	["it was HYPOTHESIZED that DESPITE south carolina's lower latitude and abundance of sunlight, given modern-day lifestyles that OFTEN PRECLUDE sunlight exposure, the majority of the women presenting for obstetrical care at this community health center network would have Vitamin D insufficiency and a significant number would have outright Vitamin D deficiency."]	[('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 25), ('PROBABLE_UNDERSTANDING', 125), ('DIFFICULT_TASK', 131)]	4	[('CHEBI_27300', 'vitamin D', 268, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 337, 'vitamin D')]
PMC3004407	12/2010	S95-PMC3004407	['the odds of Vitamin D deficiency (AS measured by 25(Oh)D concentration) did NOT APPEAR TO change as a function of Gestational age; women in their later stages of Pregnancy had a SIMILAR odds of Vitamin D deficiency and insufficiency for a given race/ethnicity than women who had their 25(Oh)D concentrations measured earlier in Pregnancy ( p = .43).']	[('PROBABLE_UNDERSTANDING', 34), ('ANOMALY_CURIOUS_FINDING', 76), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 285, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 291, 'D'), ('GO_0007565', 'female pregnancy', 328, 'pregnancy')]
PMC3032617	5/2010	S99-PMC3032617	['in the case of children Born with a body weight lower than 2500g, the significant difference FOUND among groups in favor of the Vitamin C women is INTRIGUING as it CAN be INTERPRETED as more and better energy supply to child during Gestation.']	[('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 171)]	4	[('GO_0007567', 'parturition', 24, 'born'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin C'), ('GO_0007565', 'female pregnancy', 232, 'gestation')]
PMC3034879	12/2010	S1-PMC3034879	['Postnatal Vitamin D supplementation improved Vitamin D status BUT ONLY PARTLY eliminated the differences in bone variables induced by maternal Vitamin D status during the fetal period.']	[('ANOMALY_CURIOUS_FINDING', 62), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 71)]	4	[('GO_0007567', 'parturition', 0, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3034879	12/2010	S179-PMC3034879	['INTERESTINGLY, the use of d3supplements was ASSOCIATED with improved Vitamin D status to a greater extent than use of d2supplements, which is IN LINE WITH FINDINGS of houghton and vieth [38].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3075531	7/2010	S47-PMC3075531	['third, ms risk SEEMS to decrease with migration from high to low latitudes.15If Vitamin D had any EFFECT on ms risk, we WOULD EXPECT ms incidence to decrease with increasing 25-Hydroxyvitamin D concentrations.']	[('ANOMALY_CURIOUS_FINDING', 15), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_PREDICTION', 120), ('FUTURE_PREDICTION', 126)]	4	[('CHEBI_33995', '(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene', 75, '15If'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 174, '25-hydroxyvitamin D')]
PMC3103150	3/2011	S41-PMC3103150	['these definitions are based ON recent RECOMMENDATIONS regarding classification of Vitamin D status in children, developed after consideration of BIOMARKERS such as changes in alp, bone density and calcium absorption at varying concentrations of 25Ohd16.']	[('ANOMALY_CURIOUS_FINDING', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_63310', 'mycinamicin IV(1+)', 245, '25OHD16')]
PMC3257641	3/2010	S45-PMC3257641	['NEVERTHELESS, low Vitamin D status is also PREVALENT in Pregnant caucasian populations, PARTICULARLY those not receiving supplementation (table 2).nutrients-02-00389-t002_table 2\n\ncaption (table-wrap): table 2\n\nthe prevalence of a low Vitamin D status in Pregnancy.referenceyearcountrypopulationstage Of Pregnancydefinition% n/n[127]1997iraniran women attending largest tehran hospitaldelivery<25 nmol/l80% (40/50)[128]1997-2001usaafrican american–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l44.9% (89/194)[128]1997-2001usawhite–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l2% (4/199)[128]1997-2001usaafrican–american37-42 weeks<37.5 nmol/l29.2% (54/185)[128]1997-2001usawhite37-42 weeks<37.5 nmol/l5% (10/199)[128]1997-2001usaturkish12 week Gestation<25 nmol/l83.5% (66/79)[128]1997-2001usamoroccan12 week Gestation<25 nmol/l81.2% (56/69)[128]1997-2001usaother non-western12 week Gestation<25 nmol/l59% (62/105)[129]1999irelandcaucasians in ulster–on supplements (54–55on)12 weeks<25 nmol/l4.5% (1/22)[129]1999irelandno supplements12 weeks<25 nmol/l44.2% (34/77)[129]1999irelandsupplements20 weeks<25 nmol/l22.7% (5/22)[129]1999irelandno supplements20 weeks<25 nmol/l50.6% (39/77)[129]1999irelandsupplements35 weeks<25 nmol/l0% (0/22)[129]1999irelandno supplements35 weeks<25 nmol/l20.8% (16/77)[32]1999-2000australiaveiled &/or dark skinned women attending Antenatal clinicduring Antenatal care, when a routine Blood test was ordered<22.5 nmol/l80.5% (66/82)[130]1999-2000united arab emirateskuwaitdelivery<25 nmol/l40% (86/214)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india – urbandelivery–full term, live<22.5 nmol/l84.3% (118/140)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india–urbanrural<56.3 nmol/l84%(56/67)[132]2005-2006indiaresidents of barabanki district, 26.8onsecond trimester<50 nmol/l74.1% (103/139)\n\n4.1.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 43), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('GO_0007308', 'oocyte construction', 301, 'of PregnancyDefinition'), ('GO_0007565', 'female pregnancy', 462, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 471, 'vitamins4'), ('GO_0007565', 'female pregnancy', 489, 'gestation'), ('GO_0007565', 'female pregnancy', 561, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 570, 'vitamins4'), ('GO_0007565', 'female pregnancy', 588, 'gestation'), ('GO_0007565', 'female pregnancy', 777, 'gestation'), ('GO_0007565', 'female pregnancy', 842, 'gestation'), ('GO_0007565', 'female pregnancy', 916, 'gestation'), ('GO_0007567', 'parturition', 1394, 'antenatal'), ('GO_0007567', 'parturition', 1417, 'antenatal'), ('UBERON_0000178', 'blood', 1448, 'blood')]
PMC3257641	3/2010	S150-PMC3257641	['EVEN with these trials (mostly of high risk women, many years ago) being systematically reviewed, it APPEARS that there is NOT ENOUGH EVIDENCE to evaluate the EFFECTS of Vitamin D supplementation in Pregnancy [124].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 101), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 159)]	4	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC3271033	1/2012	S140-PMC3271033	['HOWEVER, it APPEARS that, AT LEAST in a southern us setting, 400 iu/day is adequate for infants REGARDLESS OF Vitamin D status at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth')]
PMC3277098	12/2011	S25-PMC3277098	['WHILE the incidence of rickets has been largely reduced in western countries through the use of dietary supplementation and uv exposure [12], the same societies continue to experience a high prevalence of sub-clinical Vitamin D deficiency or insufficiency [13] that is LIKELY RELATED to indoor lifestyle habits with limited sun exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 269), ('SUPERFICIAL_RELATIONSHIP', 276)]	4	[('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC3277098	12/2011	S42-PMC3277098	['the resulting th2 relative dominance HAS BEEN used as an explanation for the earlier OBSERVATION (1990’s) that the rise in allergic disease COINCIDED with the introduction of routine Vitamin D fortification in high latitude regions [16,17].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC3277098	12/2011	S109-PMC3277098	['FOUND Vitamin D to BE inversely ASSOCIATED with wheeze in japanese children aged 16–24 months, an ASSOCIATION that was no longer significant when adjusted for Docosahexaenoic Acid Intake [51].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_36003', 'decenoic acid', 159, 'docosahexaenoic acid'), ('GO_0007631', 'feeding behavior', 180, 'intake')]
PMC3319623	4/2012	S59-PMC3319623	['INTERESTINGLY, SEVERAL LINES OF EVIDENCE now SUPPORT a ROLE for Vitamin D deficiency in the pathogenesis of psychiatric conditions, in particular schizophrenia[25].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3347028	3/2012	S40-PMC3347028	['WHILE there APPEARS TO BE a DIFFERENTIAL conversion rate of the two forms of Vitamin D to 25(Oh)D [8], the conversion of either form is DEPENDENT on a functional Liver and the activity of 25-hydroxylase.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('UBERON_0002107', 'liver', 162, 'liver')]
PMC3347028	3/2012	S140-PMC3347028	['for those areas of the world with higher rates of deficiency, it APPEARS that a long-standing unawareness of HOW Vitamin D is made and of the short and long-term health CONSEQUENCES of Vitamin D insufficiency has LED TO widespread insufficiencies in most populations.']	[('ANOMALY_CURIOUS_FINDING', 65), ('EXPLICIT_QUESTION', 109), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 213)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3347028	3/2012	S238-PMC3347028	['in the last five years, there has been an explosion of published data concerning the Immune EFFECTS of Vitamin D, YET LITTLE IS KNOWN in this regard about the specific Immune EFFECTS of Vitamin D during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('ANOMALY_CURIOUS_FINDING', 114), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 175)]	4	[('UBERON_0002405', 'immune system', 85, 'immune'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 168, 'immune'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC3348565	4/2012	S23-PMC3348565	['in children, Serum Calcifediol concentrations SHOULD BE maintained at 50 nmol/l (20 ng/ml) or greater for Skeletal benefits.6vitamin D deficiency rickets in children younger than 5 years is an endemic PROBLEM in developing countries, ranging from 5–45%, EVEN where sunlight is abundant,1,2,7,8and has also re-emerged in SOME developed countries.7,9\nin People, the main source of Vitamin D is through the action of ultraviolet b radiation on 7-Dehydrocholesterol in the skin, with small amounts derived from dietary sources.']	[('FUTURE_WORK', 46), ('PROBLEM_COMPLICATION', 201), ('ANOMALY_CURIOUS_FINDING', 254), ('INCOMPLETE_EVIDENCE', 320)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 19, 'calcifediol'), ('UBERON_0004288', 'skeleton', 106, 'skeletal'), ('PR_000006444', 'diacylglycerol kinase delta', 133, 'D'), ('NCBITaxon_10088', 'Mus <genus>', 352, 'people'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 441, '7-dehydrocholesterol')]
PMC3348565	4/2012	S115-PMC3348565	['AS WITH OTHER STUDIES, dietary calcium deficiency MIGHT have led to so-called wastage of body stores of Vitamin D in both groups, AFFECTING the maintenance of EVEN higher Vitamin D levels in the intervention group.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 130), ('ANOMALY_CURIOUS_FINDING', 159)]	4	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3407995	7/2012	S444-PMC3407995	['there HAS BEEN little toxicity REPORTED in Adults taking doses of Vitamin D as high as 10,000 iu/day (250 µg/day) of Vitamin d [176,177,178] ALTHOUGH toxicity becomes GENERALLY present at 20,000 iu/day (500 µg/day).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 141), ('PROBABLE_UNDERSTANDING', 167)]	4	[('UBERON_0007023', 'adult organism', 43, 'adults'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 117, 'vitamin')]
PMC3424155	8/2012	S166-PMC3424155	['a RECENT STUDY of Pregnant women in europe REPORTED that ONLY 12% had an OPTIMAL level of Vitamin D[20].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 57), ('IMPORTANT_CONSIDERATION', 73)]	4	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3427192	4/2012	S36-PMC3427192	['Vitamin D in school-aged children with asthma\nseveral RECENT STUDIES HAVE SHOWN ASSOCIATIONS between Vitamin D status and asthma outcomes in school-age children (table 2), ALTHOUGH there is considerable variation between the study populations.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 80), ('ANOMALY_CURIOUS_FINDING', 172)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3427250	8/2012	S116-PMC3427250	['the adequate intake of Vitamin D during Pregnancy and Lactation is UNKNOWN, ALTHOUGH it APPEARS TO BE greater than the current dietary RECOMMENDATIONS of 400 iu/d or 10 µg/d[58].']	[('FULL_UNKNOWN', 67), ('ANOMALY_CURIOUS_FINDING', 76), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 135)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007595', 'lactation', 54, 'lactation')]
PMC3458940	9/2012	S20-PMC3458940	['EVEN mild Gestational Vitamin A deficiency LEADS to a deficit in Nephron number, which MAY predispose the Kidney to abnormal development or function when ASSOCIATED with other morbidities[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 154)]	4	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001285', 'nephron', 65, 'nephron'), ('UBERON_0002113', 'kidney', 106, 'kidney')]
PMC3465343	10/2012	S190-PMC3465343	['moreover, EFFECTS of partial INSTEAD of absolute deprivation of Vitamin A on Spine malformation SHOULD also BE examined.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('UBERON_0001013', 'adipose tissue', 77, 'spine')]
PMC3472720	8/2012	S3-PMC3472720	['UNEXPECTEDLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'mice')]
PMC3476426	8/2012	S2-PMC3476426	['immunomodulatory EFFECTS of Vitamin D MAY act NOT ONLY through Modulation of T-Helper Cell function, BUT ALSO through induction of Cd4+Cd25Highregulatory T-Cells.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 46), ('ANOMALY_CURIOUS_FINDING', 101)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0065007', 'biological regulation', 63, 'modulation'), ('CL_0000912', 'helper T cell', 77, 'T-helper cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 131, 'CD4'), ('PR_000005166', 'CMRF35-like molecule 7', 135, 'CD25highregulatory'), ('CL_0000084', 'T cell', 154, 'T-cells')]
PMC3476426	8/2012	S131-PMC3476426	['we could NOT trace data in the literature concerning the POSSIBLE contributing ROLE of 25-Hydroxy Vitamin D deficiency in the induction of the production of Brain-specific auto-Antibodies in SOME autistic children to compare our results.']	[('ANOMALY_CURIOUS_FINDING', 9), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 191)]	4	[('CHEBI_43141', '3-hydroxypropoxy group', 87, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0000955', 'brain', 157, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibodies')]
PMC3515553	12/2012	S20-PMC3515553	['additionally, non-synonymous polymorphisms in the tcn2 Gene (rs1801198, 776c>g, p259r; rs9606756, 67a>g, i23v), that codes for the Transcobalamin Ii protein, HAVE BEEN ASSOCIATED with differences in the holotranscobalamin and total transcobalamin fractions of Vitamin B-12 and total Hcy concentration[3],[13]–[16], ALTHOUGH their EFFECTS are not fully established[16].']	[('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 315), ('SUPERFICIAL_RELATIONSHIP', 330)]	4	[('SO_0000704', 'gene', 55, 'gene'), ('PR_000016009', 'tumor-associated calcium signal transducer 2', 131, 'transcobalamin II'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 260, 'vitamin B-12'), ('CHEBI_37958', 'dye', 283, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 283, 'Hcy')]
PMC3515553	12/2012	S150-PMC3515553	['we DID NOT uncover any association between child’s genotype at Vitamin B-12 related variants and iq DESPITE FINDING an ASSOCIATION between offspring genotype and Cord Blood Vitamin B-12 concentration.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 100), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 63, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 173, 'vitamin B-12')]
PMC3515553	12/2012	S154-PMC3515553	['YET, LITTLE IS KNOWN about the INFLUENCE that low Plasma Vitamin B-12 during Pregnancy MAY have on the Cognitive ability of children later in Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 87)]	4	[('UBERON_0001969', 'blood plasma', 50, 'plasma'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 57, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0050890', 'cognition', 103, 'cognitive'), ('UBERON_0000104', 'life cycle', 142, 'life')]
PMC3534399	10/2012	S169-PMC3534399	['a single trial (in hiv-infected mothers) has investigated a LIMITED range of T-Cell subsets in Pregnancy, but not in the offspring, and FOUND that limited mmn supplementation (Vitamins B, c and e), BUT NOT Vitamin A alone, increased cd4+ and cd8+ counts [25].']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('ANOMALY_CURIOUS_FINDING', 202)]	4	[('CL_0000084', 'T cell', 77, 'T-cell'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 176, 'vitamins B'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A')]
PMC3552819	12/2012	S221-PMC3552819	['LIKEWISE, we DID NOT document any NOTABLE Pregnancy-related hypersensitivity to a Vitamin D dose of 70,000 iu in terms of its EFFECTS on calcium Homeostasis.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0042592', 'homeostatic process', 145, 'homeostasis')]
PMC3599191	1/2013	S118-PMC3599191	['EVEN the lack of OTHER micro-Nutrients such as Selenium, Vitamins E, d and c, zinc and Folic Acid is RESPONSIBLE for the onset of disorders AFFECTING the Respiratory System in the offspring [46].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_33284', 'nutrient', 29, 'nutrients'), ('CHEBI_27568', 'selenium atom', 47, 'selenium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamins E'), ('CHEBI_30751', 'formic acid', 87, 'folic acid'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory system')]
PMC3613945	2/2013	S67-PMC3613945	['the ROLE of dbp as a C5A Adjuvant is APPARENTLY NOT strictly Vitamin D independent as 1,25(Oh)2D3Can mitigate the synergistic EFFECT of dbp and c5a60.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 37), ('ANOMALY_CURIOUS_FINDING', 48), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('PR_000002319', 'catenin beta-1 isoform 1', 21, 'C5a'), ('CHEBI_60809', 'adjuvant', 25, 'adjuvant'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_83135', '(S)-penflufen', 86, '1,25(OH)2D3can')]
PMC3613945	2/2013	S163-PMC3613945	['a RECENT prospective STUDY examining more than 6100 elderly caucasians FOUND no association between dbp phenotype and osteoporosis; HOWEVER, a 33% increased risk of fracture was detected in gc1s carriers homozygous for polymorphisms in the 3′ Untranslated Region (Utr) of the Vitamin D Receptor ( vdr ) in haploblock 5 compared with non-carriers ( p \u2009=\u20090.005)88.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132)]	4	[('SO_0000205', 'three_prime_UTR', 240, '3′ untranslated region'), ('GO_0006309', 'apoptotic DNA fragmentation', 243, 'untranslated'), ('SO_0000203', 'UTR', 264, 'UTR'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 276, 'vitamin D receptor')]
PMC3613945	2/2013	S187-PMC3613945	['REPORTED no association between ultraviolet radiation (uvr) or Vitamin D Serum levels; YET, cod Liver oil supplementation earlier in Life was ASSOCIATED with an INCREASED risk of asthma112.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 87), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('UBERON_0002107', 'liver', 96, 'liver'), ('UBERON_0000104', 'life cycle', 133, 'life')]
PMC3613945	2/2013	S211-PMC3613945	['MUCH work HAS BEEN done to elucidate a Vitamin D-RELATED mechanistic ROLE in Breast cancer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 69)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0000310', 'breast', 77, 'breast')]
PMC3629265	4/2013	S1-PMC3629265	['DESPITE this long history, Vitamin D deficiency REMAINS a significant health CONCERN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 77)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3629265	4/2013	S16-PMC3629265	['DESPITE the long history of recognition of this PROBLEM, Vitamin D deficiency continues to remain a SIGNIFICANT health ISSUE (4–12).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3641012	4/2013	S238-PMC3641012	['Vitamin D DID NOT affect average Urinary Calcium Excretion, YET we did see a SMALL but significant increase in the mean adj-ca in the Vitamin D group COMPARED TO the placebo group.']	[('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 60), ('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001088', 'urine', 33, 'urinary'), ('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('GO_0036161', 'calcitonin secretion', 41, 'calcium excretion'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3641012	4/2013	S252-PMC3641012	['as well, we DID NOT calculate total intake of Vitamin D DUE TO the LACK OF adequate information regarding Vitamin D content in the bangladeshi Food supply.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBLEM_COMPLICATION', 56), ('PROBLEM_COMPLICATION', 67), ('ANOMALY_CURIOUS_FINDING', 72)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33290', 'food', 143, 'food')]
PMC3659910	1/2013	S99-PMC3659910	['women who have Vitamin D deficiency do not USUALLY feel any different BUT in SOME MAY have muscle weakness and weakened Bones.']	[('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 70), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 82)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001474', 'bone element', 120, 'bones')]
PMC3659910	1/2013	S146-PMC3659910	['[34] INTERESTINGLY, Vitamin D deficiency during Pregnancy is also ASSOCIATED with RISKS of health PROBLEMS later in childhood, including improper Bone Development at 9 yrs of age, asthma,[36] Dental Cavities, schizophrenia, and type i diabetes.']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 82), ('IMPORTANT_CONSIDERATION', 98)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('GO_0048539', 'bone marrow development', 146, 'bone development'), ('UBERON_0001076', 'neural spine', 192, 'dental cavities')]
PMC3668200	5/2013	S29-PMC3668200	['ON the CONTRARY, Vitamin D content of the Breast Milk does not meet the REQUIRED daily amount for the infants DESPITE adequate dietary supplementation of Vitamin D12), because this supplementing does not substantially increase the Vitamin D concentration in Human milk13).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 110)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 42, 'breast milk'), ('CHEBI_33279', 'vitamin D5', 154, 'vitamin D12'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 258, 'human')]
PMC3668200	5/2013	S39-PMC3668200	['DESPITE SEVERE maternal Vitamin D deficiency, fetal rickets MAY RARELY develop.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3672018	5/2013	S24-PMC3672018	['ALTHOUGH adequate exposure to uvb sunlight is PARAMOUNT to an ample supply of Vitamin D, Oral Intake, augmented by both fortification and supplementation, is NECESSARY to maintain baseline stores in populations at high latitudes were the sun can only drive dermal Synthesis Of Vitamin D from april to october [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 158)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000165', 'mouth', 89, 'oral'), ('GO_0007631', 'feeding behavior', 94, 'intake'), ('GO_0030474', 'spindle pole body duplication', 264, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 285, 'D')]
PMC3672018	5/2013	S148-PMC3672018	['the use of 50,000-100,000 Individuals from adjacent Birth years in the general population studies of events like fractures and diagnosis of t1d, a pivotal strength of THIS STUDY, makes it possible to detect EVEN minor EFFECTS of Vitamin D.\nFood disappearance statistics SHOW that Margarine Intake decreased and low fat milk slightly increased during the period covered.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('ANOMALY_CURIOUS_FINDING', 207), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 270)]	4	[('NCBITaxon_1', 'root', 26, 'individuals'), ('GO_0007567', 'parturition', 52, 'birth'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_33290', 'food', 240, 'Food'), ('CHEBI_6784', 'mestranol', 280, 'margarine'), ('GO_0007631', 'feeding behavior', 290, 'intake')]
PMC3672018	5/2013	S175-PMC3672018	['Growth and Pubertal Development, POSSIBILITY RELATED to Vitamin D exposures in early Life, PERHAPS EVEN before Conception, in addition to the outcomes studied.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 91), ('ANOMALY_CURIOUS_FINDING', 99)]	4	[('GO_0040007', 'growth', 0, 'growth ...'), ('GO_0060021', 'roof of mouth development', 11, 'pubertal development'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000104', 'life cycle', 85, 'life'), ('GO_0007620', 'copulation', 111, 'conception')]
PMC3672018	5/2013	S179-PMC3672018	['results from this study are LIKELY to CONSIDERABLY increase our current understanding of the SIGNIFICANCE of early Vitamin D intake in RELATION to later health.']	[('PROBABLE_UNDERSTANDING', 28), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 93), ('SUPERFICIAL_RELATIONSHIP', 135)]	4	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3705146	5/2013	S28-PMC3705146	['EVEN in the far reaches of populations in the arctic circle, the IMPACT of low light on skin type prevalence (karlsson et al.,2000) was not so extreme, MOST LIKELY BECAUSE a diet rich in Vitamin D from seafood helped to mitigate the lack of sun.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 152), ('PROBABLE_UNDERSTANDING', 164)]	4	[('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3705146	5/2013	S195-PMC3705146	['ALTHOUGH sunlight-induced Vitamin D is not an IMPORTANT source of Vitamin D for lower Animals, it HAS BEEN SHOWN that Prenatal dietary Vitamin D in sprague-dawley Rats has significant EFFECTS on Postnatal anxiety and social behaviors (pan et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 86, 'animals'), ('GO_0007565', 'female pregnancy', 118, 'prenatal'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 163, 'rats'), ('GO_0007567', 'parturition', 195, 'postnatal')]
PMC3713405	7/2013	S144-PMC3713405	['dvd-deficient e12 Embryos show decreased Gene Expression of nurr1, P57Kip2 and th (cui et al., 2010) SUGGESTING altered Vitamin D Signaling AFFECTS early Monoamine Cell Development, PERHAPS EVEN prior to e12.']	[('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 190)]	4	[('UBERON_0000922', 'embryo', 18, 'embryos'), ('GO_0010467', 'gene expression', 41, 'gene expression'), ('SO_0000704', 'gene', 41, 'gene'), ('PR_000004267', 'AT-rich interactive domain-containing protein 4A', 67, 'p57Kip2'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0043931', 'ossification involved in bone maturation', 120, 'vitamin D signaling'), ('CHEBI_17134', 'octopamine', 154, 'monoamine'), ('GO_0048468', 'cell development', 164, 'cell development')]
PMC3717170	5/2013	S1-PMC3717170	['the POSSIBILITY of Extraskeletal EFFECTS of Vitamin D was FIRST NOTED with the discovery of the Vitamin D Receptor (vdr) in Tissues and cells that are not involved in maintaining Mineral Homeostasis and bone health, including skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 64)]	4	[('UBERON_0001431', 'distal carpal bone 2', 19, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 96, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 124, 'tissues'), ('CHEBI_46662', 'mineral', 179, 'mineral'), ('GO_0055085', 'transmembrane transport', 179, 'mineral homeostasis'), ('UBERON_0001987', 'placenta', 232, 'placenta'), ('UBERON_0001264', 'pancreas', 242, 'pancreas'), ('UBERON_0000310', 'breast', 252, 'breast'), ('UBERON_0002367', 'prostate gland', 260, 'prostate'), ('UBERON_0001155', 'colon', 273, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 297, 'activated T cells')]
PMC3717170	5/2013	S21-PMC3717170	['UNLIKE the ASSOCIATION between Vitamin D deficiency and rickets, causal LINKS between Vitamin D deficiency and specific Extraskeletal diseases have YET to be identified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 148)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 120, 'extraskeletal')]
PMC3717170	5/2013	S109-PMC3717170	['after stratification for Vitamin D deficiency, the CORRELATIONS PERSISTED ONLY in the patients with Vitamin D deficiency: fev1 ( r = 0.37, p< 0.01;fig.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 64), ('ANOMALY_CURIOUS_FINDING', 74), ('INCOMPLETE_EVIDENCE', 74)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3717170	5/2013	S186-PMC3717170	['RECOMMENDATIONS for the appropriate amount of Vitamin D to be taken for OPTIMAL health—BE it for Musculoskeletal strength OR for the numerous nonskeletal presumptive benefits of Vitamin D—remain contentious.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 97, 'musculoskeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3728489	7/2013	S319-PMC3728489	['fish oil (that commonly contains Vitamin D) and OTHER omega 3 Fatty Acid supplements taken in infancy HAVE BEEN ASSOCIATED with improved Cognitive development, THOUGH this evidence is also far from definitive (auestad et al.,2003; karr et al.,2011; meldrum et al.,2012; luchtman and song,2013).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acid'), ('GO_0050890', 'cognition', 137, 'cognitive')]
PMC3734354	7/2013	S43-PMC3734354	['WHILE many Nutrients have a ROLE to play in Brain Development, certain ones SEEM TO BE of particular IMPORTANCE during fetal and neonatal life: protein, iron, zinc, Selenium, Iodine, Folate, Vitamin A, Choline, and Long-Chain polyunsaturated Fatty Acids (lcpufas) (georgieff,2007).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 76), ('IMPORTANT_CONSIDERATION', 101)]	4	[('CHEBI_33284', 'nutrient', 11, 'nutrients'), ('GO_0007420', 'brain development', 44, 'brain development'), ('UBERON_0000955', 'brain', 44, 'brain'), ('CHEBI_27568', 'selenium atom', 165, 'selenium'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_15354', 'choline', 202, 'choline'), ('CHEBI_28911', 'cob(III)alamin', 215, 'long-chain'), ('CHEBI_35366', 'fatty acid', 242, 'fatty acids')]
PMC3760821	9/2013	S154-PMC3760821	['maternal Vitamin D levels were also found to EXHIBIT a significant negative RELATIONSHIP with hba1clevels, SUPPORTING a ROLE for this Vitamin in maintaining Glycaemic Control.']	[('ANOMALY_CURIOUS_FINDING', 45), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 134, 'vitamin'), ('GO_0051162', 'L-arabitol metabolic process', 157, 'glycaemic control')]
PMC3798907	8/2013	S17-PMC3798907	['ALTHOUGH keen to conduct such an intervention trial we considered it IMPORTANT to conduct PRELIMINARY work to justify/REFUTE the use of Vitamin E supplements for several reasons.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	4	[('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3798907	8/2013	S66-PMC3798907	['note that, EVEN where significant EFFECTS were seen, there was considerable Individual VARIATION in the EFFECTS of Vitamin E between different cbmc samples.']	[('ANOMALY_CURIOUS_FINDING', 11), ('SUPERFICIAL_RELATIONSHIP', 34), ('DIFFICULT_TASK', 87), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('NCBITaxon_1', 'root', 76, 'individual'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin E')]
PMC3798907	8/2013	S93-PMC3798907	['it can be seen that the EFFECTS of Vitamin E supplementation on cbmc responses to these Allergens were GENERALLY inhibitory, with the NOTABLE EXCEPTIONS of stronger Proliferation to tg and increased secretion of the Regulatory cytokine Tgf-Β in cultures stimulated with either hdm or tg.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 103), ('ANOMALY_CURIOUS_FINDING', 134), ('ANOMALY_CURIOUS_FINDING', 142)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin E'), ('CHEBI_33663', 'cyclic hydrocarbon', 88, 'allergens'), ('GO_0008283', 'cell proliferation', 165, 'proliferation'), ('GO_0065007', 'biological regulation', 216, 'regulatory'), ('PR_000000046', 'TGF-beta', 236, 'TGF-β')]
PMC3814422	10/2013	S136-PMC3814422	["in SUPPORT of this, it is NOTABLE that analysis of the ASSOCIATION of maternal dietary Vitamin D with offspring asthma, wheeze and atopy in both the southampton women's survey13and alspac30failed to demonstrate an ASSOCIATION."]	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3829803	11/2013	S163-PMC3829803	['IN FACT, both Vitamin A supplementation and therapy APPEAR TO have SIGNIFICANT clinical BENEFIT in natural Mev infection [16]–[19,21].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 52), ('IMPORTANT_CONSIDERATION', 67), ('IMPORTANT_CONSIDERATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 107, 'MeV')]
PMC3829803	11/2013	S165-PMC3829803	['ALTHOUGH reduced mortality from diarrheal disease is ASSOCIATED with Vitamin A supplements in children of the developing world this BENEFIT APPEARS TO BE due largely to milder bacterial infections [14,62,63].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 132), ('ANOMALY_CURIOUS_FINDING', 140)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A')]
PMC3873449	12/2013	S39-PMC3873449	['there is considerable INTEREST in FACTORS that MAY INFLUENCE Vitamin D status in chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant')]
PMC3873449	12/2013	S177-PMC3873449	['higher amounts of Vitamin D MAY BE REQUIRED, THOUGH the precise dose REMAINS UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('ANOMALY_CURIOUS_FINDING', 45), ('FULL_UNKNOWN', 69)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3873449	12/2013	S187-PMC3873449	['ON THE BASIS of THESE FINDINGS, it SEEMS logical that Pregnant women SHOULD routinely be supplemented with Vitamin D in china.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('ANOMALY_CURIOUS_FINDING', 35), ('FUTURE_WORK', 69)]	4	[('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3873449	12/2013	S213-PMC3873449	['IMPORTANTLY, we did have the INFORMATION on multivitamin supplement usage, which allowed us to SHOW that WHILE Pregnancy-specific multivitamin supplements improve the status in women at low risk of severe Vitamin D deficiency, it does not prevent women from Vitamin D deficiency in winter.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	4	[('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4045304	2/2014	S207-PMC4045304	['a study conducted in saudi arabia FOUND that DESPITE the same amount of sun exposure, NOT ONLY was there much lower levels of 25-Hydroxy Vitamin D in autistic children as compared to controls (about half of those of controls), but also there was an extremely strong negative CORRELATION coefficient ( r = −0.84) between Vitamin D levels and autism severity on the autism severity scale [75].']	[('INCOMPLETE_EVIDENCE', 34), ('ANOMALY_CURIOUS_FINDING', 45), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 275)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 126, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 145, 'D'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D')]
PMC4045304	2/2014	S271-PMC4045304	['MORE RESEARCH IS also NEEDED to FURTHER investigate quantitative Genetic variations in various components of the Vitamin D system.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 22), ('FUTURE_WORK', 32)]	4	[('SO_0000704', 'gene', 65, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4106226	7/2014	S36-PMC4106226	['OF INTEREST, asthmatic children had less exposure to sunlight and ate a diet less rich in Vitamin D. this MAY INDICATE that asthma Control MAY benefit from a healthier Life-style and a Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 139)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0065007', 'biological regulation', 131, 'control'), ('UBERON_0000104', 'life cycle', 168, 'life'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4113768	7/2014	S682-PMC4113768	['conclusions: frequent use of high-dose oral Vitamin D APPEARS TO HAVE resulted in a high overall Vitamin D status in older new zealanders, which is in STARK CONTRAST TO the relatively low status REPORTED PREVIOUSLY.']	[('ANOMALY_CURIOUS_FINDING', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 204)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4113768	7/2014	S825-PMC4113768	['there is wide VARIATION in the content and availability of Vitamin D supplements, and DESPITE nice guidelines on Vitamin D supplementation implementation REMAINS UNCERTAIN.']	[('DIFFICULT_TASK', 14), ('ANOMALY_CURIOUS_FINDING', 86), ('INCOMPLETE_EVIDENCE', 154), ('FULL_UNKNOWN', 162)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4113768	7/2014	S2244-PMC4113768	['background: DESPITE the identification of several Genetic polymorphisms in the Vitamin D Receptor Gene (Vdrg), the rs2228570 polymorphism, identified by the Fok1 restriction enzyme, APPEARS to be the ONLY one INFLUENCING the size of the Translated protein.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 182), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209)]	4	[('SO_0000704', 'gene', 50, 'genetic'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 79, 'vitamin D receptor'), ('SO_0000704', 'gene', 98, 'gene'), ('PR_000017279', 'testis-specific basic protein Y 1', 104, 'VDRG'), ('PR_000007593', 'glutamate carboxypeptidase 2', 157, 'Fok1'), ('GO_0006412', 'translation', 237, 'translated')]
PMC4113768	7/2014	S2828-PMC4113768	['REPORTED Vitamin D intakes, HOWEVER, were SIMILAR between the sexes after adjusting for energy intake.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4113768	7/2014	S3316-PMC4113768	['background: since the publication of the ultraviolet b (uvb)-Vitamin D-cancer HYPOTHESIS BASED ON an ecological study of Colon cancer mortality rates with respect to annual solar radiation doses in the united states in 1980, the approach HAS BEEN extended to many types of cancer and various other health outcomes.']	[('INCOMPLETE_EVIDENCE', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 238)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001155', 'colon', 121, 'colon')]
PMC4169453	9/2014	S189-PMC4169453	['DESPITE the AFOREMENTIONED CONTROVERSIES, the improvement in Vitamin D status in studied groups was achieved without any evidence of hypervitaminosis D, such as elevated 25(Oh)d, hypercalcemia, or increased hypercalciuria.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 150, 'D'), ('CHEBI_30778', 'gallic acid', 170, '25(OH)')]
PMC4171568	9/2014	S72-PMC4171568	['high levels of Serum Mda and low Plasma Ascorbic Acid were FOUND in the sample as a whole BUT at follow-up normalisation of these MARKERS were observed ONLY in the group receiving Vitamin C as an adjunct to anti-psychotic treatment.']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 130), ('ANOMALY_CURIOUS_FINDING', 152)]	4	[('UBERON_0001977', 'blood serum', 15, 'serum'), ('CHEBI_34840', 'methyl methacrylate', 21, 'MDA'), ('UBERON_0001969', 'blood plasma', 33, 'plasma'), ('CHEBI_22652', 'ascorbic acid', 40, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin C')]
PMC4221707	11/2014	S137-PMC4221707	['addition from Supplements LED TO significantly higher estimated intake of Vitamin D and Folate and borderline significantly higher intake of Calcium and Vitamin B12 in the Pregnant than referent women, WHEREAS ESTIMATED Intake of iron supplement EVENED out the difference in Intakes from Foods only (table\xa02).']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 246)]	4	[('CHEBI_33341', 'titanium atom', 14, 'supplements'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 88, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium'), ('CHEBI_33279', 'vitamin D5', 153, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 153, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 172, 'pregnant'), ('GO_0007631', 'feeding behavior', 220, 'intake'), ('GO_0007631', 'feeding behavior', 275, 'intakes'), ('CHEBI_33290', 'food', 288, 'foods')]
PMC4231606	10/2013	S16-PMC4231606	['conclusion\nchildren with s-ecc APPEAR to have relatively POOR nutritional health COMPARED TO caries-free controls, and were significantly more LIKELY to have low Vitamin D, calcium, and albumin concentrations and elevated pth levels.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 143)]	4	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC4231606	10/2013	S106-PMC4231606	['multiple regression for 25(Oh)D concentrations REVEALED that levels were significantly and INDEPENDENTLY ASSOCIATED with s-ecc, regular Milk Consumption, and season of assessment BUT NOT household income and or the use of Vitamin D drops (table\xa03).']	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 91), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 179)]	4	[('CHEBI_71657', 'versiconol acetate', 24, '25(OH)D'), ('UBERON_0001913', 'milk', 136, 'milk'), ('GO_0007631', 'feeding behavior', 141, 'consumption'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4231606	10/2013	S123-PMC4231606	['EVEN after controlling for seasonal INFLUENCE on Endogenous Synthesis, low household income, and infrequent Consumption of Vitamin D drops and milk, the significant ASSOCIATION REMAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 177)]	4	[('GO_0042400', 'ectoine catabolic process', 49, 'endogenous synthesis'), ('GO_0007631', 'feeding behavior', 108, 'consumption'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4256222	12/2014	S142-PMC4256222	['IF this also is the case in the dafo88 cohort, physical activity level and childhood Vitamin D intake COULD did NOT act as CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 102), ('ANOMALY_CURIOUS_FINDING', 112), ('PROBLEM_COMPLICATION', 123)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4302429	1/2015	S186-PMC4302429	['PRESUMABLY, in addition to Cathelicidin, OTHER Immune Mediators are INVOLVED in the Vitamin D-dependent Immune pathways.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_3364', 'Canthiumine', 27, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 27, 'cathelicidin'), ('UBERON_0002405', 'immune system', 47, 'immune'), ('CHEBI_35222', 'inhibitor', 54, 'mediators'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0002405', 'immune system', 104, 'immune')]
PMC4329745	10/2014	S88-PMC4329745	['ALTHOUGH in OUR STUDY the ASSOCIATION between age and Vitamin D deficiency is not substantially.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 26)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4377870	3/2015	S75-PMC4377870	['maternal intake of Vitamin E, Vitamin D, milk, cheese and calcium during Pregnancy are negatively ASSOCIATED, WHILE Vitamin C is positively ASSOCIATED, with wheezing in early childhood [57,58].']	[('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('ANOMALY_CURIOUS_FINDING', 110), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin C')]
PMC4377870	3/2015	S76-PMC4377870	['antioxidants including Lycopene APPEAR to have positive INFLUENCES in Respiratory conditions, further detail is provided below on EVIDENCE for Vitamin C, Vitamin E and Flavonoids and their ROLE in the maternal diet, diets of children and Adults with asthma and Adults with copd.']	[('ANOMALY_CURIOUS_FINDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 189)]	4	[('CHEBI_15948', 'lycopene', 23, 'lycopene'), ('UBERON_0001004', 'respiratory system', 70, 'respiratory'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('CHEBI_72544', 'flavonoids', 168, 'flavonoids'), ('UBERON_0007023', 'adult organism', 238, 'adults'), ('UBERON_0007023', 'adult organism', 261, 'adults')]
PMC4377870	3/2015	S142-PMC4377870	['Vitamin D APPEARS to have a PROTECTIVE ROLE against the susceptibility to and severity of these infections [111], AS active Vitamin D (1,25 (Oh)2d) modifies Production Of Antimicrobial Cathelicidins and defensins that kill bacteria and induce wound Repair [112].']	[('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 39), ('PROBABLE_UNDERSTANDING', 114)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_76285', '(R)-vedaprofen', 136, ',25 (OH'), ('GO_0030154', 'cell differentiation', 157, 'production of ... cathelicidins'), ('CHEBI_65381', 'albizoside C', 171, 'antimicrobial'), ('GO_0006281', 'DNA repair', 249, 'repair')]
PMC4377870	3/2015	S160-PMC4377870	['in an OBSERVATIONAL study Single Nucleotide Polymorphisms in the Vitamin D Binding Protein (Vdbp) PREDICTED Vitamin D levels in copd patients and were FOUND TO BE a risk FACTOR for copd [123].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 98), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 170)]	4	[('SO_0000694', 'SNP', 26, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 65, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 92, 'VDBP'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4383226	2/2015	S11-PMC4383226	["many also receive Vitamin A supplements, which HAVE BEEN LINKED not ONLY to the protection of a child's Vision, but also to a lower RISK of death and an improved ability to Fight off infections."]	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 132)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('GO_0007601', 'visual perception', 104, 'vision'), ('GO_0007631', 'feeding behavior', 173, 'fight')]
PMC4396835	1/2015	S30-PMC4396835	['season of Birth findings constitute another LINK between autism and Vitamin D. in europe a MAJOR proportion of the population have CONSIDERABLY lower 25(Oh)D in winter and spring compared TO summer and autumn [36,41].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 91), ('ANOMALY_CURIOUS_FINDING', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 188)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]
PMC4396835	1/2015	S153-PMC4396835	['HOWEVER, no difference in Vitamin D levels related to gender HAS BEEN FOUND in neonates [65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 70)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4405493	4/2015	S121-PMC4405493	['UNFORTUNATELY, the increasing use of multivitamins and Mineral dietary supplements in younger to older Adults DOES NOT APPEAR TO BE ASSOCIATED with a corresponding increase in Serum 25-oh Vitamin D concentrations [3,19,41].']	[('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 110), ('ANOMALY_CURIOUS_FINDING', 119), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_46662', 'mineral', 55, 'mineral'), ('UBERON_0007023', 'adult organism', 103, 'adults'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC4448820	5/2015	S471-PMC4448820	['ALTHOUGH Vitamin A is absolutely REQUIRED for mounting an effective Immune Response, it is TEMPTING to SPECULATE that temporarily inhibiting Plasma Delivery Of Vitamin A to Tissues is beneficial to the host by creating a favorable environment for inflammation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0006955', 'immune response', 68, 'immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('GO_0070983', 'dendrite guidance', 148, 'delivery of vitamin A'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('UBERON_0000479', 'tissue', 173, 'tissues')]
PMC4448820	5/2015	S867-PMC4448820	['ANOTHER example is the observation that Vitamin A supplementation, which GENERALLY lowers mortality in children, increased the RISK of Mother-To-Child Hiv Transmission in pregnant and Postpartum hiv-infected women in tanzania (469), ALTHOUGH not in south africa (470) or malawi (471).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 73), ('IMPORTANT_CONSIDERATION', 127), ('ANOMALY_CURIOUS_FINDING', 233)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('GO_0007063', 'regulation of sister chromatid cohesion', 135, 'mother-to-child HIV transmission'), ('GO_0007565', 'female pregnancy', 184, 'postpartum')]
PMC4448820	5/2015	S1526-PMC4448820	['for many Nutrients (e.g., Vitamin D or Iodine), there APPEARS TO BE an ASSOCIATION between their BIOMARKERS and MARKERS of inflammation.']	[('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('CHEBI_33284', 'nutrient', 9, 'nutrients'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 39, 'iodine')]
PMC4488777	5/2015	S189-PMC4488777	['couples with Serum concentration exceeding 50 nmol/l have a higher CHANCE of Conception, but this DOES NOT REGARD all patients, where ESPECIALLY males SHOULD BE supplemented with Vitamin D from the beginning of the therapy.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 98), ('ANOMALY_CURIOUS_FINDING', 134), ('FUTURE_WORK', 151)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('GO_0007620', 'copulation', 77, 'conception'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4499946	7/2015	S2-PMC4499946	['IMPORTANTLY, LITTLE IS KNOWN about the EFFECT of maternal Vitamin D status on infant linear growth in communities in south asia where stunting is highly prevalent and maternal-infant Vitamin D status is commonly SUBOPTIMAL.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 13), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 212)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC4499946	7/2015	S38-PMC4499946	['there has BEEN considerable RECENT INTEREST in the ROLE of Vitamin D in maternal and infant health outcomes in low-income settings [29].']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 28), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4516377	6/2015	S52-PMC4516377	['moreover, Calcitriol inhibit s the Expression of Uncoupling Protein-2 (INVOLVED in the Regulation Of Metabolism, diet-induced Thermogenesis and body weight Control) through the classic Nuclear Vitamin D receptors in Adipocytes, thereby increasing energy efficiency.24,25additionally, the Regulation by Calcitriol of the Uncoupling Protein-2 and the levels of Intracellular calcium SEEMS to have an EFFECT on energy Metabolism by AFFECTING Adipocyte Apoptosis.24\n\n\ncaption (fig): figure 2.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('ANOMALY_CURIOUS_FINDING', 381), ('SUPERFICIAL_RELATIONSHIP', 398), ('SUPERFICIAL_RELATIONSHIP', 429)]	4	[('CHEBI_17823', 'calcitriol', 10, 'calcitriol'), ('GO_0010467', 'gene expression', 35, 'expression'), ('PR_000017016', 'E3 ubiquitin-protein ligase UBR5', 49, 'uncoupling protein-2'), ('GO_0009894', 'regulation of catabolic process', 87, 'regulation of metabolism'), ('GO_0031649', 'heat generation', 126, 'thermogenesis'), ('GO_0065007', 'biological regulation', 156, 'control'), ('GO_0005634', 'nucleus', 185, 'nuclear'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CL_0000136', 'fat cell', 216, 'adipocytes'), ('GO_0065007', 'biological regulation', 288, 'regulation'), ('CHEBI_17823', 'calcitriol', 302, 'calcitriol'), ('PR_000017016', 'E3 ubiquitin-protein ligase UBR5', 320, 'uncoupling protein-2'), ('GO_0005622', 'intracellular anatomical structure', 359, 'intracellular'), ('GO_0008152', 'metabolic process', 415, 'metabolism'), ('CL_0000136', 'fat cell', 439, 'adipocyte'), ('GO_0006915', 'apoptotic process', 449, 'apoptosis')]
PMC4586450	10/2015	S443-PMC4586450	['the ONLY ROBUST RELATIONSHIP of Nutrients with hemoglobin was positive with Vitamin C intake ( r = 0.13; p = 0.001).']	[('ANOMALY_CURIOUS_FINDING', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 16)]	4	[('CHEBI_33284', 'nutrient', 32, 'nutrients'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin C')]
PMC4586450	10/2015	S528-PMC4586450	['uptake of Vitamin D supplements was low, IN LINE WITH national surveys and DESPITE RECOMMENDATIONS that all children aged 1–5 years SHOULD receive them.']	[('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 75), ('FUTURE_WORK', 83), ('FUTURE_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4598849	10/2015	S54-PMC4598849	['another case-control study SUGGESTED that infants Born before 32 wks’ Gestation had an increased RISK of Vitamin D deficiency compared with mature infant, HOWEVER, there was no statistically significant difference in mean Cord Blood 25(Oh)D levels between sga and non-sga infants29.']	[('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('ANOMALY_CURIOUS_FINDING', 155)]	4	[('GO_0007567', 'parturition', 50, 'born'), ('GO_0007565', 'female pregnancy', 70, 'gestation'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 222, 'cord'), ('UBERON_0000178', 'blood', 227, 'blood'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4600246	10/2015	S18-PMC4600246	['it HAS BEEN PROPOSED that a substantial amount of APPARENTLY healthy patients are subclinically Vitamin K deficient BASED ON undercarboxylated Osteocalcin and Mgp,25presumably increasing the risk of vascular calcifications, cancer and osteoporosis.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 50), ('PROBABLE_UNDERSTANDING', 116)]	4	[('CHEBI_27300', 'vitamin D', 96, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 143, 'osteocalcin'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 159, 'MGP')]
PMC4600246	10/2015	S31-PMC4600246	['DESPITE the fact that Serum mgp increased in the vitamin k1group, WHEREAS mgp was decreased in the control group (treatment effect: p<0.03 in itt and secondary analyses), neither baseline nor change in mgp predicted the change in cac, SUGGESTING that the benefit of Vitamin K on cac progression is not related to increases in Serum mgp.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 235)]	4	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin K'), ('UBERON_0001977', 'blood serum', 326, 'serum')]
PMC4600246	10/2015	S78-PMC4600246	['additionally, Vitamin K MAY EVEN play a VITAL ROLE in the stabilisation of inr control for patients on warfarin.']	[('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K')]
PMC4632418	10/2015	S22-PMC4632418	['the ROLE of Vitamin D on Gdm Development HAS been studied, and Vitamin D deficiency APPEARS TO BE ASSOCIATED with altered Glucose Homeostasis during Pregnancy [12,13].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 41), ('ANOMALY_CURIOUS_FINDING', 84), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 25, 'GDM development'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_17234', 'glucose', 122, 'glucose'), ('GO_0042593', 'glucose homeostasis', 122, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
PMC4632418	10/2015	S125-PMC4632418	['INTERESTINGLY, we just FOUND that two researches [23,34] of Pregnant women with Vitamin D sufficiency are nested case-control and case-control studies, respectively, which tests the HYPOTHESIS mentioned above BETTER.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 182), ('INCOMPLETE_EVIDENCE', 209)]	4	[('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4684854	12/2015	S43-PMC4684854	['a primary OBSERVATION, HOWEVER, was that LIMITED scientific LITERATURE is available on the issue of Gestational Vitamin D insufficiency as it RELATES to long-term health outcomes.']	[('ANOMALY_CURIOUS_FINDING', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4684854	12/2015	S111-PMC4684854	['it APPEARS that fetal Vitamin D levels MAY play a modulating ROLE in Immune functions INVOLVED in atopic disorders.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 86)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 69, 'immune')]
PMC4684854	12/2015	S115-PMC4684854	['furthermore, an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks of Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [93].']	[('ANOMALY_CURIOUS_FINDING', 16), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 150, 'gestational'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0030324', 'lung development', 212, 'lung development'), ('UBERON_0002048', 'lung', 212, 'lung'), ('GO_0050905', 'neuromuscular process', 254, 'neurocognitive'), ('GO_0051318', 'G1 phase', 311, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 331, 'adolescence')]
PMC4689556	12/2015	S153-PMC4689556	['first the EFFECT (or lack OF effect) of the specific timing and dose of Vitamin D used in our study CANNOT BE generalised to OTHER dosing and timing schedules.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ANOMALY_CURIOUS_FINDING', 26), ('DIFFICULT_TASK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4689556	12/2015	S180-PMC4689556	['HOWEVER, multivariate analysis of our data SHOWED that ALTHOUGH maternal ethnicity CORRELATED with 25(Oh) Vitamin D level there was no relationship between maternal ethnicity and our measures of healthcare utilization in this trial.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_30778', 'gallic acid', 99, '25(OH)'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4691762	12/2015	S1-PMC4691762	['countries in the northern hemisphere RECOMMEND universal infant Vitamin D supplementation to optimise early Vitamin D levels, DESPITE the absence of large TRIALS proving SAFETY or efficacy for any disease outcome.']	[('FUTURE_WORK', 37), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 155), ('IMPORTANT_CONSIDERATION', 170)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4691762	12/2015	S73-PMC4691762	['we have established that composite maternal uvr dose (or 0.50 (95% ci 0.37 to 0.69) p<0.001) and maternal skin exposure index (or 0.81 (95% ci 0.66 to 0.98) p=0.03) were ASSOCIATED with breastfed infant Vitamin D status BUT infant time in the sun during the first year was NOT.15infant Feeding (amount of breastfeeding, Formula Feeding and type of formula, introduction of solid Foods) will also be recorded.']	[('SUPERFICIAL_RELATIONSHIP', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220), ('ANOMALY_CURIOUS_FINDING', 220), ('ANOMALY_CURIOUS_FINDING', 273)]	4	[('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0007631', 'feeding behavior', 286, 'feeding'), ('GO_0009057', 'macromolecule catabolic process', 320, 'formula'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_33290', 'food', 379, 'foods')]
PMC4691762	12/2015	S119-PMC4691762	['if FOUND to be both efficacious and cost-effective, Vitamin D infant supplementation would provide a readily available, low harm INTERVENTION that would optimise infant Immune health in the first year of Life and significantly reduce the population BURDEN of allergic disease.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 129), ('IMPORTANT_CONSIDERATION', 249)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune'), ('UBERON_0000104', 'life cycle', 204, 'life')]
PMC4719746	1/2016	S129-PMC4719746	['HOWEVER, 73\xa0% reported use of ≥10\xa0μg/day of Vitamin D supplements at the post-test, and only 3.5\xa0% STILL had severe deficiency, COMPARED TO 20\xa0% at inclusion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 99), ('ANOMALY_CURIOUS_FINDING', 128)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4728621	1/2016	S193-PMC4728621	['finally, maternal trimester 2 Vitamin C intake was negatively ASSOCIATED with the sum of the 6 months old Triceps and Subscapular Skinfolds, a measure of overall adiposity, WHILE maternal trimester 3 Vitamin C intake was negatively ASSOCIATED with 6 months old Triceps-for-age skinfold thickness z-score.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 173), ('ANOMALY_CURIOUS_FINDING', 173), ('SUPERFICIAL_RELATIONSHIP', 232)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 106, 'triceps'), ('UBERON_3010813', 'vent glands', 118, 'subscapular skinfolds'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 261, 'triceps')]
PMC4729160	1/2016	S19-PMC4729160	['the world health organization (who) DEFINES vitamin a deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency [2].']	[('PROBABLE_UNDERSTANDING', 36), ('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	4	[('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
PMC4770602	1/2016	S9-PMC4770602	['conclusion:\nIN SUMMARY, our results DEMONSTRATED that Vitamin D supplementation during the third Trimester of Pregnancy; DESPITE the non-significant ASSOCIATION between Vitamin D supplementation and preeclampsia, reduce the risk of preeclampsia.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 97, 'trimester'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4778858	3/2016	S110-PMC4778858	['mcleod and colleagues [33], who also conducted an ancillary study on Hapo participants, FOUND a WEAK, YET significant ASSOCIATION between 25-Ohd and fasting glucose in an australian Vitamin D replete population.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 102), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('CHEBI_17883', 'hydrogen chloride', 69, 'HAPO'), ('CHEBI_72765', 'verruculogen', 138, '25-OHD'), ('PR_000012086', 'homeobox protein OTX2', 141, 'OHD'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4785305	3/2016	S29-PMC4785305	['cooper et al 36SHOWED that Vitamin D supplementation of 1000\u2005iu daily, COMPARED TO placebo, in Pregnant women in the uk allowed a significant increase in bone Mineral content (bmc) of neonates, HOWEVER, ONLY when they were Born in winter.']	[('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ANOMALY_CURIOUS_FINDING', 194), ('ANOMALY_CURIOUS_FINDING', 203)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('CHEBI_46662', 'mineral', 159, 'Mineral'), ('GO_0007567', 'parturition', 223, 'born')]
PMC4811107	3/2016	S16-PMC4811107	['GIVEN the IMPORTANT ROLE of Vitamin D in health, there has BEEN much discussion about the best ways to prevent and treat Vitamin D deficiency [3,6].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 59)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4811107	3/2016	S94-PMC4811107	['REPORTED that neonatal Vitamin D had a positive CORRELATION with maternal Vitamin D levels ( r = 0.69, p< 0.001) in those mothers with normal Vitamin D levels BUT NOT in those with hypovitaminosis ( n = 123 maternal-child pairs) [29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 159), ('ANOMALY_CURIOUS_FINDING', 163)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC4829940	5/2016	S14-PMC4829940	['low 25(Oh)D levels HAVE BEEN ASSOCIATED with a range of adverse conditions, from Pregnancy outcomes to childhood illnesses and chronic disease including osteoporosis, cancer and Cardiovascular disease in Adulthood[3], ALTHOUGH randomized controlled trials of Vitamin D supplements do NOT SUPPORT causality for Extra-Skeletal outcomes[4],[5].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	4	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 4, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('UBERON_0004535', 'cardiovascular system', 178, 'cardiovascular'), ('UBERON_0000113', 'post-juvenile adult stage', 204, 'adulthood'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 310, 'extra-skeletal')]
PMC4829940	5/2016	S20-PMC4829940	['ALTHOUGH two RECENT randomized controlled trials observed SUGGESTIVE reductions in the incidence of asthma and recurrent wheezing following Vitamin D supplementation during Pregnancy[12],[13], the primary endpoints were not statistically significant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 58)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC4832516	10/2015	S136-PMC4832516	['similarly, NO information was AVAILABLE on maternal residential location, individually-measured sunshine exposure, or Vitamin D supplementation during Pregnancy, HOWEVER EVEN the youngest participant in the uk biobank (aged 38 in our analysis) was Conceived during a time when Gestational Vitamin D supplementation was not RECOMMENDED in the uk.']	[('FULL_UNKNOWN', 11), ('ANOMALY_CURIOUS_FINDING', 162), ('ANOMALY_CURIOUS_FINDING', 170), ('FUTURE_WORK', 323)]	4	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0070268', 'cornification', 248, 'conceived'), ('GO_0007565', 'female pregnancy', 277, 'gestational'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D')]
PMC4889866	5/2016	S95-PMC4889866	['in the study of weisse et al., ALTHOUGH both maternal and Cord Blood Vitamin D levels were ASSOCIATED with clinical Food allergy, ONLY maternal 25(Oh)d3was ASSOCIATED with an increase in Allergen sensitization [19].']	[('ANOMALY_CURIOUS_FINDING', 31), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 156)]	4	[('UBERON_0002240', 'spinal cord', 58, 'cord'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_30778', 'gallic acid', 144, '25(OH)'), ('CHEBI_50904', 'allergen', 187, 'allergen')]
PMC4889866	5/2016	S126-PMC4889866	['THUS, our data could NOT provide detailed mechanism on HOW maternal Vitamin D level AFFECTED neonatal tlr-triggered Il-10 Response.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('EXPLICIT_QUESTION', 55), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 116, 'IL-10'), ('GO_1990603', 'dark adaptation', 118, '- ... response')]
PMC4897157	5/2016	S117-PMC4897157	['in a Birth cohort study cord Blood 25(Oh)-Vitamin D deficiency was ASSOCIATED with INCREASED RISK of recurrent troublesome Lung symptoms till age 7 years, BUT SHOWED no association with Respiratory infection, asthma, or rhinitis21).']	[('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 83), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 159)]	4	[('GO_0007567', 'parturition', 5, 'birth'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CHEBI_63056', 'zinc cation', 35, '25(OH'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 123, 'lung'), ('UBERON_0001004', 'respiratory system', 186, 'respiratory')]
PMC4903143	5/2016	S97-PMC4903143	["an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency is ASSOCIATED with impaired Lung development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [34]."]	[('ANOMALY_CURIOUS_FINDING', 3), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0002048', 'lung', 196, 'lung'), ('GO_0050905', 'neuromuscular process', 238, 'neurocognitive'), ('GO_0051318', 'G1 phase', 295, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 315, 'adolescence')]
PMC4910255	6/2016	S102-PMC4910255	['in SOME cases, a comparison group of iron 60\xa0mg and Folic Acid 400\xa0μg WAS NOT AVAILABLE: nepal sarlahi included additional Vitamin A [34], mexico DID not include Folic Acid [25], indonesia used 30\xa0mg iron [29], and bangladesh jivita used 27\xa0mg iron and 600\xa0μg Folate [26].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 74), ('ANOMALY_CURIOUS_FINDING', 146)]	4	[('CHEBI_30751', 'formic acid', 52, 'folic acid'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin A'), ('CHEBI_30751', 'formic acid', 162, 'folic acid'), ('CHEBI_30863', '5-azaorotic acid', 260, 'folate')]
PMC4930210	7/2016	S128-PMC4930210	['we also FOUND that 20% of Pregnant women had Vitamin D concentraion <75 nmol/l, DESPITE more than half of these women reporting taking more than 600 iu/day of Vitamin D (the current rda) BASED ON their REPORTED intake from diet and supplements.']	[('INCOMPLETE_EVIDENCE', 8), ('ANOMALY_CURIOUS_FINDING', 80), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 202)]	4	[('GO_0007565', 'female pregnancy', 26, 'pregnant'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4934634	11/2015	S15-PMC4934634	['WHILE the incidence of Vitamin D deficiency in most countries would SEEM TO BE moderate if the iom cut-offs are used, the incidence is high in many countries IF the cut-off values advanced by the endocrine society are embraced [3].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4934634	11/2015	S163-PMC4934634	['WHILE Serum Vitamin D levels improved in the intervention group, ONLY 15% of the women obtained levels of ≥30 ng/ml (Endocrine society cut-off for Vitamin D sufficiency) DUE to severely low baseline 25(Oh)D levels in this population (3–9 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 65), ('IMPORTANT_CONSIDERATION', 170), ('IMPORTANT_CONSIDERATION', 170)]	4	[('UBERON_0001977', 'blood serum', 6, 'serum'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 117, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 199, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 199, '25(OH ... D')]
PMC4934634	11/2015	S234-PMC4934634	['STILL, SOME professionals fear that with the increase in supplementation rates, there COULD BE a rise in Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 86)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4934634	11/2015	S288-PMC4934634	['also, loss of function mutations in 24-hydroylase was found to be a risk factor for idiopathic infantile hypercalcemia making those infants more susceptible to Vitamin D toxicity EVEN at lower Vitamin D supplementation doses [86], THUS genetics CAN play a ROLE in both Vitamin D deficiency and toxicity.']	[('ANOMALY_CURIOUS_FINDING', 179), ('PROBABLE_UNDERSTANDING', 231), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 256)]	4	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4969253	8/2016	S60-PMC4969253	['a series of nine trials have BEEN RECENTLY reviewed to determine the IMPACT of Vitamin A supplementation in PREVENTING mortality and short- and long-term morbidities in very low Birth weight infants [21].']	[('ANOMALY_CURIOUS_FINDING', 29), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 108)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('GO_0007567', 'parturition', 178, 'birth')]
PMC4971719	8/2016	S138-PMC4971719	['in this adjusted model, “low Vitamin D”, at visit 1 (again, as a categorical variable) was ASSOCIATED with the bdi at 34–36 weeks’ Gestation ( p \u2009=\u20090.01), WHILE there was a TREND toward ASSOCIATION of low Dha ( p \u2009=\u20090.06) and low epa ( p \u2009=\u20090.09) with higher Bdi scores at that time point as well (r2for the model\u2009=\u20090.12).']	[('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'gestation'), ('CHEBI_17874', 'dihydrozeatin', 205, 'DHA'), ('PR_000004717', "transcription factor TFIIIB component B''", 259, 'BDI')]
PMC4976416	7/2016	S73-PMC4976416	['HOWEVER, studies looking AT the efficacy of Vitamin E in the treatment of burns and scars HAVE BEEN DISAPPOINTING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 100)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E')]
PMC4979151	8/2016	S0-PMC4979151	['Prenatal high-dose Vitamin D3Supplementation has balanced EFFECTS on Cord Blood th1 and th2 Responses\n\nabstract\n\nbackground\nantenatal Vitamin D3(vitd3) supplementation significantly increases maternal and neonatal 25-Hydroxyvitamin D3(25(Oh)D3) concentration, YET the EFFECT of an improvement in maternal-fetal Vitamin D status on the neonatal immune response is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 260), ('SUPERFICIAL_RELATIONSHIP', 268), ('FULL_UNKNOWN', 363)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_52915', 'phosphatediyl group', 19, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'vitamin D3supplementation'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0060033', 'anatomical structure regression', 92, 'responses'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_63991', '15-epi-lipoxin B4', 214, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 232, 'D3'), ('CHEBI_62946', 'ammonium sulfate', 235, '25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 241, 'D3'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin D')]
PMC4982007	8/2016	S273-PMC4982007	['HOWEVER, the percentage with Language impairment was double in children of Vitamin D deficient mothers COMPARED TO normal mothers in ONE STUDY [21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 133)]	4	[('GO_0006266', 'DNA ligation', 29, 'language'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4989298	8/2016	S373-PMC4989298	['the results REMAIN CONTROVERSIAL EVEN when CORRELATIONS between Vitamin D levels in maternal and Umbilical Cord Blood and allergic disease risk are measured directly.']	[('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('ANOMALY_CURIOUS_FINDING', 33), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 97, 'umbilical cord'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC4992225	8/2016	S263-PMC4992225	['it was INTERESTING TO INVESTIGATE TREND of Vitamin D EFFECTIVENESS in the two primiparous and multiparous subgroups.']	[('ANOMALY_CURIOUS_FINDING', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4997421	8/2016	S11-PMC4997421	['conclusion there APPEAR TO BE DISPARITIES in Serum Vitamin A levels in women of Childbearing age RELATED to income and race in the united states.']	[('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('IMPORTANT_CONSIDERATION', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	4	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 80, 'childbearing')]
PMC4997421	8/2016	S18-PMC4997421	['the united states has BEEN assumed to be free of Vitamin A deficiency BASED ON a high gross domestic product [12] and Vitamin A status has ONLY rarely BEEN investigated in the us population, especially in women of Childbearing age.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 139), ('ANOMALY_CURIOUS_FINDING', 151)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 214, 'childbearing')]
PMC4998950	4/2016	S26-PMC4998950	['lifetime maternal Vitamin D deficiency was RARE ACCORDING TO secondary care diagnoses and recorded in ONLY 547 Individuals (0.1%).']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 48), ('ANOMALY_CURIOUS_FINDING', 102), ('INCOMPLETE_EVIDENCE', 102)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('NCBITaxon_1', 'root', 111, 'individuals')]
PMC5014971	8/2016	S97-PMC5014971	['the responding physicians were GENERALLY not supportive of screening all Pregnant women for Vitamin D status; EVEN among physicians that expressed a CONCERN regarding their patient population, less than half would screen most Pregnant patients.']	[('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 110), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149)]	4	[('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnant')]
PMC5024513	9/2016	S106-PMC5024513	['results of the pooled analyses HOWEVER SHOWED that ONLY intake of Vitamin D remained significantly below both the uk rni and us rda, and intakes of potassium below the us rda.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 39), ('ANOMALY_CURIOUS_FINDING', 51)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5024513	9/2016	S107-PMC5024513	['sub-group analysis SHOWED that Micronutrient intake was lower in uk based studies than those based in the usa for all Micronutrients with the EXCEPTION of Vitamin C, HOWEVER Vitamin D was the ONLY Micronutrient where the percentage of the Drv in uk based studies was below the uk rni (21.4\xa0%, ci 0–63.5\xa0%) and us rda (14.3\xa0%, ci 0–42.3\xa0%).']	[('INCOMPLETE_EVIDENCE', 19), ('ANOMALY_CURIOUS_FINDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 192)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 31, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 118, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 197, 'micronutrient'), ('UBERON_0004004', 'cerebellum lobule', 239, 'DRV')]
PMC5024513	9/2016	S129-PMC5024513	['in terms of comparison with dietary reference values, combined analysis of the individual study means SHOWED very few statistically significant results, with the EXCEPTION of Vitamin D. one POSSIBLE EXPLANATION for this is that there was a high level of variance between participants in the majority of studies resulting in very wide confidence intervals.']	[('INCOMPLETE_EVIDENCE', 102), ('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 199)]	4	[('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC5028238	10/2016	S89-PMC5028238	["the conversion Of 7-Dehydrocholesterol to Vitamin D occurs in the skin upon exposure to ultraviolet b light (290–320\u2009nm).50under normal sunlight conditions, ONLY around 15% of available 7-Dehydrocholesterol will be converted to Vitamin D, WHEREAS excess 7-Dehydrocholesterol in the skin will be converted to inert compounds for degradation.51,52dhcr7 is the sole enzyme used to convert 7-Dehydrocholesterol to Cholesterol.53a shortage of Dhcr7 would decrease the body's ability to convert 7-Dehydrocholesterol into Cholesterol thereby causing a build-up of 7-Dehydrocholesterol, which COULD BE converted into Vitamin D in the skin."]	[('ANOMALY_CURIOUS_FINDING', 157), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('INCOMPLETE_EVIDENCE', 585)]	4	[('GO_0007608', 'sensory perception of smell', 15, 'of ...'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 18, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 186, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 236, 'D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 254, '7-dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 386, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 410, 'cholesterol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 438, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 489, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 515, 'cholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 557, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 609, 'vitamin D')]
PMC5035678	4/2016	S9-PMC5035678	['conclusions\nALTHOUGH the high Vitamin D supplementation dose in the PRESENT STUDY (compared to the 400 iu/day dose USUALLY recommended for Pregnancy) SAFELY increases the Serum 25Ohd, in gdm cases, the higher dose does not affect the plasma Glucose level or Insulin resistance at short term follow-up after Delivery.']	[('ANOMALY_CURIOUS_FINDING', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 150)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('CHEBI_17234', 'glucose', 241, 'glucose'), ('PR_000045358', 'insulin family protein', 258, 'insulin'), ('GO_0007567', 'parturition', 307, 'delivery')]
PMC5084016	10/2016	S118-PMC5084016	['IN FACT, ONLY the FIRST of the two Hydroxylation processes occurring in Vitamin D Metabolism (e.g., that responsible for the production of 25-Hydroxy-Vitamin D) is Modulated by the dietary contribution to SOME extent (the increase of circulating levels is not proportional to the amount Ingested).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 205)]	4	[('GO_0044444', 'cytoplasmic part', 35, 'hydroxylation'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 72, 'vitamin D metabolism'), ('CHEBI_43141', '3-hydroxypropoxy group', 139, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'modulated'), ('GO_0007631', 'feeding behavior', 287, 'ingested')]
PMC5084016	10/2016	S128-PMC5084016	['HOWEVER, Vitamin D deficiency is very common during Pregnancy EVEN in countries with sunny climates and is ASSOCIATED with an INCREASED RISK of developing pre-eclampsia and Gestational diabetes mellitus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 62), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 126)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0007565', 'female pregnancy', 173, 'gestational')]
PMC5084016	10/2016	S213-PMC5084016	['NOTABLY, the values recorded in italy [25,53] DIFFER from those RECOMMENDED by the italian GUIDELINES [7] from 40% (Iodine) to 85% (Vitamin D).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('FUTURE_WORK', 64), ('PROBABLE_UNDERSTANDING', 91)]	4	[('CHEBI_24859', 'iodine atom', 116, 'iodine'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5085625	9/2016	S62-PMC5085625	['DESPITE widespread deficiency of Vitamin D among Pregnant women worldwide, its ROLE in Pregnancy has LARGELY BEEN IGNORED [25,26,27].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC5118763	12/2016	S22-PMC5118763	['ALTHOUGH PREVIOUS reports from this trial SHOWED a high prevalence of anemia, zinc, and Vitamin B-12 deficiencies in early Pregnancy among the women in the trial (14), there was no differential effect of using the mmn regimen on women’s hemoglobin concentration compared with standard Iron–Folic Acid supplementation regimens (11).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 42)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('CHEBI_24870', 'ion', 285, 'iron'), ('CHEBI_30751', 'formic acid', 290, 'folic acid')]
PMC5118763	12/2016	S158-PMC5118763	['HOWEVER, there was no dose-response relation between the number of mmn capsules taken and Plasma Vitamin B-12 that COULD EXPLAIN the higher Plasma concentrations of Vitamin B-12 at week 30 in the mmn group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 121)]	4	[('UBERON_0001969', 'blood plasma', 90, 'plasma'), ('CHEBI_85855', 'diacylglycerol 46:7', 97, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 97, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 140, 'plasma'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 165, 'vitamin B-12')]
PMC5129897	10/2016	S82-PMC5129897	['a comparison during september–october FOUND a relative risk of clinical Upper Respiratory Tract infection of 0.79 (95% ci, 0.61–1.03; p = 0.09) for 258 students taking 10,000 iu/wk of Vitamin D3, compared with 234 students taking a placebo.58ALTHOUGH that study DID NOT measure 25(Oh)D concentrations, it INDICATES that young canadians taking the equivalent of 1400 iu/d of Vitamin D had a marginally nonsignificantly reduced risk of Upper Respiratory Tract infections.']	[('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 240), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 305)]	4	[('UBERON_0001557', 'upper respiratory tract', 72, 'upper respiratory tract'), ('CHEBI_33279', 'vitamin D5', 184, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 184, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('UBERON_0001557', 'upper respiratory tract', 434, 'upper respiratory tract')]
PMC5240436	1/2017	S116-PMC5240436	['the LACK OF treatment response DESPITE the provision of adequate doses of Vitamin A and zinc in mmn and sq-lns and reasonable adherence to supplementation [24] COULD HAVE been due to dietary factors inhibiting zinc absorption [48] or haemodilution in the latter half of Pregnancy lowering levels of Retinol binding protein resulting in functional Vitamin A deficiency [49].']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 166)]	4	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A'), ('GO_0007565', 'female pregnancy', 270, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 299, 'retinol'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin A')]
PMC5318550	2/2017	S136-PMC5318550	['nutrition is regarded as an UNLIKELY driver of seasonal Birth outcomes in developed countries, where Food supply fluctuates little over the year.27likewise, maternal and Cord blood Vitamin D concentrations had ONLY a very modest improvement of the MODEL.']	[('PROBABLE_UNDERSTANDING', 28), ('ANOMALY_CURIOUS_FINDING', 210), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 248)]	4	[('GO_0007567', 'parturition', 56, 'birth'), ('CHEBI_33290', 'food', 101, 'food'), ('UBERON_0002240', 'spinal cord', 170, 'cord'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC5340372	3/2017	S126-PMC5340372	['in a randomized control TRIAL, a Vitamin D supplement CAN EVEN decrease the RISK of seasonal flu in children [50].']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 58), ('IMPORTANT_CONSIDERATION', 76)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5351212	3/2017	S305-PMC5351212	['OBVIOUSLY, IF this were the case then the corrective actions of the active Vitamin D hormone MAY SIMPLY be treating an mia-induced Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 97)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5421133	5/2017	S0-PMC5421133	['marginal vitamin a deficiency EXACERBATES Memory deficits following aβ1-42injection in Rats\n\nabstract\n\nbackground:\nALTHOUGH clinical Vitamin A deficiency (vad), which is a PUBLIC HEALTH PROBLEM developing throughout the world, has been well controlled, marginal Vitamin A deficiency (mvad) is far more PREVALENT, especially among Pregnant women and preschool children in china.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('ANOMALY_CURIOUS_FINDING', 115), ('IMPORTANT_CONSIDERATION', 172), ('IMPORTANT_CONSIDERATION', 302)]	4	[('GO_0007613', 'memory', 42, 'Memory'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'Rats'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A'), ('GO_0007565', 'female pregnancy', 330, 'pregnant')]
PMC5426325	4/2017	S151-PMC5426325	['IT IS POSSIBLE that this amount was too small to INFLUENCE fracture risk at the population level, EVEN when we CONFINED the analysis to those Pregnancies with habitually low Vitamin D during late trimesters, that is, those Giving Birth during winter months.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 111)]	4	[('GO_0007565', 'female pregnancy', 142, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0040007', 'growth', 223, 'giving'), ('GO_0007567', 'parturition', 230, 'birth')]
PMC5474873	6/2017	S15-PMC5474873	['OF PARTICULAR INTEREST is ACCUMULATING EVIDENCE for the ROLE of Vitamin D in the Brain (5,6).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000955', 'brain', 81, 'brain')]
PMC5513133	7/2017	S44-PMC5513133	['african american women of Reproductive age HAVE BEEN FOUND TO BE at PARTICULARLY high RISK for Vitamin D deficiency in the united states [18].']	[('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 59), ('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 86)]	4	[('GO_0000003', 'reproduction', 26, 'reproductive'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5513133	7/2017	S121-PMC5513133	['another prospective cohort study of nulliparous women with singleton Pregnancies FOUND no significant association between Vitamin D deficiency in the 1st Trimester and risk for pe; HOWEVER, at 24–26\xa0weeks of Gestation mean maternal 25(Oh)D was significantly lower in women who developed pe COMPARED WITH those who did not ( p \xa0=\xa00.03) [60].']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 290)]	4	[('GO_0007565', 'female pregnancy', 69, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 154, 'trimester'), ('GO_0007565', 'female pregnancy', 208, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 232, '25(OH ... D')]
PMC5513133	7/2017	S263-PMC5513133	['[25] SUGGEST that Vitamin D deficiency MAY BE a FACTOR in the DISPROPORTIONATE incidence of adverse Pregnancy outcomes in african american women since this group had the lowest Vitamin D levels among the populations they studied.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 62)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC5539754	8/2017	S176-PMC5539754	['WHILE no interaction effect was OBSERVED between season and Vitamin D with regards to Glucose Homeostasis, it is well RECOGNISED that 25Ohd declines in winter, and is a modifiable FACTOR.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 118), ('SUPERFICIAL_RELATIONSHIP', 180)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_17234', 'glucose', 86, 'glucose'), ('GO_0042593', 'glucose homeostasis', 86, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 134, '25OHD')]
PMC5634602	10/2017	S36-PMC5634602	['IMPORTANTLY, SEVERAL STUDIES have DOCUMENTED an ASSOCIATION with decreasing 25(Oh)D levels and lower Gestational age at Delivery allowing for a situation where preterm infants are a highly vulnerable population at Birth with regards to their Vitamin D status [15,28,30].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 82, 'D'), ('GO_0007565', 'female pregnancy', 101, 'gestational'), ('GO_0007567', 'parturition', 120, 'delivery'), ('GO_0007567', 'parturition', 214, 'birth'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC5638722	8/2017	S119-PMC5638722	['one of the factors ACCEPTED as a REGULATOR is Vitamin D. in A STUDY, small for Gestational age probability was FOUND TO BE 7.5 fold higher in the babies of the mothers with <15 ng/ml Vitamin D levels23).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 60), ('ANOMALY_CURIOUS_FINDING', 111)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'gestational'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5664622	9/2017	S8-PMC5664622	['introduction\nthe last decade has witnessed a steady stream of REPORTS from all over the world about Vitamin D INSUFFICIENCY in the general population, EVEN in regions with high year-round sun exposure (the so-CALLED “mediterranean paradox”) [1,2].']	[('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 110), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 208)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5664622	9/2017	S87-PMC5664622	['the RECOMMENDED levels of Vitamin D were FOUND in ONLY 5% of the Pregnant women in germany [20], and 16.5% in ukraine [22].']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 50), ('INCOMPLETE_EVIDENCE', 50)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnant')]
PMC5664622	9/2017	S98-PMC5664622	['the PROBLEM of low doses of Vitamin D in preparations for Pregnant women APPEARS TO BE GLOBAL.']	[('IMPORTANT_CONSIDERATION', 4), ('PROBLEM_COMPLICATION', 4), ('ANOMALY_CURIOUS_FINDING', 73), ('IMPORTANT_CONSIDERATION', 87)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnant')]
PMC5664622	9/2017	S102-PMC5664622	['THUS, it SEEMS IMPOSSIBLE for it to ever become a significant source of Vitamin D, especially in light of exaggerated media REPORTS on chemical Pollutants absorbed by the fish.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('DIFFICULT_TASK', 15), ('INCOMPLETE_EVIDENCE', 124)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_26199', 'polyprenol', 144, 'pollutants')]
PMC5664622	9/2017	S117-PMC5664622	['IN LIGHT OF the current norms in poland [34], adequate Consumption of Vitamin D from dietary sources was REPORTED by ONLY 6% of the investigated women.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 117)]	4	[('GO_0007631', 'feeding behavior', 55, 'consumption'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5679631	11/2017	S89-PMC5679631	['use of multivitamin supplements containing Vitamin D and maternal obesity were ASSOCIATED with maternal 25(Oh)D level during both low and high seasons, WHILE recruitment group was significantly ASSOCIATED with 25(Oh)D concentration ONLY during the high season.10.1371/journal.pone.0188011.t002\n\ncaption (table-wrap): table 2\nmean maternal 25(Oh)D concentration according to season of Blood sampling and use of multivitamin supplements containing Vitamin D.Blood sampling in high season of cutaneous Vitamin D productionblood sampling in low season of cutaneous Vitamin D production maternal use of multivitamin supplement containing Vitamin Dmaternal Plasma 25(Oh)d nmol/lmaternal Plasma 25(Oh)D nmol/l no (mean (sd))45.2 (17.0)30.1 (13.5)yes (mean (sd))53.3 (17.8)40.9 (16.1)p value&p = 0.000p = 0.000model # beta (95% ci)beta (95% ci) constant52.7 (47.7, 57.7)34.6 (29.5, 39.7)maternal use of multivitamin supplement containing Vitamin D (yes vs .']	[('SUPERFICIAL_RELATIONSHIP', 79), ('ANOMALY_CURIOUS_FINDING', 152), ('SUPERFICIAL_RELATIONSHIP', 194), ('INCOMPLETE_EVIDENCE', 232)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 210, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 339, '25 ... OH ... D'), ('UBERON_0000178', 'blood', 384, 'blood'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D'), ('UBERON_0000178', 'blood', 456, 'Blood'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_61716', 'alpha-Kdo-CH2OH-(2->4)-alpha-Kdo', 633, 'vitamin DMaternal'), ('UBERON_0001969', 'blood plasma', 651, 'Plasma'), ('CHEBI_63056', 'zinc cation', 658, '25(OH'), ('UBERON_0001969', 'blood plasma', 681, 'Plasma'), ('CHEBI_71657', 'versiconol acetate', 688, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin D')]
PMC5679631	11/2017	S161-PMC5679631	['the INFLUENCE of Postnatal Vitamin D supplementation MERITS to BE analyzed in a larger group of older infants and with extensive microbial profiling approach.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 53), ('ANOMALY_CURIOUS_FINDING', 63)]	4	[('GO_0007567', 'parturition', 17, 'postnatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5706533	11/2017	S161-PMC5706533	['IF a modest dose of Vitamin D (<600 iu/day) readily eliminates deficiency in EVEN the most deficient women, then we MIGHT expect to see benefits ONLY in Placebo control trials conducted in populations where deficiency is common.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 145)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 153, 'placebo')]
PMC5732505	12/2017	S141-PMC5732505	['HOWEVER, we OBSERVED that Vitamin D deficiency at Delivery was more PREVALENT in mothers with gdm compared with non-gdm mothers, BUT this was not marked during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 68), ('ANOMALY_CURIOUS_FINDING', 129)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'delivery'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC5758521	1/2018	S13-PMC5758521	['SURPRISINGLY, high-dose Vitamin E (Α-Tocopherol) supplementation HAS BEEN ASSOCIATED with increased risk of low Birth weight8– a condition LINKED to Insulin-Like Growth Factor I (Igf-I) insufficiency9.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin E'), ('CHEBI_27725', 'butin', 35, 'α-tocopherol'), ('GO_0007567', 'parturition', 112, 'birth'), ('PR_000045358', 'insulin family protein', 149, 'insulin'), ('PR_000009659', 'laminin subunit gamma-2', 157, 'like growth factor I'), ('PR_000008919', 'interferon alpha-6', 179, 'IGF-I')]
PMC5812027	2/2018	S28-PMC5812027	['lower Vitamin D status HAS also BEEN ASSOCIATED with a medical history of recurrent Miscarriage [12] BUT ONLY two prospective studies have INVESTIGATED this, without finding that lower 25Ohd concentrations increases the risk of Pregnancy Loss [5,13].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 139)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 84, 'miscarriage'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 185, '25OHD'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]
PMC5812027	2/2018	S115-PMC5812027	['THUS, preeclampsia does not SEEM to MEDIATE the ASSOCIATIONS between Vitamin D status trajectory and neonatal Birth size or Preterm Birth.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('GO_0007565', 'female pregnancy', 124, 'preterm birth')]
PMC5838372	3/2018	S13-PMC5838372	['DESPITE improvement in the socio-economic level of the population, Vitamin D deficiency is STILL a SERIOUS health PROBLEM in turkey.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 91), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5838372	3/2018	S101-PMC5838372	['all these data CONFIRM that Vitamin D deficiency continues to be a PROBLEM in Pregnant women and their infants in turkey, DESPITE the introduction of the supplementation programme.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 67), ('ANOMALY_CURIOUS_FINDING', 122)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnant')]
PMC5941617	5/2018	S264-PMC5941617	['HOWEVER, the EFFECT of supplementation became significant on total body bmc and Lumbar Spine bmd by dividing the sample into two groups, depending on Vitamin D status [25(Oh)D levels <\u200914\xa0ng/ml vs. ≥ 14\xa0ng/ml], SUGGESTING that Vitamin D supplementation MAY result in a clinically significant increase in bone mass in subjects with Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 253)]	4	[('UBERON_0006074', 'lumbar region of vertebral column', 80, 'lumbar spine'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 168, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC5941617	5/2018	S420-PMC5941617	['a meta-analysis of six case-control studies and two cohort-studies SHOWED a reduction of the RISK of t1dm in later Life (odds ratio: 0.71; 95% ci 0.51–0.98) in infants who were supplemented with Vitamin D compared with controls, ALTHOUGH the needed time of supplementation and the dose are STILL UNCLEAR [377–379].']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 93), ('ANOMALY_CURIOUS_FINDING', 229), ('FULL_UNKNOWN', 290)]	4	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S711-PMC5941617	['if an obese Individual does not receive Vitamin D supplementation and has a sedentary indoor lifestyle with consequent reduced sun exposure, Serum 25(Oh)D evaluation MAY BE CONSIDERED to confirm Vitamin D deficiency and start adequate treatment.']	[('INCOMPLETE_EVIDENCE', 166), ('ANOMALY_CURIOUS_FINDING', 170), ('FUTURE_WORK', 173), ('IMPORTANT_CONSIDERATION', 173)]	4	[('NCBITaxon_1', 'root', 12, 'individual'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('CHEBI_71657', 'versiconol acetate', 147, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 147, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5956785	5/2018	S123-PMC5956785	['age, ethnicity, season, bmi ASSOCIATED with 25(Oh)D BUT NOT Vitamin D deficiency.no association with whole sample; SMALL negative ASSOCIATION for new onset jia; mean time since onset 28\xa0months.helinski, finland markula-patjas et al.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 52), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 46, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC6039335	7/2018	S265-PMC6039335	['a continuous supply of normal levels of dietary Vitamin A during the entire growth period MAY also result in poor marbling and qg, EVEN IF the growth rate were normal and no health PROBLEMS occurred.']	[('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('PROBLEM_COMPLICATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A')]
BMJ_2010_Apr_29_340_c1640	4/2010	S85-BMJ_2010_Apr_29_340_c1640	['this PROXY has some LIMITATIONS in that it DOES NOT take into account individual personal behaviour, concurrent dietary Vitamin D intake, or skin pigmentation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 43)]	3	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC2582131	11/2008	S68-PMC2582131	['APPROXIMATELY 33% of gdm cases, COMPARED with 14% of controls ( p<0.001), had Plasma 25-[Oh] D concentrations CONSISTENT with a diagnosis of Vitamin D deficiency (<20 ng/ml))[1](table 2) .']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 32), ('INCOMPLETE_EVIDENCE', 110)]	3	[('UBERON_0001969', 'blood plasma', 78, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 85, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC2671168	5/2009	S214-PMC2671168	['IN FACT, supplementation with some Micronutrients, such as Vitamins C and e, was ASSOCIATED with INCREASED RISK of low Birth weight[55].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_33839', 'macromolecule', 35, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 59, 'vitamins C'), ('PR_000004900', 'complement C3', 68, 'C'), ('GO_0007567', 'parturition', 119, 'birth')]
PMC2716336	7/2009	S166-PMC2716336	['HOWEVER, significant differences were FOUND in calcium, iron, zinc, riboflavin and Vitamin C intakes across the various subgroups of household wealth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 38)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin C')]
PMC2798111	12/2010	S105-PMC2798111	['WHILE prescription of a Vitamin or medication and changes in Blood levels of that vitamin or medication, in this case, Vitamin D does NOT prove direct causality, the change in circulating 25(Oh)D status was INDEPENDENT of season.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 134), ('SUPERFICIAL_RELATIONSHIP', 207)]	3	[('CHEBI_33229', 'vitamin (role)', 24, 'vitamin'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 188, '25(OH ... D')]
PMC2821652	2/2010	S24-PMC2821652	['WHILE the demands of the fetus on the maternal System for calcium increase throughout Pregnancy, the demands for Vitamin D DO NOT APPEAR TO change.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 123), ('ANOMALY_CURIOUS_FINDING', 130)]	3	[('UBERON_0000467', 'anatomical system', 47, 'system'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC2821652	2/2010	S125-PMC2821652	['our analytic technique, HOWEVER, is UNIQUE in that it utilizes the pharmacokinetics of Vitamin D Metabolism to PREDICT adherence, and the data are then compared to pill counts.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('ANOMALY_CURIOUS_FINDING', 36), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0008152', 'metabolic process', 97, 'metabolism')]
PMC2963768	10/2010	S15-PMC2963768	['low 25(Oh)D is SURPRISINGLY common in south asia, where systemic Vitamin D deficits would be expected to be PREVENTED by cutaneous Vitamin D Synthesis stimulated by exposure to sun at relatively low latitudes (3).']	[('ANOMALY_CURIOUS_FINDING', 15), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 108)]	3	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 139, 'D synthesis')]
PMC2963768	10/2010	S143-PMC2963768	['HOWEVER, rigorous studies of the broad health benefits of interventions to improve the Antenatal or Postnatal Vitamin D status in south asian mothers and infants have YET to be REPORTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 167), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 87, 'antenatal'), ('GO_0007567', 'parturition', 100, 'postnatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3004407	12/2010	S131-PMC3004407	['WHILE there was a significant variation in 25(Oh)D concentrations between racial/ethnic categories, the deficiency did not APPEAR to change as a function of Gestational age; women in their later stages of Pregnancy had a SIMILAR risk of Vitamin D deficiency and insufficiency for a given race/ethnicity compared with women who had their 25(Oh)D concentrations measured earlier in Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 123), ('SUPERFICIAL_RELATIONSHIP', 221)]	3	[('CHEBI_71657', 'versiconol acetate', 43, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 43, '25('), ('PR_000006444', 'diacylglycerol kinase delta', 49, 'D'), ('GO_0007565', 'female pregnancy', 157, 'gestational'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 337, '25(OH)D'), ('GO_0007565', 'female pregnancy', 380, 'pregnancy')]
PMC3004407	12/2010	S149-PMC3004407	['infants who are Vitamin D deficient at Birth are at the highest RISK of impaired bone development [5] that APPEARS to persist in EVEN later childhood [37].']	[('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 129)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007567', 'parturition', 39, 'birth')]
PMC3032617	5/2010	S17-PMC3032617	['HOWEVER, Plasma concentrations fall to around 11µmol/l EVEN when dietary Vitamin C is between 10 and 20mg/day [6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 55)]	3	[('UBERON_0001969', 'blood plasma', 9, 'plasma'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin C')]
PMC3032617	5/2010	S94-PMC3032617	['AS a CONFIRMATION of this data, EVEN when women in the two groups were stratified for overall number of times hospitalized, the Vitamin C group was shown to achieve significantly better results.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 32)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin C')]
PMC3034879	12/2010	S14-PMC3034879	['conclusions\nPostnatal Vitamin D supplementation improved Vitamin D status BUT ONLY PARTLY eliminated the differences in bone variables induced by maternal Vitamin D status during the fetal period.']	[('ANOMALY_CURIOUS_FINDING', 74), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 83)]	3	[('GO_0007567', 'parturition', 12, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC3034879	12/2010	S191-PMC3034879	['given that more than 20% of the infants had S-25-Ohd below 50 nmol/l, DESPITE compliance with supplementation, higher intake of vitamin D is RECOMMENDED in order to obtain all the POTENTIAL health benefits of Vitamin D [43,44].']	[('ANOMALY_CURIOUS_FINDING', 70), ('FUTURE_WORK', 141), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 44, 'S-25-OHD'), ('PR_000001900', 'neuropilin-1', 44, 'S-25-OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 136, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3061267	2/2011	S105-PMC3061267	['maternal Vitamin C levels SEEMED PARTICULARLY IMPORTANT for Birth weight along with zinc for Birth length.']	[('ANOMALY_CURIOUS_FINDING', 26), ('ANOMALY_CURIOUS_FINDING', 33), ('IMPORTANT_CONSIDERATION', 46)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('GO_0007567', 'parturition', 60, 'birth'), ('GO_0007567', 'parturition', 93, 'birth')]
PMC3169551	9/2011	S133-PMC3169551	['ALTHOUGH vitamin a capsules were less costly than iron per person (usd0.12/person/year COMPARED TO usd0.36), delivery costs for Vitamin A were higher: usd1.83 COMPARED TO usd0.40.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin A')]
PMC3257641	3/2010	S44-PMC3257641	['AS EXPECTED, Vitamin D deficiency is PARTICULARLY common in darkly Pigmented mothers, PARTICULARLY among those who have migrated to regions with lower ambient uvr than their evolutionary heritage.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 37), ('ANOMALY_CURIOUS_FINDING', 86)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 67, 'pigmented')]
PMC3257641	3/2010	S80-PMC3257641	['among Vitamin D deficient Pregnant women, fetal ultrasound revealed splaying of the Distal Metaphysis Of the fetal Femur as early as 19 weeks, with the APPEARANCE being very SIMILAR TO that SEEN in childhood (Vitamin D-deficient) rickets [56].']	[('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 190)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 26, 'pregnant'), ('UBERON_0001389', 'soleus muscle', 84, 'distal'), ('UBERON_0006865', 'metaphysis of femur', 91, 'metaphysis of ... femur'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3271033	1/2012	S6-PMC3271033	['daily Vitamin D intake of 400 iu during the first months of Life APPEARS adequate to increase Serum 25(Oh)D and SUPPORT bmc increases DESPITE low initial 25(Oh)D levels in some infants.']	[('ANOMALY_CURIOUS_FINDING', 65), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 134)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0000104', 'life cycle', 60, 'life'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 102, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D')]
PMC3271033	1/2012	S11-PMC3271033	['formula-Fed infants typically consume 300-500 iu/day from their formula and THEREFORE GENERALLY meet the current recommendations without an additional oral supplement of Vitamin D drops ESPECIALLY after the first 6 to 8 weeks of Life.']	[('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 86), ('ANOMALY_CURIOUS_FINDING', 186)]	3	[('GO_0007631', 'feeding behavior', 8, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0000104', 'life cycle', 229, 'life')]
PMC3271033	1/2012	S13-PMC3271033	['REMARKABLY, FEW DATA have LOOKED AT modern techniques of assessing bone Mineral status and compared it to Vitamin D levels and supplementation in this population [5].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26)]	3	[('CHEBI_46662', 'mineral', 72, 'mineral'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3271033	1/2012	S16-PMC3271033	['ALTHOUGH Calcium and Phosphorus are transported transplacentally without Vitamin D, the EFFECTS of low Vitamin D in utero or shortly after Birth are UNCERTAIN [7].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 149)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 9, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 21, 'phosphorus'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC3277098	12/2011	S26-PMC3277098	['ALTHOUGH often not significant in terms of rickets or osteomalacia, it REMAINS UNKNOWN WHAT, if any, are the clinical outcomes of Vitamin D insufficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 71), ('EXPLICIT_QUESTION', 87)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3277098	12/2011	S120-PMC3277098	['HOWEVER, there was no association between maternal Vitamin D and eczema RISK at 3 years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 72)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3309463	6/2011	S51-PMC3309463	['IF cryptic variation is exposed by environmental exposures, such as Vitamin D deficiency, stress or cannabis use, then Allelic EFFECTS should BE larger in populations where these exposures are prevalent.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 127), ('ANOMALY_CURIOUS_FINDING', 142)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('SO_0001023', 'allele', 119, 'allelic')]
PMC3338544	4/2012	S169-PMC3338544	['dvd deficiency has BEEN examined in one outbred Rat strain and two inbred Mouse strains, and PERHAPS the two strains chosen (c57bl/6j and 129x1/svj) MAY BE largely unresponsive to changes in Vitamin D levels.']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 149)]	3	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 48, 'rat'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'mouse'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3347007	4/2012	S100-PMC3347007	['single women had lower odds ratio (or) for sufficient total Vitamin D intake than married/coupled women, HOWEVER, this RELATION was not statistically significant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3347007	4/2012	S159-PMC3347007	['high socio-economic status and education was found TO BE directly ASSOCIATED with Vitamin D intake and supplement use in OTHER studies [17,18,27,28,29].']	[('ANOMALY_CURIOUS_FINDING', 51), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3347028	3/2012	S0-PMC3347028	['Vitamin D and its ROLE during Pregnancy in attaining optimal health of mother and fetus\n\nabstract\nDESPITE its discovery a hundred years ago, Vitamin D has emerged as one of the most CONTROVERSIAL Nutrients and prohormones of the 21st century.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 30, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_33284', 'nutrient', 196, 'nutrients')]
PMC3347028	3/2012	S63-PMC3347028	['vdre are found ONLY in the Ll-37 Gene Promoters of Primates, SUGGESTING that the ability of Vitamin D to promote Ll-37 antibacterial action is a relatively recent event in evolution.']	[('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 61)]	3	[('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 27, 'LL-37'), ('SO_0000704', 'gene', 33, 'gene'), ('SO_0000167', 'promoter', 38, 'promoters'), ('NCBITaxon_33208', 'Metazoa', 51, 'primates'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 113, 'LL-37')]
PMC3347028	3/2012	S109-PMC3347028	['throughout Gestation, IF a woman is Vitamin D deficient, it APPEARS to IMPACT fetal bone health more than maternal [66,67,68].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('GO_0007565', 'female pregnancy', 11, 'gestation'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3347028	3/2012	S224-PMC3347028	['it is INTERESTING that epidemiological studies involving Pregnant women with Preeclampsia—a clinical picture of inflammation and vasculitis—Vitamin D deficiency HAS BEEN IMPLICATED [152,153,154].']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 77, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC3348565	4/2012	S25-PMC3348565	['THEREFORE, Breastmilk, a normally POOR source of Vitamin D,11becomes EVEN more deficient.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 34), ('ANOMALY_CURIOUS_FINDING', 69)]	3	[('UBERON_0001348', 'brown adipose tissue', 11, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3355895	1/2011	S4-PMC3355895	['THUS factors such as maternal lifestyle, diet, body build, physical activity, and Vitamin D status in Pregnancy all APPEAR to INFLUENCE offspring bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 116), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_46662', 'mineral', 151, 'mineral')]
PMC3356951	4/2012	S26-PMC3356951	['Vitamin D that comes from the skin or diet is biologically inert and REQUIRES its first hydroxylation in the Liver by the Vitamin D-25-hydroxylase (25-ohase) to 25(Oh)D.[311] HOWEVER, 25(Oh)D requires a further hydroxylation in the Kidneys by the 25(Oh)D-1-Ohase (Cyp27B1) to form the biologically active form of Vitamin D 1,25(Oh)2D.']	[('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 175)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0002107', 'liver', 109, 'liver'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 161, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('UBERON_0002113', 'kidney', 232, 'kidneys'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 250, 'OH)D'), ('CHEBI_32906', 'gibberellin A24', 257, 'OHase'), ('PR_000006101', 'cytochrome P450 1A1', 264, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D'), ('CHEBI_17996', 'chloride', 324, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 325, '25(OH)2D')]
PMC3356951	4/2012	S112-PMC3356951	['levels of 25(Oh)D are inversely ASSOCIATED with bmi, waist circumference, and body fat BUT are positively ASSOCIATED with age, lean body mass, and Vitamin D intake.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 87), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('CHEBI_71657', 'versiconol acetate', 10, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 10, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3395583	7/2012	S87-PMC3395583	['NOTABLY, Vitamin D Production is strictly DEPENDENT on uvb radiation and Vitamin D levels THEREFORE follow a seasonal distribution [23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 90)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 9, 'vitamin D production'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3407995	7/2012	S91-PMC3407995	['in addition, Pregnant women with darker skin pigmentation are at EVEN greater RISK of low Vitamin D status as COMPARED to Pregnant women with lighter skin pigmentation [49].']	[('ANOMALY_CURIOUS_FINDING', 65), ('IMPORTANT_CONSIDERATION', 78), ('ANOMALY_CURIOUS_FINDING', 110)]	3	[('GO_0007565', 'female pregnancy', 13, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant')]
PMC3407995	7/2012	S278-PMC3407995	['DESPITE abundant sunshine and latitude CONSISTENT with year-long Vitamin D Synthesis, 65.5% of a largely low-risk Antenatal population in rural victoria, australia had insufficient Vitamin D. over 5.0% of women had Vitamin D levels that pose a significant neonatal and Adult health RISK [135].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 282)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 65, 'vitamin D synthesis'), ('GO_0007567', 'parturition', 114, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 114, 'antenatal'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0007023', 'adult organism', 269, 'adult')]
PMC3407995	7/2012	S432-PMC3407995	['Vitamin D\ncurrently there are NO CONSISTENT RECOMMENDATIONS amongst or EVEN within countries for Vitamin D intake during Pregnancy and Lactation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 71)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy'), ('GO_0007595', 'lactation', 135, 'lactation')]
PMC3417531	7/2012	S177-PMC3417531	['the FIRST FOUND that while inuit children had a low intake of Calcium per day, calcium absorption APPEARED TO BE more efficient in children with a bb Vitamin D receptor genotype.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 98)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 62, 'calcium'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC3427192	4/2012	S37-PMC3427192	['OF PARTICULAR INTEREST is the FINDING of racial DISPARITIES in Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 48)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3427250	8/2012	S33-PMC3427250	['ALTHOUGH previous small surveys SUGGEST that Vitamin D deficiency among Pregnant women is common in europe[29],[30], there are NO RELIABLE country-wide estimates of Vitamin D status of Pregnant women in european countries.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 127)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnant')]
PMC3427250	8/2012	S128-PMC3427250	['the current Vitamin D RECOMMENDATIONS for Pregnant women are clearly INSUFFICIENT to prevent and EVEN more to treat Vitamin D deficient Pregnant women.']	[('FUTURE_WORK', 22), ('PROBLEM_COMPLICATION', 69), ('ANOMALY_CURIOUS_FINDING', 97)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnant')]
PMC3470091	9/2012	S78-PMC3470091	['this results in the increase of calcium absorption from the Intestine.27\nPREVIOUS STUDIES,17,27of intramuscular injection of 600,000 unit of Vitamin D was ASSOCIATED with significant increases of Serum Vitamin D at 1.5, 3, and 6 months, BUT NOT significant at 9 and 12 months later.']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 155), ('ANOMALY_CURIOUS_FINDING', 237)]	3	[('UBERON_0000160', 'intestine', 60, 'intestine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3470091	9/2012	S84-PMC3470091	['OUR STUDY REVEALED that a single high dose injection of Vitamin D is more economic and effective PARTICULARLY in Lactating mothers who refrain from Consuming oral daily doses due to Postpartum care, unwillingness or depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 97)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 113, 'lactating'), ('GO_0007631', 'feeding behavior', 148, 'consuming'), ('GO_0007565', 'female pregnancy', 182, 'postpartum')]
PMC3471827	10/2012	S105-PMC3471827	['the phenotype, especially impaired Brain Formation in ttp knockdown Zebrafish Embryos RAISES the INTRIGUING POSSIBILITY that low Vitamin E status has adverse events in early Central Nervous System development in other Animals, including Humans.']	[('EXPLICIT_QUESTION', 86), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 108)]	3	[('GO_0001503', 'ossification', 35, 'brain formation'), ('UBERON_0000955', 'brain', 35, 'brain'), ('NCBITaxon_7955', 'Danio rerio', 68, 'zebrafish'), ('UBERON_0000922', 'embryo', 78, 'embryos'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 174, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 174, 'central nervous system'), ('NCBITaxon_33208', 'Metazoa', 218, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'humans')]
PMC3471827	10/2012	S131-PMC3471827	['ALTHOUGH the Α-Tocopherol concentration of the e- Embryos was >50-fold decreased from the control Embryos, they STILL possessed detectable amounts of Vitamin E. this is LIKELY due to the specific allocation of maternal Vitamin E, and its incorporation into the Yolk of the developing Oocyte.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 112), ('PROBABLE_UNDERSTANDING', 169)]	3	[('CHEBI_27725', 'butin', 13, 'α-tocopherol'), ('UBERON_0000922', 'embryo', 50, 'embryos'), ('UBERON_0000922', 'embryo', 98, 'embryos'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin E'), ('UBERON_2000084', 'yolk', 261, 'yolk'), ('CL_0000023', 'oocyte', 284, 'oocyte')]
PMC3471827	10/2012	S135-PMC3471827	['NOTABLY, as morphologic outcomes from each study are ultimately due to Vitamin E deficiency, they LIKELY INVOLVE common mechanisms.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin E')]
PMC3476426	8/2012	S134-PMC3476426	['immunomodulatory effect of Vitamin D MAY act NOT ONLY through Modulation of Helper T Cell function, BUT ALSO through induction of Cd4+Cd25Highregulatory T-Cells (Tregs) [44].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 45), ('ANOMALY_CURIOUS_FINDING', 100)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'modulation'), ('CL_0000912', 'helper T cell', 76, 'helper T cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 130, 'CD4'), ('PR_000005166', 'CMRF35-like molecule 7', 134, 'CD25highregulatory'), ('CL_0000084', 'T cell', 153, 'T-cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 162, 'Tregs')]
PMC3488410	10/2012	S113-PMC3488410	['the Vitamin D deficiency MODEL APPEARS TO BE useful to study the IMPACT of Brain disturbances during Embryonic/fetal Development [127,128].']	[('INCOMPLETE_EVIDENCE', 25), ('ANOMALY_CURIOUS_FINDING', 31), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000955', 'brain', 75, 'brain'), ('GO_0009790', 'embryo development', 101, 'embryonic ... development'), ('UBERON_0000922', 'embryo', 101, 'embryonic')]
PMC3501517	11/2012	S200-PMC3501517	['INTERESTINGLY, shih REPORTED that Serum cytokine levels were reduced in this MODEL with Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 77)]	3	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3515553	12/2012	S1-PMC3515553	['Brain Development occurs primarily in utero and early infancy, BUT the ROLE of maternal Vitamin B-12 status during Pregnancy on offspring Cognitive function is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 63), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 160)]	3	[('GO_0060132', 'prolactin secreting cell development', 0, 'Brain development'), ('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0050890', 'cognition', 138, 'cognitive')]
PMC3515553	12/2012	S95-PMC3515553	['analysis of offspring genotypes and Cord Blood Vitamin B-12 REVEALED a strong ASSOCIATION with the Fut2 variant BUT no association with tcn2 rs1801198 and a marginal effect of tcn2 rs9606756 (table s3).']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 112)]	3	[('UBERON_0002240', 'spinal cord', 36, 'cord'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 47, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 57, '12'), ('PR_000007719', 'frizzled-2', 99, 'FUT2')]
PMC3629265	4/2013	S68-PMC3629265	['it SEEMS UNLIKELY that infants in the first few months of Life would drink 2 l of formula/day, the volume NECESSARY to receive 800 iu/day of Vitamin D. four of our cases presented during the autumn and winter months, the other two infants presented during the early spring.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('IMPORTANT_CONSIDERATION', 106)]	3	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3635901	4/2013	S33-PMC3635901	['it HAS BEEN SHOWN that a LINK exists between the mycobacterium, ads, and, SURPRISINGLY, another component of the puzzle, namely, Vitamin D [18].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 74)]	3	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3651971	5/2013	S100-PMC3651971	['fifty-five per cent of children in both groups were stunted, SUGGESTING comparable levels of chronic undernutrition, ALTHOUGH children Born to mothers in the placebo group had a lower prevalence of anaemia (26% vs 36.6%, p=0.03) and lower exposure to adequately Iodised Salt in their home, BASED ON tested concentrations of ≥30\u2005ppm (78% vs 85.7%, p=0.05), than in the Vitamin A group.']	[('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 117), ('PROBABLE_UNDERSTANDING', 290)]	3	[('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_24859', 'iodine atom', 262, 'iodised salt'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin A')]
PMC3668200	5/2013	S27-PMC3668200	['THEREFORE, IT IS POSSIBLE that EVEN formula-Fed young infants are Vitamin D deficient.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 31)]	3	[('GO_0007631', 'feeding behavior', 44, 'fed'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3668200	5/2013	S42-PMC3668200	['NEVERTHELESS, it is NOTEWORTHY that infants Born to unsupplemented Vitamin D-deficient mothers were LIKELY to have early Vitamin D deficiency compared with those whose mothers were supplemented with Vitamin D during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 20), ('PROBABLE_UNDERSTANDING', 100)]	3	[('GO_0007567', 'parturition', 44, 'born'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy')]
PMC3668200	5/2013	S50-PMC3668200	['with respect to Prenatal supplementation, the GENERALLY prescribed daily intake of 400 iu of Vitamin D is NOT sufficient to achieve the OPTIMAL Vitamin D status in newborns18).']	[('PROBABLE_UNDERSTANDING', 46), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 136)]	3	[('GO_0007565', 'female pregnancy', 16, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC3672018	5/2013	S94-PMC3672018	['the HYPOTHESIS is that Individuals Born 1–2\u2009years after commencement of mandatory fortification (1961) and thus exposed to extra Vitamin D during Fetal Development and for the next 24–25\u2009years until 1985 (where fortification was ended), ALTHOUGH unexposed thereafter, will have a lower lifetime risk of developing the aforementioned disease entities COMPARED TO Individuals Born 1\u2009–2\u2009years before fortification.']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 237), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 350)]	3	[('NCBITaxon_1', 'root', 23, 'individuals'), ('GO_0007567', 'parturition', 35, 'born'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 146, 'fetal development'), ('NCBITaxon_1', 'root', 362, 'individuals'), ('GO_0007567', 'parturition', 374, 'born')]
PMC3685533	6/2013	S18-PMC3685533	['current data within the literature DEMONSTRATES a high prevalence of Vitamin D insufficiency not ONLY in Adult and in children, BUT ALSO in Pregnant women and in their neonates [3-5].']	[('INCOMPLETE_EVIDENCE', 35), ('ANOMALY_CURIOUS_FINDING', 97), ('ANOMALY_CURIOUS_FINDING', 128)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('GO_0007565', 'female pregnancy', 140, 'pregnant')]
PMC3685533	6/2013	S107-PMC3685533	['analyzing data by mothers according to their country of origin, 25Ohd Cord Blood levels were higher in neonates Born from italian mothers than from north african or african mothers, WHILE after Birth Vitamin D Serum levels were higher in italian newborns ONLY when compared with north african.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 255)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 64, '25OHD'), ('UBERON_0002240', 'spinal cord', 70, 'cord'), ('UBERON_0000178', 'blood', 75, 'blood'), ('GO_0007567', 'parturition', 112, 'born'), ('GO_0007567', 'parturition', 194, 'birth'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001977', 'blood serum', 210, 'serum')]
PMC3691177	6/2013	S126-PMC3691177	['ALTHOUGH the Vitamin D doses used in this trial were greater than the current RECOMMENDED intake for Pregnant women of 400 iu/day during Pregnancy in the united kingdom[14],[17], and 600 iu in the united states[25], ONLY a small percentage of offspring had Cord 25(Oh)D levels in the sufficient range (13% daily group, 3% bolus group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 216)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnant'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 262, '25(OH)D')]
PMC3702245	6/2013	S5-PMC3702245	['ALTHOUGH the Synthesis and Metabolism Of Vitamin D in the nonpregnant state is WELL KNOWN, its Metabolism during Pregnancy is LESS WELL UNDERSTOOD.3the classical action of vitamin d is to maintain Calcium Homeostasis and bone health.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 126)]	3	[('GO_0007416', 'synapse assembly', 13, 'synthesis ...'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 27, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0008152', 'metabolic process', 95, 'metabolism'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0055073', 'cadmium ion homeostasis', 197, 'calcium homeostasis')]
PMC3702339	6/2013	S15-PMC3702339	['the world health organization (who) defines Vitamin A deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency (3).']	[('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
PMC3710934	7/2013	S378-PMC3710934	['ON THE OTHER HAND, dietary Heme Iron Intake was positively ASSOCIATED with Lung cancer when subjects were stratified by Vitamin C supplements Intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_36084', 'dihydroxybenzoate', 27, 'heme iron'), ('GO_0007631', 'feeding behavior', 37, 'intake'), ('UBERON_0002048', 'lung', 75, 'lung'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin C'), ('GO_0007631', 'feeding behavior', 142, 'intake')]
PMC3710934	7/2013	S380-PMC3710934	['among current or ex-smokers, the ASSOCIATION was EVEN stronger (rr=20.38; 95% ci: 22.50–185.8) and reached statistical significance EVEN in the group having Vitamin C supplement Intake of >100 mg/day (rr=3.52; 95% ci: 1.24–8.97).']	[('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 49), ('ANOMALY_CURIOUS_FINDING', 132)]	3	[('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('GO_0007631', 'feeding behavior', 178, 'intake')]
PMC3713405	7/2013	S95-PMC3713405	['THUS at both the cellular and transcriptional levels, Vitamin D APPEARS fundamentally INVOLVED in the rate of Proliferation and Cell Death in the Brain.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 64), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0008283', 'cell proliferation', 110, 'proliferation'), ('GO_0008219', 'cell death', 128, 'cell death'), ('UBERON_0000955', 'brain', 146, 'brain')]
PMC3717170	5/2013	S175-PMC3717170	['INTERESTINGLY, vdr Expression in Human muscle Tissue decreases with Aging, and Vitamin D level is STRONGLY CORRELATED with muscle quality and lower muscle fat infiltration.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('GO_0010467', 'gene expression', 19, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'human'), ('UBERON_0000479', 'tissue', 46, 'tissue'), ('GO_0007568', 'aging', 68, 'aging'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3728489	7/2013	S314-PMC3728489	['NOTABLY, in a RECENT population-based case control STUDY of 424 Individuals with schizophrenia and 424 matched controls, dried Blood spots taken at Birth were tested for Vitamin D levels (mcgrath et al.,2010).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 51)]	3	[('NCBITaxon_1', 'root', 64, 'individuals'), ('UBERON_0000178', 'blood', 127, 'blood'), ('GO_0007567', 'parturition', 148, 'birth'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC3760821	9/2013	S25-PMC3760821	['DESPITE the LACK OF change/decline in 25Ohd levels, levels of the biologically active Vitamin D Metabolite, 1,25 Dihydroxy Vitamin D [1,25(Oh)2D], are KNOWN to increase by 100% or more during Pregnancy[7],[10].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 151)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 38, '25OHD'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 96, 'metabolite'), ('CHEBI_50341', '1-hydroxyethyl group', 108, '1,25 dihydroxy'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_72698', '(2R)-trihomocitric acid', 138, '(OH)2D'), ('GO_0007565', 'female pregnancy', 192, 'pregnancy')]
PMC3760821	9/2013	S183-PMC3760821	['HOWEVER, the low levels of Vitamin D FOUND in both the control and t1dm groups would APPEAR TO argue against the widespread use of augmented intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 85)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3773018	4/2013	S6-PMC3773018	['HOWEVER, in combination, persistence of low Vitamin D status at Birth and early childhood increased the risk of fs (or=2.03, 95%ci:1.02–4.04), PARTICULARLY among children carrying the c Allele of rs2243250 (or=3.23, 95%ci:1.37–7.60).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'birth'), ('SO_0001023', 'allele', 186, 'allele')]
PMC3798907	8/2013	S70-PMC3798907	['HOWEVER, just as for cbmc, there was a TREND for GENERALLY enhanced secretion of the Regulatory cytokine Tgf-Β when pbmc were supplemented with Vitamin E, and these increases were significant in the cultures responding to con a (13 of 17 cultures exhibiting an increase) or hdm, (13 of 17 cultures exhibiting an increase) (figure 2andtable 1).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 49)]	3	[('GO_0065007', 'biological regulation', 85, 'regulatory'), ('PR_000000046', 'TGF-beta', 105, 'TGF-β'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin E')]
PMC3798907	8/2013	S138-PMC3798907	['HOWEVER, our original OBSERVATION was between maternal Vitamin E intake and cbmc responses, we FOUND no associations between cbmc responses and maternal (and Cord) Blood Ascorbate Tocopherol at 10 weeks Gestation or at Delivery [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 158, 'cord'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_22651', 'ascorbate', 170, 'ascorbate'), ('CHEBI_27013', 'tocopherol', 180, 'tocopherol'), ('GO_0007565', 'female pregnancy', 203, 'gestation'), ('GO_0007567', 'parturition', 219, 'delivery')]
PMC3827489	10/2013	S22-PMC3827489	['ALTHOUGH Vitamin D deficiency IS KNOWN to be prevalent in Adults, epidemiologic data on the prevalence of Vitamin D deficiency are LACKING in korean infants, children, and adolescents.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('FULL_UNKNOWN', 131)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adults'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3829803	11/2013	S249-PMC3829803	['HOWEVER, high doses of Vitamin A in children with Rsv infection have no benefit and MAY EVEN cause harm [74,88].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 50, 'RSV')]
PMC3855580	10/2013	S153-PMC3855580	['we have PREVIOUSLY SHOWN that the ASSOCIATION between maternal Vitamin D deficiency [38] and Glucose intolerance [11,14] with offspring homa-ir was present at 9.5\xa0years of age, but NOT at 5\xa0years of age.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 34), ('ANOMALY_CURIOUS_FINDING', 181)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_17234', 'glucose', 93, 'glucose')]
PMC3873449	12/2013	S53-PMC3873449	['Vitamin D intake in Food was not collected SINCE usually little Food in chinese diet contains reasonable amounts of Vitamin D. it should be NOTED that in china, dairy Products are not fortified with Vitamin D. the questionnaire also SOUGHT information about behavioral factors like daily duration of computer use and daily duration of sun exposure (duration-number of hours per day).']	[('PROBLEM_COMPLICATION', 43), ('ANOMALY_CURIOUS_FINDING', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 233)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_33290', 'food', 20, 'food'), ('CHEBI_33290', 'food', 64, 'food'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_38873', 'prothiofos', 167, 'products'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D')]
PMC3873449	12/2013	S124-PMC3873449	['it SEEMS, HOWEVER, that all Pregnant women are at a high RISK of Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 57)]	3	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3873449	12/2013	S192-PMC3873449	['measures SHOULD BE taken to improve their knowledge about Vitamin D. treatment SHOULD BE paired with health education and advice and basic knowledge of the role of Vitamin D.\nin the study, the 25(Oh) D level was low in all subjects, but was PARTICULARLY low in less educated women.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 79), ('ANOMALY_CURIOUS_FINDING', 241)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH) D')]
PMC3901983	1/2013	S103-PMC3901983	['there are no reports now on the NUMBER of Pregnant women presenting this disturbance, BUT it is NOTABLE that Vitamin K has already limited Placental Transfer during normal Pregnancy.']	[('INCOMPLETE_EVIDENCE', 32), ('ANOMALY_CURIOUS_FINDING', 86), ('ANOMALY_CURIOUS_FINDING', 96)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin K'), ('GO_0001966', 'thigmotaxis', 139, 'placental transfer'), ('UBERON_0001987', 'placenta', 139, 'placental'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC3991049	11/2013	S72-PMC3991049	['hypercalcemia, which is the most WORRYING toxicity, occurs with Vitamin D levels of more than 80 or 100\xa0ng/ml; and in OUR STUDY no one reached this level through out Pregnancy and in newborns with normal levels of calcium IN SPITE of supplementation.']	[('IMPORTANT_CONSIDERATION', 33), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('ANOMALY_CURIOUS_FINDING', 222)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC4018592	4/2014	S22-PMC4018592	['[17] in a study in nepal, multiple Micronutrient supplementations during Pregnancy did NOT reduce early infant mortality;[18] HOWEVER, it led TO improved folate status and reduced the prevalence of riboflavin, Vitamin B6, Vitamin B12, Folate and Vitamin D deficiencies.']	[('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 35, 'micronutrient'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_33237', 'vitamin D4', 210, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 222, 'vitamin B12'), ('CHEBI_30863', '5-azaorotic acid', 235, 'folate'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4072587	6/2014	S120-PMC4072587	['ALTHOUGH Vitamin D concentration was significantly higher in the twice weekly multiple Micronutrient group compared TO daily iron Folic Acid group, (mean [sd] of 76.3 [23.8] versus 67.8 [20.6] nmol/l), the prevalence of Vitamin D deficiency (<37.5 nmol/l) was SIMILAR (4.9% (16/326) versus 3.1% (9/293).']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 260)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 87, 'micronutrient'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4072587	6/2014	S146-PMC4072587	['in our trial, EVEN THOUGH the majority of women worked as farmers, we OBSERVED a very high prevalence (60%) of women with Vitamin D levels less than 75 nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 70)]	3	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4106226	7/2014	S43-PMC4106226	['ALTHOUGH the SMALL SAMPLE size (80 t1dm cases aged 6 to 16\xa0years and 40 healthy children age and gender matched as control group), the authors FOUND that Serum Vitamin D levels were not significantly lower in diabetic subjects compared to the control group (24.7\u2009±\u20095.6 vs 26.5\u2009±\u20094.8\xa0ng/ml; p\u2009>\u20090.05).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 143)]	3	[('UBERON_0001977', 'blood serum', 154, 'serum'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4113768	7/2014	S836-PMC4113768	['15% (3/20) women surveyed said they had RISK FACTORS for Vitamin D deficiency, BUT ONLY 2 were specifically asked about Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 83)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S1037-PMC4113768	['conclusions: maternal Vitamin D supplementation during Pregnancy was ASSOCIATED with NOTABLE reductions in the risk of infections and pre-term Birth.']	[('SUPERFICIAL_RELATIONSHIP', 69), ('ANOMALY_CURIOUS_FINDING', 85), ('IMPORTANT_CONSIDERATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('GO_0007567', 'parturition', 143, 'birth')]
PMC4113768	7/2014	S1051-PMC4113768	['for β-ctx ALONE no significant association with 25(Oh) Vitamin D was observed (−0.58 ng/l, p = 0.84), WHEREAS the β-ctx to Osteocalcin ratio was inversely ASSOCIATED with 25(Oh) Vitamin D levels (−1.1% change, p = 0.003).']	[('ANOMALY_CURIOUS_FINDING', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('SUPERFICIAL_RELATIONSHIP', 155)]	3	[('CHEBI_30778', 'gallic acid', 48, '25(OH)'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 123, 'osteocalcin'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4113768	7/2014	S1559-PMC4113768	['HOWEVER, when the previously defined covariates (age, ethnicity, cosinor terms) were added to the linear regression model, Vitamin D CEASED to be a significant PREDICTOR of Cmv Antibody titre.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 133), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 173, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]
PMC4113768	7/2014	S1614-PMC4113768	['HOWEVER, Vitamin D deficiency (<50 nmol/l) APPEARS to amplify bmd loss in the hip in those not on tdf.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 43)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4113768	7/2014	S1701-PMC4113768	['Life Style is a more significant FACTOR that CONTRIBUTES in Vitamin D insufficiency EVEN in a sun rich country like pakistan.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 84)]	3	[('UBERON_0000104', 'life cycle', 0, 'Life'), ('GO_0051320', 'S phase', 5, 'style'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4113768	7/2014	S1860-PMC4113768	['conclusions: DESPITE it supposedly being an inactive Metabolite of Vitamin D, 25(Oh)2D3, APPEARS TO have biologically relevant EFFECTS on cultured Huvecs.']	[('ANOMALY_CURIOUS_FINDING', 13), ('ANOMALY_CURIOUS_FINDING', 89), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_39382', 'flufenoxuron', 53, 'metabolite'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_73394', 'Ala-Ser', 78, '25(OH)2D3'), ('CL_0002674', 'H minus', 147, 'HUVECs')]
PMC4113768	7/2014	S3345-PMC4113768	['(4) the Vitamin D status of Pregnant women SHOWED the same TREND as the air temperature fluctuations, BUT its phase lagged behind about two months, reaching its highest value in september.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 102)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnant')]
PMC4169453	9/2014	S25-PMC4169453	['further, in addition to the body composition indices (fat and lean mass) Vitamin D status SEEMS an INDEPENDENT CONTRIBUTOR to bone Mineral density in girls and women[24],[25].']	[('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_46662', 'mineral', 131, 'mineral')]
PMC4169453	9/2014	S124-PMC4169453	['Vitamin D status\nmaternal 25(Oh)D level was SIMILAR in both groups at baseline and after 3 months of Vitamin D supplementation, HOWEVER, at v6 significantly higher 25(Oh)D levels were NOTED in the 1200 iu/d group (fig.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ANOMALY_CURIOUS_FINDING', 128), ('ANOMALY_CURIOUS_FINDING', 184)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 164, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 170, 'D')]
PMC4169453	9/2014	S196-PMC4169453	['UNDOUBTEDLY, 400 iu/d of Vitamin D APPEARED UNSATISFACTORY for Lactating women.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 35), ('ANOMALY_CURIOUS_FINDING', 44)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 63, 'lactating')]
PMC4169453	9/2014	S217-PMC4169453	['ON THE OTHER HAND, stable and comparable pth concentrations were REPORTED by greer in infants supplemented with Vitamin D or receiving a placebo, DESPITE significantly lower 25(Oh)D levels in the placebo group[45].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 146)]	3	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 177, 'OH)D')]
PMC4210927	10/2014	S146-PMC4210927	['[65] FOUND that ONLY 36% of Lactating women meet energy, calcium and Vitamin D RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 16), ('FUTURE_WORK', 79)]	3	[('GO_0007594', 'puparial adhesion', 28, 'lactating'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4251419	12/2014	S79-PMC4251419	['additionally, WHILE increased sun exposure during childhood was inversely ASSOCIATED with risk of multiple sclerosis, there was no decreased risk associated with intake of Vitamin D supplements during childhood [40].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4251419	12/2014	S120-PMC4251419	['these data SUGGEST that NOT ONLY can Vitamin D Modulate Tissue inflammation through modifications to the microbiome, BUT the reverse is also POSSIBLE—the microbiome and inflammation can change the responsiveness of Tissues to Vitamin D through Regulation of the vdr.']	[('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 141)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0065007', 'biological regulation', 47, 'modulate'), ('UBERON_0000479', 'tissue', 56, 'tissue'), ('UBERON_0000479', 'tissue', 215, 'tissues'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0065007', 'biological regulation', 244, 'regulation')]
PMC4251419	12/2014	S158-PMC4251419	['YET Vitamin D supplementation trials are GENERALLY relatively short-term, with supplementation for ONLY 1-2 years.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 99)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4256222	12/2014	S129-PMC4256222	['it would be OF great INTEREST to conduct similar analysis to investigate the ASSOCIATION between maternal status of Vitamin D and offspring Forearm fractures in a study population large enough to allow such subdivision of fractures and further stratification by Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 12), ('FUTURE_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 140, 'forearm'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D')]
PMC4277121	12/2015	S231-PMC4277121	['among the Drugs showing only partial rescue in specific l/m tasks, Minocycline, Memantine, and Vitamin E were tested in the Wram, while Melatonin, Nap + sal, and peptide 6 ONLY PARTIALLY rescued acquisition in the mwm.']	[('ANOMALY_CURIOUS_FINDING', 172), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 177)]	3	[('CHEBI_23888', 'drug', 10, 'drugs'), ('CHEBI_50694', 'minocycline', 67, 'minocycline'), ('CHEBI_64312', 'memantine', 80, 'memantine'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 124, 'WRAM'), ('CHEBI_25179', 'melanins', 136, 'melatonin'), ('CHEBI_13389', 'NAD', 147, 'NAP')]
PMC4302429	1/2015	S205-PMC4302429	['in early infection (20\xa0h), low, BUT approximately equal Ifn-Γ levels were measured, SUGGESTING that Ifn-Γ was not INVOLVED in the protective action of an adequate Vitamin D supply.']	[('ANOMALY_CURIOUS_FINDING', 32), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 114)]	3	[('PR_000008920', 'interferon alpha-7', 56, 'IFN-γ'), ('PR_000008920', 'interferon alpha-7', 100, 'IFN-γ'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4303849	1/2015	S246-PMC4303849	['in this regard, a study performed with Pregnant women in germany SHOWED that during the winter months, 98% of the maternal Blood samples and 94% of the Cord Blood samples had 25Ohd levels < 50 nmol/l, WHILE in the summer months, ONLY 49% of the women and 35% of the Cord Blood samples were Vitamin D deficient [220].']	[('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 201), ('ANOMALY_CURIOUS_FINDING', 229)]	3	[('GO_0007565', 'female pregnancy', 39, 'pregnant'), ('UBERON_0000178', 'blood', 123, 'blood'), ('UBERON_0002240', 'spinal cord', 152, 'cord'), ('UBERON_0000178', 'blood', 157, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 175, '25OHD'), ('UBERON_0002240', 'spinal cord', 266, 'cord'), ('UBERON_0000178', 'blood', 271, 'blood'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC4329404	10/2014	S102-PMC4329404	['supplementation with Vitamin D after in utero and early-Life insufficiency reduces Serum Ige in pups at 6\xa0weeks of age, BUT NOT th2 cytokines\nwe measured Serum total and hdm-specific Ige TO ASSESS whether early-Life Vitamin D insufficiency AFFECTED sensitization to Allergen (fig.4a).']	[('ANOMALY_CURIOUS_FINDING', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 240)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000104', 'life cycle', 56, 'life'), ('UBERON_0001977', 'blood serum', 83, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 89, 'IgE'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 183, 'IgE'), ('UBERON_0000104', 'life cycle', 211, 'life'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_50904', 'allergen', 266, 'allergen')]
PMC4329404	10/2014	S158-PMC4329404	['an INTERESTING POINT to note is that after introduction of a Vitamin D-replete diet postweaning, Pulmonary Eosinophilic inflammation was EVEN lower than in Mice that were always Vitamin D sufficient (fig.2a).']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 15), ('ANOMALY_CURIOUS_FINDING', 137)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0002048', 'lung', 97, 'pulmonary'), ('CL_0000771', 'eosinophil', 107, 'eosinophilic'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'mice'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4329404	10/2014	S169-PMC4329404	['it is INTERESTING that in OUR STUDY, dietary Vitamin D in utero was ASSOCIATED with the highest numbers of Il-10-secreting Tregs.']	[('ANOMALY_CURIOUS_FINDING', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 68)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 107, 'IL-10'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 123, 'Tregs')]
PMC4329745	10/2014	S92-PMC4329745	['at first glance, it SEEMS that the MAJOR cause for these very low levels of Vitamin D in iranian women is the highly covered type of dressing in iran, BUT this would not rationalize the low vitamin status in iranian men (8,9).']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4377870	3/2015	S118-PMC4377870	['in asthma the experimental data for Vitamin E are COMPELLING, YET supplementation benefits are NOT WELL DESCRIBED.']	[('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 62), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin E')]
PMC4380518	9/2014	S67-PMC4380518	['in conclusion, we FOUND that lack of pnv use during Pregnancy was ASSOCIATED with Vitamin D deficiency early in Pregnancy, BUT NOT among black women.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 123)]	3	[('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4383226	2/2015	S41-PMC4383226	['WHILE Vitamin A did not APPEAR to Modulate the risk of parasitemia in a clinical trial study of ghanaian children (binka et al., 1995) and tanzanian children previously hospitalized with pneumonia (villamor et al., 2003), a cluster randomized intervention trial for breastfeeding in uganda OBSERVED a sixfold decrease in the adjusted risk of malaria infection among children receiving Vitamin A (nankabirwa et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 290)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('GO_0065007', 'biological regulation', 34, 'modulate'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin A')]
PMC4383226	2/2015	S78-PMC4383226	['doi: http://dx.doi.org/10.7554/elife.03925.006\n\nIMPACT of Vitamin A supplementation on malaria infection\nvitamin a supplementation APPEARED PROTECTIVE against plasmodium parasitemia and p ƒhrp-2 antigenemia (table 2).']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 131), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A'), ('PR_000000164', 'BMP2', 192, '-2')]
PMC4383226	2/2015	S80-PMC4383226	['HOWEVER, for antigenemia, Vitamin A was moderately more PROTECTIVE in older children (ptrend<0.001), the more time passed since supplementation (ptrend<0.001) or if supplementation was given during the wet season (ptrend=0.04).table 3reveals that ASSOCIATIONS between Vitamin A and parasitemia were stronger among children 36–59 months of age or if their mother took an Antimalarial during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 247)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin A'), ('CHEBI_67261', '(Z)-2,3-dehydroadipyl-CoA(5-)', 370, 'antimalarial'), ('GO_0007565', 'female pregnancy', 390, 'pregnancy')]
PMC4383226	2/2015	S85-PMC4383226	['we had INSUFFICIENT data to identify cross-INTERACTIONS between vaccines and Vitamin A using an adjusted model, BUT in unadjusted models we found no significant interactions between vaccination and Vitamin A supplementation.10.7554/elife.03925.007\n\ncaption (table-wrap): table 3.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 112)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
PMC4383226	2/2015	S120-PMC4383226	['the breadth and size of the study population enabled us TO EVALUATE the ASSOCIATION between malaria and childhood vaccines/Vitamin A DESPITE high vaccination coverage rates within most of the communities surveyed (desai et al., 2005).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 133)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin A')]
PMC4383226	2/2015	S131-PMC4383226	['moreover, BECAUSE of the observational nature of our study design, high-quality randomized clinical TRIALS ARE NEEDED to confirm the efficacy of Vitamin A in preventing malaria, PARTICULARLY among children exposed to Placental malaria.']	[('PROBLEM_COMPLICATION', 10), ('FUTURE_WORK', 100), ('ANOMALY_CURIOUS_FINDING', 178)]	3	[('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('UBERON_0001987', 'placenta', 217, 'placental')]
PMC4383575	1/2015	S129-PMC4383575	['HOWEVER, country of Birth, higher maternal bmi, Delivery by cesarean section, male infant sex (table 2), and low maternal intake of Fruits rich in Vitamin C and high intake of diary products as well as low adherence to healthy diet were ASSOCIATED with higher dna adduct levels in adjusted models (table 3).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 237)]	3	[('GO_0007567', 'parturition', 20, 'birth'), ('GO_0007567', 'parturition', 48, 'delivery'), ('CHEBI_33290', 'food', 132, 'fruits'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin C'), ('PR_000004900', 'complement C3', 155, 'C')]
PMC4405493	4/2015	S114-PMC4405493	['ALTHOUGH we recruited ONLY young, nulliparous, previously healthy women, the majority of our patients were either Vitamin D deficient (10%, <20 ng/ml) or Vitamin D insufficient (60%, 20–29 ng/ml) according TO the criteria published by the institute for medicine.18of the 235 patients included in the study, 41 of them had a prior Pregnancy which had resulted in a spontaneous First Trimester Miscarriage or elective termination.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 206)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 330, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 376, 'first trimester'), ('GO_0046660', 'female sex differentiation', 392, 'miscarriage')]
PMC4405493	4/2015	S138-PMC4405493	['as our study center is around 47 degrees latitude and 38% of our first Trimester Blood draws occurred in the winter, this CERTAINLY COULD CONTRIBUTE to the prevalence of Vitamin D deficiency in our population.']	[('ANOMALY_CURIOUS_FINDING', 122), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('GO_0009294', 'DNA mediated transformation', 71, 'trimester'), ('UBERON_0000178', 'blood', 81, 'blood'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4405493	4/2015	S152-PMC4405493	['HOWEVER, Vitamin D deficiency did not increase the odds of preeclampsia, EVEN when stratifying by disease severity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 73)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4417995	4/2015	S57-PMC4417995	['overall these data SEEM to INDICATE that Vitamin D deficiency is RELATED to the severity of ad.']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4417995	4/2015	S173-PMC4417995	['OF NOTE, a positive CORRELATION was EVIDENCED between the increase in Vitamin D levels and the decrease in the scorad index in march but not in january.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 36)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4427001	4/2015	S25-PMC4427001	['INTERESTINGLY Vitamin D also exerts renoprotective and antiproteinuric EFFECTS with several mechanisms INVOLVED including inhibition of Renin-angiotensin-aldosteron system (by decreasing Renin Expression), suppression of inflammation (by reducing accumulation of Inflammatory Cells), and restoration of Glomerular filtration barrier (by attenuating Podocyte damage) [13–15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('PR_000014368', 'RuvB-like 1', 136, 'renin'), ('PR_000014368', 'RuvB-like 1', 187, 'renin'), ('GO_0010467', 'gene expression', 193, 'expression'), ('CL_0000902', 'induced T-regulatory cell', 263, 'inflammatory cells'), ('UBERON_0000074', 'renal glomerulus', 303, 'glomerular'), ('CL_0000653', 'glomerular visceral epithelial cell', 349, 'podocyte')]
PMC4448820	5/2015	S249-PMC4448820	['● pem and deficiencies of Vitamin A, zinc, or iron have a ROBUST, ALBEIT variable EFFECT in reducing Antigen-Presenting Cell (Apc) function (150–160).']	[('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 66), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('CHEBI_59132', 'antigen', 101, 'antigen'), ('CL_0000593', 'androgen secreting cell', 101, 'antigen ... presenting cell'), ('PR_000004122', 'adenomatous polyposis coli protein', 126, 'APC')]
PMC4448820	5/2015	S375-PMC4448820	['Kdm6B/Jmjd3 Histone demethylase is induced by Vitamin D, but NOT Atra, in Human Colon cancer cells (217) and HAS BEEN IMPLICATED in the Regulation of Cyclin-Dependent Kinase Inhibitor 1A ( Cdkn1A ) /P21Cip1 by 1,25(Oh)2D in normal Prostate cells (218).']	[('ANOMALY_CURIOUS_FINDING', 61), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('PR_000009209', 'juxtaposed with another zinc finger protein 1', 0, 'KDM6B'), ('PR_000009211', 'lysine-specific demethylase 3A', 6, 'JMJD3'), ('CHEBI_15358', 'histone', 12, 'histone'), ('PR_000043452', 'core histone', 12, 'histone'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17033', 'biliverdin', 65, 'ATRA'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'human'), ('UBERON_0001155', 'colon', 80, 'colon'), ('GO_0065007', 'biological regulation', 136, 'regulation'), ('PR_000004910', 'complement component C8 gamma chain', 150, 'cyclin-dependent kinase inhibitor 1A'), ('CHEBI_35222', 'inhibitor', 174, 'inhibitor'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 189, 'CDKN1A'), ('PR_000014700', 'serpin B9', 199, 'p21CIP1'), ('CHEBI_37983', 'sulfur-35 atom', 210, '1'), ('CHEBI_17996', 'chloride', 211, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 212, '25(OH)2D'), ('CL_0002249', 'primitive cardiac myocyte', 231, 'prostate'), ('UBERON_0002367', 'prostate gland', 231, 'prostate')]
PMC4488777	5/2015	S24-PMC4488777	['THEREFORE, a clinician MUST BE careful when prescribing Vitamin D preparations, ESPECIALLY in male patients.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 23), ('ANOMALY_CURIOUS_FINDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4499946	7/2015	S36-PMC4499946	['the EFFECT APPEARED TO BE attributable to a significantly accelerated increase in mean Laz from Birth to 1 month of age (change of 0.53 z-score in Vitamin D versus 0.19 z-score in placebo group; p = 0.004) RATHER than a significant difference in Birth length [26].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 206)]	3	[('PR_000009655', 'laminin subunit beta-2', 87, 'LAZ'), ('GO_0007567', 'parturition', 96, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 246, 'birth')]
PMC4595656	10/2015	S71-PMC4595656	['several groups of Rats were treated and compared e.g., no depletion, replete at Birth, replete at weaning, depleted until 10 weeks of age, or depleted between 5 and 10 weeks of age, and they FOUND that ONLY the combined Prenatal and chronic Postnatal Vitamin D deprivation, BUT NOT early Life hypovitaminosis on its own, resulted in an impaired response.']	[('INCOMPLETE_EVIDENCE', 191), ('ANOMALY_CURIOUS_FINDING', 202), ('ANOMALY_CURIOUS_FINDING', 274)]	3	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 18, 'rats'), ('GO_0007567', 'parturition', 80, 'birth'), ('GO_0007565', 'female pregnancy', 220, 'prenatal'), ('GO_0007567', 'parturition', 241, 'postnatal'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('UBERON_0000104', 'life cycle', 288, 'life')]
PMC4627942	10/2015	S185-PMC4627942	['ALTHOUGH it APPEARED TO BE beneficial in the above-mentioned trial in guinea-bissau, researchers at kintampo hdss in ghana FOUND no positive effect of Vitamin A supplements in combination with vaccines during the first few months of Life (68).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0000104', 'life cycle', 233, 'life')]
PMC4632418	10/2015	S18-PMC4632418	['IN ACCORDANCE WITH these definitions, EVEN middle-age Adults are at equally high RISK with elder and children for Vitamin D deficiency and insufficiency worldwide [6].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 81)]	3	[('UBERON_0007023', 'adult organism', 54, 'adults'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4632418	10/2015	S109-PMC4632418	['UNDOUBTEDLY, the 25(Oh)D level in two studies was high, WHEREAS the prevalence of Vitamin D deficiency was low.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56)]	3	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4684854	12/2015	S80-PMC4684854	['the authors of this study also NOTED that women with lower Vitamin D levels had higher degrees of various Autoantibodies including Antiphospholipid Antibody [50], a clinical state that HAS BEEN ASSOCIATED with fetal death, recurrent early Miscarriage, Preeclampsia, and Placental insufficiency [51].']	[('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 194)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0044308', 'axonal spine', 106, 'autoantibodies'), ('CHEBI_16240', 'hydrogen peroxide', 131, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 148, 'antibody'), ('GO_0046660', 'female sex differentiation', 239, 'miscarriage'), ('GO_0007128', 'meiotic prophase I', 252, 'preeclampsia'), ('UBERON_0001987', 'placenta', 270, 'placental')]
PMC4684854	12/2015	S91-PMC4684854	['other Gestational ISSUES also APPEAR TO BE INFLUENCED by maternal Vitamin D levels.']	[('IMPORTANT_CONSIDERATION', 18), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('GO_0007565', 'female pregnancy', 6, 'gestational'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4684854	12/2015	S113-PMC4684854	['maternal Vitamin D status during Gestation also APPEARS TO have INFLUENCE on many OTHER health indices in the future of the offspring.']	[('ANOMALY_CURIOUS_FINDING', 48), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'gestation')]
PMC4719746	1/2016	S104-PMC4719746	['ONLY 37\xa0% of these women reported an intake of ≥10\xa0μg/day of Vitamin D supplements, BUT at Gestational week 28, this proportion had increased to 73\xa0% ( p \u2009<\u20090.01).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 84)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestational')]
PMC4728621	1/2016	S7-PMC4728621	['maternal trimester three gi, trimester two Saturated Fats and trimester one and three Sodium intake were positively ASSOCIATED with offspring adiposity, WHILE trimester two and three Vitamin C Intake was negatively ASSOCIATED.']	[('SUPERFICIAL_RELATIONSHIP', 116), ('ANOMALY_CURIOUS_FINDING', 153), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_52261', 'rose bengal', 43, 'saturated fats'), ('CHEBI_52632', 'potassium-39 atom', 86, 'sodium'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin C'), ('GO_0007631', 'feeding behavior', 193, 'intake')]
PMC4729160	1/2016	S128-PMC4729160	['MORE STUDIES ARE NEEDED to understand the INFLUENCE FACTORS of Vitamin A status of chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnant')]
PMC4764019	1/2016	S25-PMC4764019	['Birth month, in itself, EXHIBITS precisely that RELATIONSHIP.7the UNDERLYING presumption is that the Intrauterine environment would have been relatively deprived of Vitamin D for Births occurring in late spring, and the same environment would have been richer in Vitamin D for births occurring in late fall.']	[('ANOMALY_CURIOUS_FINDING', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('GO_0007567', 'parturition', 0, 'Birth'), ('UBERON_0022293', 'reproductive gland secretion', 101, 'intrauterine'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007567', 'parturition', 179, 'births'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D')]
PMC4784858	3/2016	S149-PMC4784858	['by focusing on Nutrients CONSIDERED as KEY during Pregnancy in french nutritional guidelines: Folate, Vitamin D, Calcium, Iodine and Iron (36) plus Dha, we NOTED that three snack additions (‘cereal bar and yogurt’, ‘toasts and egg’ and ‘pita bread filled with salad and Tuna’) and the proportional increase in Consumed Food weight increased probabilities of adequacy for four key Nutrient Intakes during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 39), ('ANOMALY_CURIOUS_FINDING', 156)]	3	[('CHEBI_33284', 'nutrient', 15, 'nutrients'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 94, 'folate'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 113, 'calcium'), ('CHEBI_24859', 'iodine atom', 122, 'iodine'), ('CHEBI_24870', 'ion', 133, 'iron'), ('CHEBI_17874', 'dihydrozeatin', 148, 'DHA'), ('NCBITaxon_10088', 'Mus <genus>', 270, 'tuna'), ('GO_0007631', 'feeding behavior', 310, 'consumed'), ('CHEBI_33290', 'food', 319, 'food'), ('CHEBI_33284', 'nutrient', 380, 'nutrient'), ('GO_0007631', 'feeding behavior', 389, 'intakes'), ('GO_0007565', 'female pregnancy', 404, 'pregnancy')]
PMC4785305	3/2016	S157-PMC4785305	['it is NOTEWORTHY that high doses of Vitamin D (up to 4000\u2005iu daily) HAVE BEEN used in PREVIOUS TRIALS conducted during Pregnancy with no reported adverse events (seeonline supplementary appendix1).']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 86)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC4811107	3/2016	S15-PMC4811107	['DESPITE its positive ROLE in health, Vitamin D deficiency is a pandemic [5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4811441	3/2016	S149-PMC4811441	['we FOUND a positive ASSOCIATION between Vitamin D status and bp trajectory, BUT non-significant for dbp after adjustment for baseline bp.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4846845	4/2016	S170-PMC4846845	['INTERESTINGLY, Vitamin D deficiency was also ASSOCIATED with Downregulation Of the Expression Of Vitamin D receptor (vdr), Foxp3 (a transcription factor ASSOCIATED with Treg Cells), and Retinoic Acid Receptor (Rar).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 153)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0010629', 'negative regulation of gene expression', 61, 'downregulation of ... expression of ...'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000007620', 'forkhead box protein E3', 123, 'FOXP3'), ('CL_0000960', 'T3 B cell', 169, 'Treg cells'), ('CHEBI_26536', 'retinoic acid', 186, 'retinoic acid'), ('PR_000001245', 'rhodopsin', 186, 'retinoic acid receptor'), ('PR_000013644', 'Ras-related protein Rab-9A', 210, 'RAR')]
PMC4877864	6/2015	S6-PMC4877864	['autistic children suffered INADEQUATE intake of some Micronutrients such as Vitamin D and c, calcium, Folate, magnesium, phosphorus, zinc, and iron, some DEFICIENCIES were highly significant ESPECIALLY at older age.']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 191)]	3	[('CHEBI_33839', 'macromolecule', 53, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate')]
PMC4889866	5/2016	S97-PMC4889866	['the RELATIONSHIP between Vitamin D and Il-10 HAS BEEN established CONSIDERABLY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 66)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 39, 'IL-10')]
PMC4896250	4/2016	S4491-PMC4896250	['HOWEVER, there were no associations with Vitamin D level and Pulmonary function and sunshine related FACTORS, such as housing type, living floor, and indoor/outdoor activity time.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 101)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002048', 'lung', 61, 'pulmonary')]
PMC4908484	6/2016	S8-PMC4908484	['ALTHOUGH in Human, most of the Vitamin D that ends up in the Blood is produced in the Kidneys, Vitamin D MAY BE synthesized in OTHER Tissues such as Endothelium, Placenta, Prostate, skin, Colon, Breast, and the Central Nervous System (Cns).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	3	[('NCBITaxon_9606', 'Homo sapiens', 12, 'human'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0002113', 'kidney', 86, 'kidneys'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000479', 'tissue', 133, 'tissues'), ('UBERON_0001986', 'endothelium', 149, 'endothelium'), ('UBERON_0001987', 'placenta', 162, 'placenta'), ('UBERON_0002367', 'prostate gland', 172, 'prostate'), ('UBERON_0001155', 'colon', 188, 'colon'), ('UBERON_0000310', 'breast', 195, 'breast'), ('UBERON_0001017', 'central nervous system', 211, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 235, 'CNS')]
PMC4930210	7/2016	S27-PMC4930210	['ALTHOUGH the literature regarding Vitamin D in Pregnancy is growing rapidly, several gaps in our knowledge REMAIN, including the prevalence of Vitamin D deficiency/ insufficiency during Pregnancy and the intake of Vitamin D during Pregnancy NEEDED to ensure optimal status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 107), ('FUTURE_WORK', 241)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnancy')]
PMC4930210	7/2016	S40-PMC4930210	['HOWEVER, Intake from Food and beverages ONLY accounted for 39% of total Vitamin D intake and the major source (39%) was from milk, which was consumed on a regular basis by participants during the second Trimester of Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 40), ('INCOMPLETE_EVIDENCE', 40)]	3	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_33290', 'food', 21, 'food'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 203, 'trimester'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy')]
PMC4930210	7/2016	S136-PMC4930210	['a RECENT STUDY of maternal Vitamin D status at third Trimester of Pregnancy and Postpartum periods of 467 Pregnant women in toronto SHOWED persistent Vitamin D deficiency/ insufficiency in two-thirds of participants DESPITE taking 400 iu/day of Vitamin D through their Prenatal Vitamin D [27].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 132), ('ANOMALY_CURIOUS_FINDING', 216)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 53, 'trimester'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('GO_0007565', 'female pregnancy', 106, 'pregnant'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
PMC4930210	7/2016	S138-PMC4930210	['IN FACT, randomized clinical trials of 2000 and 4000 iu/day Vitamin D during Pregnancy HAVE SHOWN that Vitamin D supplementation of 4000 iu/day was more EFFECTIVE in achieving Serum concentrations ≥80 nmol/l of Vitamin D [9].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 153)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4934634	11/2015	S55-PMC4934634	['ONLY 40% of the females inseminated by Vitamin D deficient Rats had normal sized litters compared to 76% from Vitamin D-replete males IN PART due to increased Pregnancy complications.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 134)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 59, 'rats'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy')]
PMC4934634	11/2015	S118-PMC4934634	['ALTHOUGH positive EFFECTS were seen, 41.7% of the participants in the intervention group and 83% in the placebo group remained Vitamin D deficient (using the endocrine society cutoff; 20.8% and 54.2%, respectively using iom guidelines) DUE TO the low intervention dose.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('PROBLEM_COMPLICATION', 236)]	3	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4934634	11/2015	S179-PMC4934634	['NOT ONLY CAN seasonal variation IMPACT cutaneous production in the infant, BUT ALSO seasonal variation in maternal uvb exposure will IMPACT Breast Milk Vitamin D concentrations.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 133)]	3	[('UBERON_0001348', 'brown adipose tissue', 140, 'breast milk'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4934634	11/2015	S199-PMC4934634	['ALTHOUGH Cord Blood 25(Oh)D levels were significantly higher in the supplemented children compared TO the control group, ONLY a small percentage of offspring receiving daily Vitamin D (13%) or bolus Vitamin D (3%) had Cord Blood Vitamin D levels ≥ 50 nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 99), ('ANOMALY_CURIOUS_FINDING', 121)]	3	[('UBERON_0009472', 'axilla', 9, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 20, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 218, 'cord'), ('UBERON_0000178', 'blood', 223, 'blood'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4934634	11/2015	S279-PMC4934634	['ALTHOUGH numerous cases of newborn Vitamin D toxicity HAVE BEEN REPORTED over the past 80 years, toxicity is RARE when compared to the number of newborns receiving Vitamin D supplementation [95,96,97,98].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 109)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4944244	7/2016	S119-PMC4944244	['HOWEVER, 20 Pregnant women who consumed Antenatal Vitamins with Vitamin D at least 400\xa0iu/day still had INADEQUATE Vitamin D levels in the third trimester [22].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 104)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('GO_0007567', 'parturition', 40, 'antenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 50, 'vitamins'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4944244	7/2016	S213-PMC4944244	['ALTHOUGH over half of respondents had met the rni for Vitamin D (≥200\xa0iu/day), many respondents STILL had Serum 25(Oh)D\u2009<\u200950\xa0nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 96), ('IMPORTANT_CONSIDERATION', 96)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D')]
PMC4982007	8/2016	S75-PMC4982007	['m; 2010 \u2003n \u2009=\u20099983 14\xa0years \u2003n \u2009=\u200910474 16\xa0years\u2003finland\u2003prospective Birth cohort studyhb concentrations at 3rd 7th and 9th Gestational monthsanaemiaschool performance14\xa0years- self report16\xa0years- school report↑maternal hb at 9\xa0months-↑ total school performance score (β\u2009=\u20090.03) and theory score at 14\xa0years and total score at 16\xa0years offspring of mothers with anaemia –low school scores (or\u2009=\u2009-0.05 at 14\xa0years and (or\u2009=\u2009-0.06) at 16\xa0yearsconfounders adjusted for: the child’s sex, bwt, Pregnancy wanted or not, me, social class, parity, marital status, ms, maternal mental health status18 low40davidson pw; 2008 \u2003n \u2009=\u2009229\u2003age 5, 9, 25and 30\xa0months\u2003republic of seychelles\u2003longitudinal cohort studyiron- total body stores at 14-24 weeks of Gestation assessed before the start of iron supplementationbayley scales of infant development: mental development index (mdi) and psychomotor development index (pdi) (9 and 30\xa0months)infant Cognition (fagan infantest-novelty preference) and Visual expectation paradigm –Visual recognition Memory (9 and 25\xa0months)a-not-b and delayed spatial alternation: inhibition, Working Memory, Planning and attention (25\xa0months)no association between maternal iron stores and Cognitive function at any age.confounders adjusted for: the child’s sex, bwt, ma, ses, he, miq and both parents living with the child (yes/no)19 low41lewis sj; 2013 \u2003n \u2009=\u2009~3,500\u2003age 8\xa0years\u2003uk\u2003population based prospective birth cohorthb concentrationsbefore 18\xa0weekshb <11.0\xa0g/dl -8\xa0%after 28\xa0weekshb <11.0\xa0g/dl -30\xa0%wechsler intelligence scale for children-iii- full- scale iqno ASSOCIATION between maternal hb and child’s iqconfounders adjusted for: ga, me, the child’s genotype, Iron supplementation, population stratification15 medium42tran td; 2013 \u2003n \u2009=\u2009378\u2003age 6\xa0months\u2003vietnam\u2003population based prospective cohort studyiron deficiency anaemia (hb <11.0\xa0g/dl and Serum ferritin <15\xa0ng/ml) during 12-28 weeks of Gestation-16\xa0%bayley scales of infant and toddler development-iii edition-Cognitive scoreinfants of anaemic mothers scored 11.6 points (0.77sd) lower in bsid Cognitive scores compared to infants of non-anaemic mothers.confounders adjusted for: parity, ma, me, wealth index, the child’s Birth and current weight, family support, bf.18 low43zhou sj; 2006 \u2003n \u2009=\u2009302\u2003age 4\xa0years; australia\u2003double blind randomized controlled trialiron Supplements (20\xa0mg/day) or placebo from 20\xa0weeks Gestation until deliverycompliance-86\xa0%stanford binet intelligence scale – iq (Verbal Reasoning, Visual Reasoning, Quantitative Reasoning and Short-Term Memory)no difference between the children of supplement group and placebo group in the mean score of composite iq or any subscales iq or in the proportion of children whose iq fell 1 or 2 sd below the mean.confounders adjusted for: sex, Birth order, Gestational age, ma, me, pe, he, bf20 low44li q; 2009 \u2003n \u2009=\u20091305\u2003age 3, 6 and 12\xa0months\u2003double blind cluster randomized controlled trial\u2003china3 intervention groups (all received Folic Acid)Folic Acid alone400\xa0μg ( n \u2009=\u2009471)-controliron 60\xa0mg\u2009+\u2009Folic Acid400\xa0μg ( n \u2009=\u2009438)multiple Micronutrients ((b Vitamins (1,2,3 6 and 12), Vitamin A, d, c, e and minerals (zinc, Iodine, copper, Selenium)\u2009+\u2009iron 30\xa0mg\u2009+\u2009400\xa0μg Folic Acid)) ( n \u2009=\u2009396)daily supplementation from enrolment until Delivery; inadequate information about compliancebayley scales of Infant Development :mental (md) and Psychomotor Development (pd)no significant difference in infants md and pd score at 3 and 6\xa0months and pd score at 12\xa0months between Supplement groupsmean md score among children of multiple Micronutrient group increased by 1 to 1.22 points COMPARED to children of Folic Acid alone, or Folic Acid\u2009+\u2009Iron group at 12\xa0monthsconfounders adjusted for: infants age, sex, Gestational age, apgar score, bwt, infant health, maternal age and bmi, parental education, occupation, ses, number of tablets consumed19 low\nqs quality score , rb risk of bias , hb haemoglobin , ga Gestational age , ma maternal age , bwt birthweight , ses socio-economic status , me maternal education , pe paternal education , miq maternal intelligence , he home environment , ms maternal smoking , bf breast-feeding , bmi body mass index\n\ncaption (table-wrap): table 7\n\nsummary of the studies examining ASSOCIATIONS of maternal Carbohydrate/protein with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb45alderman h; 2014 \u2003n \u2009=\u20096774\u2003age 16-22 years\u2003double blind cluster randomized controlled trial\u2003gambiacarbohydrate/protein supplementsintervention group:2 biscuits daily (1015\xa0kcal Carbohydrate and 22\xa0g protein) from 20\xa0weeks of Gestation to Deliverycontrol group: same Supplements for 20\xa0weeks during Postpartum but not during Pregnancyno information about complianceraven’s progressive matrices- nonverbal reasoning abilitythe mill hill vocabulary testthe backward and forward digit-span testschooling achievement (questionnaire)no difference in any of the Cognitive test scores or schooling achievement between children whose mothers received thesupplements during Pregnancy and children whose mothers received Supplements during Postpartum.confounders adjusted for: the child’s sex, age, ga, me, pe, maternal height, parity, season of Birth, language and village allocation19 low\nqs quality score, rb risk of bias, ga Gestational age, me Maternal education, pe paternal education\n\nmaternal anthropometry (table\xa02)\nall were observational studies and from developed countries [8–19].']	[('SUPERFICIAL_RELATIONSHIP', 1587), ('ANOMALY_CURIOUS_FINDING', 3631), ('SUPERFICIAL_RELATIONSHIP', 4262)]	3	[('GO_0007567', 'parturition', 69, 'Birth'), ('GO_0007565', 'female pregnancy', 124, 'gestational'), ('GO_0007565', 'female pregnancy', 490, 'pregnancy'), ('GO_0007565', 'female pregnancy', 742, 'gestation'), ('GO_0050890', 'cognition', 933, 'cognition'), ('GO_0007601', 'visual perception', 984, 'Visual'), ('GO_0007601', 'visual perception', 1013, 'visual ...'), ('GO_0007613', 'memory', 1032, 'memory'), ('GO_0007631', 'feeding behavior', 1109, 'working memory'), ('GO_0006260', 'DNA replication', 1125, 'planning'), ('GO_0050890', 'cognition', 1207, 'cognitive'), ('CHEBI_24870', 'ion', 1689, 'iron'), ('UBERON_0001977', 'blood serum', 1876, 'serum'), ('GO_0007565', 'female pregnancy', 1924, 'gestation'), ('GO_0050890', 'cognition', 1998, 'cognitive'), ('GO_0050890', 'cognition', 2082, 'cognitive'), ('GO_0007567', 'parturition', 2210, 'birth'), ('CHEBI_33341', 'titanium atom', 2355, 'supplements'), ('GO_0007565', 'female pregnancy', 2404, 'gestation'), ('GO_0016055', 'Wnt signaling pathway', 2483, 'verbal reasoning'), ('GO_0007602', 'phototransduction', 2501, 'visual reasoning'), ('GO_0031028', 'septation initiation signaling', 2519, 'quantitative reasoning'), ('GO_0007608', 'sensory perception of smell', 2546, 'short-term memory'), ('GO_0007567', 'parturition', 2794, 'birth'), ('GO_0007565', 'female pregnancy', 2807, 'gestational'), ('CHEBI_30751', 'formic acid', 2985, 'folic acid'), ('CHEBI_30751', 'formic acid', 2996, 'Folic acid'), ('CHEBI_52727', 'ethyl nile blue A', 3051, 'folic acid400'), ('CHEBI_33839', 'macromolecule', 3088, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 3107, 'vitamins'), ('CHEBI_27300', 'vitamin D', 3134, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 3173, 'iodine'), ('CHEBI_27568', 'selenium atom', 3189, 'selenium'), ('CHEBI_30751', 'formic acid', 3221, 'folic acid'), ('GO_0007567', 'parturition', 3288, 'delivery'), ('GO_0060119', 'inner ear receptor cell development', 3354, 'Infant Development'), ('GO_0035210', 'prepupal development', 3390, 'Psychomotor development'), ('CHEBI_16158', 'steroid sulfate', 3523, 'supplement'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 3581, 'micronutrient'), ('CHEBI_30751', 'formic acid', 3655, 'folic acid'), ('CHEBI_30751', 'formic acid', 3676, 'folic acid'), ('CHEBI_24870', 'ion', 3689, 'iron'), ('GO_0007565', 'female pregnancy', 3756, 'gestational'), ('GO_0007565', 'female pregnancy', 3955, 'gestational'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4287, 'carbohydrate'), ('GO_0050890', 'cognition', 4323, 'cognitive'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4649, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 4697, 'gestation'), ('GO_0051607', 'defense response to virus', 4710, 'deliveryControl'), ('CHEBI_33341', 'titanium atom', 4738, 'supplements'), ('GO_0007565', 'female pregnancy', 4770, 'postpartum'), ('GO_0007605', 'sensory perception of sound', 4796, 'pregnancyNo'), ('GO_0050890', 'cognition', 5027, 'cognitive'), ('GO_0007565', 'female pregnancy', 5136, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 5182, 'supplements'), ('GO_0007565', 'female pregnancy', 5201, 'postpartum'), ('GO_0007567', 'parturition', 5307, 'birth'), ('GO_0007565', 'female pregnancy', 5390, 'gestational'), ('GO_0007618', 'mating', 5410, 'maternal')]
PMC4988030	8/2016	S111-PMC4988030	['IF the distribution passed the goodness of fit tests or failed the tests BUT APPEARED sufficiently normal for the underlying assumptions of normality to be reasonable for practical purposes of analysis, then the diet outcome (hei total and component scores; and total fat, Sodium, Folate, and Vitamin D intakes) was modeled using a gaussian distribution with an identity link function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('ANOMALY_CURIOUS_FINDING', 77)]	3	[('CHEBI_52632', 'potassium-39 atom', 273, 'sodium'), ('CHEBI_30863', '5-azaorotic acid', 281, 'folate'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
PMC4989298	8/2016	S348-PMC4989298	['state of knowledge\na recent meta-analysis INVESTIGATED the RELATIONSHIP between alterations of Vitamin D status and a number OF pathological conditions [121].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('SUPERFICIAL_RELATIONSHIP', 59), ('ANOMALY_CURIOUS_FINDING', 125)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4990268	8/2016	S337-PMC4990268	['DESPITE this benefit, it was ASSUMED for many years that children younger than 6 months and breastfeeding either exclusively or for the majority of their intake were protected by the Vitamin A in Breastmilk.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 29)]	3	[('CHEBI_27300', 'vitamin D', 183, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 196, 'breastmilk')]
PMC4990280	8/2016	S129-PMC4990280	['in the fe60f group BUT NOT others (fe30f and mm), hb was strongly positively ASSOCIATED with Plasma hepcidin and Vitamin A in all children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('UBERON_0001969', 'blood plasma', 93, 'plasma'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin A')]
PMC4997421	8/2016	S91-PMC4997421	['BECAUSE maternal Tissues are progressively depleted of Vitamin A to supply fetal demands [14], women who initially possess marginal or EVEN adequate Vitamin A stores at the beginning of Pregnancy are at an INCREASED RISK of Vitamin A inadequacy as Pregnancy progresses.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 135), ('IMPORTANT_CONSIDERATION', 206)]	3	[('UBERON_0000479', 'tissue', 17, 'tissues'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin A'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy')]
PMC4998950	4/2016	S28-PMC4998950	['diagnosed lifetime maternal Vitamin D deficiency was ASSOCIATED with risk of asd and, in particular, of asd with intellectual disability ( p for homogeneity 0.17) (table 2), ALTHOUGH there was SOME attenuation upon adjustment for parental characteristics.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 174), ('INCOMPLETE_EVIDENCE', 193)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5014971	8/2016	S80-PMC5014971	['there was a LACK OF consensus of opinion among respondents regarding whether Pregnant women taking Prenatal Vitamins are at low RISK of Vitamin D deficiency, with equal proportions agreeing and disagreeing and the modal response being neutral.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('IMPORTANT_CONSIDERATION', 128)]	3	[('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('GO_0007565', 'female pregnancy', 99, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 108, 'vitamins'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5014971	8/2016	S116-PMC5014971	['finally, the fact that Vitamin D levels in our ancient ancestors LIKELY exceeded the iom recommendations does NOT PROVE that those higher levels are conducive to better health and wellbeing in the modern environment.']	[('PROBABLE_UNDERSTANDING', 65), ('ANOMALY_CURIOUS_FINDING', 110), ('PROBABLE_UNDERSTANDING', 114)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC5014971	8/2016	S132-PMC5014971	['ALTHOUGH few screen most of their Pregnant patients for Vitamin D status, most would RECOMMEND Vitamin D supplementation EVEN without screening.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 121)]	3	[('GO_0007565', 'female pregnancy', 34, 'pregnant'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5039809	10/2016	S89-PMC5039809	['Serum Vitamin A (Retinol and Β-Carotene) and neonatal bone indexes\nafter adjusting for maternal FACTORS, Gestational age, sex, and age at dxa scan, maternal Serum Retinol in late Pregnancy was significantly negatively ASSOCIATED with offspring total body bmc, ba, and Birth weight BUT NOT bmd or scbmc ( table 3 ).']	[('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 218), ('ANOMALY_CURIOUS_FINDING', 281)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 17, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 29, 'β-carotene'), ('GO_0007565', 'female pregnancy', 105, 'gestational'), ('UBERON_0001977', 'blood serum', 157, 'serum'), ('CHEBI_26536', 'retinoic acid', 163, 'retinol'), ('GO_0007565', 'female pregnancy', 179, 'pregnancy'), ('GO_0007567', 'parturition', 268, 'birth')]
PMC5084041	10/2016	S141-PMC5084041	['we FOUND that the ONLY DETERMINANT of change in the subgroup Born in africa and asia was Vitamin D supplement use.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 23)]	3	[('GO_0007567', 'parturition', 61, 'born'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5085625	9/2016	S71-PMC5085625	['[13] who DEMONSTRATED that Vitamin D status CORRELATES significantly with Blood pressure during the first trimester and Gestational systolic Blood pressure trajectory, BUT NOT with the prevalence of gh.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 44), ('ANOMALY_CURIOUS_FINDING', 168)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC5155676	12/2016	S100-PMC5155676	['HOWEVER, when Vitamin D replete status was considered as the outcome, ONLY non-white maternal ethnicity and Delivery in winter were significant PREDICTORS of Vitamin D nonreplete status after supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'delivery'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC5155676	12/2016	S109-PMC5155676	['HOWEVER, IMPORTANTLY, when using a 25(Oh)D more than 50 nmol/l as a cut-point for repletion, Pregnancy weight gain was not an independent predictor of achieving Vitamin D repletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9)]	3	[('CHEBI_71657', 'versiconol acetate', 35, '25(OH)D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC5155676	12/2016	S118-PMC5155676	['hollis et al SIMILARLY FOUND that EVEN with 4000 iu/d Vitamin D during Pregnancy, african-american women had lower 25(Oh)D in late Pregnancy than caucasian or hispanic women (10).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 34)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 115, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 121, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC5167470	12/2016	S41-PMC5167470	['this was followed by Vitamin 25-Oh-D3 deficiency in 40.5% of patients, B12 deficiency in 22.6%, Vitamin A in 7.7%, Calcium in 6.6%, Vitamin E in 6% and Folic Acid in 5.4%.5in another RECENT prospective STUDY that followed 49 women who got Pregnant after bs, progressively decreasing levels of Vitamins A, D, b12, and iron were OBSERVED over the course of Pregnancy, DESPITE correct compliance with oral supplements, before and during Gestation.']	[('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 327), ('ANOMALY_CURIOUS_FINDING', 366)]	3	[('CHEBI_85670', 'N-oleoyl-sn-glycero-3-phosphoethanolamine', 21, 'vitamin 25-OH-D3'), ('CHEBI_27778', 'abequose', 71, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 71, 'B12'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 115, 'calcium'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('CHEBI_30751', 'formic acid', 152, 'folic acid'), ('GO_0007565', 'female pregnancy', 239, 'pregnant'), ('CHEBI_27300', 'vitamin D', 293, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 302, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 305, 'D'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('GO_0007565', 'female pregnancy', 434, 'gestation')]
PMC5264377	7/2016	S36-PMC5264377	['EVEN THOUGH tian FOUND a positive ASSOCIATION between maternal Vitamin D levels and infant weight at Birth, Vitamin D supplementation for Pregnant women with low Serum levels of 25(Oh)D3 failed to improve Birth weight outcomes.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_32029', 'potassium acetate', 180, '(OH)D3'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 183, ')D3'), ('GO_0007567', 'parturition', 205, 'birth')]
PMC5264377	7/2016	S37-PMC5264377	['IN FACT, the benefits ASSOCIATED with Gestational Vitamin D supplementation are debatable, and MORE RESEARCH IS WARRANTED (dalgard et al ., 2016;dressler et al ., 2016).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 95)]	3	[('GO_0007565', 'female pregnancy', 38, 'gestational'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5322422	2/2017	S60-PMC5322422	['early vkdb occurs in the first 24 hours of Life BUT typically ONLY is SEEN in infants whose mothers take Medications that interfere with Vitamin K Metabolism (e.g., Anticoagulants, Anticonvulsants, or Antituberculosis Drugs).']	[('ANOMALY_CURIOUS_FINDING', 48), ('ANOMALY_CURIOUS_FINDING', 62), ('INCOMPLETE_EVIDENCE', 70)]	3	[('UBERON_0000104', 'life cycle', 43, 'life'), ('CHEBI_25441', 'mycothiols', 105, 'medications'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin K'), ('GO_0006565', 'L-serine catabolic process', 145, 'K metabolism'), ('CHEBI_33282', 'antibacterial agent', 165, 'anticoagulants'), ('CHEBI_37540', 'arabinarate(2-)', 181, 'anticonvulsants'), ('CHEBI_48617', '5-(hydroxymethyl)piperidine-2,3,4-triol', 201, 'antituberculosis'), ('CHEBI_23888', 'drug', 218, 'drugs')]
PMC5332602	3/2017	S53-PMC5332602	['the normal ranges of the levels of these elements in the Plasma or Serum of conventional Suckling Piglets are 44 to 91\xa0mg/dl for Glucose, 5.8 to 8.1\xa0g/dl for protein, 3.2 to 4.2\xa0g/dl for Albumin, 100 to 350\xa0ng/ml for Vitamin A, 0.4 to 5\xa0μg/ml for Vitamin E, and 50 to 150\xa0ng/ml for Selenium; HOWEVER, the respective ranges in gn Pigs are NOT ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('ANOMALY_CURIOUS_FINDING', 292), ('FULL_UNKNOWN', 338)]	3	[('UBERON_0001969', 'blood plasma', 57, 'plasma'), ('UBERON_0001977', 'blood serum', 67, 'serum'), ('GO_0001967', 'suckling behavior', 89, 'suckling'), ('NCBITaxon_33208', 'Metazoa', 98, 'piglets'), ('CHEBI_17234', 'glucose', 129, 'glucose'), ('PR_000005908', 'alpha-crystallin B chain', 187, 'albumin'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 282, 'selenium'), ('NCBITaxon_10088', 'Mus <genus>', 329, 'pigs')]
PMC5340372	3/2017	S1-PMC5340372	['HOWEVER, the RELATIONSHIP between Vitamin D levels and Lung function in infancy has NOT BEEN INVESTIGATED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 84)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002048', 'lung', 55, 'lung')]
PMC5340372	3/2017	S130-PMC5340372	['HOWEVER, the exact ASSOCIATION between single Cord-Serum Vitamin D level and Postnatal immunity is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('FULL_UNKNOWN', 99)]	3	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 77, 'postnatal')]
PMC5368580	4/2017	S138-PMC5368580	['HOWEVER, when compared with their adequate intakes, ONLY 2.3–11.1% of Thiamin, 2.8–7.9% of riboflavin, and 8.6–22.3% of Vitamin A were transferred to the milk via maternal supplement, whereas 30.7–98.9% of the adequate intake was provided by maternal Vitamin B-6 supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 52)]	3	[('CHEBI_26948', 'vitamin B1', 70, 'thiamin'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 251, 'vitamin B-6')]
PMC5368580	4/2017	S185-PMC5368580	['the Regulation of fat-soluble Vitamins A and E APPEARS TO occur through a specific transport system independent from Lipid Transfer, but the mechanisms INVOLVED have not been revealed (36,37).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 47), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('CHEBI_27300', 'vitamin D', 30, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 30, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('CHEBI_18059', 'lipid', 117, 'lipid'), ('GO_0060986', 'endocrine hormone secretion', 117, 'lipid transfer')]
PMC5372327	3/2017	S13-PMC5372327	['based ON the number of cell types Expressing Vitamin D receptors (vdr), 38 POTENTIAL target Tissues HAVE BEEN recognised [3].']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 100)]	3	[('GO_0010467', 'gene expression', 34, 'expressing'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0000479', 'tissue', 92, 'tissues')]
PMC5372327	3/2017	S16-PMC5372327	['IN FACT, Vitamin D HAS BEEN ESTIMATED to directly and indirectly Regulate the Expression of 2–3% of the Human Genome [4].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 65, 'regulate'), ('GO_0010467', 'gene expression', 78, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 104, 'human'), ('SO_0001026', 'genome', 110, 'genome')]
PMC5372327	3/2017	S59-PMC5372327	['Genome-wide association studies on Vitamin D insufficiency IDENTIFIED a number OF common Genetic variants that INFLUENCE 25-Ohd concentrations and the risk of insufficiency [54].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('SO_0001026', 'genome', 0, 'Genome'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_72765', 'verruculogen', 121, '25-OHD')]
PMC5405075	4/2017	S16-PMC5405075	['it is, HOWEVER, INTERESTING that, during this period, Vitamin D Metabolism is shifted from the classical determinants of Calcium Homeostasis to OTHER Regulatory mechanisms.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ANOMALY_CURIOUS_FINDING', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 54, 'vitamin D metabolism'), ('GO_0055073', 'cadmium ion homeostasis', 121, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 150, 'regulatory')]
PMC5405075	4/2017	S19-PMC5405075	['it SHOULD BE NOTICED that high Maternal Intake of 25(Oh)D or exceeding Vitamin D Serum levels during Pregnancy is not COMPLICATED from either hypercalcemia or hypercalciuria (16).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('DIFFICULT_TASK', 118)]	3	[('GO_0007618', 'mating', 31, 'maternal'), ('GO_0007631', 'feeding behavior', 40, 'intake'), ('CHEBI_71657', 'versiconol acetate', 50, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 81, 'serum'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC5405075	4/2017	S90-PMC5405075	['in addition, an INTERESTING REMARK is that study designs and analyses do not take into CONSIDERATION the starting maternal Vitamin D status and dose adequacy for the different body systems.']	[('ANOMALY_CURIOUS_FINDING', 16), ('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 87)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5405075	4/2017	S92-PMC5405075	['IRREFUTABLY, both entities of asthma and Vitamin D deficiency are MULTIFACTORIAL.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 66)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5418719	5/2017	S14-PMC5418719	['ALTHOUGH the incidence of Vitamin D insufficiency in preterm infants varies according TO DIFFERENT geographical locations, mean Serum 25(Oh)D levels during 1–3 days after Birth in preterm infants ranges from 9.5 to 25\xa0ng/ml in both europe and western world [4–7].']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_71657', 'versiconol acetate', 134, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 134, '25(OH ... D'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC5418719	5/2017	S122-PMC5418719	['the POTENTIAL risk of Vitamin D deficiency on Immune status of preterm infants at Birth has attracted much INTEREST RECENTLY [32].']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 116)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 46, 'immune'), ('GO_0007567', 'parturition', 82, 'birth')]
PMC5426325	4/2017	S26-PMC5426325	['the d-tect study is based ON the fact that until 1 june 1985 it was mandatory in denmark to fortify all Margarine with Vitamin D. margarine was fortified with 1·25 µg/100 g and APPROXIMATELY 13 % (3–29 %) of all dietary Vitamin D is ESTIMATED to have come from the fortified Margarine(31).']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 233)]	3	[('CHEBI_6784', 'mestranol', 104, 'margarine'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_6784', 'mestranol', 275, 'margarine')]
PMC5473979	6/2017	S20-PMC5473979	['several Micronutrients such as iron, zinc, Folate, Vitamin B-6, B-12, Calcium, Selenium, and N-3 Fatty Acids have BEEN LINKED to maternal mental health and wellbeing [9,10] HOWEVER, much of the work to date has focused on the Postpartum period.']	[('ANOMALY_CURIOUS_FINDING', 114), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 173)]	3	[('CHEBI_33839', 'macromolecule', 8, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 43, 'folate'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 51, 'vitamin B-6'), ('PR_000004770', 'Polycomb complex protein BMI-1', 64, 'B-12'), ('CHEBI_22313', 'alkaline earth metal atom', 70, 'calcium'), ('CHEBI_27568', 'selenium atom', 79, 'selenium'), ('CHEBI_30256', 'thiocarbonyl group', 93, 'n-3'), ('CHEBI_35366', 'fatty acid', 97, 'fatty acids'), ('GO_0007565', 'female pregnancy', 226, 'postpartum')]
PMC5513133	7/2017	S253-PMC5513133	['HOWEVER, women with a Serum Vitamin D status of ≥75\xa0nmol/l that was maintained from enrollment through late Pregnancy had a significantly lower RISK of pe versus women who had <75\xa0nmol/l ( p \xa0=\xa00.04).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 144)]	3	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy')]
PMC5537904	7/2017	S166-PMC5537904	['these data are IN AGREEMENT with results of Prenatal Vitamin D supplementation trials, which REPORTED that EVEN with supplementation, women with non-white race/ethnicity, higher pre-Pregnancy bmis, and winter Deliveries had lower 25(Oh)D levels in Pregnancy [15,61].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 107)]	3	[('GO_0007565', 'female pregnancy', 44, 'prenatal'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('GO_0007567', 'parturition', 209, 'deliveries'), ('CHEBI_71657', 'versiconol acetate', 230, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 230, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy')]
PMC5623264	9/2017	S93-PMC5623264	['multiple Micronutrient supplementation\nthe EFFECT of mmn supplementation on lbw, ptb and sga was assessed in three reviews (see\xa0onlinesupplementary table 8).35–37mmn supplementation provided one RECOMMENDED daily nutrient intake of Vitamin A, vitamin B1, vitamin B2, niacin, vitamin B6, Vitamin B12, Folic Acid, Vitamin C, vitamin d, Vitamin E, copper, Selenium and Iodine with iron and zinc to Pregnant women.47a significant reduction of lbw in the range of 11%–14%\u2009and a significant reduction of sga in the range of 10%–17%\u2009could BE observed following mmn supplementation in all three reviews.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('FUTURE_WORK', 195), ('ANOMALY_CURIOUS_FINDING', 532)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin A'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 251, 'B1'), ('CHEBI_18245', 'carboxylato group', 263, 'B2'), ('CHEBI_51231', 'DAPI', 283, 'B6'), ('CHEBI_33279', 'vitamin D5', 287, 'vitamin B12'), ('CHEBI_30751', 'formic acid', 300, 'folic acid'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 353, 'selenium'), ('CHEBI_24859', 'iodine atom', 366, 'iodine'), ('GO_0007565', 'female pregnancy', 395, 'pregnant')]
PMC5634602	10/2017	S38-PMC5634602	['preterm infants have a smaller size, leading to decreased volume Intake, and OFTEN have a compromised nutritional status during the initial hospitalization and are EVEN less LIKELY to get adequate Vitamin D intake from diet [15].']	[('PROBABLE_UNDERSTANDING', 77), ('ANOMALY_CURIOUS_FINDING', 164), ('PROBABLE_UNDERSTANDING', 174)]	3	[('GO_0007631', 'feeding behavior', 65, 'intake'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC5634602	10/2017	S98-PMC5634602	['improving Vitamin D ALONE is not adequate to prevent POOR bone mineralization; this physiology is also DEPENDENT on delivery of appropriate amounts and ratios of Calcium and Phosphorus in the parenteral and enteral diet, as well as a patient’s over all nutrition status [21].']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 162, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 174, 'phosphorus')]
PMC5634602	10/2017	S145-PMC5634602	['Vitamin D toxicity is a RARE event, and tolerance of EVEN higher doses of Vitamin D HAVE BEEN REPORTED in a variety of populations [9,52].']	[('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 53), ('INCOMPLETE_EVIDENCE', 84)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5659607	10/2017	S138-PMC5659607	['when the two trials were initiated, IT WAS THOUGHT that the EFFECTS of Vitamin D were confined to the Alveolar stage of Lung Development, occurring in the third Trimester of Pregnancy[28].']	[('ANOMALY_CURIOUS_FINDING', 36), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0003215', 'alveolus', 102, 'alveolar'), ('GO_0030324', 'lung development', 120, 'lung development'), ('UBERON_0002048', 'lung', 120, 'lung'), ('GO_0009294', 'DNA mediated transformation', 161, 'trimester'), ('GO_0007565', 'female pregnancy', 174, 'pregnancy')]
PMC5664622	9/2017	S63-PMC5664622	['all neonates with Cord Blood Vitamin D deficiency were Born to mothers with <15.3 ng/ml Venous Blood concentration, WHILE 67 (93%) infants with OPTIMAL levels of Vitamin D were Born to mothers with ≥15.3 ng/ml Venous Blood concentration of that Vitamin, INDICATING that the sensitivity and specificity of the predicted normal Cord Blood levels were 93% and 100%, respectively at the maternal concentration of ≥15.3 ng/ml.']	[('ANOMALY_CURIOUS_FINDING', 116), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 254)]	3	[('UBERON_0002240', 'spinal cord', 18, 'cord'), ('UBERON_0000178', 'blood', 23, 'blood'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 55, 'born'), ('UBERON_0001638', 'vein', 88, 'venous'), ('UBERON_0000178', 'blood', 95, 'blood'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007567', 'parturition', 177, 'born'), ('UBERON_0001638', 'vein', 210, 'venous'), ('UBERON_0000178', 'blood', 217, 'blood'), ('CHEBI_33229', 'vitamin (role)', 245, 'vitamin'), ('UBERON_0002240', 'spinal cord', 326, 'cord'), ('UBERON_0000178', 'blood', 331, 'blood')]
PMC5664622	9/2017	S93-PMC5664622	['DUE TO the fact that weather conditions, including the increasingly common heat waves which prevent exposure to sun, remain beyond Human control, supplementation SEEMS TO BE the BEST method of preventing Vitamin D insufficiency.']	[('PROBLEM_COMPLICATION', 0), ('ANOMALY_CURIOUS_FINDING', 162), ('IMPORTANT_CONSIDERATION', 178)]	3	[('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5758521	1/2018	S147-PMC5758521	['it is NOTEWORTHY that in OUR STUDY, Vitamin A and E measurements were pretty ROBUST (low intra- and inter-assay cvs), and that Birth weight was measured by research nurses using a reliable electronic weighing scale.']	[('ANOMALY_CURIOUS_FINDING', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 50, 'E'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC5812027	2/2018	S160-PMC5812027	['INTERESTINGLY, Vitamin D status at t1- around the time the maternal Blood flow of the Placenta is fully developed- is ONLY RELATED to Pregnancy loss.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0001987', 'placenta', 86, 'placenta'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC5838372	3/2018	S16-PMC5838372	['DESPITE the launch of a Vitamin D support programme for Pregnant women by the ministry of health, Vitamin D deficiency in Pregnant women and their infants continues to be a SERIOUS health PROBLEM in turkey.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 173), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant')]
PMC5838372	3/2018	S70-PMC5838372	['when the EFFECT of maternal RISK FACTORS on their infants’ Vitamin D levels was evaluated, there were no statistical differences, with the EXCEPTION of daily Vitamin D Intake.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 139)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007631', 'feeding behavior', 168, 'intake')]
PMC5838372	3/2018	S99-PMC5838372	['in THIS PRESENT STUDY, mean Vitamin D level was FOUND TO be 14.82±11.45 ng/ml in Pregnant women and 13.16±7.16 ng/ml in their infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('ANOMALY_CURIOUS_FINDING', 48)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnant')]
PMC5838372	3/2018	S102-PMC5838372	['ALTHOUGH the ministry of health has RECOMMENDED a Vitamin D intake of 1200 iu/day, we FOUND that 12.4% of mothers never used Vitamin D Supplements and 73.2% used irregular or low doses.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 36), ('INCOMPLETE_EVIDENCE', 86)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 135, 'supplements')]
PMC5941617	5/2018	S44-PMC5941617	['based ON the above CONSIDERATIONS, we SUGGEST to define Vitamin D status as reported in table\xa03.']	[('ANOMALY_CURIOUS_FINDING', 6), ('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 38)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5941617	5/2018	S93-PMC5941617	['Breast Milk represents the BEST Food to satisfy children’s nutritional NEEDS, ALTHOUGH it contains insufficient amount of Vitamin D (<\u200950\xa0iu/l) [86].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 71), ('ANOMALY_CURIOUS_FINDING', 78)]	3	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_33290', 'food', 32, 'food'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5941617	5/2018	S227-PMC5941617	['intermittent administration of Vitamin D MAY BE a reliable ALTERNATIVE to daily administration, PARTICULARLY in cases with low compliance.']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('ANOMALY_CURIOUS_FINDING', 96)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5941617	5/2018	S270-PMC5941617	['INTERESTINGLY, a RECENT STUDY showed that the beneficial EFFECT of Vitamin D on Hip bone mass in lebanese adolescent girls persisted 1\xa0year after discontinuation of supplementation [226].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001464', 'hip', 80, 'hip')]
PMC5941617	5/2018	S344-PMC5941617	['moreover, a large meta-analysis FAILED TO demonstrate that Vitamin D supplementation MAY BE beneficial in children with tubercular infection [300].']	[('ANOMALY_CURIOUS_FINDING', 32), ('DIFFICULT_TASK', 32), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5941617	5/2018	S483-PMC5941617	['ON THE CONTRARY, two meta-analyses enrolling MAINLY Adults SHOWED that Vitamin D supplementation did not decrease adiposity [444,445].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 59)]	3	[('UBERON_0007023', 'adult organism', 52, 'adults'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5941617	5/2018	S558-PMC5941617	['indeed, Vitamin D supplementation with 400\xa0iu/day HAS BEEN REPORTED insufficient in Pregnancy, PARTICULARLY for women at higher RISK of Vitamin D deficiency [512,513].']	[('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 95), ('IMPORTANT_CONSIDERATION', 128)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5952272	5/2018	S24-PMC5952272	['for this purpose, 10 Micronutrients are added to the flour, including b1, b2, b6, b12, Folic Acid, niacin, iron, zinc, Vitamin A, and Vitamin D.4\nDESPITE all the above-mentioned actions, anaemia PREVALENCE is STILL high among Pregnant women, Lactating mothers, and children less than 5\u2009years of age.']	[('ANOMALY_CURIOUS_FINDING', 146), ('IMPORTANT_CONSIDERATION', 195), ('IMPORTANT_CONSIDERATION', 209)]	3	[('CHEBI_33839', 'macromolecule', 21, 'micronutrients'), ('CHEBI_30751', 'formic acid', 87, 'folic acid'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnant'), ('GO_0007594', 'puparial adhesion', 242, 'lactating')]
PMC5956785	5/2018	S156-PMC5956785	['INTERESTINGLY, the RELATIONSHIP between reduced Vitamin D status and increased disease activity also APPEARS TO BE present and follow a north-south gradient (fig.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ANOMALY_CURIOUS_FINDING', 101)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5995352	6/2018	S34-PMC5995352	['ALTHOUGH maternal Vitamin D status during Pregnancy has no impact on foetal Bone mineralisation IF Calcium supply is adequate, observational studies have LINKED low maternal Vitamin D levels with smaller child bone mass and impaired linear growth in the first 12 months of Life [18–20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('SUPERFICIAL_RELATIONSHIP', 154)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 76, 'bone'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('UBERON_0000104', 'life cycle', 273, 'life')]
PMC1888711	5/2007	S107-PMC1888711	['supplementation with Vitamins C and E HAS BEEN SHOWN to have no effect on eclampsia, ALBEIT among well-nourished women [34,35].']	[('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 85)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamins C'), ('PR_000004900', 'complement C3', 30, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 36, 'E')]
PMC2582131	11/2008	S8-PMC2582131	['APPROXIMATELY 33% of gdm cases, COMPARED with 14% of controls ( p<0.001), had maternal Plasma 25-[Oh] D concentrations consistent with a pre-specified diagnosis of Vitamin D deficiency (<20 ng/ml).']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 32)]	2	[('UBERON_0001969', 'blood plasma', 87, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 94, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC2606998	6/2007	S10-PMC2606998	['MOST STRIKING were the low levels of Folate and Vitamin D intake both before Pregnancy and at mid-Gestation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 5)]	2	[('CHEBI_30863', '5-azaorotic acid', 37, 'folate'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007565', 'female pregnancy', 98, 'gestation')]
PMC2685863	5/2009	S18-PMC2685863	['“in fact that amount is not EVEN close.” CONSIDERING that the body makes up to 20,000 iu of Vitamin D when exposed to sunlight for 30 minutes on a summer day, ebers says 2,000 iu/day “is not a dangerous amount.”\n\npubmed central:']	[('ANOMALY_CURIOUS_FINDING', 28), ('PROBABLE_UNDERSTANDING', 41)]	2	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC2722583	1/2009	S129-PMC2722583	['in indonesia, the haemoglobin concentration of adolescent girls improved on supplementation with combinations of Iron, Folic Acid, Retinol and Vitamin C, over placebo BUT did not respond better to daily rather that weekly supplementation, ALTHOUGH Serum ferritin increased more in the daily supplemented group (angeles-agdeppa et al 1997).']	[('ANOMALY_CURIOUS_FINDING', 167), ('ANOMALY_CURIOUS_FINDING', 239)]	2	[('CHEBI_24870', 'ion', 113, 'iron'), ('CHEBI_30751', 'formic acid', 119, 'folic acid'), ('CHEBI_26536', 'retinoic acid', 131, 'retinol'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin C'), ('UBERON_0001977', 'blood serum', 248, 'serum')]
PMC2777012	4/2009	S59-PMC2777012	['children with multiple Food allergies HAVE BEEN FOUND TO BE shorter than those with one Food allergy and to have less than adequate intakes of Calcium, Vitamin D, and Vitamin E [14].']	[('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 48)]	2	[('CHEBI_33290', 'food', 23, 'food'), ('CHEBI_33290', 'food', 88, 'food'), ('CHEBI_22313', 'alkaline earth metal atom', 143, 'calcium'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin E')]
PMC2798111	12/2010	S15-PMC2798111	['Human Milk, THOUGH replete in most Nutrients, is sorely lacking in Vitamin D at the current maternal intake RECOMMENDATION of 400\u2009iu/day.']	[('ANOMALY_CURIOUS_FINDING', 12), ('FUTURE_WORK', 108)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0001913', 'milk', 6, 'milk'), ('CHEBI_33284', 'nutrient', 35, 'nutrients'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC2798111	12/2010	S117-PMC2798111	['IN SUMMARY, a single drop oil emulsion Vitamin D preparation APPEARS TO BE an effective method to deliver Vitamin D3To a breastfed infant.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 61)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_33706', 'beta-amino acid', 106, 'vitamin D3to'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 106, 'vitamin D3to')]
PMC2821652	2/2010	S5-PMC2821652	["one measurement of adherence was obtained via pill counts remaining COMPARED to a NOVEL definition for adherence using Serum 25-Hydroxy-Vitamin D (25-Oh-d) levels (absolute change in 25(Oh)D over the study period and the subject's steady-state variation in their 25(Oh)d levels)."]	[('ANOMALY_CURIOUS_FINDING', 68), ('FULL_UNKNOWN', 82)]	2	[('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_70487', '(-)-sanguinolignan C', 125, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_75393', 'Y-27632', 147, '25-OH-'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 263, '25(OH')]
PMC2889879	5/2010	S207-PMC2889879	['INTERESTINGLY, we FOUND a lower rate of psychotic-like symptoms with increasing Vitamin D intake.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC2913107	8/2010	S25-PMC2913107	['toxins delivered by Water or air pollution APPEAR to DAMAGE the Genome of the Vitamin D deficient (14).']	[('ANOMALY_CURIOUS_FINDING', 43), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('CHEBI_15377', 'water', 20, 'water'), ('SO_0001026', 'genome', 64, 'genome'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC2963768	10/2010	S7-PMC2963768	['within a larger group of 74 infants and toddlers aged 1-17 months (cases and controls recruited for the pneumonia study), young age was the ONLY significant RISK FACTOR for Vitamin D deficiency [25(Oh)D <25 nmol/l].']	[('ANOMALY_CURIOUS_FINDING', 140), ('SUPERFICIAL_RELATIONSHIP', 157)]	2	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D')]
PMC2963768	10/2010	S102-PMC2963768	['IN FACT, a seasonal differential in Vitamin D status was OBSERVED among pakistani infants (11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 57)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC2963768	10/2010	S129-PMC2963768	['ALTHOUGH 25(Oh)D <25 nmol/l is typical of clinically-apparent rickets, early stages of the disease MAY occur at higher 25(Oh)D (∼40 nmol/l) (47), with declines in 25(Oh)D occurring as the disease progresses and Vitamin D stores are depleted.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 99)]	2	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 122, 'OH)D'), ('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC2996405	11/2010	S224-PMC2996405	['the ONLY EXCEPTION is the list of Vitamin D related Genes that we had to build ex novo since no others were present in literature.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ANOMALY_CURIOUS_FINDING', 9)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 52, 'genes')]
PMC3004407	12/2010	S130-PMC3004407	['women who reported taking a Prenatal Vitamin containing 400\u2009iu Vitamin D did not differ from those who did not in Vitamin D status as measured by 25(Oh)d.\nWHILE present in caucasian women, the greatest prevalence of deficiency was NOTED in those women of darker pigmentation, specifically, african-american and hispanic women.']	[('ANOMALY_CURIOUS_FINDING', 155), ('ANOMALY_CURIOUS_FINDING', 231)]	2	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 37, 'vitamin'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 146, '25(OH')]
PMC3034879	12/2010	S98-PMC3034879	['caption (table-wrap): table\xa01\n\nbackground characteristics and changes in them from baseline value given as mean (sd)low dhigh dindependent samples t -test n 4443age, months14.9 (0.5)14.8 (0.5)0.336males, %58550.842aanthropometric and growth variables \xa0weight, kg10.8 (1.3)10.8 (1.3)0.997\xa0relative weight−1.2 (8.1)0.2 (6.7)0.382\xa0∆weight, kg7.1 (1.1)7.2 (1.0)0.624\xa0weight velocity, g/month475 (72)488 (67)0.446\xa0height, cm79.0 (2.8)78.4 (3.5)0.386\xa0height z-score0.25 (1.0)0.03 (1.2)0.378\xa0∆height, cm27.9 (2.0)27.7 (2.9)0.732\xa0height velocity, cm/month1.88 (0.12)1.87 (0.19)0.951 history of Breast feeding and dietary intakes \xa0duration of exclusive breastfeeding, months4.2 (1.9)4.3 (2.0)0.755\xa0currently Breastfed, n (%)11 (26.8)7 (16.6)0.196a\xa0energy intake, kcal/day920 (220)930 (180)0.770\xa0fat intake, g/day28.6 (7.9)28.0 (6.9)0.698\xa0protein Intake, g/day43 (13)42 (10)0.481\xa0Calcium intake, mg/day820 (320)840 (260)0.863\xa0total intake of Vitamin D, μg/day12.4 (3.1)12.2 (2.9)0.782 motor and language skills \xa0age when learnt to crawl, months8.0 (1.8)8.2 (1.8)0.690\xa0age when Learnt to stand, months8.4 (1.7)8.5 (1.6)0.668\xa0age when learnt to walk with support, months8.8 (1.6)10.1 (1.5)0.001\xa0age when Learnt to walk without support, months11.9 (1.6)12.1 (1.5)0.458\xa0number of words in use5.7 (6.2)6.8 (7.7)0.490\napearson chi square\nDESPITE lower Vitamin D concentration during Pregnancy and at Birth in low d than in high d (means 35.7 vs. 54.2\xa0nmol/l, and in the Cord 40.5 and 59.3\xa0nmol/l, independent samples t -test; p \u2009<\u20090.001, respectively), the 25-Ohd concentrations in the two groups at 14\xa0months were SIMILAR (63 vs. 66\xa0nmol/l, p \u2009=\u20090.58).']	[('ANOMALY_CURIOUS_FINDING', 1322), ('SUPERFICIAL_RELATIONSHIP', 1599)]	2	[('UBERON_0000310', 'breast', 586, 'breast'), ('GO_0007567', 'parturition', 699, 'breastfed'), ('GO_0007631', 'feeding behavior', 837, 'intake'), ('CHEBI_31341', 'calcium dihydroxide', 870, 'Calcium'), ('CHEBI_27300', 'vitamin D', 932, 'vitamin D'), ('GO_0007612', 'learning', 1067, 'learnt'), ('GO_0007612', 'learning', 1192, 'learnt'), ('CHEBI_27300', 'vitamin D', 1336, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1367, 'pregnancy'), ('GO_0007567', 'parturition', 1384, 'birth'), ('UBERON_0002240', 'spinal cord', 1454, 'cord'), ('CHEBI_72765', 'verruculogen', 1541, '25-OHD')]
PMC3034879	12/2010	S142-PMC3034879	['finally, 20% of the children had S-25-Ohd below 50\xa0nmol/l at 14\xa0months of age, ALTHOUGH their median total intake of Vitamin D was 12.2 (3.0) μg, which meets the nordic RECOMMENDATION for this age group [23].']	[('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 169)]	2	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 33, 'S-25-OHD'), ('PR_000001900', 'neuropilin-1', 33, 'S-25-OHD'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3034879	12/2010	S189-PMC3034879	['there was a positive ASSOCIATION between total intake of Vitamin D and 25-Ohd in the entire group and in high d, but NOT among those infants in low D whose Vitamin D status during Pregnancy was worse.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 117)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 71, '25-OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 148, 'D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy')]
PMC3061267	2/2011	S33-PMC3061267	['adequate Vitamin D and calcium nutrition throughout the Life-course APPEAR to reduce the RISK of osteoporosis [10].']	[('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 89)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0000104', 'life cycle', 56, 'life')]
PMC3075531	7/2010	S9-PMC3075531	['conclusions:\nwe FOUND the same results as those studies carried out in europe and north america; i.e., lower Serum Vitamin D level in ms patients than that in normal population, IN SPITE of sufficient sun exposure in isfahan region.']	[('INCOMPLETE_EVIDENCE', 16), ('ANOMALY_CURIOUS_FINDING', 178)]	2	[('UBERON_0001977', 'blood serum', 109, 'serum'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3103150	3/2011	S10-PMC3103150	['interpretation & conclusions:\nprevalence of Vitamin D deficiency and insufficiency was FOUND TO BE high in breastfed infants and their mothers, with radiological rickets in a third of infants with 25Ohd < 10 ng/ml in THIS STUDY.']	[('ANOMALY_CURIOUS_FINDING', 87), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 197, '25OHD')]
PMC3103150	3/2011	S112-PMC3103150	['we FOUND no seasonal variation in the Vitamin D levels of the infants EVEN THOUGH there was a significant difference in the mothers’ levels.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 70)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC3107676	4/2011	S71-PMC3107676	['because Vitamin C supplement use varied CONSIDERABLY by month during the first trimester, we EXAMINED prevalence of supplement use (none, less than daily, daily) separately during the first, second, and third months of Pregnancy by Nitrosatable Drug use during the first trimester.']	[('ANOMALY_CURIOUS_FINDING', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 93)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin C'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('CHEBI_75872', '(R)-sarin', 232, 'nitrosatable drug')]
PMC3107676	4/2011	S105-PMC3107676	['among women who took Nitrosatable Drugs, <40% reported daily use of a supplement with Vitamin C during the first month of Pregnancy (table 3), ALTHOUGH APPROXIMATELY 80% took such a Supplement daily by the third month.']	[('ANOMALY_CURIOUS_FINDING', 143), ('INCOMPLETE_EVIDENCE', 152)]	2	[('CHEBI_7496', 'nelfinavir', 21, 'nitrosatable drugs'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 182, 'supplement')]
PMC3257641	3/2010	S52-PMC3257641	['a daily dose of 1000 iu/day DOES NOT APPEAR TO BE sufficient to achieve and maintain Vitamin D adequacy in women who are Vitamin D deficient at the start of Pregnancy [37,38].']	[('ANOMALY_CURIOUS_FINDING', 28), ('ANOMALY_CURIOUS_FINDING', 37)]	2	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy')]
PMC3257641	3/2010	S102-PMC3257641	['in Rats, maternal Vitamin D deficiency was ASSOCIATED with an increase in Nephron number, BUT lower Renal Corpuscle size [68].']	[('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 90)]	2	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0001285', 'nephron', 74, 'nephron'), ('UBERON_0001229', 'renal corpuscle', 100, 'renal corpuscle')]
PMC3257641	3/2010	S105-PMC3257641	['Rats receiving very high-dose Vitamin D during Gestation and early development (CONSIDERABLY higher than would be administered to Humans) had adverse changes in elastin content and organization in the Aorta CONSISTENT with increased later risk of hypertension or aneurysm [73].']	[('ANOMALY_CURIOUS_FINDING', 80), ('INCOMPLETE_EVIDENCE', 207)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'gestation'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('UBERON_0000947', 'aorta', 201, 'aorta')]
PMC3277098	12/2011	S196-PMC3277098	['[70] DEMONSTRATED that children given Vitamin D (400 iu) in Water-soluble form during the first year of Life had an almost two-fold increase in asthma (or 2.18; 95% ci 1.45–3.28), Food allergy (or 1.89; 95% ci 1.33–2.65), and sensitization (or 1.88; 95% ci 1.34–2.64) at 4 years of age compared with children having received the same Vitamins in peanut oil (ALTHOUGH there was no difference in the risk of allergic rhinitis or eczema).']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 358)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_15377', 'water', 60, 'water'), ('UBERON_0000104', 'life cycle', 104, 'life'), ('CHEBI_33290', 'food', 180, 'food'), ('CHEBI_33277', 'gamma-tocotrienol', 334, 'vitamins')]
PMC3347007	4/2012	S89-PMC3347007	['thirty-seven Food groups were analyzed, BUT ONLY 14 contributed with Vitamin D. the Food groups cheese, whole fat dairy products, margarine, poultry, butter, yogurt, dressing/sauce, and Lamb contributed amounts <0.1 µg per day.']	[('ANOMALY_CURIOUS_FINDING', 40), ('ANOMALY_CURIOUS_FINDING', 44)]	2	[('CHEBI_33290', 'food', 13, 'food'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_33290', 'food', 84, 'food'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 186, 'lamb')]
PMC3347007	4/2012	S141-PMC3347007	['in a finnish Pregnancy study 74% of Vitamin D among Supplement users came from Supplements, BUT ONLY 15% reached the recommended intake level of 10 µg per day [27].']	[('ANOMALY_CURIOUS_FINDING', 92), ('ANOMALY_CURIOUS_FINDING', 96)]	2	[('GO_0007565', 'female pregnancy', 13, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 52, 'supplement'), ('CHEBI_33341', 'titanium atom', 79, 'supplements')]
PMC3347028	3/2012	S38-PMC3347028	['dietary and endogenous Vitamin D APPEAR TO act SIMILARLY with half-life between 12 and 24 h, the length of time depending on how quickly the Liver converts Vitamin D to 25-Hydroxy-Vitamin D (also known as Calcidiol).']	[('ANOMALY_CURIOUS_FINDING', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0002107', 'liver', 141, 'liver'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('CHEBI_70487', '(-)-sanguinolignan C', 169, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_17933', 'calcidiol', 205, 'calcidiol')]
PMC3347028	3/2012	S43-PMC3347028	['the half-life of 25(Oh)D is 2–3 weeks, making it a much better INDICATOR of the body’s Vitamin D status than Vitamin D. OF NOTE, 25(Oh)D can be expressed as ng/ml or nmol/l.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('ANOMALY_CURIOUS_FINDING', 120)]	2	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D')]
PMC3347028	3/2012	S174-PMC3347028	['one does not become Vitamin D toxic from sunlight exposure; HOWEVER, in comparison, People have become toxic from Ingesting too much oral Vitamin D. in an Adult, it APPEARS that the upper limit of tolerability of Vitamin D is a daily consumption of thousands of international units of Vitamin D—above 10,000 iu/day [142,143].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ANOMALY_CURIOUS_FINDING', 165)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'people'), ('GO_0007567', 'parturition', 114, 'ingesting'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
PMC3356951	4/2012	S142-PMC3356951	['age-related Macular Regeneration\nhigh Vitamin D Blood levels APPEAR TO BE ASSOCIATED with a decreased risk for the development of early age-related Macular degeneration (amd) among women younger than 75 years.']	[('ANOMALY_CURIOUS_FINDING', 61), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('UBERON_0000054', 'macula', 12, 'macular'), ('GO_0031099', 'regeneration', 20, 'regeneration'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0000054', 'macula', 148, 'macular')]
PMC3395583	7/2012	S105-PMC3395583	['Gestational Vitamin D deficiency APPEARS TO BE a PLAUSIBLE causative agent.']	[('ANOMALY_CURIOUS_FINDING', 33), ('INCOMPLETE_EVIDENCE', 49)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC3407995	7/2012	S268-PMC3407995	['in a study completed by a coalition of scientists formed to optimize Vitamin D fortification in the northern european countries, the average dietary intake of Vitamin D in young women was ONLY around 80 iu (2 μg) per day [144].']	[('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 188)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC3424155	8/2012	S169-PMC3424155	['furthermore, NOT ONLY the f1 generation BUT ALSO the f2 generation was AFFECTED by the Gestational Vitamin D deficiency of the f0 generation Mice.']	[('ANOMALY_CURIOUS_FINDING', 13), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('GO_0007565', 'female pregnancy', 87, 'gestational'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'mice')]
PMC3424155	8/2012	S188-PMC3424155	['ALTHOUGH the vitd- offspring in the present study did not show a reduction in Wt1 Expression, maternal Vitamin D deficiency did alter the ratio of immature-to-mature Glomeruli at Birth by EXTENDING the period of Glomerular maturation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 188)]	2	[('PR_000017450', 'protein Wnt-8a', 78, 'WT1'), ('GO_0010467', 'gene expression', 82, 'expression'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 166, 'glomeruli'), ('GO_0007567', 'parturition', 179, 'birth'), ('UBERON_0000074', 'renal glomerulus', 212, 'glomerular')]
PMC3424155	8/2012	S203-PMC3424155	['ALTHOUGH the mature Animals did not show significant proteinuria, maternal Vitamin D deficiency altered Podocin Expression in the f1 generation from weaning until six months of age, BUT NOT in the f2 generation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 182)]	2	[('NCBITaxon_33208', 'Metazoa', 20, 'animals'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 104, 'podocin'), ('GO_0010467', 'gene expression', 112, 'expression')]
PMC3427250	8/2012	S90-PMC3427250	['ON THE OTHER HAND risk of severe Vitamin D deficiency decreased for women who reported Alcohol Consumption during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_30879', 'alcohol', 87, 'alcohol'), ('GO_0007631', 'feeding behavior', 95, 'consumption'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy')]
PMC3427250	8/2012	S98-PMC3427250	['the high prevalence of Vitamin D deficiency in belgium stems from the fact that the contribution of dietary sources to the Vitamin D status is negligible as was shown by the flemish Food Consumption survey among preschoolers which ESTIMATED the mean Vitamin D intake at ONLY 2 µg/day[35].']	[('INCOMPLETE_EVIDENCE', 231), ('ANOMALY_CURIOUS_FINDING', 270)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food'), ('GO_0007631', 'feeding behavior', 182, 'food consumption'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D')]
PMC3427250	8/2012	S106-PMC3427250	['smoking increased the risk of both Vitamin D deficiency and severe Vitamin D deficiency; the mechanism for this APPEARS TO BE UNCLEAR[50].']	[('ANOMALY_CURIOUS_FINDING', 112), ('FULL_UNKNOWN', 126)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3427250	8/2012	S123-PMC3427250	['EVEN in the last published guidelines the treatment of Vitamin D deficient women is NOT SPECIFICALLY discussed[24].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 84)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3471827	10/2012	S11-PMC3471827	['ALTHOUGH the fetal-resorption test is STILL used to define the international units for Vitamin E[2], the cause of the Embryonic failure has never been characterized.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 38)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin E'), ('UBERON_0000922', 'embryo', 118, 'embryonic')]
PMC3472720	8/2012	S19-PMC3472720	['CURIOUSLY, deluca and plum [16] have DEMONSTRATED that prolonged Vitamin D deficiency, maintained for two generations, also diminished the severity and delayed the onset of eae in b10pl Mice.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 37)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 186, 'mice')]
PMC3485340	10/2012	S124-PMC3485340	['DESPITE this adjustment, hippocampal volumes were consistently lower in Prenatally deficient compared TO non-deficient counterparts at all time points (p<0.05 or less) (figure 2).10.1371/journal.pone.0048488.g002\n\ncaption (fig): figure 2\npersistently lower hippocampal volume corrected for Brain weight in Prenatally Vitamin C-depleted Animals.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 102)]	2	[('GO_0019230', 'proprioception', 72, 'prenatally'), ('UBERON_0000955', 'brain', 290, 'brain'), ('GO_0019230', 'proprioception', 306, 'prenatally'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin C'), ('NCBITaxon_33208', 'Metazoa', 336, 'animals')]
PMC3509518	11/2012	S84-PMC3509518	['for “any allergic disease” higher maternal dietary Vitamin C intake was ASSOCIATED with a reduced risk of diagnosed allergic disease at 1 year for the highest versus the lowest quartile (the crude odds ratio [or] = 0.48, 95% ci 0.25–0.93), ALTHOUGH the inverse linear trend and the adjusted or were not statistically significant (table 4).']	[('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 240)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin C')]
PMC3509518	11/2012	S87-PMC3509518	['there were also RELATIONSHIPS between Vitamin C intake and both Food allergy ( ptrend= 0.07) and sensitisation ( ptrend= 0.07) ALTHOUGH neither of these was statistically significant.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('ANOMALY_CURIOUS_FINDING', 127)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin C'), ('CHEBI_33290', 'food', 64, 'food')]
PMC3509518	11/2012	S105-PMC3509518	['furthermore, maternal dietary Vitamin C intake in Pregnancy APPEARED PROTECTIVE against Development Of Wheeze in the first year of Life.']	[('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0060041', 'retina development in camera-type eye', 88, 'development of wheeze'), ('UBERON_0000104', 'life cycle', 131, 'life')]
PMC3515553	12/2012	S93-PMC3515553	['Vitamin B-12 status RELATED Snps, maternal dietary intake of Vitamin B-12 and Cord Blood Vitamin B-12\nneither of the maternal Snps was associated with maternal dietary Intake of Vitamin B-12 during Pregnancy in a linear model, ALTHOUGH tcn2 rs1801198 heterozygotes showed higher Vitamin B-12 intake than either homozygote group (p\u200a=\u200a0.02).']	[('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 227)]	2	[('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B-12'), ('SO_0000694', 'SNP', 28, 'SNPs'), ('PR_000017269', 'ventral anterior homeobox 2', 61, 'Vitamin B-12'), ('UBERON_0000948', 'heart', 78, 'Cord'), ('UBERON_0000178', 'blood', 83, 'Blood'), ('PR_000017269', 'ventral anterior homeobox 2', 89, 'Vitamin B-12'), ('SO_0000694', 'SNP', 126, 'SNPs'), ('GO_0007631', 'feeding behavior', 168, 'intake'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 178, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 279, 'vitamin B-12')]
PMC3586494	2/2013	S118-PMC3586494	['maternal Vitamin A and e levels were higher than cord values, YET there was a positive CORRELATION between maternal and cord levels of these two Vitamins.']	[('ANOMALY_CURIOUS_FINDING', 62), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 145, 'vitamins')]
PMC3586494	2/2013	S179-PMC3586494	['female a/a Mice Fed a methyl-supplemented diet with extra Folate, Vitamin B-12,Choline, and betaine 2 weeks prior to Mating with male Avy/ a agouti Mice and throughout Pregnancy and Lactation passed along the agouti Gene to their offspring intact, YET DEMONSTRATED a shift in distribution towards having more offspring with the pseudoagouti phenotype [76].']	[('ANOMALY_CURIOUS_FINDING', 248), ('INCOMPLETE_EVIDENCE', 252)]	2	[('NCBITaxon_10088', 'Mus <genus>', 11, 'mice'), ('GO_0007631', 'feeding behavior', 16, 'fed'), ('CHEBI_30863', '5-azaorotic acid', 58, 'folate'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 66, 'vitamin B-12'), ('CHEBI_15354', 'choline', 79, 'choline'), ('GO_0007618', 'mating', 117, 'mating'), ('PR_000004155', 'apolipoprotein E', 134, 'Avy'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'mice'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('GO_0007595', 'lactation', 182, 'lactation'), ('SO_0000704', 'gene', 216, 'gene')]
PMC3629265	4/2013	S79-PMC3629265	['in addition, aboriginal women from manitoba HAVE BEEN SHOWN to have lower Vitamin D levels than caucasian women EVEN THOUGH Vitamin D intake did not differ between the groups.']	[('INCOMPLETE_EVIDENCE', 44), ('ANOMALY_CURIOUS_FINDING', 112)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3641012	4/2013	S94-PMC3641012	['this approach enabled the estimation of the average difference in 25(Oh)D between the two groups at a PRESUMED ‘steady-state’ (i.e., where group-averaged 25(Oh)D did not continue to appreciably rise DESPITE ongoing Vitamin D supplementation).']	[('PROBABLE_UNDERSTANDING', 102), ('ANOMALY_CURIOUS_FINDING', 199)]	2	[('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC3641012	4/2013	S165-PMC3641012	['NOTABLY, variation in Cord 25(Oh)D within the Vitamin D group was not associated with duration of supplementation (p\u2009=\u20090.86) or cumulative Vitamin D supplement dose administered (p\u2009=\u20090.93), INDICATING that the maternal-fetal Vitamin D equilibrium was achieved rapidly.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 190)]	2	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 27, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC3641012	4/2013	S166-PMC3641012	['mean maternal adj-ca concentration rose over time within the reference range; the initial rate of rise APPEARED TO BE greater in the Vitamin D group, BUT the difference was attenuated after ~2\xa0months of supplementation (figure\xa04).']	[('ANOMALY_CURIOUS_FINDING', 103), ('ANOMALY_CURIOUS_FINDING', 150)]	2	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3651971	5/2013	S161-PMC3651971	['in conclusion, in this Vitamin A deficient setting, where maternal Vitamin A supplementation reduced maternal night blindness and mortality, no long-term EFFECTS have BEEN observed on the Cognitive and motor skill development of Prepubescent offspring.']	[('SUPERFICIAL_RELATIONSHIP', 154), ('ANOMALY_CURIOUS_FINDING', 167)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin A'), ('GO_0050890', 'cognition', 188, 'cognitive ...'), ('GO_0048633', 'positive regulation of skeletal muscle tissue growth', 229, 'prepubescent')]
PMC3668200	5/2013	S43-PMC3668200	['a canadian study that evaluated Serum Vitamin D and Mineral levels among infants REPORTED that newborns whose mothers had adequate intakes of milk and Vitamin D during Pregnancy showed increased Birth weight BUT NOT Head circumference or length at Birth17).']	[('INCOMPLETE_EVIDENCE', 81), ('ANOMALY_CURIOUS_FINDING', 208)]	2	[('UBERON_0001977', 'blood serum', 32, 'serum'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_46662', 'mineral', 52, 'mineral'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('GO_0007567', 'parturition', 195, 'birth'), ('UBERON_0000033', 'head', 216, 'head'), ('GO_0007567', 'parturition', 248, 'birth17')]
PMC3672018	5/2013	S145-PMC3672018	['fortification supplied 15% of Vitamin D intake on average, which MAY BE CONSIDERED low, PARTICULARLY when the sun exposure is not ample.']	[('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 88)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC3691177	6/2013	S121-PMC3691177	['ALTHOUGH randomisation in this trial was stratified by ethnicity, and we included baseline Vitamin D in our adjusted model, IT IS POSSIBLE that this source of heterogeneity could have masked positive findings.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3702339	6/2013	S128-PMC3702339	['ONLY 199 (28.4%) and 181 (25.6%) reported Consumption of provitamin a and preformed Vitamin A-rich Foods respectively.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0)]	2	[('GO_0007631', 'feeding behavior', 42, 'consumption'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('CHEBI_33290', 'food', 99, 'foods')]
PMC3705146	5/2013	S194-PMC3705146	['in CONTRAST TO most OTHER Animals, Humans have a large cutaneous surface area that is responds to sunlight by proportional (not step-wise) adjustments to sunlight intensity for both Vitamin D (chen et al.,2007) and Melanotropin Production (farooqui et al.,1993; chakraborty et al.,1996; hiramoto et al.,2003).']	[('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20)]	2	[('NCBITaxon_33208', 'Metazoa', 26, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'humans'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0034309', 'primary alcohol biosynthetic process', 215, 'melanotropin production')]
PMC3713405	7/2013	S125-PMC3713405	['IMPORTANTLY, this behavioral sensitivity is heavily DEPENDENT on the timing of Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3713405	7/2013	S163-PMC3713405	['the interactions between, and functions of, the vdr and rxr APPEAR TO BE extremely DEPENDENT on the presence of Vitamin D. for example, the vdr-rxr heterodimer with no ligand acts as a weak transcriptional repressor (tagami et al., 1998).']	[('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC3717170	5/2013	S129-PMC3717170	['li and colleagues have isolated Monocytes from patients and examined Expression of a number OF Genes RELATED to Vitamin D Metabolism and Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 92), ('SUPERFICIAL_RELATIONSHIP', 101)]	2	[('CL_0000576', 'monocyte', 32, 'monocytes'), ('GO_0010467', 'gene expression', 69, 'expression'), ('SO_0000704', 'gene', 95, 'genes'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 112, 'vitamin D metabolism'), ('GO_0006955', 'immune response', 137, 'immune responses'), ('UBERON_0002405', 'immune system', 137, 'immune')]
PMC3717170	5/2013	S183-PMC3717170	['overall, Vitamin D APPEARS TO BE IMPLICATED in many of the physiological and pathological changes that occur with Aging.']	[('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007568', 'aging', 114, 'aging')]
PMC3728489	7/2013	S316-PMC3728489	['SURPRISINGLY, they also OBSERVED an increased risk for schizophrenia in Individuals with Vitamin D levels in the highest quintile.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24)]	2	[('NCBITaxon_1', 'root', 72, 'individuals'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3739737	8/2013	S157-PMC3739737	['DESPITE rodents having a nocturnal lifestyle, shaved Rat skin is able to Synthesise Vitamin D after uvb exposure[32], and Hair-coated Animals, such as dairy Cows, Synthesise Vitamin D3[33], SUGGESTING that a full Coat Of Hair does not prevent cutaneous Vitamin D production.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 190)]	2	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 53, 'rat'), ('GO_0007601', 'visual perception', 73, 'synthesise'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001037', 'strand of hair', 122, 'hair'), ('NCBITaxon_33208', 'Metazoa', 134, 'animals'), ('NCBITaxon_33208', 'Metazoa', 157, 'cows'), ('GO_0007601', 'visual perception', 163, 'synthesise'), ('CHEBI_33279', 'vitamin D5', 174, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 174, 'vitamin D3'), ('UBERON_0010166', 'coat of hair', 213, 'coat of hair'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC3773018	4/2013	S53-PMC3773018	['HOWEVER, children with persistently low Vitamin D status had the highest risk of fs (or= 2.04, 95%ci: 1.02–4.04), AS compared to those with sufficient Vitamin D status at Birth and follow-up.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 114)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC3773018	4/2013	S59-PMC3773018	['INTERESTINGLY, when low Vitamin D at Birth was followed by sufficient Vitamin D in early childhood, children carrying the c Allele were not at an INCREASED RISK for fs (or=1.26, 95%ci: 0.65–2.43).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 146)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('SO_0001023', 'allele', 124, 'allele')]
PMC3773018	4/2013	S84-PMC3773018	['among subjects carrying the c Allele of rs2243250, persistently low Vitamin D status dramatically increased the RISK of fs, WHILE sufficient Vitamin D status during early childhood attenuated the risk of Perinatal Vitamin D deficiency on fs to null.']	[('IMPORTANT_CONSIDERATION', 112), ('ANOMALY_CURIOUS_FINDING', 124)]	2	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0036268', 'swimming', 204, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 204, 'perinatal'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3773018	4/2013	S85-PMC3773018	['among those carrying the tt genotype, post-Natal sufficient Vitamin D status EVEN SHOWED a decreased risk of fs.']	[('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 82)]	2	[('GO_0007567', 'parturition', 43, 'natal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3798907	8/2013	S20-PMC3798907	['secondly, ALTHOUGH cbmc responses are ASSOCIATED with maternal dietary Vitamin E intake during Pregnancy, there is no association with maternal or Cord Blood Α-Tocopherol [12].']	[('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin E'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 147, 'cord'), ('UBERON_0000178', 'blood', 152, 'blood'), ('CHEBI_27725', 'butin', 158, 'α-tocopherol')]
PMC3926113	1/2014	S0-PMC3926113	['Prenatal Vitamin C deficiency results in DIFFERENTIAL levels of oxidative stress during late Gestation in foetal guinea pig Brains\n\nabstract\nantioxidant defences are comparatively low during Foetal Development making the Brain PARTICULARLY susceptible to oxidative stress during antioxidant deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('ANOMALY_CURIOUS_FINDING', 227)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('GO_0007565', 'female pregnancy', 93, 'gestation'), ('UBERON_0000955', 'brain', 124, 'brains'), ('GO_0060324', 'face development', 191, 'foetal development'), ('UBERON_0000955', 'brain', 221, 'brain')]
PMC3926113	1/2014	S148-PMC3926113	['Prenatal vitc deficiency in the guinea pig foetal Brain does not Modulate levels of Vitamin E, nt or Hne Protein modifications or Caspase-3 HOWEVER, increases sod activity as compensation ALTHOUGH this is not adequate to prevent increased Lipid peroxidation at the investigated time points.']	[('ANOMALY_CURIOUS_FINDING', 140), ('ANOMALY_CURIOUS_FINDING', 188)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('UBERON_0000955', 'brain', 50, 'brain'), ('GO_0065007', 'biological regulation', 65, 'modulate'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin E'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 101, 'HNE'), ('GO_0000239', 'pachytene', 105, 'protein'), ('PR_000002319', 'catenin beta-1 isoform 1', 130, 'caspase-3'), ('CHEBI_18059', 'lipid', 239, 'lipid')]
PMC3970319	5/2013	S23-PMC3970319	['multiple-Micronutrient supplements (mmss) provided in Pregnancy compared with Iron and Folate supplements were marginally ASSOCIATED with lower offspring systolic, BUT NOT diastolic, Blood pressure at 2 y of age in one nepalese study (10) but were unrelated to offspring Blood pressure at 6–8 y in a separate nepalese trial where mmss were compared with Vitamin A supplementation (11).']	[('SUPERFICIAL_RELATIONSHIP', 122), ('ANOMALY_CURIOUS_FINDING', 164)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_24870', 'ion', 78, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 87, 'folate'), ('UBERON_0000178', 'blood', 183, 'blood'), ('UBERON_0000178', 'blood', 271, 'blood'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin A')]
PMC4051754	6/2014	S45-PMC4051754	['the concentration of Vitamin E TENDED to be lower after +14 days relative to Parturition ( d ) in of vs. re DESPITE the lack of difference in Feed Intake Postpartum[10](figure 1).']	[('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 108)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin E'), ('GO_0019230', 'proprioception', 77, 'parturition'), ('GO_0007631', 'feeding behavior', 142, 'feed intake'), ('GO_0007565', 'female pregnancy', 154, 'postpartum')]
PMC4113768	7/2014	S133-PMC4113768	['discussion: overall, in caucasians Vitamin D status APPEARS TO BE positively CORRELATED with radial and Tibial bone mass and size.']	[('ANOMALY_CURIOUS_FINDING', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002101', 'limb', 104, 'tibial')]
PMC4113768	7/2014	S134-PMC4113768	['in south asians, Vitamin D status APPEARS TO BE positively CORRELATED with distal radial Trabecular density.']	[('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0002363', 'dura mater', 89, 'trabecular')]
PMC4113768	7/2014	S367-PMC4113768	['ALTHOUGH no children were taking vitamin supplements at the time of the study, the average Vitamin D level in african children who had ever been prescribed Vitadol-c was 34 nmol/l WHILST those who had never been prescribed Vitadol-c was 16 nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27355', 'xylulose phosphate', 156, 'vitadol'), ('CHEBI_27355', 'xylulose phosphate', 223, 'vitadol')]
PMC4113768	7/2014	S876-PMC4113768	['DESPITE Vitamin D deficiency primarily AFFECTING proximal muscle function, the three studies that met the inclusion criteria all looked predominantly at distal muscle function (Hand grip or pinch grip strength.)']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0002398', 'manus', 177, 'hand')]
PMC4113768	7/2014	S1035-PMC4113768	['risk of premature Birth was NOTABLY lower for mothers who took Vitamin D supplementation during Pregnancy (0.53, 0.43–0.66 for multivitamin; 0.44, 0.40–0.49 for single preparation), with the ASSOCIATION remaining unaffected by adjustment for infections.']	[('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 191)]	2	[('GO_0007567', 'parturition', 18, 'birth'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC4113768	7/2014	S1079-PMC4113768	['there APPEARED TO BE NO significant impact of hypovitaminosis D on the inflammatory marker crp, levels of which were SIMILAR among Vitamin D sufficient and deficient subjects.']	[('ANOMALY_CURIOUS_FINDING', 6), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 62, 'D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC4113768	7/2014	S1611-PMC4113768	['baseline covariates significantly ASSOCIATED with lower Hip bmd adjusting for age were previous tdf use, BUT ONLY in those with Vitamin D sufficiency (mean difference −0.07 g/cm3 95% confidence interval (ci) −0.01 to −0.13; p = 0.02), lean body mass (7 gram increase in lean body mass for every 1 g/cm3 increase in bmd, 95% ci 4.28,9.84; p< 0.001), Vitamin D deficiency (mean difference −0.04 g/cm3 95% ci −0.009 to 0.09; p = 0.03), Vitamin D deficiency in those not on tdf (mean difference between Vitamin D sufficiency and insufficiency in those not on tdf-0.09 g/cm3 95% ci −0.15 to −0.01; p = 0.006), and white ethnicity (−0.07, 95% ci −0.007 to −0.13).']	[('SUPERFICIAL_RELATIONSHIP', 34), ('ANOMALY_CURIOUS_FINDING', 105)]	2	[('UBERON_0001464', 'hip', 56, 'hip'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D')]
PMC4113768	7/2014	S1747-PMC4113768	['background: the public continues to receive the advice that sustaining a high level of Serum Vitamin D is IMPORTANT in maintaining good health, regardless OF the presence of an illness.']	[('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 155)]	2	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4113768	7/2014	S2287-PMC4113768	['; mohammed, g.; alshahrani, f.\nbackground: there is LITTLE EVIDENCE published on prevalence of Vitamin D deficiency among saudi women, IN SPITE of the widespread Food fortification and the excellent opportunity of available sun light all over the year.']	[('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 135)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33290', 'food', 162, 'food')]
PMC4113768	7/2014	S2365-PMC4113768	['in both groups, hdl-C levels improved significantly AS 25(Oh) Vitamin D levels increased with subsequent follow-ups, EVEN after adjusting for age, gender and bmi ( p< 0.001).']	[('PROBABLE_UNDERSTANDING', 52), ('ANOMALY_CURIOUS_FINDING', 117)]	2	[('PR_000000037', 'BMP receptor type-2', 19, '-C'), ('CHEBI_30778', 'gallic acid', 55, '25(OH)'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S2646-PMC4113768	['median maternal 25(Oh)D was 61 nmol/l (iqr 43–88 nmol/l), and ONLY 9.2% of mothers were using Vitamin D supplementation (at LEAST 400 iu/day) in late Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 62), ('PROBABLE_UNDERSTANDING', 124)]	2	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy')]
PMC4113768	7/2014	S2727-PMC4113768	['many of the websites that patients bought their Supplements from did not APPEAR to clearly highlight the risk of toxicity from Vitamin D, ALTHOUGH they all described the potential health benefits of taking Vitamin D supplements.']	[('ANOMALY_CURIOUS_FINDING', 73), ('ANOMALY_CURIOUS_FINDING', 138)]	2	[('CHEBI_33341', 'titanium atom', 48, 'supplements'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC4169453	9/2014	S139-PMC4169453	['HOWEVER, a higher percentage of Vitamin D sufficient infants (up to 70%) than mothers was NOTED in both study groups (fig.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 90)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4169453	9/2014	S150-PMC4169453	['HOWEVER, when Cord Blood was controlled for, the CORRELATION was not significant (r\u200a=\u200a0.001, p\u200a=\u200a0.99 ).10.1371/journal.pone.0107708.t004\n\ncaption (table-wrap): table 4\nSerum ipth and calcium concentrations, and Urinary Ca/cr ratio during 6 months of Vitamin D supplementation.parametertime400 iu/d group1200 iu/d group p -value between groups mothers n\u200a=\u200a67n\u200a=\u200a70ipth, pg/mlbaseline30.4 (20.2–43.5)28.6 (20–42)0.54δipth, pg/mlbaseline to 3 months−8.7±18.2−9.0±15.90.703 to 6 months4.1±10.43.5±10.30.75serum Ca, mmol/l3 months2.43 (2.36–2.49)2.44 (2.38–2.52)0.546 months2.37 (2.33–2.43)2.40 (2.36–2.47)0.13Uca/cr ratio, mmol/mmol3 months0.22 (0.12–0.38)0.3 (0.16–0.43)0.176 months0.19 (0.08–0.34)0.23 (0.11–0.41)0.27 infants n\u200a=\u200a67n\u200a=\u200a70ipth, pg/mlbaseline4.8 (3.7–7.1) (n\u200a=\u200a61)4.5 (3.8–5.8) (n\u200a=\u200a60)0.69δipth, pg/mlbaseline to 3 months10.7±10.011.5±6.30.803 to 6 months5.1±8.43.0±6.40.08serum ca, mmol/l3 months2.66 (2.61–2.73)2.67 (2.62–2.74)0.766 months2.62 (2.57–2.68)2.65 (2.62–2.7)0.009uca/cr ratio, mmol/mmol3 month1.58 (1.02–2.40)1.51 (0.89–2.47)0.556 months1.26 (0.87–1.81)1.47 (0.86–2.27)0.17\ndata presented as median (interquartile range: q1–q3) or mean ± sd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('UBERON_0002240', 'spinal cord', 14, 'cord'), ('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001977', 'blood serum', 169, 'Serum'), ('UBERON_0001088', 'urine', 212, 'urinary'), ('CHEBI_32588', 'potassium chloride', 220, 'Ca'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('CHEBI_32588', 'potassium chloride', 508, 'Ca'), ('CHEBI_73165', 'elf18', 604, '13UCa')]
PMC4169453	9/2014	S162-PMC4169453	['HOWEVER, maternal total body fat mass was comparable between groups, significant negative CORRELATIONS were noted between maternal 25(Oh)D level and maternal fat mass (r\u200a=\u200a−0.49, p \u200a=\u200a0.00001), Android fat mass (r\u200a=\u200a−0.53, p \u200a=\u200a0.00001), and gynoid fat mass (r\u200a=\u200a−0.43, p \u200a=\u200a0.00001) after 6 months of Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_71657', 'versiconol acetate', 131, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 131, '25(OH)D'), ('UBERON_0001428', 'intermedium', 194, 'android'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC4169453	9/2014	S181-PMC4169453	['HOWEVER, a Vitamin D daily dose of 1200 iu APPEARED too low to replenish Vitamin D deficiency/insufficiency states in all breastfeeding mothers from the study group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 43)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4169453	9/2014	S211-PMC4169453	['in the light of the aforementioned studies, Vitamin D supplements SEEMS to be more effective as a source of Vitamin D in many contemporary industrialized populations SUFFERING from changing lifestyles (restricted sun exposure, obesity, unhealthy diet).']	[('ANOMALY_CURIOUS_FINDING', 66), ('IMPORTANT_CONSIDERATION', 166)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4188019	1/2010	S12-PMC4188019	['conclusion: low Vitamin D levels SEEM TO BE frequent and covered woman are at a higher RISK of deficiency.']	[('ANOMALY_CURIOUS_FINDING', 33), ('IMPORTANT_CONSIDERATION', 87)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4188019	1/2010	S79-PMC4188019	['ALTHOUGH most of the Vitamin D production comes from skin conversion, the dietary intake of Vitamin D is something we’ll have to examine in FURTHER STUDIES, as well as darkness of skin and nationality.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 140)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4193194	10/2014	S212-PMC4193194	['oral supplementation with Antioxidants like Vitamin C and E and EVEN N-Acetylcysteine HAVE BEEN PROVEN to be a failure on the prevention of the disease.']	[('ANOMALY_CURIOUS_FINDING', 64), ('INCOMPLETE_EVIDENCE', 86)]	2	[('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 26, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('CHEBI_44482', 'N-oxalylglycine', 69, 'n-acetylcysteine')]
PMC4221707	11/2014	S204-PMC4221707	['the low intake of Folate, Vitamin D, and iron from Food are of SPECIAL CONCERN.']	[('ANOMALY_CURIOUS_FINDING', 63), ('PROBLEM_COMPLICATION', 71)]	2	[('CHEBI_30863', '5-azaorotic acid', 18, 'folate'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_33290', 'food', 51, 'food')]
PMC4231606	10/2013	S80-PMC4231606	['the EXCEPTION were regular Milk drinkers (≥ 5 servings weekly), who had significantly higher mean Vitamin D levels THAN non-regular milk drinkers (76.6\u2009±\u200930.3\xa0nmol/l vs. 63.2\u2009±\u200927.0, p\u2009=\u20090.042).']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	2	[('UBERON_0001913', 'milk', 27, 'milk'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4231606	10/2013	S107-PMC4231606	['s-ecc, infrequent milk Intake, and winter season were ASSOCIATED with lower 25(Oh)D levels, BUT NOT household income or Vitamin D drop use.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('ANOMALY_CURIOUS_FINDING', 92)]	2	[('GO_0007631', 'feeding behavior', 23, 'intake'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4329404	10/2014	S8-PMC4329404	['conclusion\nperi-natal Vitamin D deficiency ALONE has immunomodulatory EFFECTS including th2 skewing and reduced Il-10-Secreting T Regulatory Cells, exaggerated with additional Allergen exposure.']	[('ANOMALY_CURIOUS_FINDING', 43), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 112, 'IL-10'), ('CL_0000595', 'enucleate erythrocyte', 118, 'secreting'), ('GO_0046903', 'secretion', 118, 'secreting'), ('CL_0000902', 'induced T-regulatory cell', 128, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 130, 'regulatory'), ('CHEBI_50904', 'allergen', 176, 'allergen')]
PMC4329404	10/2014	S115-PMC4329404	['additionally, Pulmonary Il-10 remained the same in all hdm challenged pups and was not influenced by Vitamin D status EVEN THOUGH numbers of Cd4+il-10+cells were reduced with Vitamin D insufficiency (figs3d and4b).']	[('ANOMALY_CURIOUS_FINDING', 118), ('ANOMALY_CURIOUS_FINDING', 123)]	2	[('UBERON_0002048', 'lung', 14, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 24, 'IL-10'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('PR_000001204', 'C-C chemokine receptor type 8', 141, 'CD4'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4329404	10/2014	S159-PMC4329404	['SIMILARLY, Serum Ige levels were lowest in Mice that were supplemented with Vitamin D at weaning, EVEN lower than those that were always Vitamin D sufficient (fig.4a).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 98)]	2	[('UBERON_0001977', 'blood serum', 11, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 17, 'IgE'), ('NCBITaxon_10088', 'Mus <genus>', 43, 'mice'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4329404	10/2014	S183-PMC4329404	['HOWEVER, ahr is unaffected by Vitamin D deficiency in neonatal aad.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4380518	9/2014	S36-PMC4380518	['in other words, early pnv use was ASSOCIATED with Vitamin D sufficiency earlier in Pregnancy BUT NOT later in Pregnancy (table 4).']	[('SUPERFICIAL_RELATIONSHIP', 34), ('ANOMALY_CURIOUS_FINDING', 93)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC4392553	3/2015	S425-PMC4392553	['[34] FOUND deficient levels of Vitamin D in 83% of black women and 92% of their newborns, as well as in 47% of white women and 66% of their newborns, DESPITE the fact that over 90% of the women were on Prenatal Vitamins.']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 150)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 202, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 211, 'vitamins')]
PMC4417995	4/2015	S86-PMC4417995	['[39], studying ad in 157 patients, 73.3% of which between the ages of 0–15, SHOWED that, in the 36 patients with diagnosed Food sensitization, mean Serum levels of Vitamin D were significantly higher in patients with mild ad (21.2 ± 5.18\u2009ng/ml) COMPARED TO those with moderate (17.9 ± 4.02\u2009ng/ml) or severe ad (13.3 ± 5.11\u2009ng/ml).']	[('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 245)]	2	[('CHEBI_33290', 'food', 123, 'food'), ('GO_0007631', 'feeding behavior', 123, 'food'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4427001	4/2015	S151-PMC4427001	['we CONFIRMED overall high prevalence of Vitamin D deficiency in Pregnant women IN SPITE of the gdm presence.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 79)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant')]
PMC4438628	5/2015	S190-PMC4438628	['psychological stress\nprocessed and ultra-processed Foods\nFood Additives\nAdvanced Glycation End Products (Ages)\nabsence of Phytochemicals\ninadequate essential Fats\ninadequate Vitamin D\ninadequate magnesium\nAntibiotic administration\npotentially pathogenic Oral bacteria\nlack of physical activity/excess indoor screen time\ntobacco use\nAlcohol use\nsleep problems/Circadian disruptions\ncrowding\nclimatic stress\nenvironmental Toxins\n\nsummary and future directions\nDESPITE its obvious ripple into so many aspects of societal health, the ‘no health without mental health’ dictum is OFTEN afforded only lip service by funding bodies [309].']	[('ANOMALY_CURIOUS_FINDING', 458), ('PROBABLE_UNDERSTANDING', 574)]	2	[('CHEBI_33290', 'food', 51, 'foods'), ('CHEBI_78601', '11,21-dioxoprogesterone', 57, 'Food additives'), ('GO_0006116', 'NADH oxidation', 72, 'Advanced glycation'), ('CHEBI_46678', 'amosite asbestos', 81, 'glycation end products'), ('CHEBI_74913', 'AOPE', 105, 'AGEs'), ('CHEBI_26254', 'prenylnaphthoquinone', 122, 'phytochemicals'), ('CHEBI_33250', 'atom', 158, 'fats'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 205, 'Antibiotic'), ('UBERON_0000165', 'mouth', 254, 'oral'), ('CHEBI_30879', 'alcohol', 332, 'Alcohol'), ('GO_0051216', 'cartilage development', 359, 'circadian'), ('CHEBI_27026', 'toxin', 420, 'toxins')]
PMC4448820	5/2015	S299-PMC4448820	['the molecular actions of zinc APPEAR TO BE more COMPLEX than those of Vitamins A and D. in Humans, the zinc-containing proteome contains <3000 members (193).']	[('ANOMALY_CURIOUS_FINDING', 30), ('DIFFICULT_TASK', 48)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 85, 'D'), ('NCBITaxon_9606', 'Homo sapiens', 91, 'humans')]
PMC4452099	6/2015	S26-PMC4452099	['STILL, on average, 13% of all dietary Vitamin D among Adult danes was ESTIMATED to have come from the fortified Margarine [20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 70)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('CHEBI_6784', 'mestranol', 112, 'margarine')]
PMC4466139	6/2015	S107-PMC4466139	['IN FACT, over the 50% of subjects who had declared taking Vitamin D, failed to achieve OPTIMAL Serum 25Ohd concentrations.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 87)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001977', 'blood serum', 95, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 101, '25OHD')]
PMC4499946	7/2015	S30-PMC4499946	['in a study conducted in the 1970s in london, england, Prenatal Vitamin D supplementation reduced the RISK of small for Gestational age (sga) versus control, BUT there was no significant effect on Birth length [24]; however, the infants in the Vitamin D group had significantly greater mean length at 1 year of age [25].']	[('IMPORTANT_CONSIDERATION', 101), ('ANOMALY_CURIOUS_FINDING', 157)]	2	[('GO_0007565', 'female pregnancy', 54, 'prenatal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'gestational'), ('GO_0007567', 'parturition', 196, 'birth'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4586450	10/2015	S517-PMC4586450	['Nutrient intakes ESTIMATED from the ffq at age 3 years did not differ between children with asds and control subjects, EXCEPT those with asds had slightly lower intakes of Vitamin C and Ate less variety of Foods, particularly Consuming fruit and vegetables less often.']	[('INCOMPLETE_EVIDENCE', 17), ('ANOMALY_CURIOUS_FINDING', 119)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrient'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin C'), ('GO_0009636', 'response to toxic substance', 186, 'ate'), ('CHEBI_33290', 'food', 206, 'foods'), ('GO_0007631', 'feeding behavior', 226, 'consuming')]
PMC4624803	10/2015	S8-PMC4624803	['ALTHOUGH exposure of the skin to sunlight LEADS to Vitamin D Production From Cholesterol, Vitamin D deficiency is common, also in areas rich in sunshine [1,2].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0030730', 'sequestering of triglyceride', 59, 'D production from cholesterol'), ('CHEBI_16113', 'cholesterol', 77, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4632418	10/2015	S77-PMC4632418	['it is WORTH NOTING that two pooled ors for Vitamin D severe deficiency and insufficiency were calculated with the outcomes of 1.59 (95% ci, 1.11, 2.27) and 1.39 (95% ci, 1.07, 1.82), respectively (supplementary table s2).']	[('ANOMALY_CURIOUS_FINDING', 6), ('ANOMALY_CURIOUS_FINDING', 6)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4645901	8/2014	S45-PMC4645901	['the results DEMONSTRATED an ALARMINGLY high proportion (71%) of babies with Vitamin D deficiency (table 1).']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 28)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4684854	12/2015	S101-PMC4684854	['Gestational Vitamin D status also APPEARS to INFLUENCE outcomes beyond the Pregnancy and Delivery.']	[('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007567', 'parturition', 89, 'delivery')]
PMC4690051	12/2015	S15-PMC4690051	['biologically, higher Melanin Pigment in Dermis of Individuals with african ancestry CONTRIBUTES to lower production of 25(Oh)D, YET higher bioavailable 1,25(Oh)2-D circulates due to lower levels of Vitamin D Binding Protein (Vdbp) [10].']	[('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 128)]	2	[('CHEBI_25179', 'melanins', 21, 'melanin'), ('CHEBI_26130', 'biological pigment', 29, 'pigment'), ('UBERON_0002067', 'dermis', 40, 'dermis'), ('NCBITaxon_1', 'root', 50, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('CHEBI_34890', '2-nitrofuran', 157, 'OH)2-D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 198, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 225, 'VDBP')]
PMC4690051	12/2015	S135-PMC4690051	['Animal data SUGGEST the Genetic Expression of Fox2 , a regulator of Speech and Language, was lower in those on the Vitamin D deficiency diet at 14.5 days BUT Expression was higher at 17.5 days, compared to those on a Vitamin D sufficient diet [39].']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 154)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('SO_0000704', 'gene', 24, 'genetic'), ('GO_0010467', 'gene expression', 32, 'expression'), ('PR_000017653', 'zinc finger protein ZFPM2', 46, 'Fox2'), ('GO_0008380', 'RNA splicing', 68, 'speech'), ('GO_0006266', 'DNA ligation', 79, 'language'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0010467', 'gene expression', 158, 'expression'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC4728620	1/2016	S137-PMC4728620	['furthermore, a trial that provided a teaspoonful of cod Liver oil (free of Vitamin A and D) from 9 to 12 month of age FOUND an increase in voluntary attention in a free play test after the intervention, ESPECIALLY in boys, compared with un-supplemented children [73].']	[('INCOMPLETE_EVIDENCE', 118), ('ANOMALY_CURIOUS_FINDING', 203)]	2	[('UBERON_0002107', 'liver', 56, 'liver'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 83, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 89, 'D')]
PMC4764019	1/2016	S9-PMC4764019	['i defer until the end of this review consideration of the actual, numerical range of Vitamin D status values that APPEARS to permit avoidance of the barker EFFECT if it is present.']	[('ANOMALY_CURIOUS_FINDING', 114), ('SUPERFICIAL_RELATIONSHIP', 156)]	2	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4770602	1/2016	S67-PMC4770602	['[21] in other study,400 women at 20-24 week Gestation randomized to Vitamin D and Calcium supplements or no treatment, results of this study SHOWS that in the treated group reduction occurred in the incidence of Preeclampsia compared with the untreated group THOUGH this was not statistically significant.']	[('INCOMPLETE_EVIDENCE', 141), ('ANOMALY_CURIOUS_FINDING', 259)]	2	[('GO_0007565', 'female pregnancy', 44, 'gestation'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 82, 'calcium'), ('GO_0007128', 'meiotic prophase I', 212, 'preeclampsia')]
PMC4778858	3/2016	S112-PMC4778858	['INTERESTINGLY, Insulin sensitivity was significantly ASSOCIATED with maternal Serum Vitamin D level in univariate analysis.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('PR_000045358', 'insulin family protein', 15, 'insulin'), ('UBERON_0001977', 'blood serum', 78, 'serum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4843009	4/2016	S50-PMC4843009	['HOWEVER, Vitamin D deficient diet decreased the values of all three parameters in Plasma of kl/kl Mice to values SIMILAR as those in wild-type Mice.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 113)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 82, 'plasma'), ('NCBITaxon_10088', 'Mus <genus>', 98, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 143, 'mice')]
PMC4859539	5/2016	S69-PMC4859539	['DESPITE DIFFERENCES in Vitamin D status, there were no significant associations between Cathelicidin, race/ethnicity and Vitamin D status (see table 2 ).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 88, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4859539	5/2016	S103-PMC4859539	['OF NOTE, most of the children in THIS STUDY were not Vitamin D deficient and the Vitamin D ranges were relatively narrow.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 33)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4877864	6/2015	S75-PMC4877864	['low intake of Vitamin D and Calcium were OBSERVED in participated autistic children COMPARED to rdas for their ages and more obvious in older age group (6-9 years) [17].']	[('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 84)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_31341', 'calcium dihydroxide', 28, 'Calcium')]
PMC4877864	6/2015	S80-PMC4877864	['(2009) [21] compared the dietary Intake of children with autistic-spectrum disorders to that of children with typical development, they NOTED that large proportions of children did not meet the national RECOMMENDATIONS for daily intake of Vitamin D and Calcium.']	[('ANOMALY_CURIOUS_FINDING', 136), ('FUTURE_WORK', 203)]	2	[('GO_0007631', 'feeding behavior', 33, 'intake'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 253, 'calcium')]
PMC4889866	5/2016	S73-PMC4889866	['an EVEN higher percentage of Vitamin D deficiency was FOUND in the neonatal Cord Blood, with 279 (75.8%) having levels less than 20\u2009ng/ml, and 55 (15%) between 20 and 30\u2009ng/ml.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 76, 'cord'), ('UBERON_0000178', 'blood', 81, 'blood')]
PMC4910255	6/2016	S272-PMC4910255	['other outcomes\ncomparison of follow-ups did NOT confirm the impression of transiently lower systolic Blood pressure at 2.5\xa0years in the nepal janakpur trial, or of improved Lung function in children SEEN in a similar trial of Vitamin A supplementation from nepal sarlahi [66].']	[('ANOMALY_CURIOUS_FINDING', 44), ('INCOMPLETE_EVIDENCE', 199)]	2	[('UBERON_0000178', 'blood', 101, 'blood'), ('UBERON_0002048', 'lung', 173, 'lung'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A')]
PMC4923982	5/2016	S74-PMC4923982	['ALTHOUGH those in the highest quintiles for both Heme and non-heme iron Intake had higher average Glycemic loads, and Consumed more of each dietary factor on average than those in the lower quintiles, those in the highest quintile of Heme iron consumed more Saturated Fat, Cholesterol, and red/processed meat on average compared to those in the highest quintile of non-Heme iron, WHEREAS those in the highest quintile of non-Heme iron Intake consumed more polyunsaturated fat, dietary fiber, Vitamin C, and calcium on average than those in the lower quintiles.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 380)]	2	[('CHEBI_30413', 'heme', 49, 'heme'), ('GO_0007631', 'feeding behavior', 72, 'intake'), ('GO_0006096', 'glycolytic process', 98, 'glycemic'), ('GO_0007631', 'feeding behavior', 118, 'consumed'), ('CHEBI_30413', 'heme', 234, 'heme'), ('CHEBI_26710', 'sodium chloride', 258, 'saturated fat'), ('CHEBI_16113', 'cholesterol', 273, 'cholesterol'), ('CHEBI_30413', 'heme', 369, 'heme'), ('CHEBI_30413', 'heme', 425, 'heme'), ('GO_0007631', 'feeding behavior', 435, 'intake'), ('CHEBI_27300', 'vitamin D', 492, 'vitamin C')]
PMC4930210	7/2016	S119-PMC4930210	['Plasma 3-Epi-25(Oh)D3Was significantly ASSOCIATED with reported Vitamin D intake from supplements BUT not diet (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 98)]	2	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_73839', 'D-Leu-D-Leu', 7, '3-epi-25(OH)D3was'), ('PR_000008528', 'hairy/enhancer-of-split related with YRPW motif protein 1', 13, '25(OH ... D3was'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4934634	11/2015	S9-PMC4934634	['in the u.s. today, a DISPROPORTIONATE percentage of children with rickets are african american, who are characterized by low rates of Vitamin D synthesis, and exclusively Breast-Fed infants, who are characterized by low Vitamin D intakes.']	[('ANOMALY_CURIOUS_FINDING', 21), ('ANOMALY_CURIOUS_FINDING', 21)]	2	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007567', 'parturition', 171, 'breast'), ('UBERON_0000310', 'breast', 171, 'breast'), ('GO_0007631', 'feeding behavior', 178, 'fed'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4934634	11/2015	S14-PMC4934634	['ILLUSTRATIVE of the above, are the markedly DIFFERENT circulating Vitamin D concentration cut-offs for the risk of Vitamin D deficiency, insufficiency, and sufficiency levels that have been identified by the u.s. institute of medicine (iom) and the u.s. Endocrine society (table 1).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 254, 'Endocrine')]
PMC4934634	11/2015	S123-PMC4934634	['with regard to Pregnancy outcome, there were no cases of polyhydramnios (the accumulation of excess Amniotic Fluid) in the Vitamin D group compared to 17.4% in the placebo group, and a marked reduction of hyperbilirubinemia in infants from the Vitamin D supplemented group (27.3%) COMPARED TO the placebo group (60.9%) was REPORTED ( p = 0.02) [47].']	[('ANOMALY_CURIOUS_FINDING', 281), ('INCOMPLETE_EVIDENCE', 323)]	2	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('UBERON_0000173', 'amniotic fluid', 100, 'amniotic fluid'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]
PMC4934634	11/2015	S168-PMC4934634	['infants of mothers receiving Vitamin D supplementation were more LIKELY to reach Vitamin D sufficiency at Birth compare to infants of non-supplemented mothers (46.2% vs. 14%, respectively), HOWEVER, over half of the infants in the Supplement group still had suboptimal Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 65), ('ANOMALY_CURIOUS_FINDING', 190)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth'), ('CHEBI_16158', 'steroid sulfate', 231, 'supplement'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4934634	11/2015	S183-PMC4934634	['higher maternal Vitamin D intake during Pregnancy was FOUND TO BE inversely ASSOCIATED with asthma [68], allergic rhinitis [68], wheezing [69], and eczema in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy')]
PMC4934634	11/2015	S213-PMC4934634	['the data concerning Vitamin D treatment on the clinical severity of atopic dermatitis has BEEN more CONSISTENT.']	[('ANOMALY_CURIOUS_FINDING', 90), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC4969253	8/2016	S6-PMC4969253	['the developing Lung is PARTICULARLY sensitive to changes in the levels of ra; Vitamin A deficiency IS KNOWN to result in Lung hypoplasia and, when most severe, Lung Agenesis, the inability to form primordial Lung Buds [1].']	[('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 99)]	2	[('UBERON_0002048', 'lung', 15, 'lung'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin A'), ('UBERON_0002048', 'lung', 121, 'lung'), ('GO_0060425', 'lung morphogenesis', 160, 'lung agenesis'), ('UBERON_0002048', 'lung', 160, 'lung'), ('UBERON_0000118', 'lung bud', 208, 'lung buds')]
PMC4969253	8/2016	S53-PMC4969253	['INTERESTINGLY, a study in a well-nourished population of japanese children SHOWED mean Serum Vitamin A concentration significantly lower in those asthmatic than in non-asthmatic control subjects [18].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 75)]	2	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin A')]
PMC4969253	8/2016	S82-PMC4969253	['REMARKABLY, IF returned to normal Vitamin A diet later in Gestation and throughout their Postnatal Life, Adult Mice show a markedly thick Airway Sm layer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007567', 'parturition', 89, 'postnatal'), ('UBERON_0000104', 'life cycle', 99, 'life'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 111, 'mice'), ('UBERON_0001005', 'respiratory airway', 138, 'airway'), ('UBERON_0001290', 'proximal straight tubule', 145, 'SM')]
PMC4971719	8/2016	S80-PMC4971719	['ALTHOUGH 1, 25-Dihydroxyvitamin D (not 25-Oh-D) is the biologically active form of Vitamin D, circulating levels of 1, 25-dihydroxyvitamin d are not a good representation of Tissue levels, and Tissue levels are not easily measured.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_67469', '15-hydroxyajubractin C', 9, '1, 25-Dihydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000479', 'tissue', 174, 'tissue'), ('UBERON_0000479', 'tissue', 193, 'tissue')]
PMC4971719	8/2016	S94-PMC4971719	['OF NOTE, the endocrine society has SUGGESTED a Vitamin D target for Pregnant women of ≥30\xa0ng/ml [43].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnant')]
PMC4971719	8/2016	S136-PMC4971719	['HOWEVER, “low Vitamin D” at enrollment was significantly ASSOCIATED with higher bdi score at 34–36 weeks Gestation ( p \u2009=\u20090.05).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
PMC4973215	8/2016	S65-PMC4973215	['INTERESTINGLY HOWEVER, white race with Vitamin D deficiency was not significantly associated with increased odds of sga.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4976416	7/2016	S44-PMC4976416	['[30] the antioxidant supplementation through Vitamins E and C and the Mineral zinc HAS BEEN seen to APPARENTLY enhance the antioxidant protection against oxidative stress and allow less time for wound Healing.']	[('INCOMPLETE_EVIDENCE', 83), ('ANOMALY_CURIOUS_FINDING', 100)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamins E'), ('PR_000004900', 'complement C3', 60, 'C'), ('CHEBI_46662', 'mineral', 70, 'mineral'), ('GO_0007605', 'sensory perception of sound', 201, 'healing')]
PMC4976416	7/2016	S74-PMC4976416	['[5455]\ntopical Vitamin E HAS also BEEN FOUND to be effective in Granuloma annulare.']	[('INCOMPLETE_EVIDENCE', 25), ('ANOMALY_CURIOUS_FINDING', 39)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin E'), ('CL_0000592', 'large luteal cell', 64, 'granuloma')]
PMC4979151	8/2016	S6-PMC4979151	['HOWEVER, Pha stimulation significantly induced the Expression of Genes encoding th1 and th2 cytokines and down-regulated a number of Genes INVOLVED in T-Cell Development, Proliferation and Differentiation Of B Cells, signal transduction pathway, transcriptional Regulation and pattern recognition receptors (prrs) in the Vitamin D group (vitd group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_34926', 'Pitrazepin', 9, 'PHA'), ('GO_0010467', 'gene expression', 51, 'expression'), ('SO_0000704', 'gene', 65, 'genes'), ('SO_0000704', 'gene', 133, 'genes'), ('CL_0000084', 'T cell', 151, 'T-cell'), ('GO_0002296', 'T-helper 1 cell lineage commitment', 151, 'T-cell development'), ('GO_0007565', 'female pregnancy', 171, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 189, 'differentiation of B cells'), ('CL_0000236', 'B cell', 208, 'B cells'), ('GO_0065007', 'biological regulation', 262, 'regulation'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D')]
PMC4990268	8/2016	S293-PMC4990268	['YET the Ocular manifestations of Vitamin A deficiency during Pregnancy are RARE except for night blindness which typically occurs late in Pregnancy and is indicative of depleted Liver reserves.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 75)]	2	[('UBERON_0000970', 'eye', 8, 'ocular'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy'), ('UBERON_0002107', 'liver', 178, 'liver')]
PMC4990268	8/2016	S332-PMC4990268	['newborn Vitamin A advance distribution\nas mentioned in the section on Antenatal Vitamin A supplementation, almost 20 million women are Vitamin A deficient, with PARTICULARLY high prevalence in south and southeast asia[101].']	[('ANOMALY_CURIOUS_FINDING', 161), ('IMPORTANT_CONSIDERATION', 161)]	2	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 8, 'Vitamin A'), ('GO_0007567', 'parturition', 70, 'antenatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A')]
PMC4992225	8/2016	S40-PMC4992225	['it SEEMS that in addition to Calcium Homeostasis and bone health, Vitamin D is also ESSENTIAL for Brain Development and function [20,21].']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 84)]	2	[('GO_0055073', 'cadmium ion homeostasis', 29, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007420', 'brain development', 98, 'brain development'), ('UBERON_0000955', 'brain', 98, 'brain')]
PMC4992225	8/2016	S195-PMC4992225	['NONETHELESS, ONLY 9.7\xa0% in the Vitamin D group achieved Serum concentrations higher than 30\xa0ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 13)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001977', 'blood serum', 56, 'serum')]
PMC4997567	8/2016	S78-PMC4997567	['maternally, repeated Pregnancies more than 3 gravida (70%), shortened Pregnancy free intervals to less than 2 years (56%), lack OF adequate sunlight exposure to less than half an hour (80%), and inadequate maternal Gestational supplementation of Calcium and Vitamin D (62%) were contributing RISK FACTORS.']	[('ANOMALY_CURIOUS_FINDING', 128), ('SUPERFICIAL_RELATIONSHIP', 292)]	2	[('GO_0007565', 'female pregnancy', 21, 'pregnancies'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'gestational'), ('CHEBI_22313', 'alkaline earth metal atom', 246, 'calcium'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC5014971	8/2016	S5-PMC5014971	['half (52.5%) would RECOMMEND Vitamin D supplementation during Pregnancy to some patients, BUT ONLY 16.8% to all.']	[('FUTURE_WORK', 19), ('ANOMALY_CURIOUS_FINDING', 90)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC5014971	8/2016	S96-PMC5014971	['the respondents SEEMED GENERALLY knowledgeable regarding conditions that increase the risk of Vitamin D insufficiency, such as malabsorption syndrome, Gastric bypass surgery, alcohol abuse, african american race, and obesity.']	[('ANOMALY_CURIOUS_FINDING', 16), ('PROBABLE_UNDERSTANDING', 23)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001844', 'cochlea', 151, 'gastric')]
PMC5014971	8/2016	S117-PMC5014971	['the CONFLICT between researchers and experts in Vitamin D Metabolism During Pregnancy APPEARS TO BE reflected in the clinical practice of obstetrician-gynecologists.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ANOMALY_CURIOUS_FINDING', 86)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0044694', 'pore-mediated entry of viral genome into host cell', 48, 'vitamin D metabolism during'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC5014971	8/2016	S130-PMC5014971	['conclusions\nus obstetricians APPEAR cognizant of the IMPORTANCE of maternal Vitamin D status during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 29), ('IMPORTANT_CONSIDERATION', 53)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy')]
PMC5062906	10/2016	S297-PMC5062906	['when Vitamin D-dependent methylation profiles are compared between cell types, the Soma was SEEMINGLY more susceptible to perturbation with more loci AFFECTED and to a greater extent compared with Germ Cells (Sperm, fig.']	[('ANOMALY_CURIOUS_FINDING', 92), ('SUPERFICIAL_RELATIONSHIP', 150)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0044297', 'cell body', 83, 'soma'), ('CL_0000586', 'germ cell', 197, 'germ cells'), ('CL_0000019', 'sperm', 209, 'sperm')]
PMC5084016	10/2016	S137-PMC5084016	['Breastmilk, IN FACT, contains amounts of Vitamin D (<80 iu/l) that are insufficient for deficit PREVENTION in the first year of Life [63].']	[('ANOMALY_CURIOUS_FINDING', 12), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breastmilk'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 128, 'life')]
PMC5118763	12/2016	S161-PMC5118763	['DESPITE supplementation, Plasma Vitamin B-12 decreased from early to late Gestation for all 3 Micronutrient types in OUR STUDY.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	2	[('UBERON_0001969', 'blood plasma', 25, 'plasma'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 32, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 94, 'micronutrient')]
PMC5129897	10/2016	S112-PMC5129897	['a prospective study in korea FOUND that incidence of depressive symptoms was increased for those Individuals with 25(Oh)D concentrations <50\xa0nmol/l compared with those with >50\xa0nmol/l if they had Serum Total Cholesterol levels of < 240\xa0mg/dl (odds ratio [or] = 1.60 [95% ci, 1.23–2.08]) but NOT for those with Serum Total Cholesterol >240\xa0ng/dl (or = 0.97 [95% ci, 0.52–1.81]) after adjustment for confounding variables.75a study in italy conducted a clinical trial with Vitamin D for outpatients of mean age 74 ± 6\xa0years with mdd being treated with antidepressant therapy.76at the start of the 4-week trial, mean hamilton depression rating scale scores were 21.1 for the treated cases and 21.5 for the comparison subjects.']	[('INCOMPLETE_EVIDENCE', 29), ('ANOMALY_CURIOUS_FINDING', 291)]	2	[('NCBITaxon_1', 'root', 97, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 114, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 114, '25(OH)D'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_15891', 'taurine', 202, 'total'), ('CHEBI_16113', 'cholesterol', 208, 'cholesterol'), ('UBERON_0001977', 'blood serum', 310, 'serum'), ('CHEBI_66254', 'topopyrone C', 316, 'total cholesterol'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D')]
PMC5146866	12/2016	S69-PMC5146866	['risk for detection of Vitamin D insufficiency in cb of infants Born to black or hispanic mothers was COMPARABLE to those in white neonates BUT higher in babies Born to asian mothers.']	[('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 139)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'born'), ('GO_0007567', 'parturition', 160, 'born')]
PMC5146866	12/2016	S95-PMC5146866	['in the PRESENT STUDY, evaluation of the neonatal clinical data did NOT reveal any obvious association between cb Vitamin D levels and neonatal health status during the short period of Birth hospitalization.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('ANOMALY_CURIOUS_FINDING', 67)]	2	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 184, 'birth')]
PMC5146866	12/2016	S104-PMC5146866	['moreover, a review of the literature REVEALED that data obtained from questionnaires regarding the assessment of sunlight exposure do NOT precisely estimate Vitamin D status [37].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 134)]	2	[('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC5155676	12/2016	S69-PMC5155676	['of the women who were not Vitamin D replete at baseline (n = 509), 78.8% in the Cholecalciferol group were replete at 34 weeks of Gestation, COMPARED WITH ONLY 28.3% of the placebo group ( p< .001).']	[('ANOMALY_CURIOUS_FINDING', 141), ('ANOMALY_CURIOUS_FINDING', 155)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 80, 'cholecalciferol'), ('GO_0007565', 'female pregnancy', 130, 'gestation')]
PMC5351212	3/2017	S235-PMC5351212	['finally, in the context of this study, an EVEN more IMPORTANT finding was that maternal treatment with the active Vitamin D hormone 1,25Ohd was capable of preventing this altered social behavior in juvenile mia offspring.']	[('ANOMALY_CURIOUS_FINDING', 42), ('IMPORTANT_CONSIDERATION', 52)]	2	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 134, '25OHD')]
PMC5368580	4/2017	S106-PMC5368580	['however, the CONTRIBUTION of the Circadian variation to the total variance was <10% for all Vitamins, but increased CONSIDERABLY with maternal supplementation for riboflavin (36%) and Vitamin B-6 (23%) ( table 2 , supplemental table 2 ).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ANOMALY_CURIOUS_FINDING', 116)]	2	[('GO_0051216', 'cartilage development', 33, 'circadian'), ('CHEBI_33277', 'gamma-tocotrienol', 92, 'vitamins'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 184, 'vitamin B-6')]
PMC5368580	4/2017	S136-PMC5368580	['EVEN THOUGH the increase in all 4 Vitamins was significant and substantial from both doses, ONLY 0.05–0.35% of Thiamin, 0.54–0.6% of riboflavin, 1.0–1.14% of Vitamin B-6, and 4.85–6.17% of Vitamin A in the supplements were Secreted into the Breast Milk and subsequently available to the infant ( table 3 ).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 92)]	2	[('CHEBI_33277', 'gamma-tocotrienol', 34, 'vitamins'), ('CHEBI_26948', 'vitamin B1', 111, 'thiamin'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin B'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin A'), ('GO_0046903', 'secretion', 223, 'secreted'), ('UBERON_0000310', 'breast', 241, 'breast'), ('UBERON_0001913', 'milk', 248, 'milk')]
PMC5368580	4/2017	S152-PMC5368580	['lower concentrations were FOUND for niacin and Vitamin E, BUT ONLY on day 4.']	[('INCOMPLETE_EVIDENCE', 26), ('ANOMALY_CURIOUS_FINDING', 58)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin E')]
PMC5405075	4/2017	S17-PMC5405075	['ALTHOUGH 25(Oh)D circulating levels do not substantially differentiate or MAY BE reduced compared to non-Pregnant women, Serum concentrations of Vitamin D active Metabolite, 1,25(Oh)2D, are significantly elevated from early Pregnancy (13,14).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 74)]	2	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 162, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 176, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy')]
PMC5405075	4/2017	S78-PMC5405075	['OF NOTE, DESPITE the intervention significantly increased circulating Vitamin D levels in women, 1-year Postpartum no difference was preserved (76).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'postpartum')]
PMC5418719	5/2017	S70-PMC5418719	['HOWEVER, neonates Born during the Vitamin D Synthesis period, from april to october (20 neonates, 69%), had higher 25(Oh)D concentrations in Cord Blood samples than those not Born during the Vitamin D Synthesis period (7 neonates, 35%; p \u2009=\u20090.023; table\xa01).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('GO_0007567', 'parturition', 18, 'born'), ('CHEBI_28384', 'vitamin K', 34, 'Vitamin D'), ('GO_0042358', 'thiamine diphosphate catabolic process', 34, 'Vitamin D synthesis'), ('CHEBI_71657', 'versiconol acetate', 115, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 121, 'D'), ('UBERON_0002240', 'spinal cord', 141, 'cord'), ('UBERON_0000178', 'blood', 146, 'blood'), ('GO_0007567', 'parturition', 175, 'born'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 191, 'vitamin D synthesis')]
PMC5418719	5/2017	S131-PMC5418719	['INTERESTINGLY, preterm morbidities INFLUENCING Vitamin D status had no significant differences between the groups in our patients.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5445675	6/2017	S131-PMC5445675	['the general Food basket caloric content was reduced in 2004, BUT certain Micronutrients via mff increased, PARTICULARLY Vitamin A, Thiamin, riboflavin, Vitamin C, iron, and calcium (supplemental table 1).']	[('ANOMALY_CURIOUS_FINDING', 61), ('ANOMALY_CURIOUS_FINDING', 107)]	2	[('CHEBI_33290', 'food', 12, 'food'), ('CHEBI_33839', 'macromolecule', 73, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 131, 'thiamin'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin C')]
PMC5489519	6/2017	S5-PMC5489519	['western blot analysis of total cell lysate obtained from normal Human Mammary Epithelial (Hme-1) Cells treated with variable doses (0–20\u2009nm) of Vitamin D for 24\u2009h DEMONSTRATED that low levels (0.5 to 5\u2009nm) significantly increased the Trail Α BUT no change in β Expression.']	[('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 242)]	2	[('NCBITaxon_9606', 'Homo sapiens', 64, 'human'), ('UBERON_0006954', 'mammary gland myoepithelium', 70, 'mammary epithelial'), ('CL_0002295', 'type-6 epithelial cell of thymus', 78, 'epithelial         cells'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 234, 'TRAIL α'), ('GO_0010467', 'gene expression', 261, 'expression')]
PMC5489519	6/2017	S44-PMC5489519	['INTERESTINGLY, Milk from Vitamin D deficient mothers showed elevated levels of Trail proteins (Α and β) COMPARED TO Milk from mothers with sufficient Vitamin D levels.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 104)]	2	[('UBERON_0001913', 'milk', 15, 'milk'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 79, 'TRAIL'), ('PR_000006000', 'carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2', 95, 'α'), ('UBERON_0001913', 'milk', 116, 'milk'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC5513133	7/2017	S125-PMC5513133	['HOWEVER, there was no association in women with Vitamin D insufficiency who did not also have high pth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5513133	7/2017	S229-PMC5513133	['in a cochrane review of Vitamin D supplementation for women during Pregnancy, women who received Vitamin D and Calcium supplementation had a lower RISK of pre-eclampsia than those not receiving any intervention (rr 0.51; 95% ci 0.32 to 0.80; three trials, 1114 women, moderate quality), YET an increased risk for Preterm Birth (rr\xa0=\xa01.57; 95% ci: 1.02–2.43; three studies, 798 women, moderate quality).']	[('IMPORTANT_CONSIDERATION', 147), ('ANOMALY_CURIOUS_FINDING', 287)]	2	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('GO_0007565', 'female pregnancy', 313, 'preterm birth')]
PMC5523023	7/2017	S97-PMC5523023	['Prenatal supplementation of Vitamin C and E improved Pulmonary functions of newborns of smoking mothers (59), BUT in a large placebo-controlled study, this EFFECT was not confirmed (60).']	[('ANOMALY_CURIOUS_FINDING', 110), ('SUPERFICIAL_RELATIONSHIP', 156)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'E'), ('UBERON_0002048', 'lung', 53, 'pulmonary')]
PMC5537904	7/2017	S12-PMC5537904	['APPROXIMATELY 33% of Pregnant women in the united states have Vitamin D deficiency, defined as 25-Hydroxyvitamin D (25Ohd) < 50 nmol/l, EVEN THOUGH 73% report using Vitamin D-containing Prenatal supplements [2].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 136)]	2	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 95, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 116, '25OHD'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'prenatal')]
PMC5576167	8/2017	S88-PMC5576167	['the prevalence of Vitamin D deficiency and insufficiency (50.0 and 43.8%, respectively) HAS BEEN reported among Pregnant saudi women with adequate Vitamin D Intake (≥600\xa0iu/day) among ONLY 8.1% of Pregnant women [14,31,32].']	[('INCOMPLETE_EVIDENCE', 88), ('ANOMALY_CURIOUS_FINDING', 184)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007631', 'feeding behavior', 157, 'intake'), ('GO_0007565', 'female pregnancy', 197, 'pregnant')]
PMC5634602	10/2017	S23-PMC5634602	['the endocrine society also RECOMMENDS a target level of >75 nmol/l and espghan an EVEN higher target of >80 nmol/l.10.1371/journal.pone.0185950.t001\n\ncaption (table-wrap): table 1\nrecommendations for Vitamin D supplementation.recommending bodypatient agerecommended supplementationrecommended target Serum levelcommentsyear of publication american academy of pediatrics—section of breastfeeding and committee on nutrition healthy infants Birth– 12 months of age400 iu daily>50 nmol/l (targeting bone health)*begin soon after Birth, in the first few days of Life.']	[('FUTURE_WORK', 27), ('ANOMALY_CURIOUS_FINDING', 82)]	2	[('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001977', 'blood serum', 300, 'Serum'), ('GO_0007567', 'parturition', 438, 'birth'), ('GO_0007567', 'parturition', 525, 'birth'), ('UBERON_0000104', 'life cycle', 557, 'life')]
PMC5638722	8/2017	S107-PMC5638722	['SEVERE preeclampsia is FOUND TO BE 5.4 fold more in the 15- to 20-week Pregnant who have Vitamin D levels <20 ng/ml19).']	[('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 23)]	2	[('GO_0007565', 'female pregnancy', 71, 'pregnant'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5659607	10/2017	S13-PMC5659607	['conclusions\nthis combined analysis SHOWS that Vitamin D supplementation during Pregnancy results in a significant reduced risk of asthma/recurrent wheeze in the offspring, ESPECIALLY among women with 25(Oh)D level ≥ 30 ng/ml at randomization, where the risk was almost halved.']	[('INCOMPLETE_EVIDENCE', 35), ('ANOMALY_CURIOUS_FINDING', 172)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 200, '25(OH)D')]
PMC5664622	9/2017	S5-PMC5664622	['HOWEVER, ONLY 16% of the Pregnant women reached the optimal Vitamin D concentration during summer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9)]	2	[('GO_0007565', 'female pregnancy', 25, 'pregnant'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC5664622	9/2017	S84-PMC5664622	['higher maternal Vitamin D concentration during summer resulted in lower rates of mothers with Vitamin D deficiency as compared to the winter group (34% vs. 66%), BUT the scale of Vitamin D insufficiency REMAINS significant.']	[('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 203)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5664622	9/2017	S112-PMC5664622	['elevated levels of Vitamin D in mothers with gdm REMAIN a SURPRISE.']	[('INCOMPLETE_EVIDENCE', 49), ('ANOMALY_CURIOUS_FINDING', 58)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5682869	11/2017	S26-PMC5682869	['Vitamin B6, zinc, multi-Nutrient supplements and Vitamin D supplementation are NOT ADVOCATED as routine procedure.']	[('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 83)]	2	[('CHEBI_27306', 'vitamin B6', 0, 'Vitamin B6'), ('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B6'), ('CHEBI_33284', 'nutrient', 24, 'nutrient'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC5685050	10/2014	S48-PMC5685050	['in summary, DESPITE a location near the equator where sunlight is available year round, thai People are at risk for Vitamin D insufficiency DUE TO environmental, cultural, lifestyle and dietary factors.']	[('ANOMALY_CURIOUS_FINDING', 12), ('PROBLEM_COMPLICATION', 140)]	2	[('NCBITaxon_10088', 'Mus <genus>', 93, 'people'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5732505	12/2017	S1-PMC5732505	['in finland, maternal Vitamin D status has improved CONSIDERABLY DUE TO national health policies.']	[('ANOMALY_CURIOUS_FINDING', 51), ('PROBABLE_UNDERSTANDING', 64)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5784894	1/2018	S116-PMC5784894	['thus at greater age, the EFFECTS of antenatal Vitamin D depletion on response to loading were evident in Cortical bone ONLY, with bone volume fraction increasing approximately twice as much in the replete dams’ offspring.10.1371/journal.pone.0190675.g004\n\ncaption (fig): fig 4\n\nthe effect of diet and mechanical loading on Cortical (a) bone fraction, (b) bone volume and (c) and Marrow area at 18 weeks age.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 119)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001851', 'cortex', 105, 'cortical'), ('UBERON_0001851', 'cortex', 323, 'cortical'), ('UBERON_0002371', 'bone marrow', 379, 'marrow')]
PMC5838372	3/2018	S98-PMC5838372	['it should BE NOTED that all of these studies were conducted prior to the introduction of the national Pregnancy Vitamin D supplementation programme.']	[('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13)]	2	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 120, 'D')]
PMC5838372	3/2018	S114-PMC5838372	['HOWEVER, the infants of mothers in the sufficient group had significantly higher Vitamin D level than OTHER infants.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5941617	5/2018	S91-PMC5941617	['in italy children are UNABLE TO synthesize Vitamin D in the skin during late fall, winter months and early spring, EVEN if sufficiently exposed to sunlight [50].']	[('DIFFICULT_TASK', 22), ('ANOMALY_CURIOUS_FINDING', 115)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5941617	5/2018	S234-PMC5941617	['besides Vitamin D, Calcium is also IMPORTANT to treat nutritional rickets, EVEN in absence of hypocalcemia.']	[('IMPORTANT_CONSIDERATION', 35), ('ANOMALY_CURIOUS_FINDING', 75)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 19, 'calcium')]
PMC5941617	5/2018	S254-PMC5941617	['INTERESTINGLY, higher Vitamin D status from infancy through to 3\xa0years of age was ASSOCIATED with leaner body composition [205].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC5941617	5/2018	S280-PMC5941617	['another smaller rct on 50 newborns FAILED TO demonstrate an EFFECT of Vitamin D supplementation during Pregnancy (2000\xa0iu/day from 26 to 28\xa0weeks until Childbirth) on infant bone mass measured at 23\u2009±\u200910\xa0days by dxa [234].']	[('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0007623', 'circadian rhythm', 152, 'childbirth')]
PMC5941617	5/2018	S491-PMC5941617	['REPORTED no correlation between Insulin sensitivity and Vitamin D levels, EVEN after weight loss [442].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 74)]	2	[('PR_000045358', 'insulin family protein', 32, 'insulin'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5952272	5/2018	S99-PMC5952272	['children aged 6 to 59 months\nas a result of the low quality of Food the mothers of the same household were taking, there was an accumulating deficiency of Vitamin E. it is more LIKELY that children of vitamin-deficient women due to nutritional reasons are also well deficient in the same Vitamins, ALTHOUGH the severity is higher.']	[('PROBABLE_UNDERSTANDING', 177), ('ANOMALY_CURIOUS_FINDING', 298)]	2	[('CHEBI_33290', 'food', 63, 'food'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('CHEBI_33277', 'gamma-tocotrienol', 288, 'vitamins')]
PMC5956785	5/2018	S106-PMC5956785	['(1994) 37°n [47]jra n \u2009=\u200944 (28)11.8\u2009±\u20093.866.6\u2009±\u200926.7lower bone Mineral content and bone BIOMARKERS in jra patients that controls BUT higher Vitamin D in jra.n\u2009=\u200937 controls 25(Oh)D 53.2\u2009±\u200918.7\xa0nmol/l.milano, italy bianchi et al.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('ANOMALY_CURIOUS_FINDING', 130)]	2	[('CHEBI_46662', 'mineral', 64, 'mineral'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 174, '25(OH ... D')]
PMC5956785	5/2018	S282-PMC5956785	['the RELATIONSHIP between Vitamin D status and jia over time in newly diagnosed Individuals has YET to be investigated.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 95)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('NCBITaxon_1', 'root', 79, 'individuals')]
PMC6011374	6/2018	S79-PMC6011374	['ALTHOUGH, the point estimates INDICATED a marginal increased risk for developing any Pregnancy complication with severe (<\u200925\xa0nmol/l) Vitamin D deficiency compared to those who had levels between 50 and 75\xa0nmol/l (arr: 1.10; 95% ci: 0.89, 1.36).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30)]	2	[('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC6039335	7/2018	S282-PMC6039335	['WHILE Vitamin A restriction improves marbling, but Vitamin D restriction did not significantly AFFECT marbling in angus crossbred steers [133].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 95)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC1448690	4/2006	S86-PMC1448690	['the magnitude of the Th Cell Responses To Allergens decreased with Birth order and high maternal Vitamin E intake, BUT increased with a family history of atopy or maternal smoking.']	[('ANOMALY_CURIOUS_FINDING', 115)]	1	[('CL_0000545', 'T-helper 1 cell', 21, 'Th cell'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 21, 'Th cell responses to allergens'), ('CHEBI_33663', 'cyclic hydrocarbon', 42, 'allergens'), ('GO_0007567', 'parturition', 67, 'birth'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin E')]
PMC2290997	4/2008	S121-PMC2290997	['gilchrest says some sunlight enters the skin EVEN through a high-spf sunscreen, so People can maximize their dermal Vitamin D production by spending additional time outdoors while wearing protection.']	[('ANOMALY_CURIOUS_FINDING', 45)]	1	[('NCBITaxon_10088', 'Mus <genus>', 83, 'people'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2582131	11/2008	S16-PMC2582131	['NOTABLY, this condition is reversible upon repletion of Vitamin D[9]–[12].']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC2779500	11/2009	S194-PMC2779500	['in (b), a periodic cycle APPEARS when α = 4.0 × 1013molecules/( μ l day), corresponding to 116 mg of daily Vitamin C supplementation.']	[('ANOMALY_CURIOUS_FINDING', 25)]	1	[('CHEBI_27300', 'vitamin D', 107, 'vitamin C'), ('PR_000004900', 'complement C3', 115, 'C')]
PMC2798111	12/2010	S106-PMC2798111	['in addition, DESPITE the normal growth of the infants during this six-month period, on a per kilogram basis, the 400\u2009iu/day dose was adequate in helping the infant maintain adequate Vitamin D status during the six-month study period.']	[('ANOMALY_CURIOUS_FINDING', 13)]	1	[('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC2821652	2/2010	S25-PMC2821652	['the main determinants of Calcium Homeostasis during Pregnancy are Parathyroid hormone, calcitonin, and the active form of Vitamin D—1,25(Oh)2D (whose synthesis is preferentially maintained EVEN during times of Vitamin D deficiency by upregulation of enzymes for improved utilization of whatever 25(Oh)D is available).']	[('ANOMALY_CURIOUS_FINDING', 189)]	1	[('GO_0055073', 'cadmium ion homeostasis', 25, 'calcium homeostasis'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('UBERON_0001132', 'parathyroid gland', 66, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 134, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 295, '25(OH)D')]
PMC2963768	10/2010	S74-PMC2963768	['ALTHOUGH there were no significant associations between maternal dietary intake and infant/toddlers’ 25(Oh)D (data not shown) or Vitamin D deficiency (table 3), a higher proportion of the mothers of infants with 25(Oh)D ≥25 nmol/l consumed Milk, meat, and eggs on at least one occasion during the week preceding the interview (fig.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 101, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 212, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 212, '25(OH)D'), ('UBERON_0001913', 'milk', 240, 'milk')]
PMC2963768	10/2010	S96-PMC2963768	['so, it is WORTHWHILE NOTING that, among formula-Fed or Vitamin D-supplemented infants (mean Vitamin D intake of ∼370 iu per day) aged 1-6 months (n=37) enrolled in a hospital-based study during the winter in alberta, canada (53°n) (20), the mean 25(Oh)D was 78 nmol/l (roth d et al .']	[('ANOMALY_CURIOUS_FINDING', 10)]	1	[('GO_0007631', 'feeding behavior', 48, 'fed'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 246, '25(OH)D')]
PMC3032617	5/2010	S19-PMC3032617	['Citrus Fruits and juices are PARTICULARLY rich sources of Vitamin C. brussels sprouts are also rich sources [7].']	[('ANOMALY_CURIOUS_FINDING', 29)]	1	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Citrus'), ('UBERON_0001091', 'calcareous tooth', 7, 'fruits'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin C')]
PMC3034879	12/2010	S144-PMC3034879	['children in high Vitamin D group Learnt to walk with support later than children in low Vitamin D group, ALTHOUGH other developmental milestones were similar.']	[('ANOMALY_CURIOUS_FINDING', 105)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007612', 'learning', 33, 'learnt'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3034879	12/2010	S159-PMC3034879	['ALTHOUGH all infants received Vitamin D supplementation, the difference between the groups in Tibia csa was maintained until 14\xa0months of age.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000979', 'tibia', 94, 'tibia')]
PMC3034879	12/2010	S169-PMC3034879	['improved Postnatal Vitamin D status results in catch-up in bmc, BUT NOT in csa.']	[('ANOMALY_CURIOUS_FINDING', 64)]	1	[('GO_0007567', 'parturition', 9, 'postnatal'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC3103150	3/2011	S13-PMC3103150	['during the first 6-8 wk of Life, the Vitamin D status of infants is determined by the Vitamin D levels at Birth, which depend ON the Vitamin D status of the mother1.']	[('ANOMALY_CURIOUS_FINDING', 126)]	1	[('UBERON_0000104', 'life cycle', 27, 'life'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3257641	3/2010	S77-PMC3257641	['Bone Formation\nin Animal models (mainly rodents), Vitamin D–deficient and –insufficient Animals APPEAR to have normal Skeletal Mineral content [54].']	[('ANOMALY_CURIOUS_FINDING', 96)]	1	[('GO_0009297', 'pilus assembly', 0, 'Bone formation'), ('NCBITaxon_33208', 'Metazoa', 18, 'animal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 88, 'animals'), ('UBERON_0004288', 'skeleton', 118, 'skeletal'), ('CHEBI_46662', 'mineral', 127, 'mineral')]
PMC3271033	1/2012	S10-PMC3271033	['ALTHOUGH the dose of 400 iu daily is used for both Breast-Fed and formula-Fed babies, Vitamin D-deficient rickets is extremely rare in formula-Fed infants primarily due to the mandatory addition of Vitamin D to infant formulas in the united states.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0007567', 'parturition', 51, 'breast-'), ('UBERON_0000310', 'breast', 51, 'breast'), ('GO_0007631', 'feeding behavior', 58, 'fed'), ('GO_0007631', 'feeding behavior', 74, 'fed'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007631', 'feeding behavior', 143, 'fed'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC3296991	2/2012	S76-PMC3296991	['season, maternal age, race, pre-Gestational bmi, Vitamin D intake, and Vitamin D status and infant age at the time of the scan, Gestational age at Birth, Feeding pattern (Breast Fed, Formula Fed, or mixed) and Vitamin D status did NOT remain in the final predictive models.']	[('ANOMALY_CURIOUS_FINDING', 231)]	1	[('GO_0007565', 'female pregnancy', 32, 'gestational'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'gestational'), ('GO_0007567', 'parturition', 147, 'birth'), ('GO_0007631', 'feeding behavior', 154, 'feeding'), ('GO_0007567', 'parturition', 171, 'breast fed'), ('UBERON_0000310', 'breast', 171, 'breast'), ('GO_0009407', 'toxin catabolic process', 183, 'formula fed'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC3347007	4/2012	S3-PMC3347007	['67.6% of the women reported use of Vitamin D supplements BUT ONLY 36.9% reported use of Vitamin D supplements of at least 10 µg.']	[('ANOMALY_CURIOUS_FINDING', 57)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3347007	4/2012	S133-PMC3347007	['in the dnbc, 67.6% of the participants reported use of Vitamin D supplements, BUT ONLY 36.9% used supplements with a Vitamin D dose of 10 µg or more per day.']	[('ANOMALY_CURIOUS_FINDING', 78)]	1	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3347007	4/2012	S186-PMC3347007	['conclusions\n55.6% of the dncb participants report insufficient total Vitamin D intake, EVEN THOUGH 67.6% report use of Vitamin D supplements.']	[('ANOMALY_CURIOUS_FINDING', 87)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3347028	3/2012	S50-PMC3347028	['in Individuals with Vitamin D deficiency, ONLY trace amounts of Vitamin D will be found in the body because whatever comes into the circulation is quickly converted to 25(Oh)D and then to 1,25(Oh)2D to maintain Calcium Homeostasis.']	[('ANOMALY_CURIOUS_FINDING', 42)]	1	[('NCBITaxon_1', 'root', 3, 'individuals'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D'), ('CHEBI_17996', 'chloride', 189, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 190, '25(OH)2D'), ('GO_0055073', 'cadmium ion homeostasis', 211, 'calcium homeostasis')]
PMC3347028	3/2012	S54-PMC3347028	['it APPEARS that the Extrarenal function of Vitamin D has more to do with Immune function than with Calcium Metabolism and Homeostasis.']	[('ANOMALY_CURIOUS_FINDING', 3)]	1	[('UBERON_0001691', 'external ear', 20, 'extrarenal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0002405', 'immune system', 73, 'immune'), ('GO_0018884', 'carbazole metabolic process', 99, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 122, 'homeostasis')]
PMC3347028	3/2012	S86-PMC3347028	['it is INTERESTING that during Pregnancy alone and at no other time during the Lifecycle there is an uncoupling of Vitamin D Metabolism from calcium such that by the end of the first trimester, 1,25(Oh)2D levels are more than double what they are during the nonpregnant state without concurrent changes in Serum calcium concentrations [6].']	[('ANOMALY_CURIOUS_FINDING', 6)]	1	[('GO_0007565', 'female pregnancy', 30, 'pregnancy'), ('UBERON_0000104', 'life cycle', 78, 'lifecycle'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 114, 'vitamin D metabolism'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 195, '25(OH)2D'), ('UBERON_0001977', 'blood serum', 305, 'serum')]
PMC3356951	4/2012	S133-PMC3356951	['[97] a finnish study that followed children from Birth NOTED that those given Vitamin D supplements during infancy had a nearly 90% lower risk of developing type 1 diabetes compared with children who did not receive Supplements.']	[('ANOMALY_CURIOUS_FINDING', 55)]	1	[('GO_0007567', 'parturition', 49, 'birth'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 216, 'supplements')]
PMC3424155	8/2012	S13-PMC3424155	["the prevalence of Vitamin D insufficiency is high EVEN in sunny climates, such as brazil's, principally in adolescents[4]."]	[('ANOMALY_CURIOUS_FINDING', 50)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3424155	8/2012	S201-PMC3424155	['in the present study, Vitamin D restriction during Nephrogenesis reduced Podocin Expression in the f1 generation from weaning until six months of age BUT NOT in the f2 generation.']	[('ANOMALY_CURIOUS_FINDING', 150)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0001822', 'kidney development', 51, 'nephrogenesis'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 73, 'podocin'), ('GO_0010467', 'gene expression', 81, 'expression')]
PMC3427250	8/2012	S7-PMC3427250	['of all women, 74.1% (95%ci\u200a=\u200a71.8–76.5%) were Vitamin D insufficient (25-(Oh)D <30 ng/ml), 44.6% (95%ci\u200a=\u200a41.9–47.3%) were Vitamin D deficient (25-(oh)d <20 ng/ml), WHILE 12.1% (95%ci\u200a=\u200a10.3–13.8%) were severely Vitamin D deficient (25-(Oh)D <10 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 165)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_30254', 'sulfidocarbon(.1+)', 70, '25-(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 77, 'D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_72657', '19,20-DiHDPA', 233, '25-(OH)D')]
PMC3427250	8/2012	S8-PMC3427250	['of all women included, 62.0% reported taking Vitamin D-containing multivitamins, of which ONLY 24.2% started taking those before Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 90)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC3427250	8/2012	S91-PMC3427250	['INTERESTINGLY, risk of severe Vitamin D deficiency decreased with more frequent use of sunscreen Lotion and increased for women who reported preference for shadow (table 5).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_75903', 'arsenic(1-) sulfides', 97, 'lotion')]
PMC3427250	8/2012	S93-PMC3427250	['discussion\nDESPITE the fact that more than 60% of the Pregnant women reported taking multivitamins containing Vitamin D during Pregnancy, nearly 45% of the women were vitamin d deficient (25-(Oh)D <20 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 11)]	1	[('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_72657', '19,20-DiHDPA', 188, '25-(OH)D')]
PMC3427250	8/2012	S107-PMC3427250	['INTERESTINGLY the risk for severe Vitamin D deficiency was lower among women who reported Alcohol consumption during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_30879', 'alcohol', 90, 'alcohol'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC3427250	8/2012	S131-PMC3427250	['in conclusion, DESPITE that more than 60% of the Pregnant women reported taking multivitamins containing Vitamin D, Vitamin D deficiency is highly prevalent among Pregnant women in belgium and up to 12% of Pregnant women are severely Vitamin D deficient.']	[('ANOMALY_CURIOUS_FINDING', 15)]	1	[('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnant'), ('GO_0007565', 'female pregnancy', 206, 'pregnant'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D')]
PMC3472720	8/2012	S24-PMC3472720	['in this series of experiments, ONLY the Pregnant f0female Mice and their Growing Fetuses were Vitamin D deficient.']	[('ANOMALY_CURIOUS_FINDING', 31)]	1	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 58, 'mice'), ('GO_0040007', 'growth', 73, 'growing'), ('UBERON_0000309', 'body wall', 81, 'fetuses'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3513049	2/2012	S6-PMC3513049	['because of NOTABLE differences in Vitamin D concentrations between african americans and whites, analyses were stratified by race.']	[('ANOMALY_CURIOUS_FINDING', 11)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC3515553	12/2012	S148-PMC3515553	['these infants NOT ONLY showed very low Vitamin B-12 concentrations in Plasma BUT ALSO ineffective Haematopoiesis and degeneration Of Nervous Tissue[37].']	[('ANOMALY_CURIOUS_FINDING', 14)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 39, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 70, 'plasma'), ('GO_0030097', 'hemopoiesis', 98, 'haematopoiesis'), ('GO_0007608', 'sensory perception of smell', 130, 'of nervous tissue'), ('UBERON_0003714', 'neural tissue', 133, 'nervous tissue')]
PMC3552819	12/2012	S15-PMC3552819	['moreover, there is a near complete absence of Pharmacological data in south asia, where the Vitamin D status of Pregnant women [7] and young infants [8] is poor IN SPITE of the tropical climate.']	[('ANOMALY_CURIOUS_FINDING', 161)]	1	[('CHEBI_52217', 'pharmaceutical', 46, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC3668200	5/2013	S11-PMC3668200	['in exclusively breastfed infants, 25(Oh)D Serum levels were low during the winter DESPITE supplementation3), whereas Serum levels of 1,25-Oh2-D and Vitamin D-Binding Protein were higher in the winter than in the summer4).']	[('ANOMALY_CURIOUS_FINDING', 82)]	1	[('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 34, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 40, 'D'), ('UBERON_0001977', 'blood serum', 42, 'serum'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_17996', 'chloride', 134, ','), ('CHEBI_34309', '21-Fluoroprogesterone', 135, '25-OH2'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 142, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 148, 'vitamin D-binding protein')]
PMC3668200	5/2013	S30-PMC3668200	['ALTHOUGH nursing mothers were supplemented with 1,000 to 2,000 iu of Vitamin D daily, the supplementation had little effect on the Vitamin D concentration status of breastfed infants14).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3685533	6/2013	S92-PMC3685533	['at three days of Life, Vitamin D values were higher in itan ONLY when compared with nan (p\u2009<\u20090.03).']	[('ANOMALY_CURIOUS_FINDING', 60)]	1	[('UBERON_0000104', 'life cycle', 17, 'life'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC3713405	7/2013	S60-PMC3713405	['IMPORTANTLY, calcium levels in Vitamin D deficient dams and dvd-deficient pups are not altered by this protocol (eyles et al., 2006;o’loan et al., 2007).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3798907	8/2013	S5-PMC3798907	['supplementation with Vitamin C had no effect on Cbmc Proliferation, BUT increased Ifn-Γ and Il-4 production, and decreased Il-10 production.']	[('ANOMALY_CURIOUS_FINDING', 68)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin C'), ('CL_0002062', 'type I pneumocyte', 48, 'CBMC'), ('GO_0008283', 'cell proliferation', 53, 'proliferation'), ('PR_000008920', 'interferon alpha-7', 82, 'IFN-γ'), ('GO_0015114', 'phosphate ion transmembrane transporter activity', 85, '- ... - ...'), ('PR_000001470', 'interleukin-28B', 92, 'IL-4'), ('PR_000001470', 'interleukin-28B', 123, 'IL-10')]
PMC3798907	8/2013	S72-PMC3798907	['vitamin c supplementation of cbmc\nfor comparison with the effects of Vitamin E, 51 cbmc cultures responding to the set of T-Cell stimuli were supplemented with Vitamin c. there was no general effect of Vitamin C on Proliferation, ALTHOUGH it did significantly reduce the proliferative response to con a (30 of 48 cultures demonstrating a decrease) (figure 3andtable 1).']	[('ANOMALY_CURIOUS_FINDING', 230)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('CL_0000084', 'T cell', 122, 'T-cell'), ('CHEBI_33229', 'vitamin (role)', 160, 'vitamin'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin C'), ('GO_0008283', 'cell proliferation', 215, 'proliferation')]
PMC3798907	8/2013	S74-PMC3798907	['HOWEVER, Vitamin C did reduce Il-10 responses, significantly in the case of ppd (23 of 48 cultures) and hdm (29 of 46) stimulation.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('PR_000001470', 'interleukin-28B', 30, 'IL-10')]
PMC3991049	11/2013	S66-PMC3991049	['at Delivery Vitamin D deficiency and insufficiency occurred in 45.6% and 46.8% of african-american neonates, respectively, COMPARED to 9.7% and 56.4% of caucasian neonates.']	[('ANOMALY_CURIOUS_FINDING', 123)]	1	[('GO_0007567', 'parturition', 3, 'delivery'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4034700	5/2014	S131-PMC4034700	['in the experimental model of reduced Uterine perfusion pressure (rupp) of Placental ischemia-induced hypertension, treatment with Vitamins C and e did not decrease Blood pressure, WHILE the sod mimetic Tempol attenuated rupp hypertension.']	[('ANOMALY_CURIOUS_FINDING', 180)]	1	[('UBERON_0000995', 'uterus', 37, 'uterine'), ('UBERON_0001987', 'placenta', 74, 'placental'), ('CHEBI_27300', 'vitamin D', 130, 'vitamins C'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_9449', 'terbutaline', 202, 'Tempol')]
PMC4048511	5/2014	S20-PMC4048511	['a number of countries in sub-saharan africa, as well as india and afghanistan, had an ALARMINGLY high level of hidden hunger, with stunting, iron deficiency anemia, and Vitamin A deficiency all being highly prevalent.']	[('ANOMALY_CURIOUS_FINDING', 86)]	1	[('CHEBI_27300', 'vitamin D', 169, 'vitamin A')]
PMC4106226	7/2014	S44-PMC4106226	['among diabetic cases, 55% were Vitamin D deficient, WHILE 45% had normal Vitamin D level (p\u2009<\u20090.01), leading to a significant difference as regards of homa-ir and diabetes duration (p\u2009<\u20090.01).']	[('ANOMALY_CURIOUS_FINDING', 52)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4113768	7/2014	S142-PMC4113768	['DESPITE the fact that Vitamin D deficiency increases Musculoskeletal pain (heidari, b., et al.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 53, 'musculoskeletal')]
PMC4113768	7/2014	S1132-PMC4113768	['overall, 98% of the subjects supplemented with 400,000 iu of Vitamin D had their level of 25(Oh)D above 20 ng/ml at week 8, WHILE 84% and 52% of patients receiving 200,000 iu or 100,000 iu reached that level after 12 weeks of treatment.']	[('ANOMALY_CURIOUS_FINDING', 124)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 90, '25(OH)D')]
PMC4113768	7/2014	S1328-PMC4113768	['the Vitamin D in the 1000 iu dose that was not converted to 25(Oh)D may BE stored or converted to other Metabolites, or Excreted.']	[('ANOMALY_CURIOUS_FINDING', 72)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('CHEBI_25212', 'metabolite', 104, 'metabolites'), ('GO_0007588', 'excretion', 120, 'excreted')]
PMC4113768	7/2014	S1347-PMC4113768	['cancer patients APPEAR to have an improved quality of Life after Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 16)]	1	[('UBERON_0000104', 'life cycle', 54, 'life'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S1359-PMC4113768	['after administration, the variation of 25(Oh)D concentration was 6.0 (95% confidence interval [ci]: 3.4–8.6) in Vitamin D group and −0.4 (95% ci: −3.7–2.9) in Placebo, showing a significantly increase in Vitamin D group ( p = 0.0029), BUT after follow-up (visit 3), no significant difference was found between the groups with variations of 2.9 (95% ci: −0.3–6.0) in Vitamin D group and 0.7 (95% ci: −3.8–5.2) in placebo ( p = 0.4040).']	[('ANOMALY_CURIOUS_FINDING', 235)]	1	[('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 45, 'D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 159, 'placebo'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D')]
PMC4113768	7/2014	S1651-PMC4113768	['conclusions: addition of intermittent bolus-dose Vitamin D supplementation to a daily low-dose regimen improved Vitamin D status in older Adults and their carers, BUT it did not influence risk of ari, and was less effective at preventing uri.']	[('ANOMALY_CURIOUS_FINDING', 163)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0007023', 'adult organism', 138, 'adults')]
PMC4113768	7/2014	S2045-PMC4113768	['results: prevalence for Vitamin D status (25Ohd nmol/l < 30, 30–50, > 50–125, > 125) was NOTED for the following groups: preterm at 3 weeks (14%, 65%, 21%, 0%); preterm at 15 weeks on 400 iu/day (3%, 11%, 86%, 8%); Pregnant women at term (21%, 34%, 45%, 0%) with Cord Blood at term (59%, 28%, 13%, 0%); children ranging from 1–18 years (22%, 33%, 45%, 0%); osteoporosis on 400–800 iu/day (1%, 8%, 91%, 2%); and cystic fibrosis on 400–1600 iu/d (23%, 28%, 49%, 3%); healthy Adults in winter (21%, 46%, 33%, 0%); and multiple sclerosis in winter (40%, 32%, 28%, 1%).']	[('ANOMALY_CURIOUS_FINDING', 89)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 42, '25OHD'), ('GO_0007565', 'female pregnancy', 215, 'pregnant'), ('UBERON_0002240', 'spinal cord', 263, 'cord'), ('UBERON_0000178', 'blood', 268, 'blood'), ('UBERON_0007023', 'adult organism', 473, 'adults')]
PMC4113768	7/2014	S2807-PMC4113768	['ALTHOUGH Humans obtain most of their Vitamin D via the action of ultraviolet (uv)-b radiation on 7-Dehydrocholesterol in the skin (willett, w. nutritional epidemiology , 3rd ed.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('NCBITaxon_9606', 'Homo sapiens', 9, 'humans'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 97, '7-dehydrocholesterol')]
PMC4113768	7/2014	S3201-PMC4113768	['conclusion: there is an ALARMING high prevalence of Vitamin D deficiency in 85 year-olds living in north east england at all times of the year but particularly during winter and spring.']	[('ANOMALY_CURIOUS_FINDING', 24)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4113768	7/2014	S3239-PMC4113768	['HOWEVER, cases had significantly higher prevalence of Vitamin D deficiency (defined as 25ohd3< 25 nmol/l).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4169453	9/2014	S114-PMC4169453	['the participants who exited the study had similar baseline characteristics as those in the analyzed population with the EXCEPTION of a 2-fold higher rate of additional formula-Feeding (table 2).10.1371/journal.pone.0107708.g002\n\ncaption (fig): figure 2\nmaternal (a) and infants’ (b) Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 120)]	1	[('GO_0007631', 'feeding behavior', 176, 'feeding'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC4169453	9/2014	S201-PMC4169453	['EVEN higher doses of Vitamin D (4000–6400 iu/d) were tested in breastfeeding women as the combined maternal and Breastfed infant supplementation[8]–[10],[31],[42].']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'breastfed')]
PMC4169453	9/2014	S232-PMC4169453	['additionally, the dose of maternal Vitamin D supplementation had no impact on their infants’ measured dxa variables DESPITE the fact that infants received Vitamin D at a dose of 400 iu/d.']	[('ANOMALY_CURIOUS_FINDING', 116)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4231606	10/2013	S82-PMC4231606	['there were NO APPARENT differences in the Intake of Foods containing Vitamin D between the s-ecc and caries-free groups, including the frequency of milk consumption (data not shown).']	[('ANOMALY_CURIOUS_FINDING', 11)]	1	[('GO_0007631', 'feeding behavior', 42, 'intake'), ('CHEBI_33290', 'food', 52, 'foods'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4231606	10/2013	S83-PMC4231606	['HOWEVER, significantly more children receiving Vitamin D drops belonged to the caries-free group (14.0%\xa0s-ecc (n\u2009=\u20096) vs. 86.0% Caries-free (n\u2009=\u200937), p\u2009<\u20090.001).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_23042', 'carotene', 128, 'caries')]
PMC4263713	12/2014	S8-PMC4263713	['HOWEVER, no significant differences in Lymphocyte levels were found between the Rats in the other two Vitamin A supplement groups and the Vitamin A-deficient group.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CL_0000542', 'lymphocyte', 39, 'lymphocyte'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 80, 'rats'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC4289064	1/2015	S4-PMC4289064	['increases in risk were most PRONOUNCED for Vitamin A in populations with moderate levels of total Nutrient intake.']	[('ANOMALY_CURIOUS_FINDING', 28)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('CHEBI_33284', 'nutrient', 98, 'nutrient')]
PMC4302607	1/2015	S159-PMC4302607	['as a public health nurse NOTED:\nthe sites offer Vitamin D, they have milk coupons and they have Food coupons now, like for frozen vegetables and orange Juice, and so that for sure is a draw [to attend].']	[('ANOMALY_CURIOUS_FINDING', 25)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_33290', 'food', 96, 'food'), ('CHEBI_37958', 'dye', 152, 'juice')]
PMC4329404	10/2014	S10-PMC4329404	['IMPORTANTLY, supplementation with Vitamin D improves both of these pathological abnormalities.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4329404	10/2014	S89-PMC4329404	['HOWEVER, both the total cell count and percentage of cd3+Cd4+T1St2+Th2 cells were significantly increased in pups exposed to in utero and early-life Vitamin D insufficiency (figs3c and s2).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('PR_000001204', 'C-C chemokine receptor type 8', 57, 'CD4'), ('PR_000016585', 'tripeptidyl-peptidase 1', 61, 'T1ST2'), ('CL_0002061', 'T-helper 9 cell', 67, 'Th2'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4329404	10/2014	S119-PMC4329404	['Vitamin D supplementation reduces Airway collagen in hdm-exposed pups\nGoblet Cell hyperplasia was evident in hdm-exposed pups; HOWEVER, Vitamin D status did not alter this (fig.5a).']	[('ANOMALY_CURIOUS_FINDING', 127)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001005', 'respiratory airway', 34, 'airway'), ('CL_0000160', 'goblet cell', 70, 'Goblet cell'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4329404	10/2014	S171-PMC4329404	['HOWEVER, numbers of Cd4+Il-10+cells were not significantly higher in the supplemented Mice compared to those that remained Vitamin D deficient.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('PR_000001204', 'C-C chemokine receptor type 8', 20, 'CD4'), ('PR_000001470', 'interleukin-28B', 24, 'IL-10'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'mice'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4329745	10/2014	S21-PMC4329745	['those who consumed multivitamin supplements containing less than 100 units Vitamin D per daily servings were NOT excluded.']	[('ANOMALY_CURIOUS_FINDING', 109)]	1	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4380518	9/2014	S5-PMC4380518	['pnv use among black women was not associated with Vitamin D deficiency (adjusted or 1.0, 95%ci 0.4, 2.3) BUT was among white women (3.5, 95%ci 2.1, 5.8)(interaction p<0.01).']	[('ANOMALY_CURIOUS_FINDING', 105)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4405493	4/2015	S165-PMC4405493	['HOWEVER, there was no significant difference in the distribution of these patients among the various Vitamin D categories, with 10/70 (14.3%) women who were Vitamin D sufficient, 29/141 (20.5%) Vitamin D insufficient, and 3/24 (12.5%) Vitamin D deficient (p = 0.22) (table 2).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC4417995	4/2015	S95-PMC4417995	['[43] NOTED no decreased risk of ad in children whose mothers had higher intakes of Vitamin D.\ngale et al.']	[('ANOMALY_CURIOUS_FINDING', 5)]	1	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4417995	4/2015	S147-PMC4417995	['the treated group improved significantly at 60 days and had significantly higher Serum Vitamin D values than baseline, regardless OF the initial severity of ad.']	[('ANOMALY_CURIOUS_FINDING', 130)]	1	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4427001	4/2015	S4-PMC4427001	['Vitamin D was not significantly decreased in gdm compared to controls during Pregnancy; HOWEVER, both groups of Pregnant women exhibited high prevalence of Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 88)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007565', 'female pregnancy', 112, 'pregnant'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4427001	4/2015	S140-PMC4427001	['DESPITE the fact that 147 australian women with gdm were advised to take daily Prenatal multivitamins containing 400\u2009iu or 500\u2009iu Vitamin D, 41% of the participants had Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0007565', 'female pregnancy', 79, 'prenatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4448820	5/2015	S1332-PMC4448820	['as clinical symptoms disappear, crp concentrations fall sharply, BUT Nutrient concentrations (e.g., Iron, Vitamin A) do not respond as rapidly.']	[('ANOMALY_CURIOUS_FINDING', 65)]	1	[('CHEBI_33284', 'nutrient', 69, 'nutrient'), ('CHEBI_24870', 'ion', 100, 'iron'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin A')]
PMC4448820	5/2015	S1505-PMC4448820	['none of the Vitamin B-12 specific biomarkers, Serum Vitamin B-12, holotranscobalamin, and Mma, are correlated with crp or agp, EVEN in populations with a high prevalence of acute infection (787).']	[('ANOMALY_CURIOUS_FINDING', 127)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 12, 'vitamin B-12'), ('UBERON_0001977', 'blood serum', 46, 'serum'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 52, 'vitamin B-12'), ('CHEBI_34840', 'methyl methacrylate', 90, 'MMA')]
PMC4466139	6/2015	S104-PMC4466139	['in italy Foods are not supplemented with Vitamin D and the Consumption of foods with high content of Vitamin D is UNUSUAL.']	[('ANOMALY_CURIOUS_FINDING', 114)]	1	[('CHEBI_33290', 'food', 9, 'foods'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007631', 'feeding behavior', 59, 'consumption'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4488777	5/2015	S23-PMC4488777	['like females, male low (<50 nmol/l) and high (>125 nmol/l) Vitamin D Serum concentrations decrease NOT ONLY Spermatozoa count BUT ALSO their progressive movement as well as increasing morphology abnormalities.']	[('ANOMALY_CURIOUS_FINDING', 99)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001977', 'blood serum', 69, 'serum'), ('CL_0000019', 'sperm', 108, 'spermatozoa')]
PMC4514967	12/2014	S69-PMC4514967	['ra is generated from dietary Vitamin A through a number of steps, the final being conversion of Retinal to ra by Retinal dehydrogenase.53ALTHOUGH various cell types can perform this transformation, apcs, specifically those at Tissue sites like the Intestine and skin, are specialized in the provision of ra for Modulation Of Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 135)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin A'), ('UBERON_0000966', 'retina', 96, 'retinal'), ('UBERON_0000966', 'retina', 113, 'retinal'), ('UBERON_0000479', 'tissue', 226, 'tissue'), ('UBERON_0000160', 'intestine', 248, 'intestine'), ('GO_0006880', 'intracellular sequestering of iron ion', 311, 'modulation of immune responses'), ('UBERON_0002405', 'immune system', 325, 'immune')]
PMC4595656	10/2015	S111-PMC4595656	['it is NOTEWORTHY that exogenous Vitamin D supplementation of an initially deprived medium failed to elicit any cellular response.']	[('ANOMALY_CURIOUS_FINDING', 6)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4632418	10/2015	S72-PMC4632418	['prevalence of Vitamin D deficiency varied CONSIDERABLY from 3.1% to 94.70%, and 25(Oh)D level of gdm ranged from 16.50 to 97.00 nmol/l with a median of 49.30 nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 42)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D')]
PMC4632423	10/2015	S94-PMC4632423	['on average, ONLY 2%–5% of the obese women met the rnis for Iron and Folic Acid, and less than 20% for Vitamins D, e, k and Thiamine.']	[('ANOMALY_CURIOUS_FINDING', 12)]	1	[('CHEBI_24870', 'ion', 59, 'iron'), ('CHEBI_30751', 'formic acid', 68, 'folic acid'), ('CHEBI_27300', 'vitamin D', 102, 'vitamins D'), ('CHEBI_26948', 'vitamin B1', 123, 'thiamine')]
PMC4684854	12/2015	S104-PMC4684854	['intervention to normalize levels of Vitamin D APPEARS TO BE successful in restoring mental health [72].']	[('ANOMALY_CURIOUS_FINDING', 46)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC4689556	12/2015	S5-PMC4689556	['supplementation increased maternal and Cord Blood 25(Oh) Vitamin D concentrations, BUT levels remained lower than current recommendations.']	[('ANOMALY_CURIOUS_FINDING', 83)]	1	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('UBERON_0000178', 'blood', 44, 'blood'), ('CHEBI_30778', 'gallic acid', 50, '25(OH)'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4764019	1/2016	S44-PMC4764019	['briefly, at age 5 years, 13% of children Born of mothers in the lowest quartile of Vitamin D status [25(Oh)D <18 ng/ml] exhibited Learning disability, as contrasted with ONLY 4% of children Born of mothers in the highest 25(Oh)D quartile (>29 ng/ml), that is, a better than 3-fold increase in risk of the lowest quartile.']	[('ANOMALY_CURIOUS_FINDING', 170)]	1	[('GO_0007567', 'parturition', 41, 'born'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 101, '25 ... OH ... D'), ('GO_0007612', 'learning', 130, 'learning'), ('GO_0007567', 'parturition', 190, 'born'), ('CHEBI_71657', 'versiconol acetate', 221, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 221, '25(OH)D')]
PMC4772030	1/2016	S76-PMC4772030	['mff as an additional Food ration in the basic Food basket increased estimated daily intakes, in particular for Vitamin A, b-Vitamins (Thiamine, riboflavin and Nicotinamide), Ascorbic Acid, zinc and iron, while the supplementary oil ration for Pregnant women ESPECIALLY improved the intakes of Tocopherols (table 2).']	[('ANOMALY_CURIOUS_FINDING', 258)]	1	[('CHEBI_33290', 'food', 21, 'food'), ('CHEBI_33290', 'food', 46, 'food'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 124, 'vitamins'), ('CHEBI_26948', 'vitamin B1', 134, 'thiamine'), ('CHEBI_17154', 'nicotinamide', 159, 'nicotinamide'), ('CHEBI_22652', 'ascorbic acid', 174, 'ascorbic acid'), ('GO_0007565', 'female pregnancy', 243, 'pregnant'), ('CHEBI_27013', 'tocopherol', 293, 'tocopherols')]
PMC4843009	4/2016	S72-PMC4843009	['INTERESTINGLY, all those behavioral abnormalities were abrogated when kl/kl Mice were Fed a Vitamin D deficient diet.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('NCBITaxon_10088', 'Mus <genus>', 76, 'mice'), ('GO_0007631', 'feeding behavior', 86, 'fed'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4843009	4/2016	S133-PMC4843009	['the negative feedback is missing in kl/kl Mice and in those Mice the formation of 1,25(Oh)2D3Is a function of dietary Vitamin D EVEN at excessive 1,25(Oh)2D3Concentrations.']	[('ANOMALY_CURIOUS_FINDING', 128)]	1	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 60, 'mice'), ('CHEBI_87168', 'C45 carotenoid', 82, '1,25(OH)2D3is'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_73735', 'gadoterate', 148, '25(OH)2D3concentrations')]
PMC4859539	5/2016	S56-PMC4859539	['of the children in the cohort, 20.3% were FOUND TO BE Vitamin D deficient, as defined by a 25(Oh)D concentration <20 ng/ml.10.1371/journal.pone.0152711.t001\n\ncaption (table-wrap): table 1\nchild sociodemographics and clinical characteristics.characteristicvalue\xa0n = 133race/ethnicity [n (%)]\xa0\xa0\xa0\xa0\xa0black41 (30.8)\xa0\xa0\xa0\xa0white38 (28.6)\xa0\xa0\xa0\xa0hispanic54 (40.6)gender [n (%)]\xa0\xa0\xa0\xa0\xa0female62 (46.6)\xa0\xa0\xa0\xa0male71 (53.4)age1(years)4.7 ± 1.2 (2–7)bmi116.1 ± 2.5 (12.1–28.8)% fat125.5 ± 6.1 (14.6–42.9)no.']	[('ANOMALY_CURIOUS_FINDING', 42)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D')]
PMC4877864	6/2015	S54-PMC4877864	['it was NOTED that Vitamin D intakes in both groups were below the rdas for participants’ ages (group 1 = 46.8% and group 2 = 21.95%) and group2 showed highly significant p value < 0.01 compared to group 1 (p value < 0.05).']	[('ANOMALY_CURIOUS_FINDING', 7)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC4877864	6/2015	S55-PMC4877864	['furthermore, Vitamin C intakes were low ranged between borderline and inadequate intake in both groups with significant difference COMPARED to their rdas (88.64 % and 79.98 % for their ages, group 1 and group 2 respectively).']	[('ANOMALY_CURIOUS_FINDING', 131)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin C')]
PMC4903143	5/2016	S113-PMC4903143	['as discussed, most Pregnant women APPEAR TO BE deficient in Vitamin D.\nmedications in common usage (e.g., some Antibiotics, antacids, and hypertensive Drugs) diminish absorption of magnesium.']	[('ANOMALY_CURIOUS_FINDING', 34)]	1	[('GO_0007565', 'female pregnancy', 19, 'pregnant'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 111, 'antibiotics'), ('CHEBI_23888', 'drug', 151, 'drugs')]
PMC4910734	6/2015	S277-PMC4910734	['most contain Vitamins C and e, but NOT Sulfur-containing antioxidants.']	[('ANOMALY_CURIOUS_FINDING', 35)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamins C'), ('PR_000004900', 'complement C3', 22, 'C'), ('CHEBI_36933', 'oxygen-19 atom', 39, 'sulfur')]
PMC4923982	5/2016	S89-PMC4923982	['neither the associations between gdm and either Heme iron nor non-heme iron APPEARED TO differ according to smoking status or Consumption of dietary Calcium or Vitamin C (data not shown).']	[('ANOMALY_CURIOUS_FINDING', 76)]	1	[('CHEBI_30413', 'heme', 48, 'heme'), ('GO_0007631', 'feeding behavior', 126, 'consumption'), ('CHEBI_22313', 'alkaline earth metal atom', 149, 'calcium'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin C')]
PMC4934634	11/2015	S98-PMC4934634	['WHILE 25(Oh)D remains constant, the concentrations of total 1,25(Oh)2D and Vitamin D binding protein increase in the first to second Trimester and remain elevated until 3 months Postpartum [36].']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 62, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 133, 'trimester'), ('GO_0007565', 'female pregnancy', 178, 'postpartum')]
PMC4934634	11/2015	S122-PMC4934634	['improved Serum Insulin, Insulin resistance index (homa-ir), fasting Plasma Glucose, ldl and total Cholesterol were NOTED in the Vitamin D group compared to the placebo group.']	[('ANOMALY_CURIOUS_FINDING', 115)]	1	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('PR_000045358', 'insulin family protein', 15, 'insulin'), ('PR_000045358', 'insulin family protein', 24, 'insulin'), ('UBERON_0001969', 'blood plasma', 68, 'plasma'), ('CHEBI_17234', 'glucose', 75, 'glucose'), ('CHEBI_16113', 'cholesterol', 98, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4990268	8/2016	S324-PMC4990268	['increases in infant mortality for the Placebo and Β- Carotene groups were 63% and 50% respectively BUT ONLY 14% higher in the Vitamin A group.']	[('ANOMALY_CURIOUS_FINDING', 99)]	1	[('CHEBI_26130', 'biological pigment', 38, 'placebo'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 50, 'β- carotene'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin A')]
PMC4992225	8/2016	S11-PMC4992225	['HOWEVER, at Childbirth, the Vitamin D group had significantly higher 25-Hydroxyvitamin D concentration in comparison to the control group ( p\u2009<\u20090.001 ).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0007623', 'circadian rhythm', 12, 'childbirth'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxyvitamin D')]
PMC4992225	8/2016	S230-PMC4992225	['SURPRISINGLY, the change in Vitamin D concentration (baseline to Childbirth) was not correlated with changes in depression scores from baseline to 38–40 weeks of Gestation or to 4 and 8 weeks Postpartum.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 65, 'childbirth'), ('GO_0007565', 'female pregnancy', 162, 'gestation'), ('GO_0007565', 'female pregnancy', 192, 'postpartum')]
PMC4997567	8/2016	S10-PMC4997567	['introduction\negyptian young children have a high incidence of Vitamin D deficiency rickets, DESPITE the ample sunlight of egypt.']	[('ANOMALY_CURIOUS_FINDING', 92)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5017073	7/2016	S144-PMC5017073	['coffee Consumption decreases, WHILE Vitamin C increases absorption of Folate from Food.']	[('ANOMALY_CURIOUS_FINDING', 30)]	1	[('GO_0007631', 'feeding behavior', 7, 'consumption'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 70, 'folate'), ('CHEBI_33290', 'food', 82, 'food')]
PMC5051327	9/2016	S0-PMC5051327	['maternal Vitamin D deficiency and fetal distress/Birth asphyxia: a population-based nested case–control study\n\nabstract\n\nobjective\nVitamin D deficiency causes not ONLY Skeletal problems but also muscle weakness, including Heart muscle.']	[('ANOMALY_CURIOUS_FINDING', 163)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 49, 'birth'), ('CHEBI_28384', 'vitamin K', 131, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 168, 'skeletal'), ('UBERON_0000948', 'heart', 222, 'heart')]
PMC5064894	10/2016	S30-PMC5064894	['similarly, a decrease in parent-reported ari was NOTED in children in mongolia given Vitamin D-fortified Milk (300\xa0iu of Vitamin D3) [23], in a setting in which children had very low baseline Serum 25 (Oh) D levels.']	[('ANOMALY_CURIOUS_FINDING', 49)]	1	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001913', 'milk', 105, 'milk'), ('CHEBI_33279', 'vitamin D5', 121, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 121, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 192, 'serum'), ('CHEBI_71657', 'versiconol acetate', 198, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 198, '25 (OH) D')]
PMC5085625	9/2016	S93-PMC5085625	['it would be INTERESTING to measure Vitamin D levels throughout the whole Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 12)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy')]
PMC5155676	12/2016	S70-PMC5155676	['similarly, ONLY 48.4% of women who were Vitamin D replete at baseline and received placebo remained Vitamin D replete at 34 weeks of Gestation, compared with 89.8% in the Cholecalciferol group ( p< .001).']	[('ANOMALY_CURIOUS_FINDING', 11)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'gestation'), ('CHEBI_52550', 'theopalauamide', 171, 'cholecalciferol')]
PMC5155676	12/2016	S134-PMC5155676	['finally, during Pregnancy, a number OF physiological changes occur to Vitamin D Metabolism, including an increase in Vitamin D binding protein and 1,25-Dihydroxyvitamin d (15), indices that we were not able to include in our analysis.']	[('ANOMALY_CURIOUS_FINDING', 36)]	1	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 70, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_72671', '(2S,3S)-versiconal hemiacetal acetate', 147, '1,25-dihydroxyvitamin')]
PMC5322422	2/2017	S86-PMC5322422	["ALTHOUGH the Vitamin K deficiency was diagnosed and corrected early in the infant's hospitalization, the work-up of the anterior Mediastinal mass continued."]	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin K'), ('UBERON_0003728', 'mediastinum', 129, 'mediastinal')]
PMC5351212	3/2017	S29-PMC5351212	['low Vitamin D would also APPEAR TO BE prevalent in children diagnosed with autism [27].']	[('ANOMALY_CURIOUS_FINDING', 25)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC5368580	4/2017	S105-PMC5368580	['regardless OF the day, the Circadian variation in concentration was significant for all Vitamins ( p< 0.001), except for Vitamins A and e when adjusted for milk fat.']	[('ANOMALY_CURIOUS_FINDING', 11)]	1	[('GO_0051216', 'cartilage development', 27, 'circadian'), ('CHEBI_33277', 'gamma-tocotrienol', 88, 'vitamins'), ('CHEBI_27300', 'vitamin D', 121, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 121, 'vitamins A')]
PMC5405075	4/2017	S52-PMC5405075	['DESPITE that there was no difference preserved in the offspring’s 25(Oh)D level at the age of 18months, a statistically significant lower proportion of children, belonged to Vitamins D groups, were sensitized to Mite Antigens, as indicated by specific Ige measurements.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 66, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamins D'), ('CHEBI_46662', 'mineral', 212, 'mite'), ('NCBITaxon_10088', 'Mus <genus>', 212, 'mite'), ('CHEBI_59132', 'antigen', 217, 'antigens'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 252, 'IgE')]
PMC5414300	5/2017	S112-PMC5414300	['children aged 6–59\xa0months receive Vitamin A supplements during biannual national Vitamin A campaigns, ALTHOUGH coverage is unsatisfactory [11].']	[('ANOMALY_CURIOUS_FINDING', 102)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A')]
PMC5418719	5/2017	S90-PMC5418719	['among vlbw infants with 25(Oh)D concentrations\u2009<\u200910\xa0ng/ml at Birth, none had an excess level of 25(Oh)D >80\xa0ng/ml after 800\xa0iu Vitamin D supplementation, ALTHOUGH 35% of infants with Vitamin D deficiency from Birth were still Vitamin D insufficient at 36\xa0weeks pma.']	[('ANOMALY_CURIOUS_FINDING', 154)]	1	[('CHEBI_71657', 'versiconol acetate', 24, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 30, 'D'), ('GO_0007567', 'parturition', 61, 'birth'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0007567', 'parturition', 209, 'birth'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC5418719	5/2017	S109-PMC5418719	['[23] reported that daily supplementation of Vitamin D in doses of 800\xa0iu compared with 400\xa0iu APPEARS to reduce the prevalence of Vitamin D deficiency at 40\xa0weeks pma in preterm infants of 28 to 34\xa0weeks Gestation.']	[('ANOMALY_CURIOUS_FINDING', 94)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'gestation')]
PMC5418719	5/2017	S112-PMC5418719	['[9] established the 800\xa0iu/d dosage of Vitamin D met the 25(Oh)D\u2009>\u200930\xa0ng/ml in 81% of study infants at the age of 3\xa0months, WHILE the 400\xa0iu/d dosage of Vitamin D sustained those concentration in 55% of study infants.']	[('ANOMALY_CURIOUS_FINDING', 124)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC5513133	7/2017	S58-PMC5513133	['HOWEVER there was no association between Plasma Vitamin D deficiency and Interleukin-6 elevation [53].']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('UBERON_0001969', 'blood plasma', 41, 'plasma'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000001381', 'interleukin-2 receptor subunit beta', 73, 'interleukin-6')]
PMC5513133	7/2017	S130-PMC5513133	['brazil 2015 [83]↑ frequency of 25(Oh)D deficiency <20\xa0ng/ml in pe compared to healthy non obese controlspe: 52.1% (25 women)non obese controls: 14.9%(7 women)( p \xa0=\xa00.0006)abedi et al., iran, 2014 [84]↑ Vitamin D deficiency (<25.0\xa0nmol/l) in pe casesor\xa0=\xa024.0495% ci: 2.14–285.4achkar et al., canada, 2015 [81]↑ pe in women with 25(Oh)D\xa0<\xa030\xa0nmol/l vs women with at least 50\xa0nmol/ladjusted or: 2.2395% ci: 1.29–3.83anderson et al., usa, 2015 [111]↔ proportion of women with inadequate <30\xa0ng/ml 25(Oh)D levels in htn group vs control group73% (htn/pe group) vs 69% (control group)( p \xa0=\xa00.22)baker et al., 2010 [80]↑ severe pe in women with 25(Oh)D\xa0<\xa050\xa0nmol/l compared to levels of at least 75\xa0nmol/ladjusted or: 5.4195% ci: 2.02–14.52( p \xa0=\xa00.001)bodnar et al., usa, 2007 [18]↑ pe in women with 25(Oh)D\xa0<\xa037.5\xa0nmol/l compared to levels of >37.5\xa0nmol/ladjusted or: 5.095% ci: 1.7–14.1bodnar et al., usa, 2014 [79]↓ severe pe in women with 25(Oh)D\xa0≥\xa050\xa0nmol/l COMPARED to levels <50\xa0nmol/ladjusted rr: 0.6595% ci: 0.43–0.98gidlof s, et al.']	[('ANOMALY_CURIOUS_FINDING', 960)]	1	[('CHEBI_71657', 'versiconol acetate', 31, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 31, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 329, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 329, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 495, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 495, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 641, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 641, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 797, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 797, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 940, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 940, '25(OH)D')]
PMC5576167	8/2017	S68-PMC5576167	['Folic Acid was FOUND TO BE the most common dietary supplements used among Pregnant women (95.9%; n \xa0=\xa094) followed by iron, calcium and Vitamin D (88.8, 81.6 and 41%, respectively).']	[('ANOMALY_CURIOUS_FINDING', 15)]	1	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('GO_0007565', 'female pregnancy', 74, 'pregnant'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5638722	8/2017	S104-PMC5638722	['EVEN if the ratios of eos and los were greater in the group with Vitamin D levels <5 ng/ml, after performing logistic regression analysis for Gestational age and Birth weight, we determined that the Vitamin D level was not an independent risk factor.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 142, 'gestational'), ('GO_0007567', 'parturition', 162, 'birth'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D')]
PMC5659607	10/2017	S73-PMC5659607	['CORRESPONDINGLY, in copsac, 276 women (48%) had an initial level <30 ng/ml (139 received Vitamin D and 137 placebo) and 301 women (52%) had an initial level of 25(Oh)D ≥30 ng/ml (153 received Vitamin D and 148 placebo).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 160, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 160, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC5664622	9/2017	S122-PMC5664622	['ALTHOUGH the study was conducted in the capital city of poland, where mean net monthly income is the highest in the country, Vitamin D intake was low.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5679631	11/2017	S78-PMC5679631	['the analyses concerning Vitamin D supplementation of the Breast Fed infant included 616 Individuals after omitting infants receiving formula (n = 208), both Breast Milk and formula (n = 87) and lack OF information regarding Feeding (n = 2).']	[('ANOMALY_CURIOUS_FINDING', 199)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000310', 'breast', 57, 'breast'), ('GO_0007631', 'feeding behavior', 64, 'fed'), ('NCBITaxon_1', 'root', 88, 'individuals'), ('UBERON_0000310', 'breast', 157, 'breast'), ('UBERON_0001913', 'milk', 164, 'milk'), ('GO_0007631', 'feeding behavior', 224, 'feeding')]
PMC5706533	11/2017	S80-PMC5706533	['figures are number (percentage) unless stated otherwisecharacteristicall trialsregular dose trials*Bolus dose trials*trials4337†8†intervention arms55469participants enrolled:\u2003total840676871031\u2003median within individual trials (min-max)133 (16-1134)133 (16-1134)118 (50-235)meta-analyses to which each trial contributed:\u2003median maternal outcomes (min-max)2 (0-6)2 (0-6)2 (0-4)\u2003median newborn/infant outcomes (min-max)3 (0-17)3 (0-17)4 (0-7)\u2003trials that DID not contribute data to any meta-analyses2 (4.7)2 (5.4)0 (0.0)geographical region:\u2003europe7 (16.3)7 (18.9)2 (25.0)\u2003south east asia6 (14.0)2 (5.4)4 (50.0)\u2003americas5 (11.6)5 (13.5)0 (0.0)\u2003eastern mediterranean21 (48.8)19 (51.4)2 (25.0)\u2003western pacific4 (9.3)4 (10.8)0 (0.0)health status at enrolment:\u2003generally healthy37 (86.0)33 (89.2)6 (75.0)\u2003Gestational diabetes4 (9.3)2 (5.4)2 (25.0)\u2003hypocalcaemia1 (2.3)1 (2.7)\u2003multiple sclerosis1 (2.3)1 (2.7)0 (0.0)baseline Vitamin D status‡:\u2003mean 25(Oh)D <30 nmol/l10 (23.3)9 (24.3)2 (25.0)\u2003mean 25(Oh)D ≥30 nmol/l23 (53.5)20 (54.1)3 (37.5)\u2003not reported10 (23.3)8 (21.6)3 (37.5)type of Vitamin D§:\u2003d24 (7.3)3 (6.5)1 (11.1)\u2003d348 (87.3)40 (87.0)8 (88.9)\u2003not reported3 (5.5)3 (6.5)0 (0.0)supplementation frequency§:\u2003daily31 (56.4)31 (67.4)—\u2003weekly5 (9.1)5 (10.9)—\u2003every 2 weeks6 (10.9)6 (13.0)—\u2003monthly3 (5.5)3 (6.5)—\u2003 every 2 months1 (1.8)1 (2.2)—\u2003single dose3 (5.5)—3 (33.3)\u2003two doses4 (7.3)—4 (44.4)\u2003other2 (3.6)—2 (22.2)intervention dose§¶:\u2003median (min-max)2000 (200-7543)2000 (200-7543)—\u2003regular dose <2000 iu/day24 (52.2)24 (52.2)—\u2003regular dose ≥2000 iu/day22 (47.8)22 (47.8)—control intervention type:\u2003placebo29 (67.4)23 (62.2)8 (100.0)\u2003active14 (32.6)14 (37.8)0 (0.0)median Vitamin D dose in active control arms (min-max)400 (200-600)400 (200-600)—timing of initiation of supplementation§:\u20031st trimester19 (34.5)18 (39.1)1 (11.1)\u20032nd trimester30 (54.5)24 (52.2)6 (66.7)\u20033rd trimester5 (9.1)3 (6.5)2 (22.2)\u2003not reported1 (1.8)1 (2.2)0 (0.0)\n*regular dosing refers to regimens in which Supplement was administered at least three times at regular frequency throughout Pregnancy (daily, weekly, every 2 weeks, monthly, or every 2 months ); bolus dosing refers to interventions administered either once or twice during intervention period.']	[('ANOMALY_CURIOUS_FINDING', 451)]	1	[('NCBITaxon_10088', 'Mus <genus>', 99, 'Bolus'), ('GO_0007565', 'female pregnancy', 796, 'Gestational'), ('CHEBI_27300', 'vitamin D', 915, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 939, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 988, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1078, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1671, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 1981, 'supplement'), ('GO_0007565', 'female pregnancy', 2062, 'pregnancy')]
PMC5706533	11/2017	S89-PMC5706533	['no published trials were conducted in africa, THOUGH one large trial in tanzania (n=2300) is ongoing and projected to be completed and published before 2024\n\ncaption (fig)\n\nfig 3 \xa0effective equivalent daily Vitamin D dose (iu/day) versus maternal baseline mean 25-Hydroxyvitamin D (25(Oh)D) concentration (nmol/l) in published Prenatal Vitamin D supplementation trials with regular dosing regimens (29 trials; 36 comparisons).']	[('ANOMALY_CURIOUS_FINDING', 46)]	1	[('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 261, '25-hydroxyvitamin D'), ('CHEBI_30778', 'gallic acid', 282, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 288, 'D'), ('GO_0007565', 'female pregnancy', 327, 'prenatal'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC5706533	11/2017	S118-PMC5706533	['there was NO APPARENT effect of Vitamin D on Gestational age at Birth (table 3; table s18 and figs s37-s38 in appendix 10) or the risk of Preterm Birth (table 2; table s19 and figs s39-s41 in appendix 10).']	[('ANOMALY_CURIOUS_FINDING', 10)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 45, 'gestational'), ('GO_0007567', 'parturition', 64, 'birth'), ('GO_0007565', 'female pregnancy', 138, 'preterm birth')]
PMC5732505	12/2017	S118-PMC5732505	['HOWEVER, more gdm mothers were Vitamin D deficient at the Delivery compared with non-gdm mothers [7.4% (6/81) vs 2.8% (18/642) ( p \u2009=\u20090.042)].']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 58, 'delivery')]
PMC5784894	1/2018	S123-PMC5784894	['higher strains were calculated in the offspring of deplete Mice BUT the strain distribution was similar at both ages and loading configuration.fig 6shows the volume distribution of maximum principal strain within the whole bone by comparing Antenatally Vitamin D replete or deplete, and loaded with non-loaded, bones.']	[('ANOMALY_CURIOUS_FINDING', 64)]	1	[('NCBITaxon_10088', 'Mus <genus>', 59, 'mice'), ('GO_0007288', 'sperm axoneme assembly', 241, 'antenatally'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC5784894	1/2018	S127-PMC5784894	['in all groups the non-loaded bone is less stiff, EVEN more so in offspring of the replete dams.10.1371/journal.pone.0190675.g005\n\ncaption (fig): fig 5\nfalse colour images for whole bone demonstrating the maximum and minimum principal strain at 10 and 18 weeks in previously in vivo loaded and non-loaded conditions under an identical load of 0.83n (n = 1 Mouse per group).10.1371/journal.pone.0190675.g006\n\ncaption (fig): fig 6\nEarly Life Vitamin D replete or deficient comparison of percentage of volume distribution of maximum principal strain distribution at 10 and 18 weeks for loaded and nonloaded Bones (n = 1 Mouse per group).']	[('ANOMALY_CURIOUS_FINDING', 49)]	1	[('NCBITaxon_10088', 'Mus <genus>', 355, 'mouse'), ('UBERON_0001847', 'lobule of pinna', 428, 'Early life'), ('CHEBI_27300', 'vitamin D', 439, 'vitamin D'), ('UBERON_0001474', 'bone element', 603, 'bones'), ('NCBITaxon_10088', 'Mus <genus>', 616, 'mouse')]
PMC5827025	2/2018	S6-PMC5827025	['INTERESTINGLY, 8.23% Delivered Preterm infants among subjects with vdd (adjusted rr: 4.02; 95% ci: 2.33, 6.92) and 3.81% among subjects with Gestational Vitamin D insufficiency (vdi) (adjusted rr: 2.07; 95% ci: 1.16, 3.71).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0007567', 'parturition', 21, 'delivered'), ('GO_0007565', 'female pregnancy', 31, 'preterm'), ('GO_0007565', 'female pregnancy', 141, 'gestational'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC5838372	3/2018	S10-PMC5838372	['ONLY 14.4% of Pregnant women took 1000-1200 iu/day of Vitamin D. when the mother groups were evaluated in terms of risk factors, there were significant differences in daily vitamin intake and clothing style (p<0.001 and p<0.001 respectively).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0007565', 'female pregnancy', 14, 'pregnant'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5838372	3/2018	S97-PMC5838372	['in a study conducted in ankara in 2010, Vitamin D deficiency (≤20 ng/ml) in Pregnant women and their infants were FOUND TO BE 62.6% and 58.6%, respectively (33).']	[('ANOMALY_CURIOUS_FINDING', 114)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnant')]
PMC5838372	3/2018	S111-PMC5838372	['we found no differences in terms of number of parity and sunlight exposure, BUT Vitamin D levels of mothers who had covered clothing had significantly lower Blood levels than the uncovered women.']	[('ANOMALY_CURIOUS_FINDING', 76)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0000178', 'blood', 157, 'blood')]
PMC5941617	5/2018	S97-PMC5941617	['most Foods contain little amounts of Vitamin D, with the EXCEPTION of some fatty fish (table\xa01), rarely Eaten by children [9,87].']	[('ANOMALY_CURIOUS_FINDING', 57)]	1	[('CHEBI_33290', 'food', 5, 'foods'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0036268', 'swimming', 104, 'eaten')]
PMC5941617	5/2018	S461-PMC5941617	['ON THE CONTRARY, maternal Vitamin D supplementation, maternal and neonatal Vitamin D status were not related to the risk of childhood cd [415,416].']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5952272	5/2018	S92-PMC5952272	['the status of Vitamin E was better in Lactating women from the gaza strip, ALTHOUGH not significant.']	[('ANOMALY_CURIOUS_FINDING', 75)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin E'), ('GO_0007594', 'puparial adhesion', 38, 'lactating')]
PMC5956785	5/2018	S81-PMC5956785	['2008 37°n [54]children with arthritis n \u2009=\u2009183–1582.1\u2009±\u200938.7supplemental Vitamin D improved status, BUT supplemental Vitamin D or calcium did not improve bone mass.kansas, usa warady et al.']	[('ANOMALY_CURIOUS_FINDING', 100)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC6011374	6/2018	S19-PMC6011374	['the incidence of Vitamin D deficiency (˂50\xa0nmol/l) is frequent among Pregnant women EVEN in areas such as australia and the north island of new zealand where sunlight exposure is high.']	[('ANOMALY_CURIOUS_FINDING', 84)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant')]
PMC6011374	6/2018	S77-PMC6011374	['HOWEVER, when each Pregnancy complication was analysed separately, a 53% decreased risk for gdm was observed with high Vitamin D status when compared to moderate-high status (arr: 0.47; 95% ci: 0.23, 0.96).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC6011374	6/2018	S84-PMC6011374	['ALTHOUGH, a 56% decreased risk for gdm was observed in those with low-moderate levels of standardised Vitamin D when compared to moderate-high levels for women carrying a female fetus (arr: 0.44; 95% ci: 0.20, 0.97).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
